Loading…
Please wait while we prepare your analysis
| Icon | Meaning |
|---|---|
| ✅ | Strong Buy - Excellent fundamentals and deeply undervalued |
| 👍 | Buy - Slightly undervalued with good growth potential |
| ⚠️ | See Analysis - Fairly valued, further research recommended |
| ⛔ | Highly Overvalued - Trading significantly above fair value |
| ❌ | Avoid - Flagged in database as not recommended regardless of valuation |
| — | Data Missing - No reliable fair value or price data available |
|
📈 Click on any stock symbol to view full analysis and detailed recommendation. |
|
| Symbol | Fair Value | Price | Upside | Action |
|---|---|---|---|---|
| A | $110.39 | $129.58 | Above Fair Value | ⛔ Overvalued |
| AA | $62.01 | $59.16 | 4.82% | 👍 Buy |
| AAL | $18.65 | $15.24 | Avoid | ❌ Avoid |
| AAMI | $47.04 | $50.98 | Above Fair Value | ⚠️ See Analysis |
| AAOI | $12.09 | $44.30 | Insufficient EBITDA | ❌ Avoid |
| AAON | $26.14 | $96.43 | Above Fair Value | ⛔ Overvalued |
| AAP | $31.85 | $55.30 | Insufficient EBITDA | ❌ Avoid |
| AAPL | $225.82 | $278.12 | Above Fair Value | ⛔ Overvalued |
| AAT | $6.74 | $18.94 | Above Fair Value | ⛔ Overvalued |
| AB | $56.98 | $39.43 | 44.51% | ✅ Strong Buy |
| ABBV | $146.46 | $223.43 | Avoid | ❌ Avoid |
| ABCB | $83.00 | $85.94 | Above Fair Value | ⚠️ See Analysis |
| ABEO | $18.08 | $5.13 | Insufficient EBITDA | ✅ Strong Buy |
| ABEV | $3.40 | $2.94 | 15.65% | 👍 Buy |
| ABG | $354.03 | $225.21 | Avoid | ❌ Avoid |
| ABL | $17.82 | $8.47 | 110.39% | ✅ Strong Buy |
| ABM | $50.00 | $47.56 | Avoid | ❌ Avoid |
| ABNB | $89.90 | $122.18 | Above Fair Value | ⛔ Overvalued |
| ABR | $11.35 | $7.80 | Avoid | ❌ Avoid |
| ABT | $91.56 | $110.83 | Above Fair Value | ⛔ Overvalued |
| ACA | $61.95 | $124.74 | Above Fair Value | ⛔ Overvalued |
| ACAD | $14.21 | $23.56 | Above Fair Value | ⛔ Overvalued |
| ACB | $1.52 | $3.48 | Above Fair Value | ⛔ Overvalued |
| ACCO | $11.13 | $4.06 | Avoid | ❌ Avoid |
| ACEL | $12.45 | $11.28 | 10.37% | 👍 Buy |
| ACGL | $122.85 | $100.95 | 21.69% | ✅ Strong Buy |
| ACHC | $22.23 | $13.37 | Avoid | ❌ Avoid |
| ACI | $30.69 | $18.09 | 69.65% | ✅ Strong Buy |
| ACIC | $25.95 | $11.31 | 129.44% | ✅ Strong Buy |
| ACIW | $62.57 | $42.28 | 47.99% | ✅ Strong Buy |
| ACLS | $67.79 | $86.08 | Above Fair Value | ⛔ Overvalued |
| ACM | $75.77 | $101.03 | Above Fair Value | ⛔ Overvalued |
| ACMR | $38.42 | $62.48 | Above Fair Value | ⛔ Overvalued |
| ACN | $289.27 | $240.62 | 20.22% | ✅ Strong Buy |
| ACNB | $75.21 | $52.77 | 42.54% | ✅ Strong Buy |
| ACRE | $1.08 | $5.20 | Above Fair Value | ⛔ Overvalued |
| ACT | $32.38 | $43.17 | Above Fair Value | ⛔ Overvalued |
| ACTG | $0.62 | $4.20 | Above Fair Value | ⛔ Overvalued |
| ACU | $27.52 | $44.61 | Above Fair Value | ⛔ Overvalued |
| ACVA | $4.31 | $7.37 | Insufficient EBITDA | ❌ Avoid |
| ADBE | $632.25 | $268.38 | 135.58% | ✅ Strong Buy |
| ADC | $29.43 | $74.74 | Above Fair Value | ⛔ Overvalued |
| ADEA | $18.89 | $18.10 | 4.36% | 👍 Buy |
| ADI | $223.32 | $320.45 | Above Fair Value | ⛔ Overvalued |
| ADM | $46.76 | $66.33 | Above Fair Value | ⛔ Overvalued |
| ADMA | $20.76 | $16.43 | 26.35% | ✅ Strong Buy |
| ADNT | $37.54 | $26.46 | 41.87% | ✅ Strong Buy |
| ADP | $237.27 | $231.36 | 2.55% | 👍 Buy |
| ADSK | $260.94 | $240.40 | 8.54% | 👍 Buy |
| ADT | $15.27 | $8.07 | 89.22% | ✅ Strong Buy |
| ADTN | $4.57 | $9.86 | Insufficient EBITDA | ⛔ Overvalued |
| ADUS | $91.11 | $105.88 | Above Fair Value | ⛔ Overvalued |
| ADV | $3.87 | $0.76 | Insufficient EBITDA | ❌ Avoid |
| AEBI | $13.10 | $15.61 | Avoid | ❌ Avoid |
| AEE | $69.79 | $105.09 | Avoid | ❌ Avoid |
| AEHR | $1.43 | $26.39 | Insufficient EBITDA | ❌ Avoid |
| AEIS | $98.85 | $273.26 | Above Fair Value | ⛔ Overvalued |
| AEM | $136.73 | $196.60 | Above Fair Value | ⛔ Overvalued |
| AEO | $20.47 | $23.76 | Above Fair Value | ⛔ Overvalued |
| AEP | $83.60 | $120.80 | Avoid | ❌ Avoid |
| AER | $191.32 | $140.07 | Avoid | ❌ Avoid |
| AFCG | $1.89 | $2.17 | Above Fair Value | ⚠️ See Analysis |
| AFG | $161.22 | $131.04 | 23.03% | ✅ Strong Buy |
| AFL | $126.38 | $117.15 | 7.88% | 👍 Buy |
| AFRM | $50.31 | $57.03 | Avoid | ❌ Avoid |
| AG | $8.57 | $21.99 | Above Fair Value | ⛔ Overvalued |
| AGCO | $69.39 | $132.57 | Avoid | ❌ Avoid |
| AGEN | $29.20 | $2.94 | Insufficient EBITDA | ✅ Strong Buy |
| AGI | $26.79 | $40.17 | Above Fair Value | ⛔ Overvalued |
| AGM | $202.53 | $171.82 | 17.87% | ✅ Strong Buy |
| AGNC | $10.51 | $11.44 | Above Fair Value | ⚠️ See Analysis |
| AGO | $92.90 | $87.75 | 5.87% | 👍 Buy |
| AGRO | $10.25 | $8.57 | 19.60% | ✅ Strong Buy |
| AGX | $122.17 | $352.09 | Above Fair Value | ⛔ Overvalued |
| AGYS | $41.52 | $86.01 | Above Fair Value | ⛔ Overvalued |
| AHCO | $15.10 | $10.65 | 41.78% | ✅ Strong Buy |
| AHH | $2.44 | $7.18 | Above Fair Value | ⛔ Overvalued |
| AHR | $8.31 | $48.77 | Above Fair Value | ⛔ Overvalued |
| AIG | $97.63 | $76.72 | 27.25% | ✅ Strong Buy |
| AIN | $35.61 | $58.78 | Avoid | ❌ Avoid |
| AIOT | $3.43 | $4.84 | Avoid | ❌ Avoid |
| AIR | $64.53 | $113.09 | Above Fair Value | ⛔ Overvalued |
| AIT | $159.65 | $291.74 | Above Fair Value | ⛔ Overvalued |
| AIZ | $259.21 | $243.31 | 6.53% | 👍 Buy |
| AJG | $181.44 | $241.58 | Above Fair Value | ⛔ Overvalued |
| AKAM | $144.77 | $95.08 | 52.26% | ✅ Strong Buy |
| AKAN | $2,333.05 | $0.96 | Insufficient EBITDA | ❌ Avoid |
| AKBA | $2.02 | $1.39 | Insufficient EBITDA | ✅ Strong Buy |
| AKR | $4.00 | $20.98 | Above Fair Value | ⛔ Overvalued |
| AL | $88.27 | $64.55 | Avoid | ❌ Avoid |
| ALAB | $50.08 | $169.85 | Insufficient EBITDA | ⛔ Overvalued |
| ALB | $16.76 | $163.37 | Insufficient EBITDA | ⛔ Overvalued |
| ALC | $40.66 | $78.83 | Above Fair Value | ⛔ Overvalued |
| ALCO | $11.23 | $40.94 | Insufficient EBITDA | ❌ Avoid |
| ALDX | $5.83 | $5.53 | Insufficient EBITDA | ❌ Avoid |
| ALE | $54.12 | $67.90 | Avoid | ❌ Avoid |
| ALEX | $12.91 | $20.76 | Above Fair Value | ⛔ Overvalued |
| ALG | $147.07 | $208.38 | Above Fair Value | ⛔ Overvalued |
| ALGM | $11.32 | $41.57 | Above Fair Value | ⛔ Overvalued |
| ALGN | $194.74 | $187.60 | 3.81% | 👍 Buy |
| ALGT | $66.69 | $114.79 | Avoid | ❌ Avoid |
| ALHC | $5.21 | $21.75 | Insufficient EBITDA | ⛔ Overvalued |
| ALIT | $10.69 | $1.60 | Avoid | ❌ Avoid |
| ALK | $83.39 | $59.45 | Avoid | ❌ Avoid |
| ALKS | $29.74 | $34.91 | Above Fair Value | ⛔ Overvalued |
| ALKT | $14.45 | $17.43 | Insufficient EBITDA | ❌ Avoid |
| ALL | $360.54 | $207.55 | 73.71% | ✅ Strong Buy |
| ALLE | $168.35 | $179.77 | Above Fair Value | ⚠️ See Analysis |
| ALLY | $57.24 | $42.31 | 35.29% | ✅ Strong Buy |
| ALNT | $31.20 | $65.74 | Above Fair Value | ⛔ Overvalued |
| ALNY | $182.27 | $328.16 | Insufficient EBITDA | ⛔ Overvalued |
| ALRM | $53.53 | $48.22 | 11.01% | 👍 Buy |
| ALRS | $35.36 | $25.72 | 37.48% | ✅ Strong Buy |
| ALSN | $119.03 | $115.63 | 2.94% | 👍 Buy |
| ALTG | $8.93 | $7.35 | Avoid | ❌ Avoid |
| ALV | $137.84 | $125.79 | 9.58% | 👍 Buy |
| ALVO | $4.06 | $5.12 | Insufficient EBITDA | ❌ Avoid |
| ALX | $112.20 | $255.07 | Above Fair Value | ⛔ Overvalued |
| AM | $21.22 | $19.18 | 10.64% | 👍 Buy |
| AMAL | $58.44 | $41.25 | 41.67% | ✅ Strong Buy |
| AMAT | $222.45 | $322.51 | Above Fair Value | ⛔ Overvalued |
| AMBA | $11.39 | $63.64 | Insufficient EBITDA | ❌ Avoid |
| AMBP | $3.02 | $4.79 | Avoid | ❌ Avoid |
| AMCR | $12.22 | $48.17 | Avoid | ❌ Avoid |
| AMCX | $30.49 | $7.63 | 299.61% | ✅ Strong Buy |
| AMD | $93.04 | $208.44 | Above Fair Value | ⛔ Overvalued |
| AME | $128.44 | $231.91 | Above Fair Value | ⛔ Overvalued |
| AMG | $349.42 | $305.50 | 14.38% | 👍 Buy |
| AMGN | $243.51 | $384.32 | Above Fair Value | ⛔ Overvalued |
| AMH | $12.37 | $30.84 | Above Fair Value | ⛔ Overvalued |
| AMKR | $20.26 | $49.36 | Above Fair Value | ⛔ Overvalued |
| AMN | $13.79 | $20.30 | Avoid | ❌ Avoid |
| AMP | $685.29 | $542.99 | 26.21% | ✅ Strong Buy |
| AMPH | $48.15 | $29.26 | 64.56% | ✅ Strong Buy |
| AMPL | $1.86 | $7.23 | Insufficient EBITDA | ❌ Avoid |
| AMR | $291.47 | $206.32 | 41.27% | ✅ Strong Buy |
| AMRC | $17.12 | $30.92 | Avoid | ❌ Avoid |
| AMRX | $11.78 | $14.52 | Avoid | ❌ Avoid |
| AMSC | $18.78 | $28.17 | Above Fair Value | ⛔ Overvalued |
| AMSF | $37.22 | $39.19 | Above Fair Value | ⚠️ See Analysis |
| AMT | $136.92 | $171.27 | Avoid | ❌ Avoid |
| AMTM | $42.33 | $37.53 | Avoid | ❌ Avoid |
| AMWD | $30.43 | $67.54 | Above Fair Value | ⛔ Overvalued |
| AMX | $28.05 | $21.50 | 30.47% | ✅ Strong Buy |
| AMZN | $145.95 | $210.32 | Above Fair Value | ⛔ Overvalued |
| AN | $263.23 | $216.65 | Avoid | ❌ Avoid |
| ANDE | $43.83 | $66.86 | Above Fair Value | ⛔ Overvalued |
| ANET | $67.53 | $137.49 | Above Fair Value | ⛔ Overvalued |
| ANF | $140.09 | $97.66 | 43.45% | ✅ Strong Buy |
| ANGI | $23.09 | $11.85 | 94.85% | ✅ Strong Buy |
| ANIK | $3.57 | $10.46 | Above Fair Value | ⛔ Overvalued |
| ANIP | $128.83 | $81.84 | 57.42% | ✅ Strong Buy |
| AOMR | $15.64 | $8.93 | 75.14% | ✅ Strong Buy |
| AON | $309.18 | $342.04 | Above Fair Value | ⚠️ See Analysis |
| AORT | $9.82 | $39.59 | Above Fair Value | ⛔ Overvalued |
| AOS | $60.62 | $78.98 | Above Fair Value | ⛔ Overvalued |
| AOSL | $3.67 | $21.36 | Above Fair Value | ⛔ Overvalued |
| APA | $33.09 | $27.46 | 20.50% | ✅ Strong Buy |
| APAM | $34.48 | $45.12 | Above Fair Value | ⛔ Overvalued |
| APD | $181.64 | $283.12 | Avoid | ❌ Avoid |
| APEI | $34.26 | $44.89 | Above Fair Value | ⛔ Overvalued |
| APG | $18.47 | $44.45 | Above Fair Value | ⛔ Overvalued |
| APH | $68.71 | $136.23 | Above Fair Value | ⛔ Overvalued |
| APLE | $11.91 | $12.16 | Above Fair Value | ⚠️ See Analysis |
| APLS | $5.47 | $23.49 | Insufficient EBITDA | ⛔ Overvalued |
| APO | $122.49 | $133.03 | Above Fair Value | ⚠️ See Analysis |
| APOG | $44.27 | $41.79 | 5.93% | 👍 Buy |
| APP | $291.95 | $406.72 | Above Fair Value | ⛔ Overvalued |
| APPF | $120.49 | $179.73 | Above Fair Value | ⛔ Overvalued |
| APPN | $13.58 | $25.21 | Insufficient EBITDA | ❌ Avoid |
| APPS | $5.81 | $4.15 | Avoid | ❌ Avoid |
| APTV | $108.16 | $82.38 | 31.29% | ✅ Strong Buy |
| AQN | $4.43 | $6.49 | Avoid | ❌ Avoid |
| AR | $40.42 | $34.37 | 17.60% | 👍 Buy |
| ARCB | $50.91 | $111.96 | Above Fair Value | ⛔ Overvalued |
| ARCC | $25.95 | $19.31 | 34.39% | ✅ Strong Buy |
| ARCO | $9.90 | $8.55 | 15.79% | 👍 Buy |
| ARDX | $4.36 | $7.32 | Insufficient EBITDA | ❌ Avoid |
| ARE | $1.42 | $55.90 | Above Fair Value | ⛔ Overvalued |
| ARES | $89.90 | $130.46 | Above Fair Value | ⛔ Overvalued |
| ARGX | $506.70 | $811.45 | Above Fair Value | ⛔ Overvalued |
| ARHS | $7.53 | $11.10 | Above Fair Value | ⛔ Overvalued |
| ARI | $11.53 | $10.80 | Insufficient EBITDA | ❌ Avoid |
| ARKO | $1.81 | $6.64 | Above Fair Value | ⛔ Overvalued |
| ARLO | $13.75 | $12.40 | Insufficient EBITDA | 👍 Buy |
| ARLP | $24.83 | $24.37 | 1.89% | 👍 Buy |
| ARM | $38.76 | $123.70 | Above Fair Value | ⛔ Overvalued |
| ARMK | $33.07 | $38.73 | Avoid | ❌ Avoid |
| AROC | $25.19 | $32.05 | Above Fair Value | ⛔ Overvalued |
| AROW | $47.81 | $36.05 | 32.62% | ✅ Strong Buy |
| ARQT | $6.37 | $27.32 | Insufficient EBITDA | ❌ Avoid |
| ARR | $44.53 | $17.69 | 151.72% | ✅ Strong Buy |
| ARRY | $12.28 | $11.86 | Insufficient EBITDA | ❌ Avoid |
| ARTNA | $30.65 | $32.31 | Above Fair Value | ⚠️ See Analysis |
| ARW | $155.52 | $158.60 | Above Fair Value | ⚠️ See Analysis |
| AS | $18.75 | $37.51 | Above Fair Value | ⛔ Overvalued |
| ASAN | $6.27 | $8.76 | Insufficient EBITDA | ❌ Avoid |
| ASB | $45.93 | $29.37 | 56.38% | ✅ Strong Buy |
| ASC | $11.50 | $13.14 | Above Fair Value | ⚠️ See Analysis |
| ASGN | $78.16 | $52.50 | 48.88% | ✅ Strong Buy |
| ASH | $48.36 | $64.16 | Insufficient EBITDA | ❌ Avoid |
| ASIX | $35.48 | $18.50 | 91.78% | ✅ Strong Buy |
| ASLE | $10.78 | $7.45 | Avoid | ❌ Avoid |
| ASM | $8.04 | $10.15 | Above Fair Value | ⛔ Overvalued |
| ASML | $558.15 | $1,413.01 | Above Fair Value | ⛔ Overvalued |
| ASND | $94.80 | $222.15 | Insufficient EBITDA | ❌ Avoid |
| ASO | $52.46 | $59.13 | Above Fair Value | ⚠️ See Analysis |
| ASR | $289.94 | $367.92 | Above Fair Value | ⛔ Overvalued |
| ASRT | $19.64 | $12.74 | 54.16% | ✅ Strong Buy |
| ASRV | $3.54 | $3.82 | Above Fair Value | ⚠️ See Analysis |
| ASTE | $40.09 | $57.43 | Above Fair Value | ⛔ Overvalued |
| ASTH | $36.82 | $21.10 | Avoid | ❌ Avoid |
| ASUR | $17.00 | $8.91 | Insufficient EBITDA | ❌ Avoid |
| ASX | $11.37 | $20.89 | Above Fair Value | ⛔ Overvalued |
| ATEC | $1.91 | $13.82 | Insufficient EBITDA | ❌ Avoid |
| ATEN | $17.14 | $19.67 | Above Fair Value | ⚠️ See Analysis |
| ATEX | $78.58 | $28.39 | Insufficient EBITDA | ✅ Strong Buy |
| ATGE | $119.10 | $104.48 | 13.99% | 👍 Buy |
| ATI | $52.63 | $133.57 | Above Fair Value | ⛔ Overvalued |
| ATKR | $94.20 | $67.72 | 39.10% | ✅ Strong Buy |
| ATLO | $20.02 | $27.95 | Above Fair Value | ⛔ Overvalued |
| ATMU | $49.52 | $61.46 | Above Fair Value | ⛔ Overvalued |
| ATNI | $5.38 | $25.78 | Above Fair Value | ⛔ Overvalued |
| ATO | $117.25 | $171.38 | Avoid | ❌ Avoid |
| ATR | $84.41 | $134.31 | Above Fair Value | ⛔ Overvalued |
| ATRA | $11.48 | $4.88 | Insufficient EBITDA | ✅ Strong Buy |
| ATRO | $27.49 | $76.58 | Avoid | ❌ Avoid |
| AU | $109.22 | $103.95 | 5.07% | 👍 Buy |
| AUB | $57.28 | $41.78 | 37.10% | ✅ Strong Buy |
| AUBN | $29.84 | $24.63 | 21.15% | ✅ Strong Buy |
| AUDC | $7.97 | $7.64 | 4.32% | 👍 Buy |
| AUPH | $21.08 | $14.44 | 45.98% | ✅ Strong Buy |
| AVA | $35.51 | $41.50 | Avoid | ❌ Avoid |
| AVAL | $5.63 | $4.58 | 22.93% | ✅ Strong Buy |
| AVAV | $59.84 | $257.20 | Above Fair Value | ⛔ Overvalued |
| AVB | $95.54 | $173.83 | Above Fair Value | ⛔ Overvalued |
| AVD | $5.05 | $4.99 | Insufficient EBITDA | ❌ Avoid |
| AVDL | $7.86 | $21.69 | Insufficient EBITDA | ⛔ Overvalued |
| AVGO | $222.89 | $332.92 | Above Fair Value | ⛔ Overvalued |
| AVNT | $35.62 | $38.76 | Avoid | ❌ Avoid |
| AVNW | $40.38 | $26.36 | 53.19% | ✅ Strong Buy |
| AVO | $10.20 | $14.03 | Above Fair Value | ⛔ Overvalued |
| AVPT | $7.13 | $10.57 | Above Fair Value | ⛔ Overvalued |
| AVT | $70.32 | $66.62 | Avoid | ❌ Avoid |
| AVTR | $12.94 | $11.26 | Avoid | ❌ Avoid |
| AVXL | $20.24 | $4.10 | Insufficient EBITDA | ❌ Avoid |
| AVY | $150.58 | $191.51 | Above Fair Value | ⛔ Overvalued |
| AWI | $129.06 | $198.25 | Above Fair Value | ⛔ Overvalued |
| AWK | $86.67 | $124.33 | Avoid | ❌ Avoid |
| AWR | $52.66 | $70.47 | Above Fair Value | ⛔ Overvalued |
| AWX | $0.53 | $2.66 | Avoid | ❌ Avoid |
| AX | $133.96 | $101.01 | 32.62% | ✅ Strong Buy |
| AXGN | $5.93 | $34.93 | Above Fair Value | ⛔ Overvalued |
| AXL | $7.82 | $9.00 | Above Fair Value | ⛔ Overvalued |
| AXON | $118.37 | $414.20 | Above Fair Value | ⛔ Overvalued |
| AXP | $362.24 | $359.15 | 0.86% | 👍 Buy |
| AXS | $168.16 | $106.53 | 57.85% | ✅ Strong Buy |
| AXSM | $4.80 | $182.55 | Insufficient EBITDA | ❌ Avoid |
| AXTA | $36.03 | $33.81 | 6.57% | 👍 Buy |
| AYI | $360.49 | $328.39 | 9.77% | 👍 Buy |
| AZN | $80.02 | $193.03 | Above Fair Value | ⛔ Overvalued |
| AZO | $3,121.29 | $3,681.26 | Above Fair Value | ⛔ Overvalued |
| AZTA | $12.56 | $28.72 | Insufficient EBITDA | ⛔ Overvalued |
| AZZ | $95.71 | $130.00 | Above Fair Value | ⛔ Overvalued |
| BA | $69.71 | $243.03 | Above Fair Value | ⛔ Overvalued |
| BAC | $59.85 | $56.53 | 5.87% | 👍 Buy |
| BAH | $109.34 | $89.01 | 22.84% | ✅ Strong Buy |
| BALL | $59.53 | $66.47 | Avoid | ❌ Avoid |
| BAM | $34.74 | $49.61 | Above Fair Value | ⛔ Overvalued |
| BANC | $26.74 | $20.85 | 28.25% | ✅ Strong Buy |
| BAND | $31.47 | $13.43 | Avoid | ❌ Avoid |
| BANF | $109.27 | $119.04 | Above Fair Value | ⚠️ See Analysis |
| BANR | $89.82 | $64.59 | 39.06% | ✅ Strong Buy |
| BAX | $37.11 | $21.73 | Avoid | ❌ Avoid |
| BB | $2.87 | $3.46 | Above Fair Value | ⛔ Overvalued |
| BBD | $5.78 | $3.98 | 45.23% | ✅ Strong Buy |
| BBDC | $13.37 | $8.92 | 49.89% | ✅ Strong Buy |
| BBDO | $4.54 | $3.53 | 28.61% | ✅ Strong Buy |
| BBSI | $33.69 | $37.85 | Above Fair Value | ⚠️ See Analysis |
| BBVA | $29.77 | $24.09 | 23.58% | ✅ Strong Buy |
| BBW | $49.55 | $55.43 | Above Fair Value | ⚠️ See Analysis |
| BBWI | $28.72 | $23.05 | 24.60% | ✅ Strong Buy |
| BBY | $96.89 | $70.41 | 37.61% | ✅ Strong Buy |
| BC | $45.33 | $87.88 | Avoid | ❌ Avoid |
| BCAL | $26.14 | $19.16 | 36.43% | ✅ Strong Buy |
| BCAX | $77.38 | $15.36 | Insufficient EBITDA | ❌ Avoid |
| BCBP | $7.80 | $8.28 | Above Fair Value | ⚠️ See Analysis |
| BCC | $51.61 | $91.03 | Above Fair Value | ⛔ Overvalued |
| BCE | $39.09 | $25.08 | 55.86% | ✅ Strong Buy |
| BCH | $37.02 | $44.44 | Above Fair Value | ⛔ Overvalued |
| BCML | $33.26 | $30.54 | 8.91% | 👍 Buy |
| BCO | $137.49 | $130.91 | 5.03% | 👍 Buy |
| BCPC | $89.37 | $173.16 | Above Fair Value | ⛔ Overvalued |
| BCRX | $12.65 | $6.38 | Avoid | ❌ Avoid |
| BCSF | $22.47 | $13.11 | 71.40% | ✅ Strong Buy |
| BDC | $94.77 | $139.75 | Above Fair Value | ⛔ Overvalued |
| BDX | $242.27 | $210.02 | Avoid | ❌ Avoid |
| BE | $12.41 | $143.03 | Avoid | ❌ Avoid |
| BELFA | $88.82 | $205.83 | Above Fair Value | ⛔ Overvalued |
| BELFB | $87.67 | $220.78 | Above Fair Value | ⛔ Overvalued |
| BEN | $40.02 | $27.20 | 47.13% | ✅ Strong Buy |
| BF-B | $34.28 | $29.45 | 16.40% | 👍 Buy |
| BFAM | $68.02 | $86.08 | Above Fair Value | ⛔ Overvalued |
| BFC | $133.03 | $151.51 | Above Fair Value | ⚠️ See Analysis |
| BFH | $103.00 | $79.53 | 29.51% | ✅ Strong Buy |
| BFIN | $10.62 | $12.00 | Above Fair Value | ⚠️ See Analysis |
| BFS | $14.37 | $34.63 | Above Fair Value | ⛔ Overvalued |
| BG | $114.90 | $115.86 | Avoid | ❌ Avoid |
| BGC | $16.15 | $8.96 | 80.25% | ✅ Strong Buy |
| BGS | $6.11 | $5.14 | Insufficient EBITDA | ❌ Avoid |
| BH | $28.42 | $415.90 | Above Fair Value | ⛔ Overvalued |
| BHB | $49.28 | $35.60 | 38.43% | ✅ Strong Buy |
| BHC | $55.82 | $5.88 | Avoid | ❌ Avoid |
| BHE | $29.86 | $58.30 | Above Fair Value | ⛔ Overvalued |
| BHF | $251.80 | $63.73 | 295.10% | ✅ Strong Buy |
| BHFAP | $178.95 | $16.63 | 976.07% | ✅ Strong Buy |
| BHP | $75.18 | $69.64 | 7.96% | 👍 Buy |
| BHRB | $114.28 | $69.70 | 63.96% | ✅ Strong Buy |
| BIIB | $280.34 | $201.18 | 39.35% | ✅ Strong Buy |
| BILL | $62.07 | $48.94 | Avoid | ❌ Avoid |
| BIO | $151.88 | $301.50 | Insufficient EBITDA | ❌ Avoid |
| BIOA | $205.85 | $20.73 | Insufficient EBITDA | ❌ Avoid |
| BIP | $18.55 | $38.04 | Avoid | ❌ Avoid |
| BIRK | $37.69 | $38.45 | Above Fair Value | ⚠️ See Analysis |
| BJ | $87.71 | $100.40 | Above Fair Value | ⚠️ See Analysis |
| BJRI | $35.76 | $44.03 | Above Fair Value | ⛔ Overvalued |
| BK | $126.32 | $124.32 | 1.61% | 👍 Buy |
| BKE | $32.01 | $52.09 | Above Fair Value | ⛔ Overvalued |
| BKH | $56.84 | $72.30 | Avoid | ❌ Avoid |
| BKNG | $5,533.65 | $4,457.17 | 24.15% | ✅ Strong Buy |
| BKR | $40.01 | $58.92 | Above Fair Value | ⛔ Overvalued |
| BKU | $63.90 | $50.93 | 25.47% | ✅ Strong Buy |
| BL | $46.01 | $43.85 | Avoid | ❌ Avoid |
| BLBD | $55.75 | $59.21 | Above Fair Value | ⚠️ See Analysis |
| BLD | $312.28 | $517.50 | Above Fair Value | ⛔ Overvalued |
| BLDR | $90.85 | $124.42 | Above Fair Value | ⛔ Overvalued |
| BLFS | $1.86 | $22.43 | Avoid | ❌ Avoid |
| BLK | $830.66 | $1,056.38 | Above Fair Value | ⛔ Overvalued |
| BLKB | $89.99 | $47.48 | 89.53% | ✅ Strong Buy |
| BLMN | $14.60 | $7.07 | Avoid | ❌ Avoid |
| BLND | $1.68 | $1.99 | Insufficient EBITDA | ⛔ Overvalued |
| BLX | $42.79 | $48.92 | Above Fair Value | ⚠️ See Analysis |
| BMBL | $26.02 | $3.22 | Insufficient EBITDA | ❌ Avoid |
| BMI | $100.07 | $151.23 | Above Fair Value | ⛔ Overvalued |
| BMO | $218.53 | $141.73 | 54.19% | ✅ Strong Buy |
| BMRC | $39.12 | $27.40 | 42.77% | ✅ Strong Buy |
| BMRN | $72.75 | $58.13 | 25.15% | ✅ Strong Buy |
| BMY | $101.01 | $61.99 | 62.95% | ✅ Strong Buy |
| BN | $4.54 | $45.21 | Avoid | ❌ Avoid |
| BNL | $13.36 | $19.26 | Above Fair Value | ⛔ Overvalued |
| BNS | $131.00 | $76.34 | 71.60% | ✅ Strong Buy |
| BOH | $106.29 | $78.91 | 34.70% | ✅ Strong Buy |
| BOKF | $130.82 | $136.57 | Above Fair Value | ⚠️ See Analysis |
| BOOM | $1.01 | $8.15 | Insufficient EBITDA | ⛔ Overvalued |
| BOOT | $110.98 | $203.38 | Above Fair Value | ⛔ Overvalued |
| BORR | $2.35 | $5.30 | Avoid | ❌ Avoid |
| BOTJ | $23.54 | $20.45 | 15.11% | 👍 Buy |
| BOW | $47.25 | $25.04 | 88.70% | ✅ Strong Buy |
| BOX | $27.87 | $24.67 | 12.97% | 👍 Buy |
| BP | $33.12 | $39.01 | Above Fair Value | ⛔ Overvalued |
| BPOP | $178.61 | $145.97 | 22.36% | ✅ Strong Buy |
| BPRN | $48.06 | $36.42 | 31.96% | ✅ Strong Buy |
| BR | $201.86 | $181.91 | 10.97% | 👍 Buy |
| BRBR | $34.48 | $19.52 | 76.64% | ✅ Strong Buy |
| BRBS | $1.24 | $4.30 | Insufficient EBITDA | ⛔ Overvalued |
| BRC | $70.25 | $92.28 | Above Fair Value | ⛔ Overvalued |
| BRK-A | $484,898.00 | $762,570.00 | Above Fair Value | ⛔ Overvalued |
| BRK-B | $323.26 | $508.09 | Above Fair Value | ⛔ Overvalued |
| BRKR | $32.46 | $41.93 | Avoid | ❌ Avoid |
| BRO | $74.99 | $73.78 | 1.64% | 👍 Buy |
| BROS | $11.11 | $57.04 | Above Fair Value | ⛔ Overvalued |
| BRSP | $10.35 | $5.90 | Insufficient EBITDA | ✅ Strong Buy |
| BRX | $16.26 | $28.32 | Above Fair Value | ⛔ Overvalued |
| BRZE | $11.87 | $17.79 | Insufficient EBITDA | ❌ Avoid |
| BSAC | $33.75 | $36.74 | Above Fair Value | ⚠️ See Analysis |
| BSBR | $10.41 | $6.49 | 60.40% | ✅ Strong Buy |
| BSET | $10.89 | $15.76 | Insufficient EBITDA | ⛔ Overvalued |
| BSM | $10.17 | $15.00 | Above Fair Value | ⛔ Overvalued |
| BSRR | $33.33 | $37.88 | Above Fair Value | ⚠️ See Analysis |
| BSVN | $43.12 | $45.19 | Above Fair Value | ⚠️ See Analysis |
| BSX | $52.40 | $76.27 | Above Fair Value | ⛔ Overvalued |
| BSY | $33.40 | $33.17 | 0.69% | 👍 Buy |
| BTBT | $3.37 | $1.80 | 87.22% | ✅ Strong Buy |
| BTDR | $13.20 | $12.59 | Insufficient EBITDA | ❌ Avoid |
| BTE | $4.33 | $3.53 | 22.66% | ✅ Strong Buy |
| BTG | $8.55 | $5.06 | 68.97% | ✅ Strong Buy |
| BTI | $94.97 | $62.80 | 51.23% | ✅ Strong Buy |
| BTM | $4.55 | $0.83 | 448.19% | ✅ Strong Buy |
| BTMD | $13.67 | $2.23 | 513.00% | ✅ Strong Buy |
| BTSG | $19.10 | $39.68 | Avoid | ❌ Avoid |
| BTU | $22.70 | $36.92 | Above Fair Value | ⛔ Overvalued |
| BUD | $64.65 | $75.81 | Above Fair Value | ⛔ Overvalued |
| BULL | $31.04 | $6.58 | Insufficient EBITDA | ✅ Strong Buy |
| BUR | $19.70 | $8.92 | 120.85% | ✅ Strong Buy |
| BURL | $229.85 | $311.63 | Above Fair Value | ⛔ Overvalued |
| BUSE | $28.31 | $27.27 | 3.81% | 👍 Buy |
| BV | $11.42 | $13.55 | Above Fair Value | ⛔ Overvalued |
| BVN | $37.05 | $36.95 | 0.27% | 👍 Buy |
| BVS | $10.58 | $8.51 | 24.32% | ✅ Strong Buy |
| BWA | $64.19 | $52.23 | 22.90% | ✅ Strong Buy |
| BWB | $31.37 | $19.97 | 57.09% | ✅ Strong Buy |
| BWFG | $69.62 | $50.40 | 38.13% | ✅ Strong Buy |
| BWIN | $37.54 | $19.57 | 91.82% | ✅ Strong Buy |
| BWMN | $25.91 | $35.33 | Above Fair Value | ⛔ Overvalued |
| BWMX | $821.44 | $17.97 | 4,471.17% | ✅ Strong Buy |
| BWXT | $71.47 | $197.19 | Above Fair Value | ⛔ Overvalued |
| BX | $102.21 | $129.69 | Above Fair Value | ⛔ Overvalued |
| BXC | $19.38 | $79.05 | Above Fair Value | ⛔ Overvalued |
| BXMT | $10.34 | $19.61 | Above Fair Value | ⛔ Overvalued |
| BXP | $20.28 | $64.72 | Above Fair Value | ⛔ Overvalued |
| BXSL | $44.88 | $24.89 | 80.31% | ✅ Strong Buy |
| BY | $47.92 | $33.51 | 43.00% | ✅ Strong Buy |
| BYRN | $12.11 | $14.69 | Above Fair Value | ⛔ Overvalued |
| BZH | $23.45 | $25.05 | Avoid | ❌ Avoid |
| C | $138.41 | $122.69 | 12.81% | 👍 Buy |
| CABO | $647.93 | $100.75 | Avoid | ❌ Avoid |
| CAC | $76.42 | $50.13 | 52.44% | ✅ Strong Buy |
| CACC | $540.67 | $508.90 | 6.24% | 👍 Buy |
| CACI | $488.73 | $618.50 | Above Fair Value | ⛔ Overvalued |
| CADE | $56.16 | $42.11 | 33.36% | ✅ Strong Buy |
| CAG | $22.96 | $19.35 | Avoid | ❌ Avoid |
| CAH | $115.22 | $226.32 | Above Fair Value | ⛔ Overvalued |
| CAKE | $58.50 | $63.25 | Above Fair Value | ⚠️ See Analysis |
| CAL | $11.94 | $12.98 | Avoid | ❌ Avoid |
| CALM | $86.74 | $82.53 | 5.10% | 👍 Buy |
| CALX | $30.71 | $53.18 | Insufficient EBITDA | ⛔ Overvalued |
| CAMT | $45.89 | $149.02 | Above Fair Value | ⛔ Overvalued |
| CAPL | $11.84 | $21.96 | Avoid | ❌ Avoid |
| CAPR | $3.48 | $24.72 | Insufficient EBITDA | ❌ Avoid |
| CAR | $164.16 | $120.42 | Avoid | ❌ Avoid |
| CARE | $26.11 | $22.11 | 18.09% | ✅ Strong Buy |
| CARG | $36.36 | $28.61 | 27.09% | ✅ Strong Buy |
| CARR | $45.16 | $63.92 | Above Fair Value | ⛔ Overvalued |
| CARS | $39.91 | $11.14 | 258.26% | ✅ Strong Buy |
| CART | $43.25 | $34.64 | 24.86% | ✅ Strong Buy |
| CASH | $144.23 | $93.72 | 53.89% | ✅ Strong Buy |
| CASS | $54.44 | $46.76 | 16.42% | 👍 Buy |
| CASY | $275.34 | $660.90 | Above Fair Value | ⛔ Overvalued |
| CAT | $307.08 | $726.20 | Above Fair Value | ⛔ Overvalued |
| CATY | $58.17 | $54.10 | 7.52% | 👍 Buy |
| CAVA | $8.61 | $69.96 | Above Fair Value | ⛔ Overvalued |
| CB | $390.81 | $330.97 | 18.08% | ✅ Strong Buy |
| CBAN | $26.47 | $21.07 | 25.63% | ✅ Strong Buy |
| CBFV | $44.44 | $37.26 | 19.27% | ✅ Strong Buy |
| CBL | $16.16 | $36.43 | Above Fair Value | ⛔ Overvalued |
| CBNK | $49.75 | $32.81 | 51.63% | ✅ Strong Buy |
| CBOE | $239.81 | $273.36 | Above Fair Value | ⚠️ See Analysis |
| CBRE | $94.72 | $169.67 | Above Fair Value | ⛔ Overvalued |
| CBRL | $8.68 | $33.81 | Avoid | ❌ Avoid |
| CBSH | $52.48 | $55.17 | Above Fair Value | ⚠️ See Analysis |
| CBT | $86.20 | $74.58 | 15.58% | 👍 Buy |
| CBU | $69.93 | $66.39 | 5.33% | 👍 Buy |
| CBZ | $55.62 | $38.27 | Avoid | ❌ Avoid |
| CC | $18.83 | $18.32 | Avoid | ❌ Avoid |
| CCAP | $23.13 | $14.40 | 60.63% | ✅ Strong Buy |
| CCB | $86.98 | $87.94 | Above Fair Value | ⚠️ See Analysis |
| CCBG | $53.12 | $43.51 | 22.09% | ✅ Strong Buy |
| CCEC | $26.67 | $20.46 | Avoid | ❌ Avoid |
| CCEP | $67.90 | $97.56 | Above Fair Value | ⛔ Overvalued |
| CCI | $50.39 | $80.88 | Insufficient EBITDA | ⛔ Overvalued |
| CCJ | $21.55 | $113.63 | Above Fair Value | ⛔ Overvalued |
| CCK | $108.28 | $112.88 | Above Fair Value | ⚠️ See Analysis |
| CCL | $44.16 | $33.99 | Avoid | ❌ Avoid |
| CCNE | $52.20 | $29.16 | 79.01% | ✅ Strong Buy |
| CCO | $0.63 | $2.17 | Avoid | ❌ Avoid |
| CCRN | $1.34 | $8.69 | Above Fair Value | ⛔ Overvalued |
| CCS | $78.30 | $69.79 | Avoid | ❌ Avoid |
| CCSI | $123.80 | $23.67 | 423.02% | ✅ Strong Buy |
| CCU | $11.71 | $14.48 | Above Fair Value | ⛔ Overvalued |
| CDE | $22.20 | $21.44 | 3.54% | 👍 Buy |
| CDNA | $15.87 | $19.47 | Insufficient EBITDA | ❌ Avoid |
| CDNS | $141.57 | $283.52 | Above Fair Value | ⛔ Overvalued |
| CDP | $21.03 | $32.45 | Above Fair Value | ⛔ Overvalued |
| CDRE | $30.03 | $41.63 | Above Fair Value | ⛔ Overvalued |
| CDW | $166.15 | $142.62 | 16.50% | 👍 Buy |
| CE | $49.47 | $54.88 | Avoid | ❌ Avoid |
| CECO | $16.11 | $72.37 | Above Fair Value | ⛔ Overvalued |
| CEG | $170.09 | $261.42 | Above Fair Value | ⛔ Overvalued |
| CELH | $32.63 | $50.57 | Above Fair Value | ⛔ Overvalued |
| CENT | $36.69 | $37.99 | Above Fair Value | ⚠️ See Analysis |
| CENTA | $36.81 | $34.08 | 8.01% | 👍 Buy |
| CENX | $68.31 | $52.40 | 30.36% | ✅ Strong Buy |
| CERT | $10.66 | $7.23 | 47.44% | ✅ Strong Buy |
| CEVA | $9.71 | $22.54 | Insufficient EBITDA | ❌ Avoid |
| CF | $134.46 | $92.64 | 45.14% | ✅ Strong Buy |
| CFBK | $49.40 | $33.31 | 48.30% | ✅ Strong Buy |
| CFFI | $120.39 | $79.71 | 51.04% | ✅ Strong Buy |
| CFFN | $10.05 | $7.60 | 32.24% | ✅ Strong Buy |
| CFG | $63.46 | $68.12 | Above Fair Value | ⚠️ See Analysis |
| CFLT | $8.84 | $30.57 | Insufficient EBITDA | ❌ Avoid |
| CFR | $156.30 | $146.69 | 6.55% | 👍 Buy |
| CG | $47.95 | $58.71 | Above Fair Value | ⛔ Overvalued |
| CGAU | $15.17 | $17.33 | Above Fair Value | ⚠️ See Analysis |
| CGBD | $19.23 | $11.98 | 60.52% | ✅ Strong Buy |
| CGNX | $22.23 | $42.37 | Above Fair Value | ⛔ Overvalued |
| CHCO | $150.87 | $127.84 | 18.01% | ✅ Strong Buy |
| CHCT | $13.47 | $18.13 | Above Fair Value | ⛔ Overvalued |
| CHD | $65.94 | $100.53 | Above Fair Value | ⛔ Overvalued |
| CHDN | $103.27 | $93.55 | Avoid | ❌ Avoid |
| CHE | $396.68 | $447.74 | Above Fair Value | ⚠️ See Analysis |
| CHEF | $33.27 | $66.67 | Above Fair Value | ⛔ Overvalued |
| CHGG | $0.19 | $0.79 | Insufficient EBITDA | ⛔ Overvalued |
| CHH | $142.48 | $109.28 | 30.38% | ✅ Strong Buy |
| CHKP | $192.49 | $180.91 | 6.40% | 👍 Buy |
| CHMG | $93.26 | $64.40 | 44.81% | ✅ Strong Buy |
| CHRD | $104.89 | $102.89 | 1.94% | 👍 Buy |
| CHRS | $7.88 | $2.14 | Avoid | ❌ Avoid |
| CHRW | $96.09 | $200.59 | Above Fair Value | ⛔ Overvalued |
| CHT | $26.51 | $41.57 | Avoid | ❌ Avoid |
| CHTR | $536.38 | $231.14 | Avoid | ❌ Avoid |
| CHWY | $25.74 | $28.02 | Above Fair Value | ⚠️ See Analysis |
| CI | $422.83 | $292.05 | 44.78% | ✅ Strong Buy |
| CIA | $3.87 | $5.98 | Above Fair Value | ⛔ Overvalued |
| CIEN | $99.66 | $271.32 | Above Fair Value | ⛔ Overvalued |
| CIFR | $6.20 | $14.73 | Above Fair Value | ⛔ Overvalued |
| CIG | $2.52 | $2.14 | 17.76% | ✅ Strong Buy |
| CIGI | $89.30 | $139.72 | Above Fair Value | ⛔ Overvalued |
| CIM | $21.79 | $12.38 | 76.01% | ✅ Strong Buy |
| CINF | $123.95 | $172.65 | Above Fair Value | ⛔ Overvalued |
| CION | $18.98 | $8.83 | 114.95% | ✅ Strong Buy |
| CIVB | $36.77 | $24.83 | 48.09% | ✅ Strong Buy |
| CIVI | $53.24 | $27.38 | 94.45% | ✅ Strong Buy |
| CIX | $21.70 | $23.81 | Above Fair Value | ⚠️ See Analysis |
| CKX | $3.88 | $11.00 | Above Fair Value | ⛔ Overvalued |
| CL | $70.31 | $94.41 | Above Fair Value | ⛔ Overvalued |
| CLAR | $2.05 | $3.62 | Insufficient EBITDA | ❌ Avoid |
| CLB | $16.76 | $18.56 | Above Fair Value | ⚠️ See Analysis |
| CLBK | $9.82 | $18.52 | Insufficient EBITDA | ⛔ Overvalued |
| CLBT | $11.05 | $14.17 | Above Fair Value | ⛔ Overvalued |
| CLDT | $0.15 | $7.57 | Above Fair Value | ⛔ Overvalued |
| CLF | $3.11 | $14.73 | Avoid | ❌ Avoid |
| CLFD | $17.55 | $30.91 | Avoid | ❌ Avoid |
| CLH | $122.75 | $265.98 | Above Fair Value | ⛔ Overvalued |
| CLMB | $80.69 | $122.65 | Above Fair Value | ⛔ Overvalued |
| CLMT | $0.40 | $25.19 | Avoid | ❌ Avoid |
| CLOV | $0.81 | $2.13 | Insufficient EBITDA | ❌ Avoid |
| CLS | $78.49 | $307.53 | Above Fair Value | ⛔ Overvalued |
| CLSK | $6.32 | $10.08 | Above Fair Value | ⛔ Overvalued |
| CLST | $9.02 | $15.82 | Insufficient EBITDA | ⛔ Overvalued |
| CLVT | $10.98 | $2.16 | Avoid | ❌ Avoid |
| CLX | $111.68 | $119.36 | Above Fair Value | ⚠️ See Analysis |
| CM | $157.14 | $96.68 | 62.54% | ✅ Strong Buy |
| CMA | $78.10 | $88.67 | Above Fair Value | ⚠️ See Analysis |
| CMBM | $0.73 | $1.41 | Insufficient EBITDA | ❌ Avoid |
| CMBT | $6.80 | $12.47 | Avoid | ❌ Avoid |
| CMC | $91.05 | $82.99 | 9.71% | 👍 Buy |
| CMCL | $50.09 | $28.46 | 76.00% | ✅ Strong Buy |
| CMCO | $31.17 | $22.76 | Avoid | ❌ Avoid |
| CMCSA | $55.51 | $31.37 | 76.95% | ✅ Strong Buy |
| CME | $215.09 | $302.27 | Above Fair Value | ⛔ Overvalued |
| CMG | $24.07 | $39.39 | Above Fair Value | ⛔ Overvalued |
| CMI | $358.67 | $577.73 | Above Fair Value | ⛔ Overvalued |
| CMP | $12.22 | $21.75 | Avoid | ❌ Avoid |
| CMPO | $19.34 | $24.46 | Insufficient EBITDA | ❌ Avoid |
| CMPR | $61.82 | $75.64 | Avoid | ❌ Avoid |
| CMRE | $37.94 | $15.92 | 138.32% | ✅ Strong Buy |
| CMS | $52.73 | $72.84 | Avoid | ❌ Avoid |
| CMT | $17.35 | $20.45 | Above Fair Value | ⛔ Overvalued |
| CNA | $73.14 | $49.83 | 46.78% | ✅ Strong Buy |
| CNC | $46.74 | $38.46 | Insufficient EBITDA | ❌ Avoid |
| CNH | $6.74 | $12.36 | Avoid | ❌ Avoid |
| CNI | $130.51 | $101.43 | 28.67% | ✅ Strong Buy |
| CNK | $22.32 | $25.77 | Above Fair Value | ⛔ Overvalued |
| CNM | $35.16 | $57.67 | Above Fair Value | ⛔ Overvalued |
| CNMD | $64.27 | $41.52 | Avoid | ❌ Avoid |
| CNO | $52.96 | $44.64 | 18.64% | ✅ Strong Buy |
| CNOB | $45.60 | $28.67 | 59.05% | ✅ Strong Buy |
| CNP | $26.43 | $40.05 | Avoid | ❌ Avoid |
| CNQ | $42.94 | $39.10 | 9.82% | 👍 Buy |
| CNR | $111.86 | $92.24 | 21.27% | ✅ Strong Buy |
| CNS | $55.04 | $62.71 | Above Fair Value | ⚠️ See Analysis |
| CNX | $50.48 | $40.27 | 25.35% | ✅ Strong Buy |
| CNXC | $155.89 | $39.93 | Insufficient EBITDA | ❌ Avoid |
| CNXN | $43.42 | $67.92 | Above Fair Value | ⛔ Overvalued |
| COCO | $25.34 | $58.96 | Above Fair Value | ⛔ Overvalued |
| COF | $212.66 | $222.79 | Above Fair Value | ⚠️ See Analysis |
| COFS | $54.19 | $30.33 | 78.67% | ✅ Strong Buy |
| COHN | $27.80 | $18.10 | 53.59% | ✅ Strong Buy |
| COHR | $89.05 | $227.68 | Above Fair Value | ⛔ Overvalued |
| COHU | $8.26 | $30.85 | Insufficient EBITDA | ❌ Avoid |
| COIN | $180.00 | $165.12 | 9.01% | 👍 Buy |
| COKE | $121.66 | $157.74 | Above Fair Value | ⛔ Overvalued |
| COLB | $45.80 | $32.07 | 42.81% | ✅ Strong Buy |
| COLD | $2.75 | $12.66 | Above Fair Value | ⛔ Overvalued |
| COLL | $133.48 | $47.61 | 180.36% | ✅ Strong Buy |
| COLM | $43.93 | $63.07 | Above Fair Value | ⛔ Overvalued |
| COMP | $4.87 | $12.27 | Insufficient EBITDA | ⛔ Overvalued |
| CON | $24.34 | $23.50 | Avoid | ❌ Avoid |
| COO | $62.83 | $82.10 | Above Fair Value | ⛔ Overvalued |
| COP | $73.94 | $107.62 | Above Fair Value | ⛔ Overvalued |
| COR | $240.95 | $359.25 | Above Fair Value | ⛔ Overvalued |
| CORT | $16.28 | $40.83 | Above Fair Value | ⛔ Overvalued |
| COST | $361.67 | $1,001.16 | Above Fair Value | ⛔ Overvalued |
| COTY | $6.97 | $2.66 | Avoid | ❌ Avoid |
| COUR | $9.33 | $5.91 | Insufficient EBITDA | ❌ Avoid |
| CP | $75.95 | $80.39 | Above Fair Value | ⚠️ See Analysis |
| CPAC | $1.86 | $10.74 | Above Fair Value | ⛔ Overvalued |
| CPAY | $563.38 | $354.19 | 59.06% | ✅ Strong Buy |
| CPB | $29.70 | $28.83 | Avoid | ❌ Avoid |
| CPF | $33.42 | $34.53 | Above Fair Value | ⚠️ See Analysis |
| CPK | $96.90 | $129.87 | Avoid | ❌ Avoid |
| CPNG | $5.40 | $17.72 | Above Fair Value | ⛔ Overvalued |
| CPRI | $20.03 | $20.18 | Avoid | ❌ Avoid |
| CPRT | $29.10 | $40.36 | Above Fair Value | ⛔ Overvalued |
| CPRX | $47.43 | $24.44 | 94.07% | ✅ Strong Buy |
| CPS | $24.22 | $34.62 | Avoid | ❌ Avoid |
| CPT | $18.13 | $106.63 | Above Fair Value | ⛔ Overvalued |
| CQP | $57.80 | $57.65 | Avoid | ❌ Avoid |
| CR | $119.22 | $196.22 | Above Fair Value | ⛔ Overvalued |
| CRAI | $119.53 | $184.96 | Above Fair Value | ⛔ Overvalued |
| CRBG | $77.11 | $31.16 | 147.46% | ✅ Strong Buy |
| CRC | $46.31 | $55.42 | Above Fair Value | ⛔ Overvalued |
| CRCT | $4.54 | $4.62 | Above Fair Value | ⚠️ See Analysis |
| CRDO | $92.98 | $111.40 | Above Fair Value | ⛔ Overvalued |
| CRESY | $25.68 | $12.83 | 100.16% | ✅ Strong Buy |
| CRGY | $18.19 | $10.12 | 79.74% | ✅ Strong Buy |
| CRH | $76.71 | $127.13 | Above Fair Value | ⛔ Overvalued |
| CRI | $43.07 | $36.79 | 17.07% | 👍 Buy |
| CRK | $9.16 | $21.57 | Avoid | ❌ Avoid |
| CRL | $153.74 | $189.21 | Avoid | ❌ Avoid |
| CRM | $265.11 | $191.35 | 38.55% | ✅ Strong Buy |
| CRMD | $10.95 | $7.69 | Insufficient EBITDA | ✅ Strong Buy |
| CRMT | $12.17 | $24.45 | Avoid | ❌ Avoid |
| CRNC | $17.00 | $7.77 | Avoid | ❌ Avoid |
| CROX | $200.55 | $85.81 | 133.71% | ✅ Strong Buy |
| CRS | $141.74 | $365.11 | Above Fair Value | ⛔ Overvalued |
| CRSR | $8.29 | $5.17 | 60.35% | ✅ Strong Buy |
| CRT | $6.39 | $8.47 | Above Fair Value | ⛔ Overvalued |
| CRUS | $147.42 | $142.78 | 3.25% | 👍 Buy |
| CRVL | $29.98 | $48.67 | Above Fair Value | ⛔ Overvalued |
| CRWD | $122.67 | $395.50 | Avoid | ❌ Avoid |
| CSAN | $37.18 | $4.42 | Avoid | ❌ Avoid |
| CSCO | $80.49 | $84.82 | Above Fair Value | ⚠️ See Analysis |
| CSGP | $18.71 | $50.28 | Above Fair Value | ⛔ Overvalued |
| CSGS | $86.57 | $80.06 | 8.13% | 👍 Buy |
| CSL | $319.85 | $403.86 | Above Fair Value | ⛔ Overvalued |
| CSR | $24.51 | $64.25 | Above Fair Value | ⛔ Overvalued |
| CSTM | $26.31 | $24.74 | 6.35% | 👍 Buy |
| CSV | $47.79 | $44.32 | Avoid | ❌ Avoid |
| CSW | $140.48 | $290.25 | Above Fair Value | ⛔ Overvalued |
| CSX | $32.47 | $40.61 | Above Fair Value | ⛔ Overvalued |
| CTAS | $82.34 | $195.87 | Above Fair Value | ⛔ Overvalued |
| CTBI | $93.09 | $65.49 | 42.14% | ✅ Strong Buy |
| CTKB | $0.24 | $4.47 | Insufficient EBITDA | ❌ Avoid |
| CTLP | $9.90 | $10.66 | Above Fair Value | ⚠️ See Analysis |
| CTMX | $4.96 | $5.67 | Above Fair Value | ⚠️ See Analysis |
| CTO | $2.12 | $18.59 | Above Fair Value | ⛔ Overvalued |
| CTOS | $1.14 | $6.87 | Avoid | ❌ Avoid |
| CTRA | $35.11 | $30.66 | 14.51% | 👍 Buy |
| CTRE | $27.19 | $38.84 | Above Fair Value | ⛔ Overvalued |
| CTRI | $7.43 | $28.93 | Avoid | ❌ Avoid |
| CTS | $31.02 | $55.78 | Above Fair Value | ⛔ Overvalued |
| CTSH | $103.81 | $77.08 | 34.68% | ✅ Strong Buy |
| CTVA | $45.72 | $72.60 | Above Fair Value | ⛔ Overvalued |
| CUBE | $25.80 | $38.39 | Above Fair Value | ⛔ Overvalued |
| CUBI | $108.47 | $76.28 | 42.20% | ✅ Strong Buy |
| CUK | $37.64 | $33.69 | Avoid | ❌ Avoid |
| CURB | $6.04 | $25.27 | Above Fair Value | ⛔ Overvalued |
| CURI | $0.61 | $3.30 | Above Fair Value | ⛔ Overvalued |
| CUZ | $4.36 | $25.64 | Above Fair Value | ⛔ Overvalued |
| CVAC | $3.67 | $4.66 | Above Fair Value | ⛔ Overvalued |
| CVBF | $19.85 | $21.43 | Above Fair Value | ⚠️ See Analysis |
| CVCO | $382.08 | $538.73 | Above Fair Value | ⛔ Overvalued |
| CVE | $14.68 | $20.57 | Above Fair Value | ⛔ Overvalued |
| CVGW | $21.28 | $25.43 | Above Fair Value | ⛔ Overvalued |
| CVI | $19.17 | $24.54 | Above Fair Value | ⛔ Overvalued |
| CVLG | $22.01 | $29.11 | Above Fair Value | ⛔ Overvalued |
| CVLT | $90.22 | $86.07 | 4.82% | 👍 Buy |
| CVNA | $89.29 | $403.67 | Above Fair Value | ⛔ Overvalued |
| CVS | $89.01 | $78.35 | Avoid | ❌ Avoid |
| CVX | $104.89 | $180.86 | Above Fair Value | ⛔ Overvalued |
| CW | $199.91 | $649.32 | Above Fair Value | ⛔ Overvalued |
| CWAN | $5.09 | $23.85 | Avoid | ❌ Avoid |
| CWBC | $44.44 | $25.41 | 74.89% | ✅ Strong Buy |
| CWCO | $18.91 | $37.03 | Above Fair Value | ⛔ Overvalued |
| CWEN | $22.12 | $38.64 | Avoid | ❌ Avoid |
| CWH | $10.88 | $13.62 | Avoid | ❌ Avoid |
| CWK | $15.96 | $16.16 | Avoid | ❌ Avoid |
| CWST | $22.61 | $104.65 | Above Fair Value | ⛔ Overvalued |
| CWT | $36.70 | $44.47 | Avoid | ❌ Avoid |
| CX | $8.70 | $12.20 | Above Fair Value | ⛔ Overvalued |
| CXM | $8.73 | $6.00 | 45.50% | ✅ Strong Buy |
| CXT | $57.40 | $56.05 | 2.41% | 👍 Buy |
| CXW | $17.75 | $18.72 | Above Fair Value | ⚠️ See Analysis |
| CYBR | $89.34 | $391.77 | Avoid | ❌ Avoid |
| CYH | $10.19 | $3.15 | Avoid | ❌ Avoid |
| CZFS | $117.13 | $65.72 | 78.24% | ✅ Strong Buy |
| CZNC | $32.47 | $23.49 | 38.23% | ✅ Strong Buy |
| CZR | $5.01 | $20.52 | Above Fair Value | ⛔ Overvalued |
| CZWI | $27.02 | $19.00 | 42.21% | ✅ Strong Buy |
| D | $48.60 | $62.33 | Avoid | ❌ Avoid |
| DAC | $359.95 | $102.08 | 252.62% | ✅ Strong Buy |
| DAKT | $15.55 | $25.41 | Above Fair Value | ⛔ Overvalued |
| DAL | $87.66 | $75.35 | 16.34% | 👍 Buy |
| DAN | $22.36 | $31.69 | Avoid | ❌ Avoid |
| DAR | $20.41 | $48.20 | Avoid | ❌ Avoid |
| DASH | $57.75 | $182.47 | Above Fair Value | ⛔ Overvalued |
| DAVA | $15.17 | $5.46 | 177.84% | ✅ Strong Buy |
| DAVE | $199.55 | $183.22 | 8.91% | 👍 Buy |
| DAY | $61.15 | $69.86 | Avoid | ❌ Avoid |
| DB | $49.54 | $37.22 | 33.10% | ✅ Strong Buy |
| DBI | $4.77 | $6.95 | Avoid | ❌ Avoid |
| DBRG | $5.64 | $15.43 | Above Fair Value | ⛔ Overvalued |
| DBX | $64.70 | $25.00 | 158.80% | ✅ Strong Buy |
| DCI | $70.86 | $109.03 | Above Fair Value | ⛔ Overvalued |
| DCO | $49.69 | $121.08 | Avoid | ❌ Avoid |
| DCOM | $60.82 | $36.23 | 67.87% | ✅ Strong Buy |
| DCTH | $4.21 | $9.37 | Insufficient EBITDA | ⛔ Overvalued |
| DD | $23.18 | $46.73 | Above Fair Value | ⛔ Overvalued |
| DDD | $0.80 | $2.20 | Insufficient EBITDA | ⛔ Overvalued |
| DDOG | $46.69 | $111.69 | Above Fair Value | ⛔ Overvalued |
| DDS | $412.73 | $666.51 | Above Fair Value | ⛔ Overvalued |
| DE | $315.05 | $583.11 | Avoid | ❌ Avoid |
| DEA | $6.72 | $24.16 | Above Fair Value | ⛔ Overvalued |
| DEC | $49.25 | $13.35 | 268.91% | ✅ Strong Buy |
| DECK | $114.57 | $115.45 | Above Fair Value | ⚠️ See Analysis |
| DEI | $1.22 | $10.59 | Above Fair Value | ⛔ Overvalued |
| DELL | $178.05 | $121.05 | 47.09% | ✅ Strong Buy |
| DENN | $6.14 | $6.25 | Avoid | ❌ Avoid |
| DEO | $134.44 | $96.88 | 38.77% | ✅ Strong Buy |
| DFH | $23.54 | $19.57 | Avoid | ❌ Avoid |
| DFIN | $67.77 | $48.29 | 40.34% | ✅ Strong Buy |
| DG | $109.30 | $146.65 | Above Fair Value | ⛔ Overvalued |
| DGICA | $27.92 | $18.98 | 47.10% | ✅ Strong Buy |
| DGICB | $33.68 | $19.69 | 71.05% | ✅ Strong Buy |
| DGII | $36.06 | $44.16 | Above Fair Value | ⛔ Overvalued |
| DGX | $154.01 | $190.71 | Above Fair Value | ⛔ Overvalued |
| DH | $4.66 | $1.99 | Insufficient EBITDA | ❌ Avoid |
| DHI | $140.36 | $156.27 | Above Fair Value | ⚠️ See Analysis |
| DHIL | $151.28 | $171.00 | Above Fair Value | ⚠️ See Analysis |
| DHR | $129.75 | $216.61 | Above Fair Value | ⛔ Overvalued |
| DHT | $17.22 | $14.87 | 15.80% | 👍 Buy |
| DHX | $2.37 | $1.99 | Avoid | ❌ Avoid |
| DIN | $70.52 | $36.00 | Avoid | ❌ Avoid |
| DINO | $69.84 | $58.59 | 19.20% | ✅ Strong Buy |
| DIOD | $26.66 | $60.84 | Above Fair Value | ⛔ Overvalued |
| DIS | $102.42 | $108.70 | Above Fair Value | ⚠️ See Analysis |
| DIT | $12.23 | $113.15 | Avoid | ❌ Avoid |
| DJCO | $1,390.07 | $575.92 | 141.37% | ✅ Strong Buy |
| DK | $22.55 | $35.53 | Insufficient EBITDA | ❌ Avoid |
| DKL | $44.84 | $52.59 | Avoid | ❌ Avoid |
| DKNG | $27.13 | $26.62 | Insufficient EBITDA | ❌ Avoid |
| DKS | $205.09 | $208.29 | Above Fair Value | ⚠️ See Analysis |
| DLB | $78.73 | $64.85 | 21.40% | ✅ Strong Buy |
| DLNG | $17.88 | $3.76 | 375.53% | ✅ Strong Buy |
| DLR | $57.41 | $171.62 | Above Fair Value | ⛔ Overvalued |
| DLTR | $93.12 | $123.83 | Above Fair Value | ⛔ Overvalued |
| DLX | $26.92 | $27.80 | Avoid | ❌ Avoid |
| DMLP | $26.92 | $24.53 | 9.74% | 👍 Buy |
| DNOW | $14.54 | $16.76 | Above Fair Value | ⛔ Overvalued |
| DOC | $4.99 | $16.85 | Above Fair Value | ⛔ Overvalued |
| DOCN | $34.57 | $62.92 | Avoid | ❌ Avoid |
| DOCS | $45.26 | $27.73 | 63.22% | ✅ Strong Buy |
| DOCU | $81.70 | $47.13 | 73.35% | ✅ Strong Buy |
| DOLE | $16.91 | $16.23 | 4.19% | 👍 Buy |
| DOMH | $60.29 | $3.73 | Insufficient EBITDA | ✅ Strong Buy |
| DOMO | $0.08 | $5.23 | Insufficient EBITDA | ❌ Avoid |
| DORM | $133.69 | $130.10 | 2.76% | 👍 Buy |
| DOV | $154.64 | $223.66 | Above Fair Value | ⛔ Overvalued |
| DOW | $10.58 | $31.78 | Above Fair Value | ⛔ Overvalued |
| DOX | $141.23 | $73.34 | 92.57% | ✅ Strong Buy |
| DPZ | $325.53 | $394.88 | Avoid | ❌ Avoid |
| DRH | $5.34 | $9.56 | Above Fair Value | ⛔ Overvalued |
| DRI | $191.94 | $216.27 | Above Fair Value | ⚠️ See Analysis |
| DRS | $16.25 | $38.93 | Above Fair Value | ⛔ Overvalued |
| DRVN | $21.16 | $17.06 | Avoid | ❌ Avoid |
| DSGR | $22.40 | $30.86 | Avoid | ❌ Avoid |
| DSGX | $51.63 | $66.78 | Above Fair Value | ⛔ Overvalued |
| DSP | $9.50 | $10.35 | Above Fair Value | ⚠️ See Analysis |
| DSX | $2.67 | $2.29 | Avoid | ❌ Avoid |
| DT | $32.98 | $33.71 | Above Fair Value | ⚠️ See Analysis |
| DTE | $99.58 | $134.82 | Avoid | ❌ Avoid |
| DTM | $77.57 | $128.58 | Above Fair Value | ⛔ Overvalued |
| DUK | $85.69 | $121.86 | Avoid | ❌ Avoid |
| DUOL | $214.03 | $119.40 | 79.25% | ✅ Strong Buy |
| DV | $20.21 | $9.34 | 116.38% | ✅ Strong Buy |
| DVA | $221.06 | $140.83 | Avoid | ❌ Avoid |
| DVN | $58.13 | $43.81 | 32.69% | ✅ Strong Buy |
| DX | $16.34 | $14.07 | 16.13% | 👍 Buy |
| DXC | $49.50 | $15.20 | 225.66% | ✅ Strong Buy |
| DXCM | $42.40 | $69.97 | Above Fair Value | ⛔ Overvalued |
| DXPE | $78.65 | $149.61 | Above Fair Value | ⛔ Overvalued |
| DXYZ | $21.68 | $30.88 | Above Fair Value | ⛔ Overvalued |
| DY | $175.94 | $400.47 | Above Fair Value | ⛔ Overvalued |
| E | $40.88 | $42.32 | Above Fair Value | ⚠️ See Analysis |
| EA | $92.58 | $200.00 | Above Fair Value | ⛔ Overvalued |
| EAT | $159.51 | $168.93 | Above Fair Value | ⚠️ See Analysis |
| EBAY | $60.64 | $86.55 | Above Fair Value | ⛔ Overvalued |
| EBC | $29.08 | $21.89 | 32.85% | ✅ Strong Buy |
| EBF | $19.56 | $20.41 | Above Fair Value | ⚠️ See Analysis |
| EBMT | $27.19 | $23.45 | 15.95% | 👍 Buy |
| EC | $18.61 | $12.23 | 52.17% | ✅ Strong Buy |
| ECG | $72.91 | $97.29 | Above Fair Value | ⛔ Overvalued |
| ECL | $129.88 | $290.33 | Above Fair Value | ⛔ Overvalued |
| ECO | $39.89 | $40.32 | Above Fair Value | ⚠️ See Analysis |
| ECPG | $122.30 | $57.75 | 111.77% | ✅ Strong Buy |
| ECVT | $7.23 | $11.05 | Avoid | ❌ Avoid |
| ED | $79.07 | $107.34 | Avoid | ❌ Avoid |
| EE | $21.11 | $37.11 | Above Fair Value | ⛔ Overvalued |
| EEFT | $155.51 | $75.02 | 107.29% | ✅ Strong Buy |
| EEX | $1.70 | $4.92 | Avoid | ❌ Avoid |
| EFC | $23.46 | $13.00 | 80.46% | ✅ Strong Buy |
| EFSC | $76.44 | $59.89 | 27.63% | ✅ Strong Buy |
| EFX | $137.31 | $195.62 | Above Fair Value | ⛔ Overvalued |
| EFXT | $15.90 | $17.83 | Above Fair Value | ⚠️ See Analysis |
| EG | $714.21 | $328.39 | 117.49% | ✅ Strong Buy |
| EGAN | $6.46 | $10.00 | Above Fair Value | ⛔ Overvalued |
| EGBN | $22.75 | $27.58 | Insufficient EBITDA | ⛔ Overvalued |
| EGHT | $6.78 | $2.62 | Avoid | ❌ Avoid |
| EGO | $50.22 | $39.02 | 28.70% | ✅ Strong Buy |
| EGP | $92.29 | $189.91 | Above Fair Value | ⛔ Overvalued |
| EGY | $11.15 | $4.84 | 130.37% | ✅ Strong Buy |
| EHAB | $8.96 | $11.13 | Insufficient EBITDA | ❌ Avoid |
| EHC | $98.69 | $105.39 | Above Fair Value | ⚠️ See Analysis |
| EHTH | $2.41 | $2.22 | 8.56% | 👍 Buy |
| EIG | $22.56 | $45.46 | Above Fair Value | ⛔ Overvalued |
| EIX | $80.19 | $64.01 | Avoid | ❌ Avoid |
| EL | $47.45 | $99.47 | Avoid | ❌ Avoid |
| ELAN | $13.75 | $25.20 | Avoid | ❌ Avoid |
| ELF | $52.65 | $82.09 | Avoid | ❌ Avoid |
| ELMD | $17.43 | $29.11 | Above Fair Value | ⛔ Overvalued |
| ELP | $11.17 | $9.27 | 20.50% | ✅ Strong Buy |
| ELS | $39.95 | $65.48 | Above Fair Value | ⛔ Overvalued |
| ELV | $394.17 | $338.98 | 16.28% | 👍 Buy |
| EMBC | $23.93 | $10.87 | Avoid | ❌ Avoid |
| EME | $381.88 | $764.35 | Above Fair Value | ⛔ Overvalued |
| EMN | $80.92 | $77.43 | 4.51% | 👍 Buy |
| EMR | $111.95 | $157.38 | Above Fair Value | ⛔ Overvalued |
| ENB | $33.16 | $50.32 | Avoid | ❌ Avoid |
| ENIC | $4,647.53 | $4.24 | Avoid | ❌ Avoid |
| ENOV | $38.42 | $22.59 | Insufficient EBITDA | ❌ Avoid |
| ENPH | $49.86 | $49.80 | 0.12% | 👍 Buy |
| ENR | $38.76 | $23.40 | Avoid | ❌ Avoid |
| ENS | $149.49 | $172.22 | Above Fair Value | ⛔ Overvalued |
| ENSG | $101.91 | $197.80 | Above Fair Value | ⛔ Overvalued |
| ENTG | $47.13 | $122.37 | Avoid | ❌ Avoid |
| ENVA | $136.69 | $161.10 | Above Fair Value | ⛔ Overvalued |
| EOG | $133.13 | $113.70 | 17.09% | 👍 Buy |
| EPAC | $28.18 | $42.67 | Above Fair Value | ⛔ Overvalued |
| EPAM | $243.34 | $186.68 | 30.35% | ✅ Strong Buy |
| EPC | $36.73 | $20.75 | Avoid | ❌ Avoid |
| EPD | $34.41 | $34.91 | Above Fair Value | ⚠️ See Analysis |
| EPM | $0.74 | $4.10 | Above Fair Value | ⛔ Overvalued |
| EPR | $39.06 | $56.25 | Above Fair Value | ⛔ Overvalued |
| EPRT | $21.26 | $31.75 | Above Fair Value | ⛔ Overvalued |
| EPSN | $4.96 | $4.85 | 2.27% | 👍 Buy |
| EQBK | $76.82 | $47.49 | 61.76% | ✅ Strong Buy |
| EQH | $54.27 | $45.52 | 19.22% | ✅ Strong Buy |
| EQIX | $270.89 | $848.12 | Above Fair Value | ⛔ Overvalued |
| EQNR | $34.67 | $27.52 | 25.98% | ✅ Strong Buy |
| EQR | $24.84 | $63.89 | Above Fair Value | ⛔ Overvalued |
| EQT | $50.90 | $56.79 | Above Fair Value | ⚠️ See Analysis |
| EQX | $13.57 | $14.56 | Above Fair Value | ⚠️ See Analysis |
| ERIC | $8.01 | $11.16 | Above Fair Value | ⛔ Overvalued |
| ERIE | $218.51 | $287.71 | Above Fair Value | ⛔ Overvalued |
| ERII | $12.57 | $15.47 | Above Fair Value | ⛔ Overvalued |
| ERO | $47.69 | $30.61 | 55.80% | ✅ Strong Buy |
| ES | $65.24 | $67.36 | Avoid | ❌ Avoid |
| ESAB | $82.11 | $134.05 | Above Fair Value | ⛔ Overvalued |
| ESCA | $12.25 | $14.31 | Above Fair Value | ⛔ Overvalued |
| ESE | $132.43 | $253.10 | Above Fair Value | ⛔ Overvalued |
| ESEA | $225.63 | $53.50 | 321.74% | ✅ Strong Buy |
| ESI | $22.60 | $29.94 | Above Fair Value | ⛔ Overvalued |
| ESLT | $171.33 | $665.00 | Above Fair Value | ⛔ Overvalued |
| ESNT | $76.83 | $65.28 | 17.69% | ✅ Strong Buy |
| ESOA | $4.84 | $9.42 | Avoid | ❌ Avoid |
| ESP | $43.60 | $56.87 | Above Fair Value | ⛔ Overvalued |
| ESPR | $1.37 | $3.40 | Avoid | ❌ Avoid |
| ESQ | $102.18 | $115.37 | Above Fair Value | ⚠️ See Analysis |
| ESRT | $1.80 | $6.75 | Above Fair Value | ⛔ Overvalued |
| ESS | $119.90 | $258.06 | Above Fair Value | ⛔ Overvalued |
| ESTC | $49.06 | $59.12 | Above Fair Value | ⛔ Overvalued |
| ET | $14.67 | $17.94 | Avoid | ❌ Avoid |
| ETD | $21.68 | $24.54 | Above Fair Value | ⚠️ See Analysis |
| ETN | $188.50 | $373.82 | Above Fair Value | ⛔ Overvalued |
| ETR | $55.90 | $97.96 | Avoid | ❌ Avoid |
| ETSY | $37.08 | $57.82 | Above Fair Value | ⛔ Overvalued |
| EVCM | $12.36 | $10.76 | Avoid | ❌ Avoid |
| EVER | $49.46 | $18.09 | 173.41% | ✅ Strong Buy |
| EVH | $3.39 | $2.85 | Avoid | ❌ Avoid |
| EVI | $11.31 | $23.50 | Above Fair Value | ⛔ Overvalued |
| EVR | $298.62 | $357.73 | Above Fair Value | ⛔ Overvalued |
| EVRG | $58.60 | $76.75 | Avoid | ❌ Avoid |
| EVTC | $84.76 | $27.02 | 213.69% | ✅ Strong Buy |
| EW | $53.60 | $78.71 | Above Fair Value | ⛔ Overvalued |
| EWBC | $115.21 | $122.50 | Above Fair Value | ⚠️ See Analysis |
| EWCZ | $8.16 | $4.03 | Avoid | ❌ Avoid |
| EXAS | $11.43 | $103.18 | Insufficient EBITDA | ❌ Avoid |
| EXC | $36.77 | $44.33 | Avoid | ❌ Avoid |
| EXE | $114.24 | $110.37 | 3.51% | 👍 Buy |
| EXEL | $51.15 | $43.90 | 16.51% | 👍 Buy |
| EXFY | $3.21 | $1.38 | Avoid | ❌ Avoid |
| EXK | $7.30 | $11.36 | Avoid | ❌ Avoid |
| EXLS | $35.77 | $31.70 | 12.84% | 👍 Buy |
| EXP | $233.66 | $225.85 | 3.46% | 👍 Buy |
| EXPD | $100.11 | $165.04 | Above Fair Value | ⛔ Overvalued |
| EXPE | $242.33 | $236.85 | 2.31% | 👍 Buy |
| EXPI | $2.43 | $8.66 | Avoid | ❌ Avoid |
| EXPO | $41.37 | $79.79 | Above Fair Value | ⛔ Overvalued |
| EXR | $102.00 | $140.01 | Above Fair Value | ⛔ Overvalued |
| EXTR | $18.31 | $15.24 | 20.14% | ✅ Strong Buy |
| EYE | $11.72 | $28.92 | Above Fair Value | ⛔ Overvalued |
| EZPW | $19.66 | $25.63 | Above Fair Value | ⛔ Overvalued |
| F | $16.48 | $13.80 | Avoid | ❌ Avoid |
| FA | $15.45 | $11.94 | Avoid | ❌ Avoid |
| FAF | $67.71 | $67.34 | 0.55% | 👍 Buy |
| FANG | $157.15 | $166.93 | Above Fair Value | ⚠️ See Analysis |
| FAST | $18.83 | $47.73 | Above Fair Value | ⛔ Overvalued |
| FBIN | $57.38 | $61.85 | Above Fair Value | ⚠️ See Analysis |
| FBIZ | $86.18 | $59.85 | 43.99% | ✅ Strong Buy |
| FBK | $71.30 | $61.61 | 15.73% | 👍 Buy |
| FBNC | $72.70 | $62.23 | 16.82% | 👍 Buy |
| FBP | $26.78 | $23.22 | 15.33% | 👍 Buy |
| FBRT | $17.66 | $10.18 | 73.48% | ✅ Strong Buy |
| FC | $17.94 | $19.49 | Above Fair Value | ⚠️ See Analysis |
| FCAP | $69.47 | $54.20 | 28.17% | ✅ Strong Buy |
| FCBC | $25.74 | $41.31 | Above Fair Value | ⛔ Overvalued |
| FCCO | $38.80 | $30.84 | 25.81% | ✅ Strong Buy |
| FCF | $24.40 | $18.83 | 29.58% | ✅ Strong Buy |
| FCFS | $144.46 | $181.92 | Above Fair Value | ⛔ Overvalued |
| FCN | $130.12 | $178.93 | Above Fair Value | ⛔ Overvalued |
| FCNCA | $3,008.67 | $2,160.99 | 39.23% | ✅ Strong Buy |
| FCPT | $17.86 | $25.34 | Above Fair Value | ⛔ Overvalued |
| FCX | $41.69 | $60.67 | Above Fair Value | ⛔ Overvalued |
| FDBC | $70.12 | $47.32 | 48.18% | ✅ Strong Buy |
| FDP | $32.99 | $38.47 | Above Fair Value | ⛔ Overvalued |
| FDS | $393.35 | $207.32 | 89.73% | ✅ Strong Buy |
| FDUS | $26.68 | $18.86 | 41.46% | ✅ Strong Buy |
| FDX | $260.87 | $369.23 | Above Fair Value | ⛔ Overvalued |
| FE | $31.51 | $46.63 | Avoid | ❌ Avoid |
| FELE | $66.41 | $107.55 | Above Fair Value | ⛔ Overvalued |
| FENC | $8.57 | $7.84 | Avoid | ❌ Avoid |
| FERG | $164.91 | $262.76 | Above Fair Value | ⛔ Overvalued |
| FFBC | $48.06 | $30.90 | 55.53% | ✅ Strong Buy |
| FFIC | $23.26 | $16.84 | 38.12% | ✅ Strong Buy |
| FFIN | $38.34 | $34.78 | 10.24% | 👍 Buy |
| FFIV | $350.59 | $276.57 | 26.76% | ✅ Strong Buy |
| FFWM | $4.92 | $6.43 | Insufficient EBITDA | ⛔ Overvalued |
| FG | $69.67 | $28.38 | 145.49% | ✅ Strong Buy |
| FGBI | $5.07 | $8.93 | Insufficient EBITDA | ⛔ Overvalued |
| FHB | $35.22 | $27.23 | 29.34% | ✅ Strong Buy |
| FHI | $49.87 | $52.12 | Above Fair Value | ⚠️ See Analysis |
| FHN | $24.80 | $26.23 | Above Fair Value | ⚠️ See Analysis |
| FIBK | $39.54 | $38.82 | 1.85% | 👍 Buy |
| FICO | $1,100.77 | $1,391.00 | Above Fair Value | ⛔ Overvalued |
| FIG | $4.38 | $21.99 | Insufficient EBITDA | ❌ Avoid |
| FIGS | $1.97 | $10.74 | Above Fair Value | ⛔ Overvalued |
| FIHL | $53.76 | $19.40 | 177.11% | ✅ Strong Buy |
| FIS | $101.97 | $51.93 | Avoid | ❌ Avoid |
| FISI | $30.89 | $35.14 | Above Fair Value | ⚠️ See Analysis |
| FISV | $163.60 | $60.00 | 172.67% | ✅ Strong Buy |
| FITB | $64.54 | $55.08 | 17.18% | 👍 Buy |
| FIVE | $118.35 | $202.61 | Above Fair Value | ⛔ Overvalued |
| FIVN | $61.66 | $17.08 | Avoid | ❌ Avoid |
| FIX | $437.76 | $1,230.26 | Above Fair Value | ⛔ Overvalued |
| FIZZ | $34.51 | $35.30 | Above Fair Value | ⚠️ See Analysis |
| FKWL | $0.51 | $4.10 | Above Fair Value | ⛔ Overvalued |
| FLEX | $39.50 | $63.98 | Above Fair Value | ⛔ Overvalued |
| FLG | $15.85 | $14.27 | Insufficient EBITDA | 👍 Buy |
| FLGT | $3.87 | $23.44 | Insufficient EBITDA | ❌ Avoid |
| FLNC | $3.70 | $19.44 | Insufficient EBITDA | ❌ Avoid |
| FLNG | $30.78 | $26.38 | 16.68% | 👍 Buy |
| FLO | $14.47 | $11.96 | Avoid | ❌ Avoid |
| FLOC | $28.90 | $22.84 | 26.53% | ✅ Strong Buy |
| FLR | $27.94 | $46.92 | Avoid | ❌ Avoid |
| FLS | $52.33 | $85.46 | Above Fair Value | ⛔ Overvalued |
| FLUT | $161.01 | $152.53 | Avoid | ❌ Avoid |
| FLXS | $42.65 | $57.55 | Above Fair Value | ⛔ Overvalued |
| FLYW | $16.47 | $11.25 | 46.40% | ✅ Strong Buy |
| FMAO | $36.86 | $28.29 | 30.29% | ✅ Strong Buy |
| FMBH | $69.61 | $44.59 | 56.11% | ✅ Strong Buy |
| FMC | $37.91 | $14.76 | Avoid | ❌ Avoid |
| FMNB | $25.62 | $13.53 | 89.36% | ✅ Strong Buy |
| FMX | $58.35 | $110.37 | Above Fair Value | ⛔ Overvalued |
| FN | $203.79 | $503.99 | Above Fair Value | ⛔ Overvalued |
| FNB | $14.66 | $18.90 | Above Fair Value | ⛔ Overvalued |
| FND | $33.74 | $69.38 | Above Fair Value | ⛔ Overvalued |
| FNF | $81.18 | $57.61 | 40.91% | ✅ Strong Buy |
| FNKO | $1.07 | $3.97 | Avoid | ❌ Avoid |
| FNLC | $47.42 | $30.01 | 58.01% | ✅ Strong Buy |
| FNV | $100.69 | $232.08 | Above Fair Value | ⛔ Overvalued |
| FNWD | $31.59 | $38.79 | Above Fair Value | ⛔ Overvalued |
| FOLD | $7.88 | $14.30 | Avoid | ❌ Avoid |
| FONR | $15.49 | $18.56 | Above Fair Value | ⛔ Overvalued |
| FOR | $41.76 | $29.27 | 42.67% | ✅ Strong Buy |
| FORM | $22.86 | $90.29 | Above Fair Value | ⛔ Overvalued |
| FORR | $18.70 | $7.27 | Avoid | ❌ Avoid |
| FORTY | $84.71 | $132.38 | Above Fair Value | ⛔ Overvalued |
| FOUR | $100.88 | $59.28 | Avoid | ❌ Avoid |
| FOX | $33.46 | $58.35 | Above Fair Value | ⛔ Overvalued |
| FOXA | $70.27 | $64.78 | 8.47% | 👍 Buy |
| FOXF | $20.18 | $19.20 | Avoid | ❌ Avoid |
| FPI | $4.02 | $11.61 | Above Fair Value | ⛔ Overvalued |
| FR | $26.75 | $59.79 | Above Fair Value | ⛔ Overvalued |
| FRAF | $50.13 | $48.06 | 4.31% | 👍 Buy |
| FRBA | $24.24 | $17.11 | 41.67% | ✅ Strong Buy |
| FRD | $20.31 | $20.14 | Avoid | ❌ Avoid |
| FRHC | $1.64 | $122.76 | Above Fair Value | ⛔ Overvalued |
| FRME | $57.31 | $42.34 | 35.36% | ✅ Strong Buy |
| FRO | $31.52 | $29.37 | Avoid | ❌ Avoid |
| FROG | $19.63 | $47.99 | Insufficient EBITDA | ❌ Avoid |
| FRPH | $3.63 | $23.96 | Above Fair Value | ⛔ Overvalued |
| FRPT | $37.59 | $69.90 | Above Fair Value | ⛔ Overvalued |
| FRSH | $14.14 | $8.92 | Insufficient EBITDA | ❌ Avoid |
| FRST | $16.66 | $14.26 | Insufficient EBITDA | 👍 Buy |
| FRT | $53.62 | $105.76 | Above Fair Value | ⛔ Overvalued |
| FSBC | $40.41 | $41.38 | Above Fair Value | ⚠️ See Analysis |
| FSBW | $38.63 | $42.28 | Above Fair Value | ⚠️ See Analysis |
| FSFG | $52.21 | $33.98 | 53.65% | ✅ Strong Buy |
| FSK | $31.96 | $12.86 | 148.52% | ✅ Strong Buy |
| FSLR | $314.87 | $218.73 | 43.95% | ✅ Strong Buy |
| FSLY | $1.83 | $8.57 | Insufficient EBITDA | ❌ Avoid |
| FSM | $14.85 | $10.38 | 43.06% | ✅ Strong Buy |
| FSS | $58.65 | $116.71 | Above Fair Value | ⛔ Overvalued |
| FSTR | $16.00 | $31.74 | Above Fair Value | ⛔ Overvalued |
| FSV | $86.98 | $160.80 | Above Fair Value | ⛔ Overvalued |
| FTAI | $85.79 | $272.61 | Above Fair Value | ⛔ Overvalued |
| FTDR | $79.68 | $57.33 | 38.98% | ✅ Strong Buy |
| FTI | $32.00 | $59.06 | Above Fair Value | ⛔ Overvalued |
| FTK | $15.71 | $17.33 | Above Fair Value | ⚠️ See Analysis |
| FTLF | $14.74 | $15.36 | Avoid | ❌ Avoid |
| FTNT | $76.50 | $82.76 | Above Fair Value | ⚠️ See Analysis |
| FTRE | $10.50 | $14.65 | Insufficient EBITDA | ❌ Avoid |
| FTS | $33.48 | $54.01 | Avoid | ❌ Avoid |
| FTV | $53.38 | $60.12 | Above Fair Value | ⚠️ See Analysis |
| FUBO | $6.04 | $1.58 | Insufficient EBITDA | ✅ Strong Buy |
| FUL | $62.43 | $66.06 | Avoid | ❌ Avoid |
| FULT | $30.53 | $22.75 | 34.20% | ✅ Strong Buy |
| FUN | $0.65 | $18.73 | Avoid | ❌ Avoid |
| FUNC | $61.56 | $39.60 | 55.45% | ✅ Strong Buy |
| FUSB | $13.94 | $15.59 | Above Fair Value | ⚠️ See Analysis |
| FVCB | $20.81 | $15.99 | 30.14% | ✅ Strong Buy |
| FVRR | $43.80 | $15.46 | 183.31% | ✅ Strong Buy |
| FWONA | $51.60 | $77.96 | Avoid | ❌ Avoid |
| FWONK | $33.12 | $85.25 | Avoid | ❌ Avoid |
| FWRG | $5.25 | $17.54 | Avoid | ❌ Avoid |
| FXNC | $30.10 | $28.60 | 5.24% | 👍 Buy |
| GABC | $61.01 | $44.37 | 37.50% | ✅ Strong Buy |
| GAIN | $9.54 | $13.89 | Above Fair Value | ⛔ Overvalued |
| GAMB | $17.99 | $4.42 | 307.01% | ✅ Strong Buy |
| GAP | $31.81 | $29.13 | 9.20% | 👍 Buy |
| GATX | $131.50 | $188.43 | Avoid | ❌ Avoid |
| GBCI | $50.68 | $53.19 | Above Fair Value | ⚠️ See Analysis |
| GBDC | $9.82 | $12.55 | Above Fair Value | ⛔ Overvalued |
| GBLI | $30.92 | $28.60 | 8.11% | 👍 Buy |
| GBTG | $8.13 | $5.61 | 44.92% | ✅ Strong Buy |
| GBX | $59.17 | $54.60 | Avoid | ❌ Avoid |
| GCBC | $19.72 | $24.51 | Above Fair Value | ⛔ Overvalued |
| GCMG | $15.01 | $9.89 | 51.77% | ✅ Strong Buy |
| GCO | $21.95 | $29.07 | Avoid | ❌ Avoid |
| GCT | $39.73 | $40.25 | Above Fair Value | ⚠️ See Analysis |
| GD | $249.60 | $360.07 | Above Fair Value | ⛔ Overvalued |
| GDDY | $167.48 | $97.22 | 72.27% | ✅ Strong Buy |
| GDEN | $8.46 | $27.69 | Above Fair Value | ⛔ Overvalued |
| GDOT | $21.64 | $12.02 | 80.03% | ✅ Strong Buy |
| GDRX | $7.20 | $2.44 | 195.08% | ✅ Strong Buy |
| GDYN | $8.23 | $7.13 | 15.43% | 👍 Buy |
| GE | $100.80 | $321.00 | Above Fair Value | ⛔ Overvalued |
| GEF | $60.64 | $75.29 | Avoid | ❌ Avoid |
| GEHC | $90.32 | $80.65 | 11.99% | 👍 Buy |
| GEL | $22.91 | $17.19 | Avoid | ❌ Avoid |
| GEN | $27.72 | $24.25 | Avoid | ❌ Avoid |
| GENI | $7.22 | $6.09 | Avoid | ❌ Avoid |
| GEO | $14.60 | $15.90 | Above Fair Value | ⚠️ See Analysis |
| GES | $22.76 | $16.81 | Avoid | ❌ Avoid |
| GETY | $2.39 | $1.18 | Avoid | ❌ Avoid |
| GEV | $272.11 | $779.35 | Above Fair Value | ⛔ Overvalued |
| GFF | $85.36 | $94.84 | Avoid | ❌ Avoid |
| GFI | $43.01 | $53.51 | Above Fair Value | ⛔ Overvalued |
| GFL | $12.79 | $42.52 | Avoid | ❌ Avoid |
| GFS | $31.10 | $42.91 | Above Fair Value | ⛔ Overvalued |
| GGG | $61.09 | $92.76 | Above Fair Value | ⛔ Overvalued |
| GHC | $782.20 | $1,158.23 | Above Fair Value | ⛔ Overvalued |
| GHI | $24.23 | $7.64 | 217.15% | ✅ Strong Buy |
| GHM | $22.89 | $83.24 | Above Fair Value | ⛔ Overvalued |
| GIB | $141.58 | $82.73 | 71.14% | ✅ Strong Buy |
| GIC | $27.00 | $32.68 | Above Fair Value | ⛔ Overvalued |
| GIII | $39.20 | $30.51 | 28.48% | ✅ Strong Buy |
| GIL | $60.10 | $71.23 | Above Fair Value | ⛔ Overvalued |
| GILD | $100.56 | $152.50 | Above Fair Value | ⛔ Overvalued |
| GILT | $7.45 | $18.46 | Above Fair Value | ⛔ Overvalued |
| GIS | $61.64 | $47.87 | Avoid | ❌ Avoid |
| GL | $243.53 | $146.51 | 66.22% | ✅ Strong Buy |
| GLAD | $39.69 | $19.02 | 108.68% | ✅ Strong Buy |
| GLBE | $29.71 | $32.61 | Above Fair Value | ⚠️ See Analysis |
| GLDD | $16.01 | $15.58 | 2.76% | 👍 Buy |
| GLNG | $14.51 | $42.27 | Above Fair Value | ⛔ Overvalued |
| GLOB | $120.08 | $60.03 | 100.03% | ✅ Strong Buy |
| GLP | $30.30 | $46.94 | Avoid | ❌ Avoid |
| GLPG | $3.13 | $33.36 | Avoid | ❌ Avoid |
| GLPI | $43.04 | $45.32 | Above Fair Value | ⚠️ See Analysis |
| GLRE | $28.18 | $14.04 | 100.71% | ✅ Strong Buy |
| GLUE | $4.78 | $19.55 | Insufficient EBITDA | ⛔ Overvalued |
| GLW | $43.86 | $122.16 | Above Fair Value | ⛔ Overvalued |
| GLXY | $8.37 | $19.76 | Insufficient EBITDA | ⛔ Overvalued |
| GM | $86.97 | $84.24 | Avoid | ❌ Avoid |
| GMAB | $32.76 | $30.90 | 6.02% | 👍 Buy |
| GME | $10.79 | $24.98 | Above Fair Value | ⛔ Overvalued |
| GMED | $70.28 | $87.81 | Above Fair Value | ⛔ Overvalued |
| GMRE | $1.94 | $36.63 | Above Fair Value | ⛔ Overvalued |
| GNE | $10.37 | $14.15 | Above Fair Value | ⛔ Overvalued |
| GNK | $19.62 | $20.77 | Above Fair Value | ⚠️ See Analysis |
| GNRC | $121.19 | $183.53 | Above Fair Value | ⛔ Overvalued |
| GNTX | $30.23 | $24.12 | 25.33% | ✅ Strong Buy |
| GNW | $5.56 | $9.03 | Above Fair Value | ⛔ Overvalued |
| GO | $11.25 | $10.07 | 11.72% | 👍 Buy |
| GOGO | $9.26 | $4.18 | Avoid | ❌ Avoid |
| GOLF | $55.66 | $101.54 | Above Fair Value | ⛔ Overvalued |
| GOOD | $2.05 | $11.52 | Above Fair Value | ⛔ Overvalued |
| GOOG | $233.16 | $323.10 | Above Fair Value | ⛔ Overvalued |
| GOOGL | $233.01 | $322.86 | Above Fair Value | ⛔ Overvalued |
| GOOS | $12.56 | $11.24 | 11.74% | 👍 Buy |
| GORO | $0.59 | $1.59 | Insufficient EBITDA | ❌ Avoid |
| GPC | $116.71 | $148.51 | Above Fair Value | ⛔ Overvalued |
| GPI | $550.31 | $346.28 | Avoid | ❌ Avoid |
| GPK | $22.86 | $13.26 | Avoid | ❌ Avoid |
| GPN | $219.51 | $72.86 | 201.28% | ✅ Strong Buy |
| GPOR | $316.09 | $212.22 | 48.94% | ✅ Strong Buy |
| GPRE | $2.12 | $13.85 | Avoid | ❌ Avoid |
| GPRK | $10.74 | $8.32 | 29.09% | ✅ Strong Buy |
| GPRO | $0.80 | $1.00 | Insufficient EBITDA | ❌ Avoid |
| GRAB | $1.06 | $4.27 | Above Fair Value | ⛔ Overvalued |
| GRBK | $97.82 | $75.46 | 29.63% | ✅ Strong Buy |
| GRC | $30.03 | $65.70 | Above Fair Value | ⛔ Overvalued |
| GRFS | $16.00 | $9.28 | 72.41% | ✅ Strong Buy |
| GRMN | $167.57 | $202.33 | Above Fair Value | ⛔ Overvalued |
| GRND | $10.76 | $10.23 | 5.18% | 👍 Buy |
| GRNT | $9.55 | $5.10 | 87.25% | ✅ Strong Buy |
| GROW | $0.89 | $3.00 | Insufficient EBITDA | ⛔ Overvalued |
| GRRR | $24.07 | $11.75 | Insufficient EBITDA | ❌ Avoid |
| GS | $737.47 | $928.75 | Above Fair Value | ⛔ Overvalued |
| GSAT | $6.61 | $57.65 | Above Fair Value | ⛔ Overvalued |
| GSBC | $83.49 | $64.07 | 30.31% | ✅ Strong Buy |
| GSBD | $18.53 | $9.20 | 101.41% | ✅ Strong Buy |
| GSHD | $32.39 | $66.17 | Above Fair Value | ⛔ Overvalued |
| GSK | $43.11 | $60.23 | Above Fair Value | ⛔ Overvalued |
| GSL | $122.51 | $36.66 | 234.18% | ✅ Strong Buy |
| GSM | $1.42 | $5.16 | Avoid | ❌ Avoid |
| GT | $12.46 | $10.54 | Avoid | ❌ Avoid |
| GTES | $19.18 | $26.81 | Above Fair Value | ⛔ Overvalued |
| GTLB | $23.99 | $32.13 | Insufficient EBITDA | ❌ Avoid |
| GTLS | $164.24 | $207.45 | Avoid | ❌ Avoid |
| GTM | $20.22 | $7.31 | Avoid | ❌ Avoid |
| GTN | $26.03 | $4.35 | Avoid | ❌ Avoid |
| GTX | $21.63 | $19.21 | 12.60% | 👍 Buy |
| GTY | $19.98 | $30.81 | Above Fair Value | ⛔ Overvalued |
| GVA | $76.64 | $130.18 | Above Fair Value | ⛔ Overvalued |
| GWRE | $64.65 | $128.19 | Above Fair Value | ⛔ Overvalued |
| GWRS | $4.39 | $8.83 | Avoid | ❌ Avoid |
| GWW | $727.12 | $1,197.65 | Above Fair Value | ⛔ Overvalued |
| GXO | $35.95 | $58.91 | Avoid | ❌ Avoid |
| H | $39.61 | $162.87 | Avoid | ❌ Avoid |
| HAE | $78.18 | $59.34 | 31.75% | ✅ Strong Buy |
| HAFC | $27.14 | $28.09 | Above Fair Value | ⚠️ See Analysis |
| HAFN | $9.80 | $6.24 | 57.05% | ✅ Strong Buy |
| HAIN | $1.63 | $1.23 | Insufficient EBITDA | ❌ Avoid |
| HAL | $32.28 | $34.98 | Above Fair Value | ⚠️ See Analysis |
| HALO | $137.08 | $81.23 | 68.76% | ✅ Strong Buy |
| HAS | $73.25 | $93.84 | Avoid | ❌ Avoid |
| HASI | $33.75 | $36.13 | Above Fair Value | ⚠️ See Analysis |
| HAYW | $12.07 | $16.71 | Above Fair Value | ⛔ Overvalued |
| HBAN | $22.27 | $19.27 | 15.57% | 👍 Buy |
| HBB | $33.13 | $19.48 | 70.07% | ✅ Strong Buy |
| HBCP | $93.23 | $63.04 | 47.89% | ✅ Strong Buy |
| HBI | $8.49 | $6.47 | Avoid | ❌ Avoid |
| HBIO | $0.95 | $0.50 | Insufficient EBITDA | ❌ Avoid |
| HBM | $14.89 | $24.73 | Above Fair Value | ⛔ Overvalued |
| HBNC | $31.85 | $18.58 | Insufficient EBITDA | ✅ Strong Buy |
| HBT | $25.16 | $29.51 | Above Fair Value | ⛔ Overvalued |
| HCA | $378.33 | $501.69 | Above Fair Value | ⛔ Overvalued |
| HCAT | $4.89 | $2.15 | Insufficient EBITDA | ❌ Avoid |
| HCC | $33.93 | $89.05 | Above Fair Value | ⛔ Overvalued |
| HCI | $306.38 | $163.29 | 87.63% | ✅ Strong Buy |
| HCKT | $28.94 | $16.17 | 78.97% | ✅ Strong Buy |
| HCM | $15.40 | $15.18 | Avoid | ❌ Avoid |
| HCSG | $13.32 | $19.40 | Above Fair Value | ⛔ Overvalued |
| HD | $273.23 | $385.15 | Above Fair Value | ⛔ Overvalued |
| HDB | $26.35 | $34.46 | Above Fair Value | ⛔ Overvalued |
| HDSN | $6.16 | $7.41 | Above Fair Value | ⛔ Overvalued |
| HE | $10.13 | $17.08 | Insufficient EBITDA | ⛔ Overvalued |
| HEI | $112.99 | $326.67 | Above Fair Value | ⛔ Overvalued |
| HELE | $47.77 | $18.76 | Avoid | ❌ Avoid |
| HESM | $31.29 | $35.73 | Above Fair Value | ⚠️ See Analysis |
| HFBL | $19.56 | $18.44 | 6.07% | 👍 Buy |
| HFWA | $41.25 | $28.19 | 46.33% | ✅ Strong Buy |
| HG | $58.57 | $29.70 | 97.21% | ✅ Strong Buy |
| HGV | $59.14 | $47.64 | Avoid | ❌ Avoid |
| HHH | $45.11 | $82.04 | Avoid | ❌ Avoid |
| HI | $36.12 | $31.98 | Avoid | ❌ Avoid |
| HIFS | $338.37 | $333.37 | 1.50% | 👍 Buy |
| HIG | $164.67 | $142.56 | 15.51% | 👍 Buy |
| HII | $247.99 | $397.77 | Above Fair Value | ⛔ Overvalued |
| HIMS | $12.52 | $23.02 | Avoid | ❌ Avoid |
| HIPO | $8.15 | $29.50 | Insufficient EBITDA | ⛔ Overvalued |
| HIVE | $3.48 | $2.33 | 49.36% | ✅ Strong Buy |
| HIW | $8.41 | $26.01 | Above Fair Value | ⛔ Overvalued |
| HL | $11.46 | $22.77 | Above Fair Value | ⛔ Overvalued |
| HLF | $28.88 | $16.99 | 69.98% | ✅ Strong Buy |
| HLI | $148.93 | $172.96 | Above Fair Value | ⛔ Overvalued |
| HLIO | $40.21 | $72.52 | Above Fair Value | ⛔ Overvalued |
| HLIT | $7.28 | $10.10 | Above Fair Value | ⛔ Overvalued |
| HLMN | $8.50 | $10.48 | Above Fair Value | ⛔ Overvalued |
| HLN | $8.11 | $10.98 | Above Fair Value | ⛔ Overvalued |
| HLNE | $146.64 | $131.72 | 11.33% | 👍 Buy |
| HLT | $150.72 | $314.38 | Avoid | ❌ Avoid |
| HLX | $3.98 | $8.56 | Above Fair Value | ⛔ Overvalued |
| HMC | $38.92 | $32.82 | 18.59% | ✅ Strong Buy |
| HMN | $66.09 | $43.18 | 53.06% | ✅ Strong Buy |
| HMY | $25.46 | $20.37 | 24.99% | ✅ Strong Buy |
| HNI | $53.46 | $52.55 | 1.73% | 👍 Buy |
| HNNA | $11.68 | $9.88 | 18.22% | ✅ Strong Buy |
| HNRG | $8.65 | $20.06 | Insufficient EBITDA | ❌ Avoid |
| HNST | $2.17 | $2.29 | Above Fair Value | ⚠️ See Analysis |
| HNVR | $34.73 | $23.36 | 48.67% | ✅ Strong Buy |
| HOFT | $10.25 | $15.54 | Insufficient EBITDA | ❌ Avoid |
| HOG | $50.25 | $20.49 | Avoid | ❌ Avoid |
| HOLX | $64.76 | $74.81 | Above Fair Value | ⛔ Overvalued |
| HOMB | $35.03 | $30.59 | 14.51% | 👍 Buy |
| HON | $172.24 | $238.38 | Above Fair Value | ⛔ Overvalued |
| HOOD | $48.80 | $82.82 | Above Fair Value | ⛔ Overvalued |
| HOPE | $18.00 | $12.51 | 43.88% | ✅ Strong Buy |
| HOUS | $1.75 | $17.64 | Avoid | ❌ Avoid |
| HOV | $27.05 | $125.88 | Avoid | ❌ Avoid |
| HP | $7.47 | $35.97 | Above Fair Value | ⛔ Overvalued |
| HPE | $33.98 | $23.61 | Avoid | ❌ Avoid |
| HPK | $3.49 | $4.79 | Above Fair Value | ⛔ Overvalued |
| HPQ | $44.19 | $19.65 | 124.89% | ✅ Strong Buy |
| HQI | $8.90 | $10.95 | Above Fair Value | ⛔ Overvalued |
| HQY | $78.59 | $79.45 | Above Fair Value | ⚠️ See Analysis |
| HRB | $50.58 | $32.88 | 53.83% | ✅ Strong Buy |
| HRI | $101.71 | $180.31 | Avoid | ❌ Avoid |
| HRL | $21.90 | $24.93 | Above Fair Value | ⚠️ See Analysis |
| HRMY | $67.20 | $37.27 | 80.31% | ✅ Strong Buy |
| HROW | $19.65 | $47.32 | Avoid | ❌ Avoid |
| HRTG | $69.93 | $26.54 | 163.49% | ✅ Strong Buy |
| HSBC | $142.70 | $89.29 | 59.82% | ✅ Strong Buy |
| HSHP | $1.04 | $10.48 | Avoid | ❌ Avoid |
| HSIC | $70.01 | $79.72 | Above Fair Value | ⚠️ See Analysis |
| HSII | $44.58 | $59.01 | Above Fair Value | ⛔ Overvalued |
| HST | $13.09 | $19.35 | Above Fair Value | ⛔ Overvalued |
| HSTM | $13.50 | $20.09 | Above Fair Value | ⛔ Overvalued |
| HSY | $122.24 | $231.53 | Above Fair Value | ⛔ Overvalued |
| HTB | $43.64 | $44.55 | Above Fair Value | ⚠️ See Analysis |
| HTBK | $11.95 | $13.70 | Above Fair Value | ⚠️ See Analysis |
| HTCR | $1.90 | $0.26 | Insufficient EBITDA | ❌ Avoid |
| HTGC | $26.40 | $16.45 | 60.49% | ✅ Strong Buy |
| HTH | $24.45 | $39.83 | Above Fair Value | ⛔ Overvalued |
| HTLD | $5.32 | $11.47 | Above Fair Value | ⛔ Overvalued |
| HTO | $44.85 | $52.37 | Above Fair Value | ⛔ Overvalued |
| HUBB | $338.35 | $503.80 | Above Fair Value | ⛔ Overvalued |
| HUBG | $24.65 | $41.96 | Above Fair Value | ⛔ Overvalued |
| HUBS | $210.04 | $232.58 | Above Fair Value | ⚠️ See Analysis |
| HUM | $209.74 | $193.94 | 8.15% | 👍 Buy |
| HURN | $122.37 | $169.67 | Above Fair Value | ⛔ Overvalued |
| HUT | $0.59 | $53.06 | Above Fair Value | ⛔ Overvalued |
| HVT | $21.66 | $27.31 | Above Fair Value | ⛔ Overvalued |
| HWC | $100.92 | $74.41 | 35.63% | ✅ Strong Buy |
| HWKN | $56.91 | $134.38 | Above Fair Value | ⛔ Overvalued |
| HWM | $55.00 | $223.16 | Above Fair Value | ⛔ Overvalued |
| HXL | $31.06 | $86.00 | Above Fair Value | ⛔ Overvalued |
| HY | $1.78 | $36.48 | Avoid | ❌ Avoid |
| HZO | $14.07 | $29.98 | Avoid | ❌ Avoid |
| IAC | $6.78 | $35.65 | Insufficient EBITDA | ⛔ Overvalued |
| IAG | $23.88 | $19.12 | 24.90% | ✅ Strong Buy |
| IART | $31.96 | $11.26 | Avoid | ❌ Avoid |
| IAS | $14.24 | $10.34 | 37.72% | ✅ Strong Buy |
| IBCP | $46.17 | $36.60 | 26.15% | ✅ Strong Buy |
| IBKR | $54.76 | $74.59 | Above Fair Value | ⛔ Overvalued |
| IBM | $129.87 | $298.93 | Above Fair Value | ⛔ Overvalued |
| IBN | $30.72 | $31.18 | Above Fair Value | ⚠️ See Analysis |
| IBOC | $105.84 | $74.58 | 41.91% | ✅ Strong Buy |
| IBP | $160.87 | $328.92 | Above Fair Value | ⛔ Overvalued |
| IBTA | $29.20 | $20.54 | 42.16% | ✅ Strong Buy |
| ICE | $138.12 | $169.00 | Above Fair Value | ⛔ Overvalued |
| ICFI | $94.15 | $87.07 | 8.13% | 👍 Buy |
| ICHR | $6.54 | $32.15 | Avoid | ❌ Avoid |
| ICL | $6.14 | $5.49 | 11.84% | 👍 Buy |
| ICLR | $217.79 | $150.59 | 44.62% | ✅ Strong Buy |
| ICMB | $2.77 | $2.83 | Above Fair Value | ⚠️ See Analysis |
| ICUI | $111.23 | $154.16 | Above Fair Value | ⛔ Overvalued |
| IDA | $84.98 | $135.33 | Avoid | ❌ Avoid |
| IDT | $54.78 | $48.26 | 13.51% | 👍 Buy |
| IDXX | $320.72 | $644.61 | Above Fair Value | ⛔ Overvalued |
| IEP | $10.14 | $8.02 | Avoid | ❌ Avoid |
| IESC | $262.84 | $455.88 | Above Fair Value | ⛔ Overvalued |
| IEX | $133.91 | $211.37 | Above Fair Value | ⛔ Overvalued |
| IFF | $65.04 | $74.82 | Avoid | ❌ Avoid |
| IGIC | $30.00 | $25.60 | 17.19% | 👍 Buy |
| IHG | $83.34 | $144.83 | Above Fair Value | ⛔ Overvalued |
| IHRT | $5.67 | $3.24 | Avoid | ❌ Avoid |
| IHS | $10.22 | $8.22 | Insufficient EBITDA | ❌ Avoid |
| III | $4.78 | $5.24 | Above Fair Value | ⚠️ See Analysis |
| IIIN | $40.09 | $36.61 | 9.51% | 👍 Buy |
| IIIV | $21.24 | $20.97 | 1.29% | 👍 Buy |
| IIPR | $72.21 | $48.65 | 48.43% | ✅ Strong Buy |
| ILMN | $95.22 | $119.72 | Insufficient EBITDA | ⛔ Overvalued |
| IMAX | $22.79 | $37.28 | Above Fair Value | ⛔ Overvalued |
| IMKTA | $58.20 | $84.90 | Above Fair Value | ⛔ Overvalued |
| IMMR | $18.28 | $6.68 | 173.65% | ✅ Strong Buy |
| IMO | $102.02 | $112.68 | Above Fair Value | ⚠️ See Analysis |
| IMPP | $28.78 | $3.33 | 764.26% | ✅ Strong Buy |
| IMXI | $25.57 | $15.55 | 64.44% | ✅ Strong Buy |
| INBK | $42.66 | $22.00 | Insufficient EBITDA | ✅ Strong Buy |
| INCY | $106.44 | $108.39 | Above Fair Value | ⚠️ See Analysis |
| INDB | $122.57 | $86.01 | 42.51% | ✅ Strong Buy |
| INDV | $38.57 | $34.36 | 12.25% | 👍 Buy |
| INFU | $5.11 | $7.72 | Above Fair Value | ⛔ Overvalued |
| INFY | $16.62 | $16.84 | Above Fair Value | ⚠️ See Analysis |
| ING | $31.55 | $30.06 | 4.96% | 👍 Buy |
| INGM | $40.35 | $21.81 | 85.01% | ✅ Strong Buy |
| INGR | $155.93 | $120.11 | 29.82% | ✅ Strong Buy |
| INOD | $19.15 | $47.59 | Above Fair Value | ⛔ Overvalued |
| INSE | $7.61 | $8.70 | Above Fair Value | ⚠️ See Analysis |
| INSP | $39.44 | $65.70 | Above Fair Value | ⛔ Overvalued |
| INSW | $66.86 | $61.06 | 9.50% | 👍 Buy |
| INTA | $29.61 | $23.92 | Insufficient EBITDA | ❌ Avoid |
| INTC | $12.76 | $50.59 | Above Fair Value | ⛔ Overvalued |
| INTR | $16.76 | $8.87 | 88.95% | ✅ Strong Buy |
| INTU | $620.10 | $443.77 | 39.73% | ✅ Strong Buy |
| INVA | $31.45 | $21.80 | 44.27% | ✅ Strong Buy |
| INVH | $17.28 | $26.34 | Above Fair Value | ⛔ Overvalued |
| INVX | $19.74 | $25.35 | Above Fair Value | ⛔ Overvalued |
| IOSP | $68.22 | $86.31 | Above Fair Value | ⛔ Overvalued |
| IOT | $16.70 | $25.42 | Insufficient EBITDA | ⛔ Overvalued |
| IP | $14.32 | $46.58 | Avoid | ❌ Avoid |
| IPAR | $79.37 | $102.37 | Above Fair Value | ⛔ Overvalued |
| IPGP | $26.57 | $109.61 | Above Fair Value | ⛔ Overvalued |
| IPI | $11.75 | $32.88 | Above Fair Value | ⛔ Overvalued |
| IQV | $191.95 | $187.49 | Avoid | ❌ Avoid |
| IR | $47.43 | $98.50 | Above Fair Value | ⛔ Overvalued |
| IRDM | $15.02 | $20.00 | Avoid | ❌ Avoid |
| IREN | $27.18 | $41.83 | Above Fair Value | ⛔ Overvalued |
| IRM | $33.69 | $95.78 | Avoid | ❌ Avoid |
| IRMD | $37.63 | $95.97 | Above Fair Value | ⛔ Overvalued |
| IRS | $1.04 | $16.14 | Insufficient EBITDA | ⛔ Overvalued |
| IRT | $3.93 | $16.60 | Above Fair Value | ⛔ Overvalued |
| IRWD | $8.37 | $4.56 | 83.55% | ✅ Strong Buy |
| ISRG | $212.11 | $488.15 | Above Fair Value | ⛔ Overvalued |
| ISSC | $11.65 | $19.59 | Above Fair Value | ⛔ Overvalued |
| ISTR | $45.03 | $30.11 | 49.55% | ✅ Strong Buy |
| IT | $336.68 | $156.33 | 115.36% | ✅ Strong Buy |
| ITGR | $82.59 | $86.45 | Above Fair Value | ⚠️ See Analysis |
| ITIC | $248.21 | $279.27 | Above Fair Value | ⚠️ See Analysis |
| ITRI | $108.63 | $104.05 | 4.40% | 👍 Buy |
| ITRN | $57.89 | $45.96 | 25.96% | ✅ Strong Buy |
| ITT | $100.30 | $206.87 | Above Fair Value | ⛔ Overvalued |
| ITW | $190.16 | $293.57 | Above Fair Value | ⛔ Overvalued |
| IVR | $13.97 | $8.82 | 58.39% | ✅ Strong Buy |
| IVT | $14.47 | $30.42 | Above Fair Value | ⛔ Overvalued |
| IVZ | $31.48 | $26.82 | 17.38% | 👍 Buy |
| IX | $33.69 | $32.30 | Avoid | ❌ Avoid |
| J | $95.91 | $148.81 | Above Fair Value | ⛔ Overvalued |
| JACK | $60.38 | $22.77 | Avoid | ❌ Avoid |
| JAKK | $25.10 | $18.10 | 38.67% | ✅ Strong Buy |
| JAMF | $20.65 | $13.05 | Insufficient EBITDA | ❌ Avoid |
| JAZZ | $219.70 | $165.50 | Avoid | ❌ Avoid |
| JBHT | $134.83 | $227.91 | Above Fair Value | ⛔ Overvalued |
| JBI | $9.42 | $7.27 | 29.57% | ✅ Strong Buy |
| JBL | $184.16 | $258.25 | Above Fair Value | ⛔ Overvalued |
| JBSS | $89.09 | $78.61 | 13.33% | 👍 Buy |
| JBTM | $117.81 | $168.55 | Above Fair Value | ⛔ Overvalued |
| JCI | $66.57 | $137.65 | Above Fair Value | ⛔ Overvalued |
| JEF | $58.06 | $58.94 | Above Fair Value | ⚠️ See Analysis |
| JHG | $63.14 | $48.22 | 30.94% | ✅ Strong Buy |
| JHX | $22.27 | $23.64 | Avoid | ❌ Avoid |
| JILL | $33.51 | $16.80 | 99.46% | ✅ Strong Buy |
| JJSF | $71.10 | $82.54 | Above Fair Value | ⛔ Overvalued |
| JKHY | $124.42 | $173.36 | Above Fair Value | ⛔ Overvalued |
| JLL | $249.61 | $342.76 | Above Fair Value | ⛔ Overvalued |
| JMSB | $26.38 | $20.88 | 26.34% | ✅ Strong Buy |
| JNJ | $205.86 | $239.99 | Above Fair Value | ⛔ Overvalued |
| JOE | $29.07 | $68.56 | Above Fair Value | ⛔ Overvalued |
| JOUT | $20.92 | $46.88 | Above Fair Value | ⛔ Overvalued |
| JPM | $301.82 | $322.40 | Above Fair Value | ⚠️ See Analysis |
| JRSH | $3.66 | $3.07 | 19.22% | ✅ Strong Buy |
| JRVR | $15.91 | $7.04 | Insufficient EBITDA | ✅ Strong Buy |
| JVA | $3.12 | $3.10 | 0.65% | 👍 Buy |
| K | $44.95 | $83.44 | Above Fair Value | ⛔ Overvalued |
| KAI | $139.06 | $343.11 | Above Fair Value | ⛔ Overvalued |
| KALU | $77.15 | $138.51 | Avoid | ❌ Avoid |
| KBDC | $16.44 | $14.06 | 16.93% | 👍 Buy |
| KBH | $61.33 | $60.94 | 0.64% | 👍 Buy |
| KBR | $48.93 | $43.49 | 12.51% | 👍 Buy |
| KD | $66.54 | $23.49 | 183.27% | ✅ Strong Buy |
| KDP | $35.03 | $28.41 | Avoid | ❌ Avoid |
| KE | $17.57 | $26.29 | Above Fair Value | ⛔ Overvalued |
| KELYA | $18.07 | $11.11 | Avoid | ❌ Avoid |
| KEP | $79.69 | $21.56 | 269.62% | ✅ Strong Buy |
| KEX | $87.01 | $122.38 | Above Fair Value | ⛔ Overvalued |
| KEY | $29.02 | $23.21 | Insufficient EBITDA | ✅ Strong Buy |
| KEYS | $187.66 | $230.95 | Above Fair Value | ⛔ Overvalued |
| KFRC | $35.56 | $36.08 | Above Fair Value | ⚠️ See Analysis |
| KFY | $75.33 | $68.11 | 10.60% | 👍 Buy |
| KGC | $30.92 | $32.09 | Above Fair Value | ⚠️ See Analysis |
| KGS | $36.20 | $49.91 | Avoid | ❌ Avoid |
| KHC | $41.11 | $24.64 | Avoid | ❌ Avoid |
| KIM | $11.93 | $21.83 | Above Fair Value | ⛔ Overvalued |
| KINS | $28.69 | $16.05 | 78.75% | ✅ Strong Buy |
| KKR | $94.27 | $103.20 | Above Fair Value | ⚠️ See Analysis |
| KLAC | $1,017.14 | $1,442.95 | Above Fair Value | ⛔ Overvalued |
| KLC | $7.70 | $4.83 | Avoid | ❌ Avoid |
| KLIC | $32.79 | $70.92 | Above Fair Value | ⛔ Overvalued |
| KMB | $99.34 | $104.33 | Above Fair Value | ⚠️ See Analysis |
| KMI | $17.28 | $30.50 | Avoid | ❌ Avoid |
| KMPR | $50.66 | $34.24 | 47.96% | ✅ Strong Buy |
| KMT | $22.55 | $40.32 | Above Fair Value | ⛔ Overvalued |
| KMX | $41.46 | $47.17 | Avoid | ❌ Avoid |
| KN | $17.44 | $26.98 | Above Fair Value | ⛔ Overvalued |
| KNF | $45.51 | $80.00 | Above Fair Value | ⛔ Overvalued |
| KNOP | $10.17 | $10.39 | Avoid | ❌ Avoid |
| KNSA | $17.80 | $43.09 | Insufficient EBITDA | ⛔ Overvalued |
| KNSL | $475.94 | $414.10 | 14.93% | 👍 Buy |
| KNTK | $26.56 | $41.58 | Avoid | ❌ Avoid |
| KNX | $21.63 | $60.17 | Above Fair Value | ⛔ Overvalued |
| KO | $60.16 | $79.03 | Above Fair Value | ⛔ Overvalued |
| KOF | $103.06 | $110.90 | Above Fair Value | ⚠️ See Analysis |
| KOP | $51.36 | $32.30 | Avoid | ❌ Avoid |
| KR | $76.73 | $67.50 | 13.67% | 👍 Buy |
| KRC | $15.99 | $35.00 | Above Fair Value | ⛔ Overvalued |
| KREF | $5.74 | $7.32 | Above Fair Value | ⛔ Overvalued |
| KRG | $6.10 | $24.87 | Above Fair Value | ⛔ Overvalued |
| KRMN | $6.58 | $95.36 | Avoid | ❌ Avoid |
| KRNY | $11.69 | $8.15 | 43.44% | ✅ Strong Buy |
| KRO | $0.80 | $6.08 | Avoid | ❌ Avoid |
| KROS | $29.95 | $17.57 | Insufficient EBITDA | ✅ Strong Buy |
| KRP | $11.79 | $13.79 | Above Fair Value | ⛔ Overvalued |
| KRT | $23.66 | $25.85 | Above Fair Value | ⚠️ See Analysis |
| KRUS | $3.76 | $79.29 | Above Fair Value | ⛔ Overvalued |
| KRYS | $162.25 | $272.74 | Above Fair Value | ⛔ Overvalued |
| KSS | $18.12 | $18.50 | Above Fair Value | ⚠️ See Analysis |
| KTB | $71.60 | $67.03 | 6.82% | 👍 Buy |
| KTOS | $11.67 | $94.41 | Above Fair Value | ⛔ Overvalued |
| KVHI | $2.95 | $5.95 | Avoid | ❌ Avoid |
| KVUE | $16.75 | $18.13 | Above Fair Value | ⚠️ See Analysis |
| KVYO | $14.43 | $19.14 | Insufficient EBITDA | ❌ Avoid |
| KWR | $106.11 | $170.07 | Avoid | ❌ Avoid |
| L | $90.69 | $111.27 | Above Fair Value | ⛔ Overvalued |
| LAD | $440.79 | $344.24 | Avoid | ❌ Avoid |
| LADR | $10.04 | $10.27 | Above Fair Value | ⚠️ See Analysis |
| LAKE | $5.89 | $9.65 | Insufficient EBITDA | ❌ Avoid |
| LAMR | $110.48 | $133.23 | Above Fair Value | ⛔ Overvalued |
| LAR | $3.72 | $6.73 | Insufficient EBITDA | ❌ Avoid |
| LARK | $44.74 | $28.15 | 58.93% | ✅ Strong Buy |
| LASR | $5.34 | $51.12 | Insufficient EBITDA | ❌ Avoid |
| LAUR | $28.70 | $35.01 | Above Fair Value | ⛔ Overvalued |
| LAZ | $36.87 | $56.80 | Above Fair Value | ⛔ Overvalued |
| LB | $29.68 | $56.72 | Insufficient EBITDA | ⛔ Overvalued |
| LBRDA | $187.57 | $53.64 | 249.68% | ✅ Strong Buy |
| LBRDK | $91.45 | $53.76 | 70.11% | ✅ Strong Buy |
| LBRT | $12.88 | $25.23 | Above Fair Value | ⛔ Overvalued |
| LCII | $111.89 | $154.65 | Above Fair Value | ⛔ Overvalued |
| LCNB | $25.85 | $17.48 | 47.88% | ✅ Strong Buy |
| LCUT | $4.53 | $3.34 | Avoid | ❌ Avoid |
| LDI | $2.55 | $2.15 | Insufficient EBITDA | ✅ Strong Buy |
| LDOS | $201.20 | $192.99 | 4.25% | 👍 Buy |
| LE | $10.62 | $17.99 | Above Fair Value | ⛔ Overvalued |
| LEA | $167.53 | $140.95 | 18.86% | ✅ Strong Buy |
| LECO | $174.64 | $298.88 | Above Fair Value | ⛔ Overvalued |
| LEG | $13.69 | $12.89 | Insufficient EBITDA | 👍 Buy |
| LEN | $99.52 | $114.02 | Above Fair Value | ⚠️ See Analysis |
| LEN-B | $95.70 | $106.67 | Above Fair Value | ⚠️ See Analysis |
| LEU | $92.99 | $263.47 | Above Fair Value | ⛔ Overvalued |
| LEVI | $21.25 | $20.55 | 3.41% | 👍 Buy |
| LFST | $3.77 | $6.83 | Above Fair Value | ⛔ Overvalued |
| LFT | $3.24 | $1.35 | 140.00% | ✅ Strong Buy |
| LFUS | $191.56 | $349.68 | Above Fair Value | ⛔ Overvalued |
| LFVN | $20.05 | $5.03 | 298.61% | ✅ Strong Buy |
| LGIH | $58.45 | $59.12 | Avoid | ❌ Avoid |
| LGND | $169.26 | $190.44 | Above Fair Value | ⚠️ See Analysis |
| LHX | $160.16 | $349.66 | Above Fair Value | ⛔ Overvalued |
| LIEN | $17.52 | $10.11 | 73.29% | ✅ Strong Buy |
| LIF | $24.86 | $54.41 | Above Fair Value | ⛔ Overvalued |
| LII | $463.93 | $529.98 | Above Fair Value | ⚠️ See Analysis |
| LILA | $3.43 | $8.00 | Avoid | ❌ Avoid |
| LILAK | $3.41 | $8.08 | Avoid | ❌ Avoid |
| LIN | $303.08 | $448.24 | Above Fair Value | ⛔ Overvalued |
| LINC | $9.30 | $26.13 | Above Fair Value | ⛔ Overvalued |
| LIND | $4.00 | $20.07 | Avoid | ❌ Avoid |
| LION | $4.62 | $9.04 | Above Fair Value | ⛔ Overvalued |
| LITE | $164.22 | $551.99 | Avoid | ❌ Avoid |
| LIVN | $58.26 | $66.56 | Avoid | ❌ Avoid |
| LKFN | $73.03 | $62.62 | 16.62% | 👍 Buy |
| LKQ | $44.82 | $34.58 | 29.61% | ✅ Strong Buy |
| LLY | $672.30 | $1,058.18 | Above Fair Value | ⛔ Overvalued |
| LLYVA | $29.73 | $80.01 | Insufficient EBITDA | ❌ Avoid |
| LLYVK | $27.49 | $81.46 | Insufficient EBITDA | ❌ Avoid |
| LMAT | $42.26 | $87.42 | Above Fair Value | ⛔ Overvalued |
| LMB | $51.63 | $86.13 | Above Fair Value | ⛔ Overvalued |
| LMNR | $9.74 | $14.45 | Insufficient EBITDA | ❌ Avoid |
| LMT | $373.34 | $623.58 | Above Fair Value | ⛔ Overvalued |
| LNC | $84.56 | $40.31 | 109.77% | ✅ Strong Buy |
| LNG | $243.15 | $213.11 | 14.10% | 👍 Buy |
| LNKB | $11.55 | $9.29 | 24.33% | ✅ Strong Buy |
| LNN | $100.37 | $134.03 | Above Fair Value | ⛔ Overvalued |
| LNT | $46.54 | $66.69 | Avoid | ❌ Avoid |
| LNTH | $84.53 | $64.89 | 30.27% | ✅ Strong Buy |
| LOAN | $3.97 | $4.51 | Above Fair Value | ⚠️ See Analysis |
| LOAR | $11.42 | $65.55 | Above Fair Value | ⛔ Overvalued |
| LOB | $63.64 | $40.83 | 55.87% | ✅ Strong Buy |
| LOCO | $13.03 | $10.94 | 19.10% | ✅ Strong Buy |
| LOGI | $99.27 | $91.45 | 8.55% | 👍 Buy |
| LOPE | $164.38 | $169.72 | Above Fair Value | ⚠️ See Analysis |
| LOVE | $24.21 | $13.22 | 83.13% | ✅ Strong Buy |
| LOW | $226.66 | $278.38 | Above Fair Value | ⛔ Overvalued |
| LPG | $37.46 | $32.35 | 15.80% | 👍 Buy |
| LPL | $4.52 | $3.96 | 14.14% | 👍 Buy |
| LPLA | $335.58 | $385.14 | Above Fair Value | ⚠️ See Analysis |
| LPRO | $1.70 | $1.69 | Insufficient EBITDA | 👍 Buy |
| LPX | $42.69 | $96.97 | Above Fair Value | ⛔ Overvalued |
| LQDT | $24.20 | $32.51 | Above Fair Value | ⛔ Overvalued |
| LRCX | $136.80 | $231.01 | Above Fair Value | ⛔ Overvalued |
| LRN | $130.65 | $87.83 | 48.75% | ✅ Strong Buy |
| LSBK | $13.89 | $15.37 | Above Fair Value | ⚠️ See Analysis |
| LSCC | $24.88 | $86.41 | Above Fair Value | ⛔ Overvalued |
| LSTR | $86.12 | $162.08 | Above Fair Value | ⛔ Overvalued |
| LTC | $19.98 | $37.39 | Above Fair Value | ⛔ Overvalued |
| LTH | $29.25 | $29.82 | Above Fair Value | ⚠️ See Analysis |
| LTM | $78.70 | $64.84 | 21.38% | ✅ Strong Buy |
| LUCK | $6.57 | $6.63 | Avoid | ❌ Avoid |
| LULU | $247.89 | $172.85 | 43.41% | ✅ Strong Buy |
| LUNR | $1.09 | $17.52 | Insufficient EBITDA | ❌ Avoid |
| LUV | $25.92 | $54.26 | Above Fair Value | ⛔ Overvalued |
| LVS | $55.56 | $57.80 | Above Fair Value | ⚠️ See Analysis |
| LW | $59.79 | $50.12 | 19.29% | ✅ Strong Buy |
| LXFR | $15.58 | $15.50 | 0.52% | 👍 Buy |
| LXP | $22.63 | $51.55 | Above Fair Value | ⛔ Overvalued |
| LXU | $6.09 | $9.66 | Avoid | ❌ Avoid |
| LYB | $26.90 | $55.10 | Avoid | ❌ Avoid |
| LYFT | $10.10 | $16.46 | Above Fair Value | ⛔ Overvalued |
| LYG | $6.11 | $5.91 | 3.38% | 👍 Buy |
| LYTS | $16.32 | $22.89 | Above Fair Value | ⛔ Overvalued |
| LYV | $29.34 | $140.84 | Above Fair Value | ⛔ Overvalued |
| LZ | $10.98 | $8.05 | 36.40% | ✅ Strong Buy |
| LZB | $37.75 | $38.80 | Above Fair Value | ⚠️ See Analysis |
| M | $23.12 | $22.70 | 1.85% | 👍 Buy |
| MA | $474.83 | $548.74 | Above Fair Value | ⛔ Overvalued |
| MAA | $72.83 | $132.13 | Above Fair Value | ⛔ Overvalued |
| MAN | $44.15 | $36.64 | Avoid | ❌ Avoid |
| MANH | $131.65 | $145.07 | Above Fair Value | ⚠️ See Analysis |
| MANU | $3.89 | $17.34 | Above Fair Value | ⛔ Overvalued |
| MAPS | $2.28 | $0.72 | 216.67% | ✅ Strong Buy |
| MAR | $215.21 | $333.24 | Above Fair Value | ⛔ Overvalued |
| MARA | $9.73 | $8.24 | 18.08% | ✅ Strong Buy |
| MAS | $82.43 | $72.87 | 13.12% | 👍 Buy |
| MASI | $116.82 | $139.15 | Insufficient EBITDA | ❌ Avoid |
| MAT | $22.93 | $21.49 | 6.70% | 👍 Buy |
| MATV | $10.45 | $14.55 | Avoid | ❌ Avoid |
| MATW | $16.59 | $27.16 | Avoid | ❌ Avoid |
| MATX | $161.12 | $162.94 | Above Fair Value | ⚠️ See Analysis |
| MAX | $24.47 | $8.95 | 173.41% | ✅ Strong Buy |
| MBC | $13.03 | $13.59 | Above Fair Value | ⚠️ See Analysis |
| MBCN | $37.45 | $34.86 | 7.43% | 👍 Buy |
| MBI | $7.83 | $6.58 | Insufficient EBITDA | ✅ Strong Buy |
| MBIN | $70.12 | $42.48 | 65.07% | ✅ Strong Buy |
| MBLY | $7.16 | $8.71 | Above Fair Value | ⛔ Overvalued |
| MBUU | $27.47 | $31.24 | Above Fair Value | ⚠️ See Analysis |
| MBWM | $82.53 | $54.71 | 50.85% | ✅ Strong Buy |
| MC | $46.14 | $73.25 | Above Fair Value | ⛔ Overvalued |
| MCB | $167.63 | $96.39 | 73.91% | ✅ Strong Buy |
| MCBS | $29.13 | $29.97 | Above Fair Value | ⚠️ See Analysis |
| MCD | $260.03 | $327.16 | Above Fair Value | ⛔ Overvalued |
| MCFT | $22.31 | $25.17 | Above Fair Value | ⚠️ See Analysis |
| MCHP | $45.87 | $76.01 | Avoid | ❌ Avoid |
| MCK | $569.87 | $948.68 | Above Fair Value | ⛔ Overvalued |
| MCO | $352.75 | $452.49 | Above Fair Value | ⛔ Overvalued |
| MCRB | $11.25 | $13.96 | Insufficient EBITDA | ⛔ Overvalued |
| MCRI | $87.03 | $98.87 | Above Fair Value | ⚠️ See Analysis |
| MCS | $5.92 | $15.62 | Above Fair Value | ⛔ Overvalued |
| MCW | $10.05 | $6.14 | 63.68% | ✅ Strong Buy |
| MCY | $101.53 | $95.19 | 6.66% | 👍 Buy |
| MD | $31.18 | $20.89 | Insufficient EBITDA | ✅ Strong Buy |
| MDB | $112.25 | $344.35 | Insufficient EBITDA | ❌ Avoid |
| MDBH | $22.79 | $3.21 | 609.97% | ✅ Strong Buy |
| MDGL | $39.17 | $477.60 | Insufficient EBITDA | ❌ Avoid |
| MDLN | $17.86 | $47.30 | Above Fair Value | ⛔ Overvalued |
| MDLZ | $43.01 | $60.02 | Avoid | ❌ Avoid |
| MDT | $93.69 | $102.90 | Above Fair Value | ⚠️ See Analysis |
| MDU | $12.18 | $20.34 | Avoid | ❌ Avoid |
| MDV | $1.62 | $15.30 | Above Fair Value | ⛔ Overvalued |
| MDXG | $4.45 | $5.15 | Above Fair Value | ⛔ Overvalued |
| MED | $0.36 | $11.36 | Above Fair Value | ⛔ Overvalued |
| MEDP | $316.84 | $542.04 | Above Fair Value | ⛔ Overvalued |
| MEG | $21.57 | $24.69 | Avoid | ❌ Avoid |
| MEI | $5.93 | $9.09 | Avoid | ❌ Avoid |
| MEOH | $45.97 | $47.23 | Above Fair Value | ⚠️ See Analysis |
| MESO | $1.20 | $15.95 | Insufficient EBITDA | ❌ Avoid |
| MET | $115.82 | $76.38 | 51.64% | ✅ Strong Buy |
| META | $538.65 | $661.46 | Above Fair Value | ⛔ Overvalued |
| MFA | $20.73 | $9.74 | 112.83% | ✅ Strong Buy |
| MFC | $34.62 | $38.04 | Above Fair Value | ⚠️ See Analysis |
| MFIC | $16.86 | $11.31 | 49.07% | ✅ Strong Buy |
| MFIN | $23.06 | $10.34 | 123.02% | ✅ Strong Buy |
| MG | $12.47 | $14.67 | Above Fair Value | ⛔ Overvalued |
| MGA | $68.58 | $54.02 | 26.95% | ✅ Strong Buy |
| MGEE | $48.40 | $79.58 | Above Fair Value | ⛔ Overvalued |
| MGIC | $17.79 | $21.85 | Above Fair Value | ⛔ Overvalued |
| MGM | $31.24 | $37.49 | Above Fair Value | ⛔ Overvalued |
| MGNI | $16.97 | $11.29 | 50.31% | ✅ Strong Buy |
| MGPI | $33.68 | $26.27 | Avoid | ❌ Avoid |
| MGRC | $83.72 | $119.43 | Above Fair Value | ⛔ Overvalued |
| MGY | $24.88 | $26.99 | Above Fair Value | ⚠️ See Analysis |
| MGYR | $24.56 | $18.40 | 33.48% | ✅ Strong Buy |
| MHK | $163.18 | $131.89 | 23.72% | ✅ Strong Buy |
| MHO | $170.76 | $141.86 | 20.37% | ✅ Strong Buy |
| MIDD | $151.64 | $161.11 | Avoid | ❌ Avoid |
| MIR | $8.74 | $24.07 | Above Fair Value | ⛔ Overvalued |
| MIRM | $0.27 | $100.47 | Insufficient EBITDA | ❌ Avoid |
| MITK | $22.39 | $11.83 | 89.26% | ✅ Strong Buy |
| MITT | $12.87 | $8.48 | 51.77% | ✅ Strong Buy |
| MKC | $52.69 | $67.42 | Above Fair Value | ⛔ Overvalued |
| MKC-V | $50.40 | $67.21 | Above Fair Value | ⛔ Overvalued |
| MKL | $1,629.53 | $2,102.15 | Above Fair Value | ⛔ Overvalued |
| MKSI | $134.98 | $242.96 | Avoid | ❌ Avoid |
| MKTX | $152.15 | $162.33 | Above Fair Value | ⚠️ See Analysis |
| MLAB | $107.02 | $93.27 | Avoid | ❌ Avoid |
| MLCO | $10.63 | $6.35 | Avoid | ❌ Avoid |
| MLI | $98.25 | $117.86 | Above Fair Value | ⛔ Overvalued |
| MLKN | $28.52 | $22.54 | Avoid | ❌ Avoid |
| MLM | $321.82 | $690.00 | Above Fair Value | ⛔ Overvalued |
| MLR | $36.97 | $44.60 | Above Fair Value | ⛔ Overvalued |
| MMI | $9.90 | $26.60 | Above Fair Value | ⛔ Overvalued |
| MMM | $104.24 | $172.65 | Above Fair Value | ⛔ Overvalued |
| MMS | $133.70 | $75.08 | 78.08% | ✅ Strong Buy |
| MMSI | $55.51 | $82.50 | Above Fair Value | ⛔ Overvalued |
| MMYT | $28.98 | $57.10 | Avoid | ❌ Avoid |
| MNDY | $122.15 | $98.00 | 24.64% | ✅ Strong Buy |
| MNKD | $2.84 | $5.78 | Above Fair Value | ⛔ Overvalued |
| MNR | $12.24 | $12.33 | Above Fair Value | ⚠️ See Analysis |
| MNRO | $9.47 | $21.00 | Above Fair Value | ⛔ Overvalued |
| MNSB | $29.61 | $22.86 | 29.53% | ✅ Strong Buy |
| MNST | $40.68 | $82.54 | Above Fair Value | ⛔ Overvalued |
| MNTK | $1.50 | $1.81 | Above Fair Value | ⛔ Overvalued |
| MO | $46.47 | $65.40 | Above Fair Value | ⛔ Overvalued |
| MOD | $62.75 | $215.72 | Above Fair Value | ⛔ Overvalued |
| MOFG | $46.76 | $48.18 | Insufficient EBITDA | ⚠️ See Analysis |
| MOH | $190.16 | $131.72 | 44.37% | ✅ Strong Buy |
| MORN | $194.53 | $165.47 | 17.56% | 👍 Buy |
| MOS | $35.60 | $28.60 | 24.48% | ✅ Strong Buy |
| MOV | $15.62 | $24.50 | Above Fair Value | ⛔ Overvalued |
| MP | $8.12 | $61.26 | Avoid | ❌ Avoid |
| MPAA | $17.34 | $13.14 | 31.96% | ✅ Strong Buy |
| MPB | $52.53 | $34.61 | 51.78% | ✅ Strong Buy |
| MPC | $156.30 | $203.00 | Above Fair Value | ⛔ Overvalued |
| MPLX | $61.96 | $56.00 | 10.64% | 👍 Buy |
| MPTI | $47.16 | $64.38 | Above Fair Value | ⛔ Overvalued |
| MPW | $1.60 | $5.02 | Above Fair Value | ⛔ Overvalued |
| MPWR | $397.98 | $1,229.82 | Above Fair Value | ⛔ Overvalued |
| MPX | $5.37 | $8.22 | Above Fair Value | ⛔ Overvalued |
| MRAM | $5.31 | $10.92 | Above Fair Value | ⛔ Overvalued |
| MRBK | $26.17 | $20.71 | 26.36% | ✅ Strong Buy |
| MRCC | $6.99 | $6.33 | 10.43% | 👍 Buy |
| MRCY | $20.07 | $82.20 | Avoid | ❌ Avoid |
| MRK | $119.10 | $121.93 | Above Fair Value | ⚠️ See Analysis |
| MRP | $40.24 | $31.69 | Insufficient EBITDA | ❌ Avoid |
| MRTN | $3.50 | $13.56 | Above Fair Value | ⛔ Overvalued |
| MRVL | $54.96 | $80.28 | Above Fair Value | ⛔ Overvalued |
| MRX | $64.12 | $40.48 | 58.40% | ✅ Strong Buy |
| MS | $147.70 | $179.96 | Above Fair Value | ⛔ Overvalued |
| MSA | $126.11 | $193.13 | Above Fair Value | ⛔ Overvalued |
| MSB | $16.66 | $35.20 | Above Fair Value | ⛔ Overvalued |
| MSBI | $22.55 | $23.98 | Insufficient EBITDA | ⚠️ See Analysis |
| MSCI | $469.57 | $557.78 | Above Fair Value | ⛔ Overvalued |
| MSDL | $22.29 | $15.18 | 46.84% | ✅ Strong Buy |
| MSEX | $37.31 | $51.24 | Avoid | ❌ Avoid |
| MSFT | $402.94 | $401.14 | 0.45% | 👍 Buy |
| MSGE | $25.10 | $60.85 | Avoid | ❌ Avoid |
| MSI | $308.93 | $422.18 | Above Fair Value | ⛔ Overvalued |
| MSM | $68.28 | $95.56 | Above Fair Value | ⛔ Overvalued |
| MSTR | $513.33 | $134.93 | Insufficient EBITDA | ✅ Strong Buy |
| MT | $50.08 | $61.30 | Above Fair Value | ⛔ Overvalued |
| MTB | $311.39 | $238.01 | 30.83% | ✅ Strong Buy |
| MTCH | $64.70 | $31.63 | 104.55% | ✅ Strong Buy |
| MTD | $997.11 | $1,373.57 | Above Fair Value | ⛔ Overvalued |
| MTDR | $77.53 | $47.35 | 63.74% | ✅ Strong Buy |
| MTG | $41.35 | $27.31 | 51.41% | ✅ Strong Buy |
| MTH | $78.40 | $75.91 | 3.28% | 👍 Buy |
| MTN | $131.27 | $138.64 | Avoid | ❌ Avoid |
| MTRN | $71.63 | $151.37 | Above Fair Value | ⛔ Overvalued |
| MTSI | $91.87 | $235.87 | Avoid | ❌ Avoid |
| MTUS | $10.71 | $21.30 | Above Fair Value | ⛔ Overvalued |
| MTW | $7.96 | $15.03 | Avoid | ❌ Avoid |
| MTX | $77.12 | $72.77 | Avoid | ❌ Avoid |
| MTZ | $99.98 | $259.16 | Above Fair Value | ⛔ Overvalued |
| MU | $555.56 | $394.69 | 40.76% | ✅ Strong Buy |
| MUFG | $13.13 | $19.14 | Above Fair Value | ⛔ Overvalued |
| MUSA | $383.30 | $377.89 | 1.43% | 👍 Buy |
| MVBF | $18.60 | $28.90 | Above Fair Value | ⛔ Overvalued |
| MVO | $20.33 | $1.41 | 1,341.84% | ✅ Strong Buy |
| MVST | $3.09 | $2.53 | Insufficient EBITDA | ❌ Avoid |
| MWA | $21.15 | $29.18 | Above Fair Value | ⛔ Overvalued |
| MXL | $19.93 | $18.72 | Insufficient EBITDA | ❌ Avoid |
| MYE | $15.83 | $22.17 | Above Fair Value | ⛔ Overvalued |
| MYGN | $0.46 | $5.12 | Insufficient EBITDA | ❌ Avoid |
| MYRG | $110.24 | $268.76 | Above Fair Value | ⛔ Overvalued |
| MZTI | $117.34 | $154.74 | Above Fair Value | ⛔ Overvalued |
| NABL | $8.33 | $5.61 | 48.48% | ✅ Strong Buy |
| NAGE | $4.42 | $5.20 | Above Fair Value | ⛔ Overvalued |
| NAT | $2.13 | $4.26 | Avoid | ❌ Avoid |
| NATH | $94.45 | $101.20 | Above Fair Value | ⚠️ See Analysis |
| NATL | $78.86 | $40.17 | 96.32% | ✅ Strong Buy |
| NATR | $12.70 | $26.33 | Above Fair Value | ⛔ Overvalued |
| NAVI | $11.04 | $10.05 | 9.85% | 👍 Buy |
| NBBK | $40.25 | $22.37 | 79.93% | ✅ Strong Buy |
| NBHC | $45.04 | $41.75 | 7.88% | 👍 Buy |
| NBIS | $15.18 | $86.10 | Insufficient EBITDA | ❌ Avoid |
| NBIX | $133.05 | $141.20 | Above Fair Value | ⚠️ See Analysis |
| NBN | $169.01 | $125.34 | 34.84% | ✅ Strong Buy |
| NBR | $116.00 | $69.78 | 66.24% | ✅ Strong Buy |
| NBTB | $67.75 | $46.65 | 45.23% | ✅ Strong Buy |
| NBTX | $15.95 | $20.85 | Insufficient EBITDA | ❌ Avoid |
| NC | $41.64 | $54.20 | Above Fair Value | ⛔ Overvalued |
| NCDL | $13.61 | $13.49 | 0.89% | 👍 Buy |
| NCI | $3.40 | $1.15 | 195.65% | ✅ Strong Buy |
| NCLH | $38.85 | $23.32 | Avoid | ❌ Avoid |
| NCMI | $1.25 | $3.58 | Above Fair Value | ⛔ Overvalued |
| NCNO | $18.92 | $18.15 | Avoid | ❌ Avoid |
| NCSM | $56.55 | $38.67 | 46.24% | ✅ Strong Buy |
| NDAQ | $58.68 | $84.83 | Above Fair Value | ⛔ Overvalued |
| NDSN | $201.34 | $290.18 | Above Fair Value | ⛔ Overvalued |
| NE | $12.65 | $39.20 | Above Fair Value | ⛔ Overvalued |
| NECB | $48.26 | $24.75 | 94.99% | ✅ Strong Buy |
| NEE | $56.39 | $89.47 | Avoid | ❌ Avoid |
| NEM | $89.58 | $115.32 | Above Fair Value | ⛔ Overvalued |
| NEN | $70.35 | $63.75 | Avoid | ❌ Avoid |
| NEO | $2.10 | $11.42 | Insufficient EBITDA | ❌ Avoid |
| NEOG | $5.13 | $10.80 | Insufficient EBITDA | ❌ Avoid |
| NET | $20.63 | $173.21 | Avoid | ❌ Avoid |
| NEU | $650.25 | $723.90 | Above Fair Value | ⚠️ See Analysis |
| NEWT | $28.52 | $13.94 | 104.59% | ✅ Strong Buy |
| NFBK | $17.50 | $13.87 | 26.17% | ✅ Strong Buy |
| NFG | $95.85 | $85.77 | 11.75% | 👍 Buy |
| NFLX | $60.02 | $82.20 | Above Fair Value | ⛔ Overvalued |
| NGD | $15.11 | $10.57 | 42.95% | ✅ Strong Buy |
| NGG | $93.24 | $88.06 | 5.88% | 👍 Buy |
| NGS | $25.23 | $36.48 | Above Fair Value | ⛔ Overvalued |
| NGVC | $30.17 | $26.43 | 14.15% | 👍 Buy |
| NGVT | $62.86 | $72.69 | Insufficient EBITDA | ❌ Avoid |
| NHC | $81.41 | $161.57 | Above Fair Value | ⛔ Overvalued |
| NHI | $41.97 | $84.07 | Above Fair Value | ⛔ Overvalued |
| NI | $26.31 | $44.10 | Avoid | ❌ Avoid |
| NIC | $196.93 | $152.25 | 29.35% | ✅ Strong Buy |
| NJR | $47.01 | $52.42 | Avoid | ❌ Avoid |
| NKE | $35.21 | $63.92 | Above Fair Value | ⛔ Overvalued |
| NKSH | $29.36 | $38.94 | Above Fair Value | ⛔ Overvalued |
| NL | $6.94 | $6.19 | 12.12% | 👍 Buy |
| NLY | $36.96 | $22.85 | 61.75% | ✅ Strong Buy |
| NMFC | $18.03 | $7.96 | 126.51% | ✅ Strong Buy |
| NMIH | $63.67 | $41.05 | 55.10% | ✅ Strong Buy |
| NMM | $133.41 | $60.22 | 121.54% | ✅ Strong Buy |
| NMR | $9.90 | $9.12 | Avoid | ❌ Avoid |
| NMRK | $22.65 | $16.85 | Avoid | ❌ Avoid |
| NNBR | $1.95 | $1.63 | Avoid | ❌ Avoid |
| NNI | $121.13 | $132.12 | Avoid | ❌ Avoid |
| NNN | $30.28 | $42.91 | Above Fair Value | ⛔ Overvalued |
| NOC | $427.31 | $709.11 | Above Fair Value | ⛔ Overvalued |
| NODK | $1.51 | $13.57 | Above Fair Value | ⛔ Overvalued |
| NOG | $52.81 | $25.64 | 105.97% | ✅ Strong Buy |
| NOK | $4.25 | $7.07 | Above Fair Value | ⛔ Overvalued |
| NOMD | $24.99 | $12.90 | Avoid | ❌ Avoid |
| NOV | $14.10 | $18.91 | Above Fair Value | ⛔ Overvalued |
| NOVT | $60.31 | $141.47 | Above Fair Value | ⛔ Overvalued |
| NOW | $87.33 | $100.74 | Above Fair Value | ⛔ Overvalued |
| NPB | $32.64 | $17.23 | Insufficient EBITDA | ✅ Strong Buy |
| NPKI | $6.19 | $14.11 | Above Fair Value | ⛔ Overvalued |
| NPO | $108.53 | $267.57 | Above Fair Value | ⛔ Overvalued |
| NRC | $15.81 | $15.94 | Above Fair Value | ⚠️ See Analysis |
| NRDS | $31.59 | $10.54 | 199.72% | ✅ Strong Buy |
| NREF | $12.90 | $14.85 | Above Fair Value | ⛔ Overvalued |
| NRG | $119.05 | $153.32 | Above Fair Value | ⛔ Overvalued |
| NRIM | $40.06 | $25.85 | 54.97% | ✅ Strong Buy |
| NRP | $82.30 | $120.39 | Above Fair Value | ⛔ Overvalued |
| NRT | $5.20 | $9.26 | Above Fair Value | ⛔ Overvalued |
| NRXP | $1.94 | $1.91 | Insufficient EBITDA | ❌ Avoid |
| NSA | $8.81 | $32.68 | Above Fair Value | ⛔ Overvalued |
| NSC | $185.06 | $306.48 | Above Fair Value | ⛔ Overvalued |
| NSIT | $122.43 | $89.14 | 37.35% | ✅ Strong Buy |
| NSP | $31.46 | $38.92 | Above Fair Value | ⛔ Overvalued |
| NSSC | $23.22 | $43.65 | Above Fair Value | ⛔ Overvalued |
| NTAP | $133.11 | $103.34 | 28.81% | ✅ Strong Buy |
| NTB | $85.11 | $53.08 | 60.34% | ✅ Strong Buy |
| NTCT | $42.02 | $27.67 | Insufficient EBITDA | ✅ Strong Buy |
| NTGR | $4.48 | $20.50 | Insufficient EBITDA | ❌ Avoid |
| NTIC | $5.21 | $9.09 | Above Fair Value | ⛔ Overvalued |
| NTNX | $43.56 | $40.26 | 8.20% | 👍 Buy |
| NTR | $71.51 | $68.61 | 4.23% | 👍 Buy |
| NTRS | $153.97 | $152.15 | 1.20% | 👍 Buy |
| NTST | $4.78 | $19.33 | Above Fair Value | ⛔ Overvalued |
| NU | $15.87 | $17.40 | Above Fair Value | ⚠️ See Analysis |
| NUE | $143.08 | $192.84 | Above Fair Value | ⛔ Overvalued |
| NUS | $20.76 | $10.81 | Insufficient EBITDA | ✅ Strong Buy |
| NUVB | $8.22 | $5.70 | Insufficient EBITDA | ❌ Avoid |
| NVAX | $29.64 | $8.25 | Insufficient EBITDA | ✅ Strong Buy |
| NVDA | $183.27 | $185.41 | Above Fair Value | ⚠️ See Analysis |
| NVEC | $47.17 | $64.70 | Above Fair Value | ⛔ Overvalued |
| NVGS | $19.94 | $18.23 | 9.38% | 👍 Buy |
| NVMI | $145.96 | $459.95 | Above Fair Value | ⛔ Overvalued |
| NVR | $7,193.45 | $8,009.84 | Above Fair Value | ⚠️ See Analysis |
| NVS | $145.65 | $156.42 | Above Fair Value | ⚠️ See Analysis |
| NVST | $19.68 | $29.10 | Above Fair Value | ⛔ Overvalued |
| NVT | $62.83 | $112.64 | Above Fair Value | ⛔ Overvalued |
| NWBI | $19.39 | $13.34 | 45.35% | ✅ Strong Buy |
| NWE | $50.28 | $68.18 | Avoid | ❌ Avoid |
| NWFL | $53.80 | $31.89 | 68.70% | ✅ Strong Buy |
| NWL | $7.14 | $4.63 | Avoid | ❌ Avoid |
| NWN | $40.59 | $48.07 | Avoid | ❌ Avoid |
| NWPX | $39.95 | $74.32 | Above Fair Value | ⛔ Overvalued |
| NWS | $18.67 | $25.65 | Above Fair Value | ⛔ Overvalued |
| NWSA | $18.60 | $22.50 | Above Fair Value | ⛔ Overvalued |
| NX | $27.73 | $21.29 | Insufficient EBITDA | ❌ Avoid |
| NXPI | $242.63 | $224.32 | 8.16% | 👍 Buy |
| NXST | $299.44 | $221.27 | 35.33% | ✅ Strong Buy |
| NXT | $78.77 | $121.37 | Above Fair Value | ⛔ Overvalued |
| NYT | $42.26 | $68.11 | Above Fair Value | ⛔ Overvalued |
| O | $23.46 | $63.23 | Above Fair Value | ⛔ Overvalued |
| OBDC | $19.16 | $11.46 | 67.19% | ✅ Strong Buy |
| OBK | $48.74 | $45.63 | 6.82% | 👍 Buy |
| OBT | $44.13 | $35.21 | 25.33% | ✅ Strong Buy |
| OC | $148.58 | $135.74 | Avoid | ❌ Avoid |
| OCFC | $30.75 | $19.78 | 55.46% | ✅ Strong Buy |
| OCSL | $19.81 | $12.14 | 63.18% | ✅ Strong Buy |
| ODC | $45.66 | $64.31 | Above Fair Value | ⛔ Overvalued |
| ODD | $53.52 | $30.07 | 77.98% | ✅ Strong Buy |
| ODFL | $71.87 | $202.47 | Above Fair Value | ⛔ Overvalued |
| ODP | $36.18 | $28.00 | 29.21% | ✅ Strong Buy |
| OEC | $9.35 | $7.05 | Avoid | ❌ Avoid |
| OFG | $60.39 | $40.94 | 47.51% | ✅ Strong Buy |
| OFIX | $10.59 | $12.80 | Insufficient EBITDA | ❌ Avoid |
| OFLX | $30.97 | $37.32 | Above Fair Value | ⛔ Overvalued |
| OFS | $12.25 | $4.46 | 174.66% | ✅ Strong Buy |
| OGE | $32.69 | $43.96 | Avoid | ❌ Avoid |
| OGN | $94.69 | $8.21 | Avoid | ❌ Avoid |
| OGS | $65.17 | $82.49 | Avoid | ❌ Avoid |
| OHI | $27.42 | $45.28 | Above Fair Value | ⛔ Overvalued |
| OI | $19.90 | $16.63 | Avoid | ❌ Avoid |
| OII | $22.88 | $32.19 | Above Fair Value | ⛔ Overvalued |
| OIS | $4.31 | $9.10 | Above Fair Value | ⛔ Overvalued |
| OKE | $86.60 | $81.84 | Avoid | ❌ Avoid |
| OKTA | $84.99 | $86.74 | Above Fair Value | ⚠️ See Analysis |
| OLED | $122.62 | $121.11 | 1.25% | 👍 Buy |
| OLLI | $71.23 | $112.50 | Above Fair Value | ⛔ Overvalued |
| OLN | $6.26 | $24.83 | Avoid | ❌ Avoid |
| OLP | $11.66 | $22.44 | Above Fair Value | ⛔ Overvalued |
| OLPX | $1.47 | $1.50 | Above Fair Value | ⚠️ See Analysis |
| OMAB | $134.08 | $124.48 | 7.71% | 👍 Buy |
| OMC | $97.08 | $69.87 | 38.94% | ✅ Strong Buy |
| OMCL | $27.44 | $37.07 | Above Fair Value | ⛔ Overvalued |
| OMER | $6.78 | $11.23 | Insufficient EBITDA | ❌ Avoid |
| OMF | $71.65 | $61.64 | 16.24% | 👍 Buy |
| ON | $44.35 | $65.20 | Above Fair Value | ⛔ Overvalued |
| ONB | $39.74 | $25.88 | 53.55% | ✅ Strong Buy |
| ONC | $114.39 | $353.92 | Insufficient EBITDA | ⛔ Overvalued |
| ONEW | $10.06 | $13.86 | Insufficient EBITDA | ❌ Avoid |
| ONIT | $160.27 | $42.27 | 279.16% | ✅ Strong Buy |
| ONON | $20.93 | $43.47 | Above Fair Value | ⛔ Overvalued |
| ONTF | $2.36 | $7.89 | Insufficient EBITDA | ❌ Avoid |
| ONTO | $96.83 | $208.50 | Above Fair Value | ⛔ Overvalued |
| OOMA | $22.07 | $11.86 | 86.09% | ✅ Strong Buy |
| OPAL | $24.45 | $2.41 | Avoid | ❌ Avoid |
| OPBK | $27.42 | $14.20 | 93.10% | ✅ Strong Buy |
| OPCH | $25.90 | $34.00 | Above Fair Value | ⛔ Overvalued |
| OPRA | $23.06 | $12.71 | 81.43% | ✅ Strong Buy |
| OPRX | $15.63 | $10.89 | Insufficient EBITDA | ✅ Strong Buy |
| OPY | $136.04 | $92.48 | 47.10% | ✅ Strong Buy |
| OR | $20.79 | $40.03 | Above Fair Value | ⛔ Overvalued |
| ORA | $36.63 | $123.15 | Avoid | ❌ Avoid |
| ORC | $12.99 | $7.61 | 70.70% | ✅ Strong Buy |
| ORCL | $197.79 | $142.82 | 38.49% | ✅ Strong Buy |
| ORGO | $3.02 | $3.77 | Above Fair Value | ⛔ Overvalued |
| ORI | $42.66 | $41.77 | 2.13% | 👍 Buy |
| ORLA | $14.09 | $15.60 | Above Fair Value | ⚠️ See Analysis |
| ORLY | $67.02 | $94.22 | Above Fair Value | ⛔ Overvalued |
| ORMP | $18.82 | $3.41 | Insufficient EBITDA | ✅ Strong Buy |
| ORN | $3.74 | $14.13 | Above Fair Value | ⛔ Overvalued |
| ORRF | $60.12 | $39.48 | 52.28% | ✅ Strong Buy |
| OS | $3.85 | $23.51 | Insufficient EBITDA | ❌ Avoid |
| OSBC | $32.45 | $21.04 | 54.23% | ✅ Strong Buy |
| OSCR | $0.07 | $12.24 | Avoid | ❌ Avoid |
| OSIS | $149.54 | $271.26 | Above Fair Value | ⛔ Overvalued |
| OSK | $148.72 | $171.71 | Above Fair Value | ⛔ Overvalued |
| OSPN | $27.57 | $11.25 | 145.07% | ✅ Strong Buy |
| OSW | $17.64 | $21.27 | Above Fair Value | ⛔ Overvalued |
| OTEX | $72.23 | $25.07 | 188.11% | ✅ Strong Buy |
| OTIS | $97.35 | $89.85 | 8.35% | 👍 Buy |
| OTTR | $83.89 | $87.15 | Above Fair Value | ⚠️ See Analysis |
| OUT | $12.56 | $26.89 | Above Fair Value | ⛔ Overvalued |
| OVBC | $42.58 | $42.76 | Above Fair Value | ⚠️ See Analysis |
| OVLY | $43.14 | $33.62 | 28.32% | ✅ Strong Buy |
| OVV | $54.74 | $46.53 | 17.64% | 👍 Buy |
| OWL | $22.94 | $12.52 | Avoid | ❌ Avoid |
| OXBR | $0.12 | $1.11 | Insufficient EBITDA | ⛔ Overvalued |
| OXM | $34.44 | $40.02 | Above Fair Value | ⛔ Overvalued |
| OXY | $22.90 | $46.31 | Above Fair Value | ⛔ Overvalued |
| OZK | $63.89 | $51.40 | 24.30% | ✅ Strong Buy |
| PAA | $19.25 | $19.40 | Above Fair Value | ⚠️ See Analysis |
| PAAS | $42.59 | $55.21 | Above Fair Value | ⛔ Overvalued |
| PAC | $187.05 | $287.51 | Above Fair Value | ⛔ Overvalued |
| PACS | $33.60 | $38.68 | Above Fair Value | ⛔ Overvalued |
| PAG | $165.11 | $166.68 | Above Fair Value | ⚠️ See Analysis |
| PAGP | $22.08 | $20.71 | 6.62% | 👍 Buy |
| PAHC | $42.44 | $53.07 | Avoid | ❌ Avoid |
| PANL | $6.04 | $8.71 | Above Fair Value | ⛔ Overvalued |
| PANW | $80.35 | $159.32 | Above Fair Value | ⛔ Overvalued |
| PAR | $7.60 | $22.24 | Insufficient EBITDA | ❌ Avoid |
| PARR | $67.58 | $43.30 | 56.07% | ✅ Strong Buy |
| PATH | $13.02 | $12.89 | Insufficient EBITDA | 👍 Buy |
| PATK | $54.84 | $140.85 | Avoid | ❌ Avoid |
| PAX | $17.78 | $14.16 | 25.56% | ✅ Strong Buy |
| PAY | $9.94 | $24.81 | Above Fair Value | ⛔ Overvalued |
| PAYC | $245.05 | $130.97 | 87.10% | ✅ Strong Buy |
| PAYO | $4.82 | $6.33 | Above Fair Value | ⛔ Overvalued |
| PAYS | $5.76 | $3.72 | 54.84% | ✅ Strong Buy |
| PAYX | $118.83 | $98.53 | 20.60% | ✅ Strong Buy |
| PB | $69.01 | $74.51 | Above Fair Value | ⚠️ See Analysis |
| PBA | $36.21 | $42.69 | Above Fair Value | ⛔ Overvalued |
| PBF | $22.54 | $35.51 | Insufficient EBITDA | ❌ Avoid |
| PBH | $71.40 | $66.33 | 7.64% | 👍 Buy |
| PBHC | $17.40 | $12.97 | 34.16% | ✅ Strong Buy |
| PBI | $13.63 | $10.78 | Avoid | ❌ Avoid |
| PBT | $3.89 | $18.42 | Above Fair Value | ⛔ Overvalued |
| PBYI | $8.75 | $6.94 | 26.08% | ✅ Strong Buy |
| PCAR | $66.14 | $127.35 | Above Fair Value | ⛔ Overvalued |
| PCB | $23.16 | $23.57 | Above Fair Value | ⚠️ See Analysis |
| PCG | $22.42 | $16.40 | Avoid | ❌ Avoid |
| PCH | $10.80 | $41.73 | Above Fair Value | ⛔ Overvalued |
| PCOR | $23.57 | $51.29 | Insufficient EBITDA | ❌ Avoid |
| PCRX | $48.50 | $21.00 | 130.95% | ✅ Strong Buy |
| PCTY | $167.79 | $117.85 | 42.38% | ✅ Strong Buy |
| PCYO | $10.14 | $11.15 | Above Fair Value | ⚠️ See Analysis |
| PD | $22.27 | $8.04 | Insufficient EBITDA | ❌ Avoid |
| PDCC | $55.52 | $13.49 | 311.56% | ✅ Strong Buy |
| PDFS | $18.77 | $29.07 | Above Fair Value | ⛔ Overvalued |
| PDLB | $13.53 | $16.95 | Above Fair Value | ⛔ Overvalued |
| PEBK | $44.56 | $38.61 | 15.41% | 👍 Buy |
| PEBO | $52.87 | $34.18 | 54.68% | ✅ Strong Buy |
| PECO | $13.06 | $37.53 | Above Fair Value | ⛔ Overvalued |
| PEG | $60.37 | $80.65 | Avoid | ❌ Avoid |
| PEGA | $42.25 | $40.12 | 5.31% | 👍 Buy |
| PEN | $48.24 | $341.02 | Above Fair Value | ⛔ Overvalued |
| PENG | $35.98 | $18.78 | 91.59% | ✅ Strong Buy |
| PENN | $12.27 | $13.41 | Avoid | ❌ Avoid |
| PEP | $138.27 | $170.49 | Above Fair Value | ⛔ Overvalued |
| PETS | $0.15 | $2.88 | Above Fair Value | ⛔ Overvalued |
| PFBC | $104.90 | $91.19 | 15.03% | 👍 Buy |
| PFE | $48.84 | $27.22 | 79.43% | ✅ Strong Buy |
| PFG | $136.57 | $97.34 | 40.30% | ✅ Strong Buy |
| PFGC | $77.44 | $94.40 | Avoid | ❌ Avoid |
| PFIS | $93.47 | $56.12 | 66.55% | ✅ Strong Buy |
| PFLT | $16.82 | $9.51 | 76.87% | ✅ Strong Buy |
| PFS | $33.93 | $23.79 | 42.62% | ✅ Strong Buy |
| PFSI | $207.28 | $95.60 | 116.82% | ✅ Strong Buy |
| PG | $127.70 | $159.17 | Above Fair Value | ⛔ Overvalued |
| PGC | $41.96 | $35.23 | 19.10% | ✅ Strong Buy |
| PGNY | $31.48 | $21.95 | 43.42% | ✅ Strong Buy |
| PGR | $266.21 | $202.29 | 31.60% | ✅ Strong Buy |
| PH | $496.98 | $976.49 | Above Fair Value | ⛔ Overvalued |
| PHG | $19.55 | $29.46 | Above Fair Value | ⛔ Overvalued |
| PHIN | $69.33 | $73.69 | Above Fair Value | ⚠️ See Analysis |
| PHM | $132.69 | $135.09 | Above Fair Value | ⚠️ See Analysis |
| PHR | $22.62 | $12.20 | Insufficient EBITDA | ✅ Strong Buy |
| PI | $35.73 | $116.04 | Avoid | ❌ Avoid |
| PII | $21.05 | $69.33 | Avoid | ❌ Avoid |
| PINE | $3.76 | $19.64 | Above Fair Value | ⛔ Overvalued |
| PINS | $39.05 | $19.60 | 99.23% | ✅ Strong Buy |
| PIPR | $242.81 | $364.38 | Above Fair Value | ⛔ Overvalued |
| PJT | $166.62 | $162.50 | 2.54% | 👍 Buy |
| PK | $8.37 | $11.53 | Above Fair Value | ⛔ Overvalued |
| PKBK | $42.23 | $28.71 | 47.09% | ✅ Strong Buy |
| PKE | $6.06 | $24.32 | Above Fair Value | ⛔ Overvalued |
| PKG | $166.73 | $238.86 | Above Fair Value | ⛔ Overvalued |
| PKOH | $32.76 | $24.94 | Avoid | ❌ Avoid |
| PKX | $52.46 | $63.27 | Above Fair Value | ⛔ Overvalued |
| PLAB | $31.33 | $37.24 | Above Fair Value | ⛔ Overvalued |
| PLAY | $10.02 | $19.27 | Avoid | ❌ Avoid |
| PLBC | $89.67 | $53.41 | 67.89% | ✅ Strong Buy |
| PLD | $41.69 | $136.95 | Above Fair Value | ⛔ Overvalued |
| PLMR | $161.06 | $127.62 | 26.20% | ✅ Strong Buy |
| PLNT | $65.79 | $91.61 | Above Fair Value | ⛔ Overvalued |
| PLOW | $31.25 | $40.37 | Above Fair Value | ⛔ Overvalued |
| PLPC | $115.21 | $280.41 | Above Fair Value | ⛔ Overvalued |
| PLTK | $14.37 | $3.57 | 302.52% | ✅ Strong Buy |
| PLTR | $16.46 | $135.90 | Above Fair Value | ⛔ Overvalued |
| PLUS | $78.09 | $86.82 | Above Fair Value | ⚠️ See Analysis |
| PLX | $1.56 | $2.89 | Above Fair Value | ⛔ Overvalued |
| PLXS | $104.19 | $206.22 | Above Fair Value | ⛔ Overvalued |
| PLYM | $34.25 | $21.98 | 55.82% | ✅ Strong Buy |
| PM | $95.01 | $182.81 | Above Fair Value | ⛔ Overvalued |
| PMT | $28.29 | $12.22 | 131.51% | ✅ Strong Buy |
| PNC | $230.76 | $242.48 | Above Fair Value | ⚠️ See Analysis |
| PNFP | $179.02 | $102.26 | 75.06% | ✅ Strong Buy |
| PNNT | $7.50 | $5.68 | 32.04% | ✅ Strong Buy |
| PNR | $72.13 | $97.35 | Above Fair Value | ⛔ Overvalued |
| PNTG | $17.48 | $30.35 | Above Fair Value | ⛔ Overvalued |
| PNW | $64.57 | $93.52 | Avoid | ❌ Avoid |
| PODD | $88.39 | $241.93 | Above Fair Value | ⛔ Overvalued |
| POOL | $230.08 | $266.16 | Above Fair Value | ⛔ Overvalued |
| POR | $43.05 | $50.65 | Avoid | ❌ Avoid |
| POST | $106.81 | $114.61 | Avoid | ❌ Avoid |
| POWI | $32.47 | $47.34 | Above Fair Value | ⛔ Overvalued |
| POWL | $212.22 | $584.22 | Above Fair Value | ⛔ Overvalued |
| PPC | $62.60 | $43.37 | 44.34% | ✅ Strong Buy |
| PPG | $125.15 | $126.51 | Above Fair Value | ⚠️ See Analysis |
| PPL | $26.82 | $35.92 | Avoid | ❌ Avoid |
| PR | $18.70 | $16.93 | 10.45% | 👍 Buy |
| PRA | $14.20 | $24.35 | Above Fair Value | ⛔ Overvalued |
| PRAA | $33.20 | $11.45 | 189.96% | ✅ Strong Buy |
| PRCH | $3.80 | $7.25 | Above Fair Value | ⛔ Overvalued |
| PRDO | $33.61 | $31.71 | 5.99% | 👍 Buy |
| PRG | $46.80 | $34.60 | 35.26% | ✅ Strong Buy |
| PRGO | $33.71 | $14.64 | Avoid | ❌ Avoid |
| PRI | $367.67 | $275.87 | 33.28% | ✅ Strong Buy |
| PRIM | $76.71 | $160.54 | Above Fair Value | ⛔ Overvalued |
| PRK | $173.41 | $176.52 | Above Fair Value | ⚠️ See Analysis |
| PRKS | $55.49 | $37.03 | Avoid | ❌ Avoid |
| PRLB | $26.66 | $67.17 | Above Fair Value | ⛔ Overvalued |
| PRM | $18.48 | $26.94 | Above Fair Value | ⛔ Overvalued |
| PRMB | $30.05 | $19.63 | Avoid | ❌ Avoid |
| PRO | $17.32 | $23.25 | Insufficient EBITDA | ❌ Avoid |
| PROV | $17.62 | $16.26 | 8.36% | 👍 Buy |
| PRSU | $16.46 | $37.49 | Avoid | ❌ Avoid |
| PRT | $3.36 | $3.54 | Above Fair Value | ⚠️ See Analysis |
| PRTA | $14.20 | $8.91 | Insufficient EBITDA | ❌ Avoid |
| PRTH | $12.59 | $5.55 | Avoid | ❌ Avoid |
| PRU | $194.08 | $102.80 | 88.79% | ✅ Strong Buy |
| PRVA | $18.58 | $21.99 | Above Fair Value | ⛔ Overvalued |
| PSA | $227.82 | $287.00 | Above Fair Value | ⛔ Overvalued |
| PSBD | $20.20 | $11.45 | 76.42% | ✅ Strong Buy |
| PSEC | $3.39 | $2.64 | Insufficient EBITDA | ✅ Strong Buy |
| PSFE | $35.93 | $7.11 | Avoid | ❌ Avoid |
| PSIX | $76.41 | $80.97 | Above Fair Value | ⚠️ See Analysis |
| PSMT | $90.62 | $156.83 | Above Fair Value | ⛔ Overvalued |
| PSN | $47.96 | $69.44 | Above Fair Value | ⛔ Overvalued |
| PSO | $12.44 | $12.26 | 1.47% | 👍 Buy |
| PSTG | $41.40 | $70.99 | Above Fair Value | ⛔ Overvalued |
| PSTL | $10.69 | $19.21 | Above Fair Value | ⛔ Overvalued |
| PSX | $113.69 | $157.80 | Above Fair Value | ⛔ Overvalued |
| PTC | $166.77 | $155.72 | 7.10% | 👍 Buy |
| PTCT | $130.28 | $74.68 | Insufficient EBITDA | ✅ Strong Buy |
| PTGX | $7.91 | $84.49 | Above Fair Value | ⛔ Overvalued |
| PTLO | $3.03 | $5.96 | Avoid | ❌ Avoid |
| PTON | $2.78 | $4.63 | Avoid | ❌ Avoid |
| PUBM | $3.73 | $6.49 | Above Fair Value | ⛔ Overvalued |
| PUK | $29.24 | $32.63 | Above Fair Value | ⚠️ See Analysis |
| PVH | $148.31 | $66.12 | Avoid | ❌ Avoid |
| PVL | $0.94 | $1.79 | Above Fair Value | ⛔ Overvalued |
| PWP | $15.66 | $23.26 | Insufficient EBITDA | ⛔ Overvalued |
| PWR | $159.69 | $508.11 | Above Fair Value | ⛔ Overvalued |
| PX | $21.01 | $10.20 | 105.98% | ✅ Strong Buy |
| PYPL | $102.06 | $40.42 | 152.50% | ✅ Strong Buy |
| PZZA | $34.57 | $34.68 | Avoid | ❌ Avoid |
| QCOM | $221.87 | $137.34 | 61.55% | ✅ Strong Buy |
| QCRH | $95.11 | $95.40 | Above Fair Value | ⚠️ See Analysis |
| QDEL | $35.46 | $29.10 | Insufficient EBITDA | ❌ Avoid |
| QGEN | $40.20 | $50.95 | Above Fair Value | ⛔ Overvalued |
| QLYS | $181.42 | $110.80 | 63.74% | ✅ Strong Buy |
| QNST | $21.52 | $12.24 | 75.82% | ✅ Strong Buy |
| QRVO | $113.14 | $83.72 | 35.14% | ✅ Strong Buy |
| QSR | $73.13 | $70.90 | Avoid | ❌ Avoid |
| QTWO | $46.51 | $57.02 | Above Fair Value | ⛔ Overvalued |
| QUAD | $13.38 | $6.32 | 111.71% | ✅ Strong Buy |
| QXO | $6.56 | $23.01 | Avoid | ❌ Avoid |
| R | $195.52 | $217.50 | Above Fair Value | ⚠️ See Analysis |
| RACE | $204.56 | $333.79 | Above Fair Value | ⛔ Overvalued |
| RAIL | $8.95 | $12.44 | Above Fair Value | ⛔ Overvalued |
| RAMP | $47.22 | $23.21 | 103.45% | ✅ Strong Buy |
| RAY | $5.99 | $4.36 | 37.39% | ✅ Strong Buy |
| RBB | $18.36 | $22.06 | Above Fair Value | ⛔ Overvalued |
| RBBN | $3.88 | $1.96 | Avoid | ❌ Avoid |
| RBC | $200.33 | $544.02 | Above Fair Value | ⛔ Overvalued |
| RBCAA | $100.76 | $74.15 | 35.89% | ✅ Strong Buy |
| RBRK | $1.61 | $51.07 | Insufficient EBITDA | ❌ Avoid |
| RCI | $80.14 | $36.07 | 122.18% | ✅ Strong Buy |
| RCKY | $33.40 | $33.34 | 0.18% | 👍 Buy |
| RCL | $270.09 | $348.00 | Above Fair Value | ⛔ Overvalued |
| RDDT | $83.10 | $139.83 | Insufficient EBITDA | ⛔ Overvalued |
| RDN | $49.82 | $33.56 | 48.45% | ✅ Strong Buy |
| RDNT | $9.56 | $69.24 | Above Fair Value | ⛔ Overvalued |
| RDVT | $25.43 | $40.78 | Above Fair Value | ⛔ Overvalued |
| REAL | $0.43 | $13.09 | Insufficient EBITDA | ❌ Avoid |
| RECT | $1.96 | $1.54 | 27.27% | ✅ Strong Buy |
| REFI | $12.04 | $12.10 | Above Fair Value | ⚠️ See Analysis |
| REG | $40.32 | $75.22 | Above Fair Value | ⛔ Overvalued |
| REGN | $692.98 | $785.51 | Above Fair Value | ⚠️ See Analysis |
| REI | $2.94 | $1.24 | 137.10% | ✅ Strong Buy |
| RELL | $6.36 | $11.36 | Above Fair Value | ⛔ Overvalued |
| RELY | $21.01 | $13.01 | Insufficient EBITDA | ✅ Strong Buy |
| REPX | $52.41 | $28.51 | 83.83% | ✅ Strong Buy |
| RES | $3.66 | $5.77 | Above Fair Value | ⛔ Overvalued |
| REVG | $53.31 | $63.90 | Above Fair Value | ⛔ Overvalued |
| REX | $26.29 | $35.54 | Above Fair Value | ⛔ Overvalued |
| REXR | $18.03 | $38.97 | Above Fair Value | ⛔ Overvalued |
| REYN | $25.99 | $22.77 | 14.14% | 👍 Buy |
| REZI | $31.27 | $36.38 | Avoid | ❌ Avoid |
| RF | $24.57 | $30.93 | Above Fair Value | ⛔ Overvalued |
| RGA | $215.63 | $225.36 | Above Fair Value | ⚠️ See Analysis |
| RGCO | $18.41 | $21.85 | Avoid | ❌ Avoid |
| RGEN | $30.12 | $142.18 | Above Fair Value | ⛔ Overvalued |
| RGLD | $155.43 | $265.77 | Above Fair Value | ⛔ Overvalued |
| RGP | $2.61 | $4.37 | Avoid | ❌ Avoid |
| RGR | $16.90 | $38.33 | Above Fair Value | ⛔ Overvalued |
| RH | $169.63 | $211.16 | Avoid | ❌ Avoid |
| RHI | $26.21 | $31.40 | Above Fair Value | ⛔ Overvalued |
| RHP | $63.33 | $97.96 | Above Fair Value | ⛔ Overvalued |
| RICK | $27.30 | $24.30 | Avoid | ❌ Avoid |
| RIG | $1.47 | $5.39 | Avoid | ❌ Avoid |
| RIGL | $75.14 | $34.15 | 120.03% | ✅ Strong Buy |
| RIO | $104.01 | $93.41 | 11.35% | 👍 Buy |
| RIOT | $1.23 | $14.45 | Above Fair Value | ⛔ Overvalued |
| RITM | $27.43 | $10.73 | 155.64% | ✅ Strong Buy |
| RJF | $182.29 | $172.14 | 5.90% | 👍 Buy |
| RKT | $8.43 | $18.88 | Above Fair Value | ⛔ Overvalued |
| RL | $240.40 | $342.89 | Above Fair Value | ⛔ Overvalued |
| RLGT | $4.32 | $7.15 | Above Fair Value | ⛔ Overvalued |
| RLI | $47.78 | $61.72 | Above Fair Value | ⛔ Overvalued |
| RLJ | $0.65 | $7.97 | Above Fair Value | ⛔ Overvalued |
| RM | $46.24 | $35.55 | 30.07% | ✅ Strong Buy |
| RMAX | $18.32 | $7.40 | Avoid | ❌ Avoid |
| RMBI | $16.05 | $14.31 | 12.16% | 👍 Buy |
| RMBS | $50.12 | $107.10 | Above Fair Value | ⛔ Overvalued |
| RMD | $212.45 | $271.63 | Above Fair Value | ⛔ Overvalued |
| RMNI | $5.31 | $3.29 | Insufficient EBITDA | ✅ Strong Buy |
| RMR | $12.86 | $17.60 | Above Fair Value | ⛔ Overvalued |
| RNG | $74.30 | $27.03 | 174.88% | ✅ Strong Buy |
| RNR | $562.71 | $300.56 | 87.22% | ✅ Strong Buy |
| RNST | $56.63 | $41.80 | 35.48% | ✅ Strong Buy |
| RNW | $363.68 | $5.20 | Avoid | ❌ Avoid |
| ROAD | $49.05 | $127.05 | Avoid | ❌ Avoid |
| ROCK | $62.69 | $53.91 | 16.29% | 👍 Buy |
| ROG | $37.29 | $105.93 | Above Fair Value | ⛔ Overvalued |
| ROK | $254.85 | $415.02 | Above Fair Value | ⛔ Overvalued |
| ROKU | $9.61 | $85.85 | Above Fair Value | ⛔ Overvalued |
| ROL | $24.82 | $64.84 | Above Fair Value | ⛔ Overvalued |
| ROOT | $51.04 | $62.08 | Above Fair Value | ⛔ Overvalued |
| ROP | $368.86 | $362.42 | 1.78% | 👍 Buy |
| ROST | $124.36 | $190.74 | Above Fair Value | ⛔ Overvalued |
| RPAY | $17.42 | $3.38 | 415.38% | ✅ Strong Buy |
| RPD | $39.42 | $10.81 | Avoid | ❌ Avoid |
| RPM | $83.66 | $116.94 | Above Fair Value | ⛔ Overvalued |
| RPRX | $76.27 | $44.65 | Avoid | ❌ Avoid |
| RPT | $8.44 | $15.63 | Insufficient EBITDA | ⛔ Overvalued |
| RRBI | $101.86 | $91.04 | 11.88% | 👍 Buy |
| RRC | $53.66 | $36.57 | 46.73% | ✅ Strong Buy |
| RRR | $39.44 | $65.45 | Avoid | ❌ Avoid |
| RRX | $124.27 | $211.80 | Avoid | ❌ Avoid |
| RS | $217.96 | $353.27 | Above Fair Value | ⛔ Overvalued |
| RSG | $117.07 | $219.94 | Above Fair Value | ⛔ Overvalued |
| RSI | $11.62 | $17.67 | Above Fair Value | ⛔ Overvalued |
| RTO | $30.17 | $32.16 | Above Fair Value | ⚠️ See Analysis |
| RTX | $91.79 | $198.66 | Above Fair Value | ⛔ Overvalued |
| RUN | $14.05 | $19.93 | Insufficient EBITDA | ❌ Avoid |
| RUSHA | $40.87 | $72.64 | Above Fair Value | ⛔ Overvalued |
| RUSHB | $38.87 | $66.53 | Above Fair Value | ⛔ Overvalued |
| RVLV | $17.98 | $26.92 | Above Fair Value | ⛔ Overvalued |
| RVSB | $3.87 | $5.41 | Above Fair Value | ⛔ Overvalued |
| RVTY | $74.73 | $101.59 | Above Fair Value | ⛔ Overvalued |
| RWAY | $20.81 | $8.85 | 135.14% | ✅ Strong Buy |
| RWT | $11.81 | $5.66 | 108.66% | ✅ Strong Buy |
| RXO | $1.45 | $16.90 | Avoid | ❌ Avoid |
| RY | $122.01 | $170.40 | Above Fair Value | ⛔ Overvalued |
| RYAAY | $71.52 | $68.61 | 4.24% | 👍 Buy |
| RYAM | $3.84 | $8.06 | Avoid | ❌ Avoid |
| RYAN | $44.19 | $47.52 | Above Fair Value | ⚠️ See Analysis |
| RYI | $16.90 | $29.94 | Avoid | ❌ Avoid |
| RYN | $7.41 | $22.46 | Above Fair Value | ⛔ Overvalued |
| SA | $0.67 | $30.00 | Insufficient EBITDA | ❌ Avoid |
| SABR | $3.36 | $1.19 | Avoid | ❌ Avoid |
| SAFE | $24.45 | $15.07 | 62.24% | ✅ Strong Buy |
| SAFT | $59.81 | $80.22 | Above Fair Value | ⛔ Overvalued |
| SAH | $92.55 | $62.46 | Avoid | ❌ Avoid |
| SAIA | $134.35 | $415.46 | Above Fair Value | ⛔ Overvalued |
| SAIC | $181.18 | $98.36 | Avoid | ❌ Avoid |
| SAIL | $5.05 | $14.71 | Above Fair Value | ⛔ Overvalued |
| SAM | $171.58 | $246.76 | Above Fair Value | ⛔ Overvalued |
| SAMG | $15.96 | $14.90 | 7.11% | 👍 Buy |
| SANM | $136.32 | $149.79 | Above Fair Value | ⚠️ See Analysis |
| SAP | $150.60 | $203.34 | Above Fair Value | ⛔ Overvalued |
| SAR | $30.77 | $23.47 | 31.10% | ✅ Strong Buy |
| SARO | $20.70 | $30.57 | Above Fair Value | ⛔ Overvalued |
| SB | $6.62 | $5.58 | 18.64% | ✅ Strong Buy |
| SBAC | $212.41 | $180.74 | Avoid | ❌ Avoid |
| SBCF | $46.44 | $35.09 | 32.35% | ✅ Strong Buy |
| SBET | $58.46 | $7.03 | Insufficient EBITDA | ❌ Avoid |
| SBFG | $32.19 | $22.12 | 45.52% | ✅ Strong Buy |
| SBGI | $15.51 | $13.69 | Avoid | ❌ Avoid |
| SBH | $32.67 | $16.16 | 102.17% | ✅ Strong Buy |
| SBLK | $27.72 | $22.72 | 22.01% | ✅ Strong Buy |
| SBR | $49.79 | $69.55 | Above Fair Value | ⛔ Overvalued |
| SBRA | $9.15 | $19.03 | Above Fair Value | ⛔ Overvalued |
| SBS | $24.62 | $27.59 | Above Fair Value | ⚠️ See Analysis |
| SBSI | $32.34 | $33.55 | Above Fair Value | ⚠️ See Analysis |
| SBUX | $60.39 | $99.45 | Above Fair Value | ⛔ Overvalued |
| SCCO | $104.15 | $200.04 | Above Fair Value | ⛔ Overvalued |
| SCHL | $24.25 | $34.11 | Above Fair Value | ⛔ Overvalued |
| SCHW | $121.15 | $105.08 | 15.29% | 👍 Buy |
| SCI | $64.02 | $85.11 | Avoid | ❌ Avoid |
| SCL | $37.62 | $62.73 | Above Fair Value | ⛔ Overvalued |
| SCM | $16.50 | $11.82 | 39.59% | ✅ Strong Buy |
| SCS | $14.62 | $16.14 | Above Fair Value | ⚠️ See Analysis |
| SCSC | $51.93 | $38.39 | 35.27% | ✅ Strong Buy |
| SCVL | $22.22 | $20.55 | 8.13% | 👍 Buy |
| SD | $20.82 | $16.81 | 23.85% | ✅ Strong Buy |
| SDA | $3.83 | $1.89 | Insufficient EBITDA | ❌ Avoid |
| SDRL | $11.45 | $39.90 | Above Fair Value | ⛔ Overvalued |
| SE | $85.99 | $108.54 | Above Fair Value | ⛔ Overvalued |
| SEB | $5,436.27 | $5,434.73 | 0.03% | 👍 Buy |
| SEDG | $4.92 | $35.92 | Insufficient EBITDA | ❌ Avoid |
| SEE | $46.51 | $41.82 | Avoid | ❌ Avoid |
| SEI | $17.34 | $51.58 | Above Fair Value | ⛔ Overvalued |
| SEIC | $110.39 | $84.45 | 30.72% | ✅ Strong Buy |
| SELF | $3.94 | $5.07 | Above Fair Value | ⛔ Overvalued |
| SEM | $16.85 | $15.69 | Avoid | ❌ Avoid |
| SEMR | $6.69 | $11.81 | Above Fair Value | ⛔ Overvalued |
| SENEA | $109.26 | $119.48 | Above Fair Value | ⚠️ See Analysis |
| SEVN | $8.58 | $8.93 | Above Fair Value | ⚠️ See Analysis |
| SEZL | $94.13 | $67.71 | 39.02% | ✅ Strong Buy |
| SF | $145.11 | $130.61 | 11.10% | 👍 Buy |
| SFBC | $41.08 | $44.15 | Above Fair Value | ⚠️ See Analysis |
| SFBS | $106.84 | $85.68 | 24.70% | ✅ Strong Buy |
| SFD | $29.64 | $24.47 | 21.13% | ✅ Strong Buy |
| SFL | $1.29 | $9.15 | Avoid | ❌ Avoid |
| SFM | $88.51 | $67.32 | 31.48% | ✅ Strong Buy |
| SFNC | $28.47 | $21.81 | Insufficient EBITDA | ✅ Strong Buy |
| SFST | $76.40 | $59.40 | 28.62% | ✅ Strong Buy |
| SGA | $3.38 | $11.32 | Above Fair Value | ⛔ Overvalued |
| SGC | $7.70 | $10.33 | Avoid | ❌ Avoid |
| SGHC | $13.57 | $9.11 | 48.96% | ✅ Strong Buy |
| SGI | $58.10 | $96.32 | Avoid | ❌ Avoid |
| SGML | $7.35 | $5.88 | Avoid | ❌ Avoid |
| SGRY | $11.02 | $13.56 | Avoid | ❌ Avoid |
| SGU | $20.87 | $13.17 | 58.47% | ✅ Strong Buy |
| SHAK | $19.39 | $98.30 | Above Fair Value | ⛔ Overvalued |
| SHBI | $26.49 | $20.33 | 30.30% | ✅ Strong Buy |
| SHC | $12.81 | $17.75 | Avoid | ❌ Avoid |
| SHEL | $77.39 | $75.29 | 2.79% | 👍 Buy |
| SHIP | $24.26 | $10.67 | Avoid | ❌ Avoid |
| SHLS | $8.39 | $10.29 | Above Fair Value | ⛔ Overvalued |
| SHO | $1.11 | $9.15 | Above Fair Value | ⛔ Overvalued |
| SHOO | $30.20 | $35.71 | Above Fair Value | ⛔ Overvalued |
| SHOP | $30.64 | $112.05 | Above Fair Value | ⛔ Overvalued |
| SHW | $246.25 | $361.98 | Above Fair Value | ⛔ Overvalued |
| SIG | $138.49 | $97.00 | 42.77% | ✅ Strong Buy |
| SIGA | $15.21 | $6.70 | 127.01% | ✅ Strong Buy |
| SIGI | $111.95 | $90.10 | 24.25% | ✅ Strong Buy |
| SII | $60.74 | $118.87 | Above Fair Value | ⛔ Overvalued |
| SIMO | $107.18 | $128.06 | Above Fair Value | ⛔ Overvalued |
| SIRI | $43.47 | $21.68 | Insufficient EBITDA | ❌ Avoid |
| SITC | $7.88 | $6.45 | 22.17% | ✅ Strong Buy |
| SITE | $72.28 | $150.01 | Above Fair Value | ⛔ Overvalued |
| SITM | $105.19 | $418.69 | Insufficient EBITDA | ❌ Avoid |
| SJM | $115.36 | $109.51 | Insufficient EBITDA | ❌ Avoid |
| SKIN | $2.83 | $1.28 | Avoid | ❌ Avoid |
| SKM | $15.14 | $28.42 | Above Fair Value | ⛔ Overvalued |
| SKT | $19.35 | $33.55 | Above Fair Value | ⛔ Overvalued |
| SKWD | $80.66 | $43.98 | 83.40% | ✅ Strong Buy |
| SKY | $55.42 | $83.59 | Above Fair Value | ⛔ Overvalued |
| SKYT | $0.62 | $30.35 | Above Fair Value | ⛔ Overvalued |
| SKYW | $129.94 | $105.96 | 22.63% | ✅ Strong Buy |
| SLB | $42.86 | $50.70 | Above Fair Value | ⛔ Overvalued |
| SLF | $91.84 | $65.21 | 40.84% | ✅ Strong Buy |
| SLG | $0.34 | $43.72 | Above Fair Value | ⛔ Overvalued |
| SLGN | $58.23 | $48.89 | Avoid | ❌ Avoid |
| SLI | $8.50 | $4.38 | Insufficient EBITDA | ✅ Strong Buy |
| SLM | $46.22 | $27.30 | 69.30% | ✅ Strong Buy |
| SLNO | $33.63 | $41.53 | Insufficient EBITDA | ❌ Avoid |
| SLP | $19.78 | $14.57 | Insufficient EBITDA | ✅ Strong Buy |
| SLQT | $4.45 | $1.10 | 304.55% | ✅ Strong Buy |
| SLRC | $11.71 | $15.19 | Above Fair Value | ⛔ Overvalued |
| SLVM | $45.60 | $50.74 | Above Fair Value | ⚠️ See Analysis |
| SM | $61.21 | $21.08 | 190.37% | ✅ Strong Buy |
| SMA | $3.86 | $32.06 | Above Fair Value | ⛔ Overvalued |
| SMBC | $99.47 | $65.50 | 51.86% | ✅ Strong Buy |
| SMBK | $50.70 | $42.99 | 17.93% | ✅ Strong Buy |
| SMCI | $44.83 | $34.38 | 30.40% | ✅ Strong Buy |
| SMFG | $21.00 | $23.04 | Above Fair Value | ⚠️ See Analysis |
| SMG | $60.31 | $66.34 | Above Fair Value | ⚠️ See Analysis |
| SMP | $51.89 | $44.13 | 17.58% | 👍 Buy |
| SMPL | $31.78 | $17.33 | 83.38% | ✅ Strong Buy |
| SMTC | $32.40 | $86.50 | Above Fair Value | ⛔ Overvalued |
| SN | $90.22 | $116.72 | Above Fair Value | ⛔ Overvalued |
| SNA | $318.22 | $369.34 | Above Fair Value | ⛔ Overvalued |
| SNCY | $18.73 | $21.84 | Above Fair Value | ⛔ Overvalued |
| SND | $1.31 | $4.91 | Above Fair Value | ⛔ Overvalued |
| SNDK | $977.04 | $597.95 | Insufficient EBITDA | ❌ Avoid |
| SNDR | $11.42 | $29.48 | Above Fair Value | ⛔ Overvalued |
| SNEX | $102.73 | $120.54 | Above Fair Value | ⛔ Overvalued |
| SNN | $25.62 | $34.69 | Above Fair Value | ⛔ Overvalued |
| SNOW | $37.65 | $168.43 | Insufficient EBITDA | ❌ Avoid |
| SNPS | $316.02 | $426.88 | Avoid | ❌ Avoid |
| SNV | $85.90 | $50.05 | 71.63% | ✅ Strong Buy |
| SNX | $188.44 | $171.38 | 9.95% | 👍 Buy |
| SNY | $69.41 | $47.83 | 45.12% | ✅ Strong Buy |
| SO | $63.90 | $90.08 | Avoid | ❌ Avoid |
| SOFI | $8.77 | $20.86 | Above Fair Value | ⛔ Overvalued |
| SOL | $6.47 | $1.94 | Insufficient EBITDA | ❌ Avoid |
| SOLV | $100.42 | $78.12 | 28.55% | ✅ Strong Buy |
| SON | $78.33 | $51.32 | Avoid | ❌ Avoid |
| SONY | $16.95 | $22.26 | Above Fair Value | ⛔ Overvalued |
| SPB | $63.58 | $75.72 | Above Fair Value | ⛔ Overvalued |
| SPFI | $55.15 | $43.21 | 27.63% | ✅ Strong Buy |
| SPG | $148.45 | $199.60 | Above Fair Value | ⛔ Overvalued |
| SPGI | $403.05 | $439.28 | Above Fair Value | ⚠️ See Analysis |
| SPH | $29.45 | $19.75 | Avoid | ❌ Avoid |
| SPNS | $28.27 | $43.45 | Above Fair Value | ⛔ Overvalued |
| SPNT | $29.53 | $20.79 | 42.04% | ✅ Strong Buy |
| SPOK | $12.25 | $13.23 | Above Fair Value | ⚠️ See Analysis |
| SPOT | $173.65 | $422.61 | Above Fair Value | ⛔ Overvalued |
| SPRO | $15.88 | $2.42 | Insufficient EBITDA | ❌ Avoid |
| SPSC | $90.62 | $79.53 | 13.94% | 👍 Buy |
| SPT | $20.76 | $8.00 | Insufficient EBITDA | ❌ Avoid |
| SPXC | $105.69 | $222.32 | Above Fair Value | ⛔ Overvalued |
| SQM | $48.48 | $71.48 | Above Fair Value | ⛔ Overvalued |
| SR | $73.19 | $86.08 | Avoid | ❌ Avoid |
| SRAD | $7.77 | $16.99 | Above Fair Value | ⛔ Overvalued |
| SRBK | $6.82 | $17.50 | Above Fair Value | ⛔ Overvalued |
| SRCE | $106.17 | $70.45 | 50.70% | ✅ Strong Buy |
| SRE | $64.48 | $87.36 | Avoid | ❌ Avoid |
| SRI | $3.14 | $8.47 | Insufficient EBITDA | ❌ Avoid |
| SRPT | $64.33 | $18.50 | Avoid | ❌ Avoid |
| SSB | $127.14 | $107.82 | 17.92% | ✅ Strong Buy |
| SSD | $134.75 | $194.28 | Above Fair Value | ⛔ Overvalued |
| SSNC | $120.82 | $77.39 | 56.12% | ✅ Strong Buy |
| SSP | $5.91 | $3.39 | Avoid | ❌ Avoid |
| SSRM | $34.00 | $24.16 | Insufficient EBITDA | ✅ Strong Buy |
| SSSS | $38.15 | $8.98 | Insufficient EBITDA | ✅ Strong Buy |
| SSTK | $81.16 | $18.68 | 334.48% | ✅ Strong Buy |
| SSYS | $3.90 | $11.25 | Insufficient EBITDA | ❌ Avoid |
| ST | $57.70 | $35.99 | Avoid | ❌ Avoid |
| STAA | $3.28 | $17.58 | Insufficient EBITDA | ❌ Avoid |
| STAG | $23.79 | $39.31 | Above Fair Value | ⛔ Overvalued |
| STBA | $41.58 | $44.13 | Above Fair Value | ⚠️ See Analysis |
| STC | $62.91 | $71.44 | Above Fair Value | ⚠️ See Analysis |
| STE | $158.94 | $252.16 | Above Fair Value | ⛔ Overvalued |
| STEL | $31.12 | $39.17 | Above Fair Value | ⛔ Overvalued |
| STEP | $38.52 | $62.43 | Insufficient EBITDA | ⛔ Overvalued |
| STGW | $12.77 | $5.18 | Avoid | ❌ Avoid |
| STKL | $3.74 | $6.40 | Avoid | ❌ Avoid |
| STLD | $155.68 | $202.39 | Above Fair Value | ⛔ Overvalued |
| STM | $17.51 | $29.85 | Above Fair Value | ⛔ Overvalued |
| STN | $77.17 | $101.53 | Above Fair Value | ⛔ Overvalued |
| STNG | $70.59 | $68.43 | 3.16% | 👍 Buy |
| STOK | $1.16 | $32.40 | Insufficient EBITDA | ⛔ Overvalued |
| STRA | $108.55 | $81.36 | 33.42% | ✅ Strong Buy |
| STRL | $152.85 | $401.29 | Above Fair Value | ⛔ Overvalued |
| STRW | $14.69 | $13.05 | 12.57% | 👍 Buy |
| STRZ | $1.02 | $9.20 | Above Fair Value | ⛔ Overvalued |
| STT | $152.11 | $132.35 | 14.93% | 👍 Buy |
| STVN | $13.44 | $15.50 | Above Fair Value | ⛔ Overvalued |
| STWD | $20.53 | $18.12 | 13.30% | 👍 Buy |
| STX | $141.35 | $429.32 | Above Fair Value | ⛔ Overvalued |
| STZ | $187.77 | $164.33 | Avoid | ❌ Avoid |
| SU | $51.31 | $53.80 | Above Fair Value | ⚠️ See Analysis |
| SUI | $44.06 | $125.69 | Above Fair Value | ⛔ Overvalued |
| SUN | $71.11 | $57.60 | Avoid | ❌ Avoid |
| SUNS | $19.38 | $9.30 | 108.39% | ✅ Strong Buy |
| SUPN | $60.54 | $51.65 | 17.21% | 👍 Buy |
| SUPV | $4.54 | $11.01 | Above Fair Value | ⛔ Overvalued |
| SVM | $10.47 | $10.41 | 0.58% | 👍 Buy |
| SVV | $8.92 | $11.53 | Avoid | ❌ Avoid |
| SWBI | $3.58 | $11.68 | Above Fair Value | ⛔ Overvalued |
| SWK | $70.51 | $89.39 | Avoid | ❌ Avoid |
| SWKH | $33.81 | $17.25 | 96.00% | ✅ Strong Buy |
| SWKS | $91.95 | $62.10 | 48.07% | ✅ Strong Buy |
| SWX | $50.79 | $83.26 | Above Fair Value | ⛔ Overvalued |
| SXC | $6.94 | $8.27 | Above Fair Value | ⛔ Overvalued |
| SXI | $127.24 | $254.24 | Above Fair Value | ⛔ Overvalued |
| SXT | $50.29 | $97.48 | Above Fair Value | ⛔ Overvalued |
| SYBT | $86.24 | $71.20 | 21.12% | ✅ Strong Buy |
| SYF | $86.80 | $75.16 | 15.49% | 👍 Buy |
| SYK | $240.23 | $358.29 | Above Fair Value | ⛔ Overvalued |
| SYM | $13.83 | $59.74 | Insufficient EBITDA | ❌ Avoid |
| SYNA | $82.03 | $89.23 | Avoid | ❌ Avoid |
| SYY | $85.64 | $86.53 | Above Fair Value | ⚠️ See Analysis |
| T | $28.46 | $27.13 | 4.90% | 👍 Buy |
| TAC | $4.10 | $13.24 | Avoid | ❌ Avoid |
| TAK | $1,170.26 | $17.89 | Avoid | ❌ Avoid |
| TALK | $2.06 | $3.88 | Above Fair Value | ⛔ Overvalued |
| TAP | $74.50 | $51.76 | Avoid | ❌ Avoid |
| TARS | $20.52 | $64.62 | Insufficient EBITDA | ❌ Avoid |
| TATT | $25.11 | $47.88 | Above Fair Value | ⛔ Overvalued |
| TBBK | $72.36 | $62.02 | 16.67% | 👍 Buy |
| TBCH | $14.58 | $12.07 | 20.80% | ✅ Strong Buy |
| TBI | $3.41 | $5.42 | Insufficient EBITDA | ❌ Avoid |
| TBPH | $13.52 | $20.48 | Insufficient EBITDA | ❌ Avoid |
| TCBI | $114.81 | $104.47 | 9.90% | 👍 Buy |
| TCBK | $62.89 | $52.23 | 20.41% | ✅ Strong Buy |
| TCBS | $11.06 | $17.16 | Insufficient EBITDA | ⛔ Overvalued |
| TCBX | $52.40 | $43.46 | 20.57% | ✅ Strong Buy |
| TCMD | $11.17 | $27.91 | Above Fair Value | ⛔ Overvalued |
| TCPC | $13.59 | $4.86 | Insufficient EBITDA | ✅ Strong Buy |
| TD | $67.12 | $96.68 | Above Fair Value | ⛔ Overvalued |
| TDC | $48.19 | $27.47 | 75.43% | ✅ Strong Buy |
| TDG | $755.74 | $1,285.53 | Avoid | ❌ Avoid |
| TDS | $3.96 | $45.80 | Above Fair Value | ⛔ Overvalued |
| TDW | $51.30 | $66.35 | Above Fair Value | ⛔ Overvalued |
| TDY | $441.61 | $647.56 | Above Fair Value | ⛔ Overvalued |
| TEAM | $123.26 | $94.72 | 30.13% | ✅ Strong Buy |
| TECH | $39.12 | $66.78 | Above Fair Value | ⛔ Overvalued |
| TECK | $33.02 | $55.01 | Above Fair Value | ⛔ Overvalued |
| TEF | $4.26 | $3.81 | 11.81% | 👍 Buy |
| TEL | $172.06 | $215.91 | Above Fair Value | ⛔ Overvalued |
| TEN | $50.33 | $26.99 | 86.48% | ✅ Strong Buy |
| TENB | $34.62 | $21.23 | 63.07% | ✅ Strong Buy |
| TER | $81.70 | $300.11 | Above Fair Value | ⛔ Overvalued |
| TEVA | $39.19 | $34.69 | 12.97% | 👍 Buy |
| TEX | $68.00 | $62.74 | 8.38% | 👍 Buy |
| TFC | $60.03 | $55.81 | 7.56% | 👍 Buy |
| TFII | $66.76 | $121.88 | Above Fair Value | ⛔ Overvalued |
| TFIN | $16.94 | $68.34 | Above Fair Value | ⛔ Overvalued |
| TFPM | $18.73 | $34.25 | Above Fair Value | ⛔ Overvalued |
| TFSL | $6.59 | $14.92 | Above Fair Value | ⛔ Overvalued |
| TFX | $222.88 | $108.42 | Avoid | ❌ Avoid |
| TG | $0.72 | $9.26 | Above Fair Value | ⛔ Overvalued |
| TGB | $3.62 | $7.85 | Avoid | ❌ Avoid |
| TGLS | $57.16 | $52.08 | 9.75% | 👍 Buy |
| TGNA | $33.59 | $19.07 | 76.14% | ✅ Strong Buy |
| TGS | $31.04 | $29.42 | 5.51% | 👍 Buy |
| TGT | $114.28 | $115.55 | Above Fair Value | ⚠️ See Analysis |
| TGTX | $27.04 | $28.86 | Above Fair Value | ⚠️ See Analysis |
| THC | $259.86 | $201.37 | 29.05% | ✅ Strong Buy |
| THFF | $103.13 | $67.83 | 52.04% | ✅ Strong Buy |
| THG | $230.68 | $175.97 | 31.09% | ✅ Strong Buy |
| THO | $71.16 | $119.98 | Above Fair Value | ⛔ Overvalued |
| THR | $33.10 | $50.42 | Above Fair Value | ⛔ Overvalued |
| THRM | $37.19 | $32.20 | 15.50% | 👍 Buy |
| THRY | $16.02 | $3.90 | 310.77% | ✅ Strong Buy |
| THS | $23.26 | $24.63 | Avoid | ❌ Avoid |
| TIC | $4.39 | $9.55 | Avoid | ❌ Avoid |
| TIGO | $52.62 | $66.95 | Above Fair Value | ⛔ Overvalued |
| TIGR | $24.22 | $8.14 | 197.54% | ✅ Strong Buy |
| TILE | $23.44 | $34.63 | Above Fair Value | ⛔ Overvalued |
| TIMB | $25.57 | $24.46 | 4.54% | 👍 Buy |
| TIPT | $15.07 | $17.74 | Above Fair Value | ⛔ Overvalued |
| TJX | $95.97 | $155.86 | Above Fair Value | ⛔ Overvalued |
| TK | $12.53 | $10.49 | 19.45% | ✅ Strong Buy |
| TKO | $92.62 | $211.90 | Above Fair Value | ⛔ Overvalued |
| TKR | $77.91 | $106.04 | Above Fair Value | ⛔ Overvalued |
| TLF | $16.20 | $3.18 | 409.43% | ✅ Strong Buy |
| TLK | $26.79 | $20.49 | 30.75% | ✅ Strong Buy |
| TLN | $171.20 | $345.00 | Above Fair Value | ⛔ Overvalued |
| TLX | $4.81 | $7.10 | Above Fair Value | ⛔ Overvalued |
| TM | $214.80 | $244.22 | Avoid | ❌ Avoid |
| TMDX | $67.18 | $135.06 | Above Fair Value | ⛔ Overvalued |
| TMHC | $91.24 | $65.18 | 39.98% | ✅ Strong Buy |
| TMO | $376.79 | $542.83 | Above Fair Value | ⛔ Overvalued |
| TMP | $105.94 | $84.34 | 25.61% | ✅ Strong Buy |
| TMUS | $181.35 | $197.39 | Above Fair Value | ⚠️ See Analysis |
| TNC | $86.40 | $81.97 | 5.40% | 👍 Buy |
| TNET | $87.41 | $55.96 | 56.20% | ✅ Strong Buy |
| TNL | $107.57 | $73.45 | Avoid | ❌ Avoid |
| TOL | $171.90 | $153.28 | 12.15% | 👍 Buy |
| TOWN | $53.83 | $37.65 | 42.97% | ✅ Strong Buy |
| TPB | $73.56 | $129.97 | Above Fair Value | ⛔ Overvalued |
| TPC | $43.70 | $83.48 | Insufficient EBITDA | ⛔ Overvalued |
| TPG | $48.16 | $55.02 | Above Fair Value | ⚠️ See Analysis |
| TPH | $31.38 | $35.46 | Above Fair Value | ⚠️ See Analysis |
| TPL | $586.47 | $366.03 | 60.22% | ✅ Strong Buy |
| TPR | $105.92 | $152.10 | Avoid | ❌ Avoid |
| TPVG | $10.89 | $5.73 | 90.05% | ✅ Strong Buy |
| TR | $20.68 | $39.29 | Above Fair Value | ⛔ Overvalued |
| TRC | $1.88 | $16.61 | Insufficient EBITDA | ❌ Avoid |
| TREE | $69.83 | $47.46 | 47.13% | ✅ Strong Buy |
| TREX | $27.92 | $44.00 | Above Fair Value | ⛔ Overvalued |
| TRGP | $136.02 | $211.44 | Avoid | ❌ Avoid |
| TRI | $67.11 | $88.07 | Above Fair Value | ⛔ Overvalued |
| TRIN | $26.88 | $16.19 | 66.03% | ✅ Strong Buy |
| TRIP | $27.00 | $12.77 | 111.43% | ✅ Strong Buy |
| TRMB | $61.37 | $66.15 | Above Fair Value | ⚠️ See Analysis |
| TRMD | $33.23 | $24.90 | 33.45% | ✅ Strong Buy |
| TRMK | $56.51 | $44.69 | 26.45% | ✅ Strong Buy |
| TRN | $28.13 | $30.39 | Avoid | ❌ Avoid |
| TRNO | $41.67 | $66.10 | Above Fair Value | ⛔ Overvalued |
| TRNS | $32.16 | $76.33 | Above Fair Value | ⛔ Overvalued |
| TROW | $176.96 | $94.58 | 87.10% | ✅ Strong Buy |
| TRP | $43.29 | $59.82 | Avoid | ❌ Avoid |
| TRS | $21.55 | $36.11 | Above Fair Value | ⛔ Overvalued |
| TRST | $30.67 | $46.07 | Above Fair Value | ⛔ Overvalued |
| TRTX | $8.40 | $8.95 | Above Fair Value | ⚠️ See Analysis |
| TRU | $72.81 | $73.48 | Above Fair Value | ⚠️ See Analysis |
| TRUP | $69.69 | $33.17 | 110.10% | ✅ Strong Buy |
| TRV | $396.63 | $301.49 | 31.56% | ✅ Strong Buy |
| TS | $51.37 | $46.91 | 9.51% | 👍 Buy |
| TSBK | $54.87 | $39.63 | 38.46% | ✅ Strong Buy |
| TSCO | $24.09 | $55.61 | Above Fair Value | ⛔ Overvalued |
| TSEM | $41.72 | $139.04 | Above Fair Value | ⛔ Overvalued |
| TSLA | $38.64 | $411.11 | Above Fair Value | ⛔ Overvalued |
| TSLX | $28.30 | $20.17 | 40.31% | ✅ Strong Buy |
| TSM | $307.98 | $348.85 | Above Fair Value | ⚠️ See Analysis |
| TSN | $52.72 | $65.26 | Above Fair Value | ⛔ Overvalued |
| TSQ | $6.71 | $6.63 | Avoid | ❌ Avoid |
| TT | $210.46 | $454.76 | Above Fair Value | ⛔ Overvalued |
| TTAM | $18.51 | $18.66 | Above Fair Value | ⚠️ See Analysis |
| TTAN | $19.74 | $63.74 | Insufficient EBITDA | ❌ Avoid |
| TTC | $88.23 | $98.20 | Above Fair Value | ⚠️ See Analysis |
| TTD | $45.29 | $27.04 | 67.49% | ✅ Strong Buy |
| TTE | $84.13 | $73.83 | 13.95% | 👍 Buy |
| TTEC | $18.29 | $3.03 | Insufficient EBITDA | ❌ Avoid |
| TTEK | $21.85 | $41.29 | Above Fair Value | ⛔ Overvalued |
| TTGT | $11.27 | $5.18 | Insufficient EBITDA | ❌ Avoid |
| TTI | $3.99 | $11.67 | Above Fair Value | ⛔ Overvalued |
| TTMI | $32.59 | $98.58 | Above Fair Value | ⛔ Overvalued |
| TTWO | $67.63 | $195.59 | Insufficient EBITDA | ❌ Avoid |
| TU | $10.64 | $14.13 | Avoid | ❌ Avoid |
| TVTX | $20.04 | $29.71 | Insufficient EBITDA | ❌ Avoid |
| TW | $67.81 | $112.13 | Above Fair Value | ⛔ Overvalued |
| TWI | $3.51 | $11.06 | Avoid | ❌ Avoid |
| TWIN | $15.09 | $16.60 | Above Fair Value | ⚠️ See Analysis |
| TWLO | $98.39 | $115.02 | Above Fair Value | ⛔ Overvalued |
| TWO | $15.69 | $11.04 | Avoid | ❌ Avoid |
| TX | $54.76 | $43.46 | 26.00% | ✅ Strong Buy |
| TXN | $132.65 | $221.44 | Above Fair Value | ⛔ Overvalued |
| TXNM | $38.45 | $58.99 | Avoid | ❌ Avoid |
| TXO | $5.35 | $12.04 | Above Fair Value | ⛔ Overvalued |
| TXRH | $106.37 | $190.97 | Above Fair Value | ⛔ Overvalued |
| TXT | $93.23 | $95.44 | Above Fair Value | ⚠️ See Analysis |
| TYL | $269.47 | $348.35 | Above Fair Value | ⛔ Overvalued |
| TZOO | $12.29 | $5.62 | 118.68% | ✅ Strong Buy |
| UAA | $1.44 | $7.56 | Avoid | ❌ Avoid |
| UAL | $157.16 | $115.91 | 35.59% | ✅ Strong Buy |
| UAMY | $1.72 | $8.61 | Insufficient EBITDA | ❌ Avoid |
| UAN | $190.93 | $102.39 | 86.47% | ✅ Strong Buy |
| UBCP | $19.40 | $14.00 | 38.57% | ✅ Strong Buy |
| UBER | $88.55 | $74.77 | 18.43% | ✅ Strong Buy |
| UBFO | $9.80 | $11.41 | Above Fair Value | ⛔ Overvalued |
| UBS | $32.93 | $43.91 | Above Fair Value | ⛔ Overvalued |
| UBSI | $38.34 | $45.52 | Above Fair Value | ⛔ Overvalued |
| UCB | $38.01 | $36.51 | 4.11% | 👍 Buy |
| UCTT | $16.53 | $48.29 | Avoid | ❌ Avoid |
| UDMY | $7.87 | $4.69 | Insufficient EBITDA | ✅ Strong Buy |
| UDR | $9.21 | $37.55 | Above Fair Value | ⛔ Overvalued |
| UE | $5.41 | $21.03 | Above Fair Value | ⛔ Overvalued |
| UEIC | $0.74 | $3.99 | Above Fair Value | ⛔ Overvalued |
| UFCS | $50.64 | $37.05 | 36.68% | ✅ Strong Buy |
| UFPI | $78.39 | $114.19 | Above Fair Value | ⛔ Overvalued |
| UFPT | $144.59 | $267.34 | Above Fair Value | ⛔ Overvalued |
| UG | $9.13 | $7.15 | 27.69% | ✅ Strong Buy |
| UGI | $41.62 | $37.09 | Avoid | ❌ Avoid |
| UGP | $5.46 | $5.09 | 7.27% | 👍 Buy |
| UHAL | $8.36 | $49.92 | Above Fair Value | ⛔ Overvalued |
| UHS | $308.17 | $218.56 | 41.00% | ✅ Strong Buy |
| UHT | $24.02 | $42.10 | Above Fair Value | ⛔ Overvalued |
| UI | $322.05 | $622.33 | Above Fair Value | ⛔ Overvalued |
| UIS | $13.09 | $2.33 | Avoid | ❌ Avoid |
| UL | $45.14 | $72.12 | Above Fair Value | ⛔ Overvalued |
| ULH | $13.16 | $18.04 | Avoid | ❌ Avoid |
| ULS | $35.93 | $71.49 | Above Fair Value | ⛔ Overvalued |
| ULTA | $498.71 | $690.37 | Above Fair Value | ⛔ Overvalued |
| UMBF | $171.60 | $134.32 | 27.75% | ✅ Strong Buy |
| UMC | $8.50 | $10.06 | Above Fair Value | ⛔ Overvalued |
| UMH | $2.14 | $15.91 | Above Fair Value | ⛔ Overvalued |
| UNB | $37.72 | $24.84 | 51.85% | ✅ Strong Buy |
| UNF | $105.47 | $201.35 | Above Fair Value | ⛔ Overvalued |
| UNFI | $31.03 | $40.69 | Avoid | ❌ Avoid |
| UNH | $261.04 | $276.65 | Above Fair Value | ⚠️ See Analysis |
| UNIT | $119.89 | $8.05 | 1,389.32% | ✅ Strong Buy |
| UNM | $110.42 | $74.56 | 48.10% | ✅ Strong Buy |
| UNP | $209.05 | $252.62 | Above Fair Value | ⛔ Overvalued |
| UNTY | $95.64 | $56.20 | 70.18% | ✅ Strong Buy |
| UPBD | $63.61 | $20.54 | 209.69% | ✅ Strong Buy |
| UPS | $93.15 | $117.34 | Above Fair Value | ⛔ Overvalued |
| UPWK | $25.21 | $18.93 | 33.17% | ✅ Strong Buy |
| URBN | $82.89 | $72.47 | 14.38% | 👍 Buy |
| URI | $621.45 | $899.55 | Above Fair Value | ⛔ Overvalued |
| UROY | $0.61 | $3.95 | Insufficient EBITDA | ⛔ Overvalued |
| USAC | $20.22 | $26.35 | Avoid | ❌ Avoid |
| USAS | $6.01 | $7.13 | Insufficient EBITDA | ❌ Avoid |
| USB | $68.32 | $60.69 | 12.57% | 👍 Buy |
| USCB | $30.96 | $20.13 | 53.80% | ✅ Strong Buy |
| USFD | $55.26 | $90.33 | Above Fair Value | ⛔ Overvalued |
| USLM | $74.24 | $108.55 | Above Fair Value | ⛔ Overvalued |
| USNA | $29.26 | $21.34 | 37.11% | ✅ Strong Buy |
| USPH | $43.87 | $85.58 | Above Fair Value | ⛔ Overvalued |
| UTHR | $496.16 | $485.36 | 2.23% | 👍 Buy |
| UTI | $10.59 | $25.52 | Above Fair Value | ⛔ Overvalued |
| UTL | $43.77 | $50.57 | Avoid | ❌ Avoid |
| UTMD | $67.84 | $61.64 | 10.06% | 👍 Buy |
| UTZ | $12.42 | $10.98 | Avoid | ❌ Avoid |
| UUUU | $2.05 | $21.22 | Insufficient EBITDA | ❌ Avoid |
| UVE | $68.80 | $31.71 | 116.97% | ✅ Strong Buy |
| UVSP | $45.36 | $35.83 | 26.60% | ✅ Strong Buy |
| UVV | $53.26 | $57.82 | Avoid | ❌ Avoid |
| UWMC | $4.62 | $4.75 | Avoid | ❌ Avoid |
| V | $336.52 | $331.58 | 1.49% | 👍 Buy |
| VABK | $46.91 | $42.04 | 11.58% | 👍 Buy |
| VAC | $90.54 | $55.58 | Avoid | ❌ Avoid |
| VAL | $47.83 | $62.41 | Above Fair Value | ⛔ Overvalued |
| VALU | $41.41 | $37.10 | 11.62% | 👍 Buy |
| VBNK | $21.06 | $16.40 | 28.41% | ✅ Strong Buy |
| VC | $139.35 | $100.90 | 38.11% | ✅ Strong Buy |
| VCEL | $6.28 | $36.19 | Above Fair Value | ⛔ Overvalued |
| VCIG | $16,317.00 | $0.38 | 4,293,847.37% | ✅ Strong Buy |
| VCTR | $52.83 | $71.25 | Above Fair Value | ⛔ Overvalued |
| VCYT | $31.24 | $36.19 | Above Fair Value | ⛔ Overvalued |
| VECO | $23.84 | $30.69 | Above Fair Value | ⛔ Overvalued |
| VEEV | $198.08 | $183.65 | 7.86% | 👍 Buy |
| VEL | $31.46 | $20.49 | 53.54% | ✅ Strong Buy |
| VERX | $15.69 | $15.73 | Above Fair Value | ⚠️ See Analysis |
| VET | $6.37 | $10.21 | Above Fair Value | ⛔ Overvalued |
| VFC | $11.65 | $20.34 | Avoid | ❌ Avoid |
| VG | $14.06 | $9.90 | Avoid | ❌ Avoid |
| VHI | $25.22 | $15.51 | 62.60% | ✅ Strong Buy |
| VIA | $1.18 | $20.56 | Insufficient EBITDA | ❌ Avoid |
| VIAV | $10.86 | $26.38 | Above Fair Value | ⛔ Overvalued |
| VICI | $35.47 | $28.76 | 23.33% | ✅ Strong Buy |
| VICR | $31.83 | $159.87 | Above Fair Value | ⛔ Overvalued |
| VIK | $65.31 | $76.99 | Above Fair Value | ⛔ Overvalued |
| VINP | $118.01 | $12.18 | 868.88% | ✅ Strong Buy |
| VIRC | $8.84 | $6.50 | 36.00% | ✅ Strong Buy |
| VIRT | $90.45 | $38.53 | 134.75% | ✅ Strong Buy |
| VITL | $27.80 | $26.85 | 3.54% | 👍 Buy |
| VLGEA | $45.90 | $38.33 | 19.75% | ✅ Strong Buy |
| VLO | $145.78 | $202.68 | Above Fair Value | ⛔ Overvalued |
| VLTO | $88.94 | $90.57 | Above Fair Value | ⚠️ See Analysis |
| VLY | $12.72 | $13.71 | Above Fair Value | ⚠️ See Analysis |
| VMC | $141.03 | $323.72 | Above Fair Value | ⛔ Overvalued |
| VMD | $9.12 | $8.64 | 5.56% | 👍 Buy |
| VMI | $294.73 | $473.68 | Above Fair Value | ⛔ Overvalued |
| VNO | $58.63 | $31.27 | 87.50% | ✅ Strong Buy |
| VNOM | $31.30 | $42.89 | Avoid | ❌ Avoid |
| VNT | $40.30 | $42.10 | Above Fair Value | ⚠️ See Analysis |
| VOC | $3.09 | $2.85 | 8.42% | 👍 Buy |
| VOD | $11.99 | $15.11 | Above Fair Value | ⛔ Overvalued |
| VOXR | $1.03 | $5.18 | Above Fair Value | ⛔ Overvalued |
| VOYA | $141.10 | $75.90 | 85.90% | ✅ Strong Buy |
| VPG | $12.58 | $55.98 | Above Fair Value | ⛔ Overvalued |
| VRE | $10.07 | $16.64 | Above Fair Value | ⛔ Overvalued |
| VREX | $11.93 | $14.00 | Avoid | ❌ Avoid |
| VRRM | $25.58 | $18.87 | 35.56% | ✅ Strong Buy |
| VRSK | $183.58 | $179.10 | 2.50% | 👍 Buy |
| VRSN | $236.93 | $224.17 | 5.69% | 👍 Buy |
| VRT | $73.67 | $195.58 | Above Fair Value | ⛔ Overvalued |
| VRTS | $343.82 | $140.29 | 145.08% | ✅ Strong Buy |
| VRTX | $360.16 | $477.92 | Above Fair Value | ⛔ Overvalued |
| VSAT | $5.30 | $41.70 | Avoid | ❌ Avoid |
| VSCO | $42.19 | $62.44 | Above Fair Value | ⛔ Overvalued |
| VSEC | $52.45 | $199.99 | Above Fair Value | ⛔ Overvalued |
| VSH | $10.42 | $19.95 | Above Fair Value | ⛔ Overvalued |
| VST | $42.09 | $149.65 | Above Fair Value | ⛔ Overvalued |
| VSTS | $4.00 | $7.18 | Avoid | ❌ Avoid |
| VTLE | $106.10 | $17.92 | Avoid | ❌ Avoid |
| VTOL | $92.54 | $45.00 | 105.64% | ✅ Strong Buy |
| VTR | $6.83 | $82.55 | Above Fair Value | ⛔ Overvalued |
| VTRS | $27.98 | $14.58 | Avoid | ❌ Avoid |
| VTS | $8.34 | $21.56 | Above Fair Value | ⛔ Overvalued |
| VVV | $36.31 | $37.53 | Above Fair Value | ⚠️ See Analysis |
| VVX | $81.24 | $67.29 | 20.73% | ✅ Strong Buy |
| VYX | $11.79 | $9.85 | 19.70% | ✅ Strong Buy |
| VZ | $78.84 | $46.31 | 70.24% | ✅ Strong Buy |
| W | $37.17 | $92.60 | Insufficient EBITDA | ❌ Avoid |
| WAB | $141.36 | $246.32 | Above Fair Value | ⛔ Overvalued |
| WABC | $55.42 | $52.48 | 5.60% | 👍 Buy |
| WAFD | $47.97 | $33.71 | 42.30% | ✅ Strong Buy |
| WAL | $128.15 | $94.39 | 35.77% | ✅ Strong Buy |
| WASH | $50.52 | $36.75 | 37.47% | ✅ Strong Buy |
| WAT | $314.96 | $381.29 | Above Fair Value | ⛔ Overvalued |
| WAY | $29.28 | $24.30 | 20.49% | ✅ Strong Buy |
| WBD | $5.15 | $27.36 | Above Fair Value | ⛔ Overvalued |
| WBS | $80.91 | $73.13 | 10.64% | 👍 Buy |
| WBTN | $4.93 | $11.17 | Insufficient EBITDA | ❌ Avoid |
| WCC | $196.01 | $315.27 | Avoid | ❌ Avoid |
| WCN | $79.30 | $169.20 | Above Fair Value | ⛔ Overvalued |
| WD | $72.85 | $63.23 | Avoid | ❌ Avoid |
| WDAY | $227.19 | $162.92 | 39.45% | ✅ Strong Buy |
| WDC | $126.15 | $282.58 | Above Fair Value | ⛔ Overvalued |
| WDFC | $117.04 | $238.53 | Above Fair Value | ⛔ Overvalued |
| WDS | $22.48 | $18.15 | 23.86% | ✅ Strong Buy |
| WEAV | $1.73 | $6.25 | Insufficient EBITDA | ❌ Avoid |
| WEC | $67.69 | $111.42 | Avoid | ❌ Avoid |
| WELL | $30.51 | $195.92 | Above Fair Value | ⛔ Overvalued |
| WEN | $14.96 | $8.02 | Avoid | ❌ Avoid |
| WERN | $6.08 | $34.76 | Above Fair Value | ⛔ Overvalued |
| WES | $57.58 | $41.12 | 40.03% | ✅ Strong Buy |
| WEX | $282.07 | $158.95 | Avoid | ❌ Avoid |
| WEYS | $31.86 | $32.83 | Above Fair Value | ⚠️ See Analysis |
| WFC | $91.14 | $93.97 | Above Fair Value | ⚠️ See Analysis |
| WFG | $0.97 | $73.37 | Above Fair Value | ⛔ Overvalued |
| WFRD | $81.07 | $105.51 | Above Fair Value | ⛔ Overvalued |
| WGO | $38.92 | $48.79 | Above Fair Value | ⛔ Overvalued |
| WGS | $15.81 | $84.29 | Insufficient EBITDA | ⛔ Overvalued |
| WH | $82.11 | $77.29 | Avoid | ❌ Avoid |
| WHD | $47.52 | $58.00 | Above Fair Value | ⛔ Overvalued |
| WHF | $13.75 | $6.46 | 112.85% | ✅ Strong Buy |
| WHG | $14.26 | $17.84 | Above Fair Value | ⛔ Overvalued |
| WHR | $82.13 | $86.52 | Avoid | ❌ Avoid |
| WINA | $259.25 | $452.68 | Above Fair Value | ⛔ Overvalued |
| WING | $91.18 | $264.01 | Above Fair Value | ⛔ Overvalued |
| WIT | $2.53 | $2.51 | 0.80% | 👍 Buy |
| WIX | $129.67 | $75.42 | 71.93% | ✅ Strong Buy |
| WK | $31.46 | $69.85 | Insufficient EBITDA | ❌ Avoid |
| WKC | $24.93 | $27.99 | Avoid | ❌ Avoid |
| WLDN | $54.08 | $115.20 | Above Fair Value | ⛔ Overvalued |
| WLFC | $182.83 | $200.18 | Avoid | ❌ Avoid |
| WLK | $10.00 | $95.93 | Avoid | ❌ Avoid |
| WLKP | $22.76 | $20.68 | 10.06% | 👍 Buy |
| WLY | $65.70 | $29.24 | 124.69% | ✅ Strong Buy |
| WLYB | $29.40 | $29.79 | Above Fair Value | ⚠️ See Analysis |
| WM | $140.61 | $226.79 | Above Fair Value | ⛔ Overvalued |
| WMB | $30.10 | $66.92 | Avoid | ❌ Avoid |
| WMG | $35.10 | $29.05 | 20.83% | ✅ Strong Buy |
| WMK | $48.58 | $73.68 | Above Fair Value | ⛔ Overvalued |
| WMS | $97.62 | $175.38 | Above Fair Value | ⛔ Overvalued |
| WMT | $42.30 | $131.18 | Above Fair Value | ⛔ Overvalued |
| WNC | $85,313.00 | $11.03 | Insufficient EBITDA | ✅ Strong Buy |
| WNEB | $11.59 | $14.32 | Above Fair Value | ⛔ Overvalued |
| WOOF | $2.33 | $2.62 | Avoid | ❌ Avoid |
| WOR | $49.07 | $59.10 | Above Fair Value | ⛔ Overvalued |
| WPC | $37.90 | $71.21 | Above Fair Value | ⛔ Overvalued |
| WPM | $54.46 | $135.98 | Above Fair Value | ⛔ Overvalued |
| WPP | $49.30 | $18.48 | 166.77% | ✅ Strong Buy |
| WRB | $66.94 | $70.41 | Above Fair Value | ⚠️ See Analysis |
| WRBY | $5.99 | $25.52 | Above Fair Value | ⛔ Overvalued |
| WRLD | $151.72 | $123.09 | 23.26% | ✅ Strong Buy |
| WS | $37.18 | $47.70 | Above Fair Value | ⛔ Overvalued |
| WSBC | $53.07 | $37.89 | 40.06% | ✅ Strong Buy |
| WSBF | $17.42 | $18.05 | Above Fair Value | ⚠️ See Analysis |
| WSC | $16.90 | $22.26 | Avoid | ❌ Avoid |
| WSFS | $76.62 | $70.65 | 8.45% | 👍 Buy |
| WSM | $139.54 | $220.67 | Above Fair Value | ⛔ Overvalued |
| WSO | $216.87 | $419.92 | Above Fair Value | ⛔ Overvalued |
| WSR | $8.00 | $14.99 | Above Fair Value | ⛔ Overvalued |
| WST | $125.09 | $248.95 | Above Fair Value | ⛔ Overvalued |
| WT | $15.89 | $15.74 | 0.95% | 👍 Buy |
| WTBA | $42.36 | $26.31 | 61.00% | ✅ Strong Buy |
| WTFC | $189.71 | $161.35 | 17.58% | 👍 Buy |
| WTM | $1,767.89 | $2,185.00 | Above Fair Value | ⛔ Overvalued |
| WTRG | $33.00 | $37.42 | Avoid | ❌ Avoid |
| WTS | $151.93 | $319.22 | Above Fair Value | ⛔ Overvalued |
| WTTR | $4.07 | $12.89 | Above Fair Value | ⛔ Overvalued |
| WTW | $278.00 | $330.04 | Above Fair Value | ⛔ Overvalued |
| WU | $13.10 | $10.28 | 27.43% | ✅ Strong Buy |
| WWD | $135.62 | $388.50 | Above Fair Value | ⛔ Overvalued |
| WWR | $0.39 | $0.91 | Insufficient EBITDA | ❌ Avoid |
| WWW | $16.49 | $18.59 | Avoid | ❌ Avoid |
| WY | $2.65 | $26.64 | Avoid | ❌ Avoid |
| WYNN | $99.00 | $117.96 | Avoid | ❌ Avoid |
| XEL | $55.44 | $75.90 | Avoid | ❌ Avoid |
| XERS | $4.34 | $7.01 | Insufficient EBITDA | ❌ Avoid |
| XHR | $5.99 | $15.56 | Above Fair Value | ⛔ Overvalued |
| XMTR | $8.89 | $66.03 | Insufficient EBITDA | ❌ Avoid |
| XOM | $98.21 | $149.05 | Above Fair Value | ⛔ Overvalued |
| XOMA | $14.39 | $24.86 | Insufficient EBITDA | ⛔ Overvalued |
| XPEL | $31.51 | $51.93 | Above Fair Value | ⛔ Overvalued |
| XPER | $17.86 | $5.38 | 231.97% | ✅ Strong Buy |
| XPO | $44.79 | $203.61 | Above Fair Value | ⛔ Overvalued |
| XPOF | $9.44 | $8.55 | Insufficient EBITDA | ❌ Avoid |
| XPON | $622.07 | $0.78 | Insufficient EBITDA | ❌ Avoid |
| XPRO | $14.13 | $16.66 | Above Fair Value | ⛔ Overvalued |
| XRAY | $21.33 | $13.76 | Insufficient EBITDA | ❌ Avoid |
| XRX | $15.07 | $2.34 | Insufficient EBITDA | ❌ Avoid |
| XYL | $82.34 | $142.12 | Above Fair Value | ⛔ Overvalued |
| XYZ | $57.98 | $55.97 | 3.59% | 👍 Buy |
| YELP | $46.63 | $24.42 | 90.95% | ✅ Strong Buy |
| YETI | $57.34 | $47.15 | 21.61% | ✅ Strong Buy |
| YEXT | $12.05 | $4.90 | 145.92% | ✅ Strong Buy |
| YORW | $23.14 | $31.81 | Avoid | ❌ Avoid |
| YOU | $34.72 | $33.76 | 2.84% | 👍 Buy |
| YUM | $117.60 | $162.93 | Avoid | ❌ Avoid |
| YUMC | $44.88 | $57.95 | Above Fair Value | ⛔ Overvalued |
| YYAI | $119.03 | $1.15 | 10,250.43% | ✅ Strong Buy |
| Z | $32.34 | $54.97 | Above Fair Value | ⛔ Overvalued |
| ZBH | $128.37 | $89.91 | 42.78% | ✅ Strong Buy |
| ZBRA | $246.67 | $251.40 | Above Fair Value | ⚠️ See Analysis |
| ZD | $122.32 | $33.51 | 265.03% | ✅ Strong Buy |
| ZDGE | $4.63 | $3.09 | Insufficient EBITDA | ✅ Strong Buy |
| ZETA | $15.08 | $16.89 | Insufficient EBITDA | ⚠️ See Analysis |
| ZEUS | $21.95 | $51.14 | Avoid | ❌ Avoid |
| ZG | $31.79 | $54.50 | Above Fair Value | ⛔ Overvalued |
| ZGN | $4.55 | $10.39 | Above Fair Value | ⛔ Overvalued |
| ZIM | $35.72 | $20.68 | 72.73% | ✅ Strong Buy |
| ZION | $94.67 | $65.29 | 45.00% | ✅ Strong Buy |
| ZIP | $6.13 | $2.11 | Avoid | ❌ Avoid |
| ZM | $100.35 | $92.20 | 8.84% | 👍 Buy |
| ZS | $88.48 | $167.33 | Above Fair Value | ⛔ Overvalued |
| ZTS | $140.18 | $127.42 | 10.01% | 👍 Buy |
| ZUMZ | $12.67 | $24.91 | Above Fair Value | ⛔ Overvalued |
| ZVRA | $13.31 | $8.60 | Insufficient EBITDA | ✅ Strong Buy |
| ZWS | $25.01 | $52.78 | Above Fair Value | ⛔ Overvalued |
| ZYME | $4.64 | $22.72 | Insufficient EBITDA | ❌ Avoid |
| A | $110.39 | $129.58 | Above Fair Value | ⛔ Overvalued |
| AA | $62.01 | $59.16 | 4.82% | 👍 Buy |
| AAL | $18.65 | $15.24 | Avoid | ❌ Avoid |
| AAMI | $47.04 | $50.98 | Above Fair Value | ⚠️ See Analysis |
| AAOI | $12.09 | $44.30 | Insufficient EBITDA | ❌ Avoid |
| AAON | $26.14 | $96.43 | Above Fair Value | ⛔ Overvalued |
| AAP | $31.85 | $55.30 | Insufficient EBITDA | ❌ Avoid |
| AAPL | $225.82 | $278.12 | Above Fair Value | ⛔ Overvalued |
| AAT | $6.74 | $18.94 | Above Fair Value | ⛔ Overvalued |
| AB | $56.98 | $39.43 | 44.51% | ✅ Strong Buy |
| ABBV | $146.46 | $223.43 | Avoid | ❌ Avoid |
| ABCB | $83.00 | $85.94 | Above Fair Value | ⚠️ See Analysis |
| ABEO | $18.08 | $5.13 | Insufficient EBITDA | ✅ Strong Buy |
| ABEV | $3.40 | $2.94 | 15.65% | 👍 Buy |
| ABG | $354.03 | $225.21 | Avoid | ❌ Avoid |
| ABL | $17.82 | $8.47 | 110.39% | ✅ Strong Buy |
| ABM | $50.00 | $47.56 | Avoid | ❌ Avoid |
| ABNB | $89.90 | $122.18 | Above Fair Value | ⛔ Overvalued |
| ABR | $11.35 | $7.80 | Avoid | ❌ Avoid |
| ABT | $91.56 | $110.83 | Above Fair Value | ⛔ Overvalued |
| ACA | $61.95 | $124.74 | Above Fair Value | ⛔ Overvalued |
| ACAD | $14.21 | $23.56 | Above Fair Value | ⛔ Overvalued |
| ACB | $1.52 | $3.48 | Above Fair Value | ⛔ Overvalued |
| ACCO | $11.13 | $4.06 | Avoid | ❌ Avoid |
| ACEL | $12.45 | $11.28 | 10.37% | 👍 Buy |
| ACGL | $122.85 | $100.95 | 21.69% | ✅ Strong Buy |
| ACHC | $22.23 | $13.37 | Avoid | ❌ Avoid |
| ACI | $30.69 | $18.09 | 69.65% | ✅ Strong Buy |
| ACIC | $25.95 | $11.31 | 129.44% | ✅ Strong Buy |
| ACIW | $62.57 | $42.28 | 47.99% | ✅ Strong Buy |
| ACLS | $67.79 | $86.08 | Above Fair Value | ⛔ Overvalued |
| ACM | $75.77 | $101.03 | Above Fair Value | ⛔ Overvalued |
| ACMR | $38.42 | $62.48 | Above Fair Value | ⛔ Overvalued |
| ACN | $289.27 | $240.62 | 20.22% | ✅ Strong Buy |
| ACNB | $75.21 | $52.77 | 42.54% | ✅ Strong Buy |
| ACRE | $1.08 | $5.20 | Above Fair Value | ⛔ Overvalued |
| ACT | $32.38 | $43.17 | Above Fair Value | ⛔ Overvalued |
| ACTG | $0.62 | $4.20 | Above Fair Value | ⛔ Overvalued |
| ACU | $27.52 | $44.61 | Above Fair Value | ⛔ Overvalued |
| ACVA | $4.31 | $7.37 | Insufficient EBITDA | ❌ Avoid |
| ADBE | $632.25 | $268.38 | 135.58% | ✅ Strong Buy |
| ADC | $29.43 | $74.74 | Above Fair Value | ⛔ Overvalued |
| ADEA | $18.89 | $18.10 | 4.36% | 👍 Buy |
| ADI | $223.32 | $320.45 | Above Fair Value | ⛔ Overvalued |
| ADM | $46.76 | $66.33 | Above Fair Value | ⛔ Overvalued |
| ADMA | $20.76 | $16.43 | 26.35% | ✅ Strong Buy |
| ADNT | $37.54 | $26.46 | 41.87% | ✅ Strong Buy |
| ADP | $237.27 | $231.36 | 2.55% | 👍 Buy |
| ADSK | $260.94 | $240.40 | 8.54% | 👍 Buy |
| ADT | $15.27 | $8.07 | 89.22% | ✅ Strong Buy |
| ADTN | $4.57 | $9.86 | Insufficient EBITDA | ⛔ Overvalued |
| ADUS | $91.11 | $105.88 | Above Fair Value | ⛔ Overvalued |
| ADV | $3.87 | $0.76 | Insufficient EBITDA | ❌ Avoid |
| AEBI | $13.10 | $15.61 | Avoid | ❌ Avoid |
| AEE | $69.79 | $105.09 | Avoid | ❌ Avoid |
| AEHR | $1.43 | $26.39 | Insufficient EBITDA | ❌ Avoid |
| AEIS | $98.85 | $273.26 | Above Fair Value | ⛔ Overvalued |
| AEM | $136.73 | $196.60 | Above Fair Value | ⛔ Overvalued |
| AEO | $20.47 | $23.76 | Above Fair Value | ⛔ Overvalued |
| AEP | $83.60 | $120.80 | Avoid | ❌ Avoid |
| AER | $191.32 | $140.07 | Avoid | ❌ Avoid |
| AFCG | $1.89 | $2.17 | Above Fair Value | ⚠️ See Analysis |
| AFG | $161.22 | $131.04 | 23.03% | ✅ Strong Buy |
| AFL | $126.38 | $117.15 | 7.88% | 👍 Buy |
| AFRM | $50.31 | $57.03 | Avoid | ❌ Avoid |
| AG | $8.57 | $21.99 | Above Fair Value | ⛔ Overvalued |
| AGCO | $69.39 | $132.57 | Avoid | ❌ Avoid |
| AGEN | $29.20 | $2.94 | Insufficient EBITDA | ✅ Strong Buy |
| AGI | $26.79 | $40.17 | Above Fair Value | ⛔ Overvalued |
| AGM | $202.53 | $171.82 | 17.87% | ✅ Strong Buy |
| AGNC | $10.51 | $11.44 | Above Fair Value | ⚠️ See Analysis |
| AGO | $92.90 | $87.75 | 5.87% | 👍 Buy |
| AGRO | $10.25 | $8.57 | 19.60% | ✅ Strong Buy |
| AGX | $122.17 | $352.09 | Above Fair Value | ⛔ Overvalued |
| AGYS | $41.52 | $86.01 | Above Fair Value | ⛔ Overvalued |
| AHCO | $15.10 | $10.65 | 41.78% | ✅ Strong Buy |
| AHH | $2.44 | $7.18 | Above Fair Value | ⛔ Overvalued |
| AHR | $8.31 | $48.77 | Above Fair Value | ⛔ Overvalued |
| AIG | $97.63 | $76.72 | 27.25% | ✅ Strong Buy |
| AIN | $35.61 | $58.78 | Avoid | ❌ Avoid |
| AIOT | $3.43 | $4.84 | Avoid | ❌ Avoid |
| AIR | $64.53 | $113.09 | Above Fair Value | ⛔ Overvalued |
| AIT | $159.65 | $291.74 | Above Fair Value | ⛔ Overvalued |
| AIZ | $259.21 | $243.31 | 6.53% | 👍 Buy |
| AJG | $181.44 | $241.58 | Above Fair Value | ⛔ Overvalued |
| AKAM | $144.77 | $95.08 | 52.26% | ✅ Strong Buy |
| AKAN | $2,333.05 | $0.96 | Insufficient EBITDA | ❌ Avoid |
| AKBA | $2.02 | $1.39 | Insufficient EBITDA | ✅ Strong Buy |
| AKR | $4.00 | $20.98 | Above Fair Value | ⛔ Overvalued |
| AL | $88.27 | $64.55 | Avoid | ❌ Avoid |
| ALAB | $50.08 | $169.85 | Insufficient EBITDA | ⛔ Overvalued |
| ALB | $16.76 | $163.37 | Insufficient EBITDA | ⛔ Overvalued |
| ALC | $40.66 | $78.83 | Above Fair Value | ⛔ Overvalued |
| ALCO | $11.23 | $40.94 | Insufficient EBITDA | ❌ Avoid |
| ALDX | $5.83 | $5.53 | Insufficient EBITDA | ❌ Avoid |
| ALE | $54.12 | $67.90 | Avoid | ❌ Avoid |
| ALEX | $12.91 | $20.76 | Above Fair Value | ⛔ Overvalued |
| ALG | $147.07 | $208.38 | Above Fair Value | ⛔ Overvalued |
| ALGM | $11.32 | $41.57 | Above Fair Value | ⛔ Overvalued |
| ALGN | $194.74 | $187.60 | 3.81% | 👍 Buy |
| ALGT | $66.69 | $114.79 | Avoid | ❌ Avoid |
| ALHC | $5.21 | $21.75 | Insufficient EBITDA | ⛔ Overvalued |
| ALIT | $10.69 | $1.60 | Avoid | ❌ Avoid |
| ALK | $83.39 | $59.45 | Avoid | ❌ Avoid |
| ALKS | $29.74 | $34.91 | Above Fair Value | ⛔ Overvalued |
| ALKT | $14.45 | $17.43 | Insufficient EBITDA | ❌ Avoid |
| ALL | $360.54 | $207.55 | 73.71% | ✅ Strong Buy |
| ALLE | $168.35 | $179.77 | Above Fair Value | ⚠️ See Analysis |
| ALLY | $57.24 | $42.31 | 35.29% | ✅ Strong Buy |
| ALNT | $31.20 | $65.74 | Above Fair Value | ⛔ Overvalued |
| ALNY | $182.27 | $328.16 | Insufficient EBITDA | ⛔ Overvalued |
| ALRM | $53.53 | $48.22 | 11.01% | 👍 Buy |
| ALRS | $35.36 | $25.72 | 37.48% | ✅ Strong Buy |
| ALSN | $119.03 | $115.63 | 2.94% | 👍 Buy |
| ALTG | $8.93 | $7.35 | Avoid | ❌ Avoid |
| ALV | $137.84 | $125.79 | 9.58% | 👍 Buy |
| ALVO | $4.06 | $5.12 | Insufficient EBITDA | ❌ Avoid |
| ALX | $112.20 | $255.07 | Above Fair Value | ⛔ Overvalued |
| AM | $21.22 | $19.18 | 10.64% | 👍 Buy |
| AMAL | $58.44 | $41.25 | 41.67% | ✅ Strong Buy |
| AMAT | $222.45 | $322.51 | Above Fair Value | ⛔ Overvalued |
| AMBA | $11.39 | $63.64 | Insufficient EBITDA | ❌ Avoid |
| AMBP | $3.02 | $4.79 | Avoid | ❌ Avoid |
| AMCR | $12.22 | $48.17 | Avoid | ❌ Avoid |
| AMCX | $30.49 | $7.63 | 299.61% | ✅ Strong Buy |
| AMD | $93.04 | $208.44 | Above Fair Value | ⛔ Overvalued |
| AME | $128.44 | $231.91 | Above Fair Value | ⛔ Overvalued |
| AMG | $349.42 | $305.50 | 14.38% | 👍 Buy |
| AMGN | $243.51 | $384.32 | Above Fair Value | ⛔ Overvalued |
| AMH | $12.37 | $30.84 | Above Fair Value | ⛔ Overvalued |
| AMKR | $20.26 | $49.36 | Above Fair Value | ⛔ Overvalued |
| AMN | $13.79 | $20.30 | Avoid | ❌ Avoid |
| AMP | $685.29 | $542.99 | 26.21% | ✅ Strong Buy |
| AMPH | $48.15 | $29.26 | 64.56% | ✅ Strong Buy |
| AMPL | $1.86 | $7.23 | Insufficient EBITDA | ❌ Avoid |
| AMR | $291.47 | $206.32 | 41.27% | ✅ Strong Buy |
| AMRC | $17.12 | $30.92 | Avoid | ❌ Avoid |
| AMRX | $11.78 | $14.52 | Avoid | ❌ Avoid |
| AMSC | $18.78 | $28.17 | Above Fair Value | ⛔ Overvalued |
| AMSF | $37.22 | $39.19 | Above Fair Value | ⚠️ See Analysis |
| AMT | $136.92 | $171.27 | Avoid | ❌ Avoid |
| AMTM | $42.33 | $37.53 | Avoid | ❌ Avoid |
| AMWD | $30.43 | $67.54 | Above Fair Value | ⛔ Overvalued |
| AMX | $28.05 | $21.50 | 30.47% | ✅ Strong Buy |
| AMZN | $145.95 | $210.32 | Above Fair Value | ⛔ Overvalued |
| AN | $263.23 | $216.65 | Avoid | ❌ Avoid |
| ANDE | $43.83 | $66.86 | Above Fair Value | ⛔ Overvalued |
| ANET | $67.53 | $137.49 | Above Fair Value | ⛔ Overvalued |
| ANF | $140.09 | $97.66 | 43.45% | ✅ Strong Buy |
| ANGI | $23.09 | $11.85 | 94.85% | ✅ Strong Buy |
| ANIK | $3.57 | $10.46 | Above Fair Value | ⛔ Overvalued |
| ANIP | $128.83 | $81.84 | 57.42% | ✅ Strong Buy |
| AOMR | $15.64 | $8.93 | 75.14% | ✅ Strong Buy |
| AON | $309.18 | $342.04 | Above Fair Value | ⚠️ See Analysis |
| AORT | $9.82 | $39.59 | Above Fair Value | ⛔ Overvalued |
| AOS | $60.62 | $78.98 | Above Fair Value | ⛔ Overvalued |
| AOSL | $3.67 | $21.36 | Above Fair Value | ⛔ Overvalued |
| APA | $33.09 | $27.46 | 20.50% | ✅ Strong Buy |
| APAM | $34.48 | $45.12 | Above Fair Value | ⛔ Overvalued |
| APD | $181.64 | $283.12 | Avoid | ❌ Avoid |
| APEI | $34.26 | $44.89 | Above Fair Value | ⛔ Overvalued |
| APG | $18.47 | $44.45 | Above Fair Value | ⛔ Overvalued |
| APH | $68.71 | $136.23 | Above Fair Value | ⛔ Overvalued |
| APLE | $11.91 | $12.16 | Above Fair Value | ⚠️ See Analysis |
| APLS | $5.47 | $23.49 | Insufficient EBITDA | ⛔ Overvalued |
| APO | $122.49 | $133.03 | Above Fair Value | ⚠️ See Analysis |
| APOG | $44.27 | $41.79 | 5.93% | 👍 Buy |
| APP | $291.95 | $406.72 | Above Fair Value | ⛔ Overvalued |
| APPF | $120.49 | $179.73 | Above Fair Value | ⛔ Overvalued |
| APPN | $13.58 | $25.21 | Insufficient EBITDA | ❌ Avoid |
| APPS | $5.81 | $4.15 | Avoid | ❌ Avoid |
| APTV | $108.16 | $82.38 | 31.29% | ✅ Strong Buy |
| AQN | $4.43 | $6.49 | Avoid | ❌ Avoid |
| AR | $40.42 | $34.37 | 17.60% | 👍 Buy |
| ARCB | $50.91 | $111.96 | Above Fair Value | ⛔ Overvalued |
| ARCC | $25.95 | $19.31 | 34.39% | ✅ Strong Buy |
| ARCO | $9.90 | $8.55 | 15.79% | 👍 Buy |
| ARDX | $4.36 | $7.32 | Insufficient EBITDA | ❌ Avoid |
| ARE | $1.42 | $55.90 | Above Fair Value | ⛔ Overvalued |
| ARES | $89.90 | $130.46 | Above Fair Value | ⛔ Overvalued |
| ARGX | $506.70 | $811.45 | Above Fair Value | ⛔ Overvalued |
| ARHS | $7.53 | $11.10 | Above Fair Value | ⛔ Overvalued |
| ARI | $11.53 | $10.80 | Insufficient EBITDA | ❌ Avoid |
| ARKO | $1.81 | $6.64 | Above Fair Value | ⛔ Overvalued |
| ARLO | $13.75 | $12.40 | Insufficient EBITDA | 👍 Buy |
| ARLP | $24.83 | $24.37 | 1.89% | 👍 Buy |
| ARM | $38.76 | $123.70 | Above Fair Value | ⛔ Overvalued |
| ARMK | $33.07 | $38.73 | Avoid | ❌ Avoid |
| AROC | $25.19 | $32.05 | Above Fair Value | ⛔ Overvalued |
| AROW | $47.81 | $36.05 | 32.62% | ✅ Strong Buy |
| ARQT | $6.37 | $27.32 | Insufficient EBITDA | ❌ Avoid |
| ARR | $44.53 | $17.69 | 151.72% | ✅ Strong Buy |
| ARRY | $12.28 | $11.86 | Insufficient EBITDA | ❌ Avoid |
| ARTNA | $30.65 | $32.31 | Above Fair Value | ⚠️ See Analysis |
| ARW | $155.52 | $158.60 | Above Fair Value | ⚠️ See Analysis |
| AS | $18.75 | $37.51 | Above Fair Value | ⛔ Overvalued |
| ASAN | $6.27 | $8.76 | Insufficient EBITDA | ❌ Avoid |
| ASB | $45.93 | $29.37 | 56.38% | ✅ Strong Buy |
| ASC | $11.50 | $13.14 | Above Fair Value | ⚠️ See Analysis |
| ASGN | $78.16 | $52.50 | 48.88% | ✅ Strong Buy |
| ASH | $48.36 | $64.16 | Insufficient EBITDA | ❌ Avoid |
| ASIX | $35.48 | $18.50 | 91.78% | ✅ Strong Buy |
| ASLE | $10.78 | $7.45 | Avoid | ❌ Avoid |
| ASM | $8.04 | $10.15 | Above Fair Value | ⛔ Overvalued |
| ASML | $558.15 | $1,413.01 | Above Fair Value | ⛔ Overvalued |
| ASND | $94.80 | $222.15 | Insufficient EBITDA | ❌ Avoid |
| ASO | $52.46 | $59.13 | Above Fair Value | ⚠️ See Analysis |
| ASR | $289.94 | $367.92 | Above Fair Value | ⛔ Overvalued |
| ASRT | $19.64 | $12.74 | 54.16% | ✅ Strong Buy |
| ASRV | $3.54 | $3.82 | Above Fair Value | ⚠️ See Analysis |
| ASTE | $40.09 | $57.43 | Above Fair Value | ⛔ Overvalued |
| ASTH | $36.82 | $21.10 | Avoid | ❌ Avoid |
| ASUR | $17.00 | $8.91 | Insufficient EBITDA | ❌ Avoid |
| ASX | $11.37 | $20.89 | Above Fair Value | ⛔ Overvalued |
| ATEC | $1.91 | $13.82 | Insufficient EBITDA | ❌ Avoid |
| ATEN | $17.14 | $19.67 | Above Fair Value | ⚠️ See Analysis |
| ATEX | $78.58 | $28.39 | Insufficient EBITDA | ✅ Strong Buy |
| ATGE | $119.10 | $104.48 | 13.99% | 👍 Buy |
| ATI | $52.63 | $133.57 | Above Fair Value | ⛔ Overvalued |
| ATKR | $94.20 | $67.72 | 39.10% | ✅ Strong Buy |
| ATLO | $20.02 | $27.95 | Above Fair Value | ⛔ Overvalued |
| ATMU | $49.52 | $61.46 | Above Fair Value | ⛔ Overvalued |
| ATNI | $5.38 | $25.78 | Above Fair Value | ⛔ Overvalued |
| ATO | $117.25 | $171.38 | Avoid | ❌ Avoid |
| ATR | $84.41 | $134.31 | Above Fair Value | ⛔ Overvalued |
| ATRA | $11.48 | $4.88 | Insufficient EBITDA | ✅ Strong Buy |
| ATRO | $27.49 | $76.58 | Avoid | ❌ Avoid |
| AU | $109.22 | $103.95 | 5.07% | 👍 Buy |
| AUB | $57.28 | $41.78 | 37.10% | ✅ Strong Buy |
| AUBN | $29.84 | $24.63 | 21.15% | ✅ Strong Buy |
| AUDC | $7.97 | $7.64 | 4.32% | 👍 Buy |
| AUPH | $21.08 | $14.44 | 45.98% | ✅ Strong Buy |
| AVA | $35.51 | $41.50 | Avoid | ❌ Avoid |
| AVAL | $5.63 | $4.58 | 22.93% | ✅ Strong Buy |
| AVAV | $59.84 | $257.20 | Above Fair Value | ⛔ Overvalued |
| AVB | $95.54 | $173.83 | Above Fair Value | ⛔ Overvalued |
| AVD | $5.05 | $4.99 | Insufficient EBITDA | ❌ Avoid |
| AVDL | $7.86 | $21.69 | Insufficient EBITDA | ⛔ Overvalued |
| AVGO | $222.89 | $332.92 | Above Fair Value | ⛔ Overvalued |
| AVNT | $35.62 | $38.76 | Avoid | ❌ Avoid |
| AVNW | $40.38 | $26.36 | 53.19% | ✅ Strong Buy |
| AVO | $10.20 | $14.03 | Above Fair Value | ⛔ Overvalued |
| AVPT | $7.13 | $10.57 | Above Fair Value | ⛔ Overvalued |
| AVT | $70.32 | $66.62 | Avoid | ❌ Avoid |
| AVTR | $12.94 | $11.26 | Avoid | ❌ Avoid |
| AVXL | $20.24 | $4.10 | Insufficient EBITDA | ❌ Avoid |
| AVY | $150.58 | $191.51 | Above Fair Value | ⛔ Overvalued |
| AWI | $129.06 | $198.25 | Above Fair Value | ⛔ Overvalued |
| AWK | $86.67 | $124.33 | Avoid | ❌ Avoid |
| AWR | $52.66 | $70.47 | Above Fair Value | ⛔ Overvalued |
| AWX | $0.53 | $2.66 | Avoid | ❌ Avoid |
| AX | $133.96 | $101.01 | 32.62% | ✅ Strong Buy |
| AXGN | $5.93 | $34.93 | Above Fair Value | ⛔ Overvalued |
| AXL | $7.82 | $9.00 | Above Fair Value | ⛔ Overvalued |
| AXON | $118.37 | $414.20 | Above Fair Value | ⛔ Overvalued |
| AXP | $362.24 | $359.15 | 0.86% | 👍 Buy |
| AXS | $168.16 | $106.53 | 57.85% | ✅ Strong Buy |
| AXSM | $4.80 | $182.55 | Insufficient EBITDA | ❌ Avoid |
| AXTA | $36.03 | $33.81 | 6.57% | 👍 Buy |
| AYI | $360.49 | $328.39 | 9.77% | 👍 Buy |
| AZN | $80.02 | $193.03 | Above Fair Value | ⛔ Overvalued |
| AZO | $3,121.29 | $3,681.26 | Above Fair Value | ⛔ Overvalued |
| AZTA | $12.56 | $28.72 | Insufficient EBITDA | ⛔ Overvalued |
| AZZ | $95.71 | $130.00 | Above Fair Value | ⛔ Overvalued |
| BA | $69.71 | $243.03 | Above Fair Value | ⛔ Overvalued |
| BAC | $59.85 | $56.53 | 5.87% | 👍 Buy |
| BAH | $109.34 | $89.01 | 22.84% | ✅ Strong Buy |
| BALL | $59.53 | $66.47 | Avoid | ❌ Avoid |
| BAM | $34.74 | $49.61 | Above Fair Value | ⛔ Overvalued |
| BANC | $26.74 | $20.85 | 28.25% | ✅ Strong Buy |
| BAND | $31.47 | $13.43 | Avoid | ❌ Avoid |
| BANF | $109.27 | $119.04 | Above Fair Value | ⚠️ See Analysis |
| BANR | $89.82 | $64.59 | 39.06% | ✅ Strong Buy |
| BAX | $37.11 | $21.73 | Avoid | ❌ Avoid |
| BB | $2.87 | $3.46 | Above Fair Value | ⛔ Overvalued |
| BBD | $5.78 | $3.98 | 45.23% | ✅ Strong Buy |
| BBDC | $13.37 | $8.92 | 49.89% | ✅ Strong Buy |
| BBDO | $4.54 | $3.53 | 28.61% | ✅ Strong Buy |
| BBSI | $33.69 | $37.85 | Above Fair Value | ⚠️ See Analysis |
| BBVA | $29.77 | $24.09 | 23.58% | ✅ Strong Buy |
| BBW | $49.55 | $55.43 | Above Fair Value | ⚠️ See Analysis |
| BBWI | $28.72 | $23.05 | 24.60% | ✅ Strong Buy |
| BBY | $96.89 | $70.41 | 37.61% | ✅ Strong Buy |
| BC | $45.33 | $87.88 | Avoid | ❌ Avoid |
| BCAL | $26.14 | $19.16 | 36.43% | ✅ Strong Buy |
| BCAX | $77.38 | $15.36 | Insufficient EBITDA | ❌ Avoid |
| BCBP | $7.80 | $8.28 | Above Fair Value | ⚠️ See Analysis |
| BCC | $51.61 | $91.03 | Above Fair Value | ⛔ Overvalued |
| BCE | $39.09 | $25.08 | 55.86% | ✅ Strong Buy |
| BCH | $37.02 | $44.44 | Above Fair Value | ⛔ Overvalued |
| BCML | $33.26 | $30.54 | 8.91% | 👍 Buy |
| BCO | $137.49 | $130.91 | 5.03% | 👍 Buy |
| BCPC | $89.37 | $173.16 | Above Fair Value | ⛔ Overvalued |
| BCRX | $12.65 | $6.38 | Avoid | ❌ Avoid |
| BCSF | $22.47 | $13.11 | 71.40% | ✅ Strong Buy |
| BDC | $94.77 | $139.75 | Above Fair Value | ⛔ Overvalued |
| BDX | $242.27 | $210.02 | Avoid | ❌ Avoid |
| BE | $12.41 | $143.03 | Avoid | ❌ Avoid |
| BELFA | $88.82 | $205.83 | Above Fair Value | ⛔ Overvalued |
| BELFB | $87.67 | $220.78 | Above Fair Value | ⛔ Overvalued |
| BEN | $40.02 | $27.20 | 47.13% | ✅ Strong Buy |
| BF-B | $34.28 | $29.45 | 16.40% | 👍 Buy |
| BFAM | $68.02 | $86.08 | Above Fair Value | ⛔ Overvalued |
| BFC | $133.03 | $151.51 | Above Fair Value | ⚠️ See Analysis |
| BFH | $103.00 | $79.53 | 29.51% | ✅ Strong Buy |
| BFIN | $10.62 | $12.00 | Above Fair Value | ⚠️ See Analysis |
| BFS | $14.37 | $34.63 | Above Fair Value | ⛔ Overvalued |
| BG | $114.90 | $115.86 | Avoid | ❌ Avoid |
| BGC | $16.15 | $8.96 | 80.25% | ✅ Strong Buy |
| BGS | $6.11 | $5.14 | Insufficient EBITDA | ❌ Avoid |
| BH | $28.42 | $415.90 | Above Fair Value | ⛔ Overvalued |
| BHB | $49.28 | $35.60 | 38.43% | ✅ Strong Buy |
| BHC | $55.82 | $5.88 | Avoid | ❌ Avoid |
| BHE | $29.86 | $58.30 | Above Fair Value | ⛔ Overvalued |
| BHF | $251.80 | $63.73 | 295.10% | ✅ Strong Buy |
| BHFAP | $178.95 | $16.63 | 976.07% | ✅ Strong Buy |
| BHP | $75.18 | $69.64 | 7.96% | 👍 Buy |
| BHRB | $114.28 | $69.70 | 63.96% | ✅ Strong Buy |
| BIIB | $280.34 | $201.18 | 39.35% | ✅ Strong Buy |
| BILL | $62.07 | $48.94 | Avoid | ❌ Avoid |
| BIO | $151.88 | $301.50 | Insufficient EBITDA | ❌ Avoid |
| BIOA | $205.85 | $20.73 | Insufficient EBITDA | ❌ Avoid |
| BIP | $18.55 | $38.04 | Avoid | ❌ Avoid |
| BIRK | $37.69 | $38.45 | Above Fair Value | ⚠️ See Analysis |
| BJ | $87.71 | $100.40 | Above Fair Value | ⚠️ See Analysis |
| BJRI | $35.76 | $44.03 | Above Fair Value | ⛔ Overvalued |
| BK | $126.32 | $124.32 | 1.61% | 👍 Buy |
| BKE | $32.01 | $52.09 | Above Fair Value | ⛔ Overvalued |
| BKH | $56.84 | $72.30 | Avoid | ❌ Avoid |
| BKNG | $5,533.65 | $4,457.17 | 24.15% | ✅ Strong Buy |
| BKR | $40.01 | $58.92 | Above Fair Value | ⛔ Overvalued |
| BKU | $63.90 | $50.93 | 25.47% | ✅ Strong Buy |
| BL | $46.01 | $43.85 | Avoid | ❌ Avoid |
| BLBD | $55.75 | $59.21 | Above Fair Value | ⚠️ See Analysis |
| BLD | $312.28 | $517.50 | Above Fair Value | ⛔ Overvalued |
| BLDR | $90.85 | $124.42 | Above Fair Value | ⛔ Overvalued |
| BLFS | $1.86 | $22.43 | Avoid | ❌ Avoid |
| BLK | $830.66 | $1,056.38 | Above Fair Value | ⛔ Overvalued |
| BLKB | $89.99 | $47.48 | 89.53% | ✅ Strong Buy |
| BLMN | $14.60 | $7.07 | Avoid | ❌ Avoid |
| BLND | $1.68 | $1.99 | Insufficient EBITDA | ⛔ Overvalued |
| BLX | $42.79 | $48.92 | Above Fair Value | ⚠️ See Analysis |
| BMBL | $26.02 | $3.22 | Insufficient EBITDA | ❌ Avoid |
| BMI | $100.07 | $151.23 | Above Fair Value | ⛔ Overvalued |
| BMO | $218.53 | $141.73 | 54.19% | ✅ Strong Buy |
| BMRC | $39.12 | $27.40 | 42.77% | ✅ Strong Buy |
| BMRN | $72.75 | $58.13 | 25.15% | ✅ Strong Buy |
| BMY | $101.01 | $61.99 | 62.95% | ✅ Strong Buy |
| BN | $4.54 | $45.21 | Avoid | ❌ Avoid |
| BNL | $13.36 | $19.26 | Above Fair Value | ⛔ Overvalued |
| BNS | $131.00 | $76.34 | 71.60% | ✅ Strong Buy |
| BOH | $106.29 | $78.91 | 34.70% | ✅ Strong Buy |
| BOKF | $130.82 | $136.57 | Above Fair Value | ⚠️ See Analysis |
| BOOM | $1.01 | $8.15 | Insufficient EBITDA | ⛔ Overvalued |
| BOOT | $110.98 | $203.38 | Above Fair Value | ⛔ Overvalued |
| BORR | $2.35 | $5.30 | Avoid | ❌ Avoid |
| BOTJ | $23.54 | $20.45 | 15.11% | 👍 Buy |
| BOW | $47.25 | $25.04 | 88.70% | ✅ Strong Buy |
| BOX | $27.87 | $24.67 | 12.97% | 👍 Buy |
| BP | $33.12 | $39.01 | Above Fair Value | ⛔ Overvalued |
| BPOP | $178.61 | $145.97 | 22.36% | ✅ Strong Buy |
| BPRN | $48.06 | $36.42 | 31.96% | ✅ Strong Buy |
| BR | $201.86 | $181.91 | 10.97% | 👍 Buy |
| BRBR | $34.48 | $19.52 | 76.64% | ✅ Strong Buy |
| BRBS | $1.24 | $4.30 | Insufficient EBITDA | ⛔ Overvalued |
| BRC | $70.25 | $92.28 | Above Fair Value | ⛔ Overvalued |
| BRK-A | $484,898.00 | $762,570.00 | Above Fair Value | ⛔ Overvalued |
| BRK-B | $323.26 | $508.09 | Above Fair Value | ⛔ Overvalued |
| BRKR | $32.46 | $41.93 | Avoid | ❌ Avoid |
| BRO | $74.99 | $73.78 | 1.64% | 👍 Buy |
| BROS | $11.11 | $57.04 | Above Fair Value | ⛔ Overvalued |
| BRSP | $10.35 | $5.90 | Insufficient EBITDA | ✅ Strong Buy |
| BRX | $16.26 | $28.32 | Above Fair Value | ⛔ Overvalued |
| BRZE | $11.87 | $17.79 | Insufficient EBITDA | ❌ Avoid |
| BSAC | $33.75 | $36.74 | Above Fair Value | ⚠️ See Analysis |
| BSBR | $10.41 | $6.49 | 60.40% | ✅ Strong Buy |
| BSET | $10.89 | $15.76 | Insufficient EBITDA | ⛔ Overvalued |
| BSM | $10.17 | $15.00 | Above Fair Value | ⛔ Overvalued |
| BSRR | $33.33 | $37.88 | Above Fair Value | ⚠️ See Analysis |
| BSVN | $43.12 | $45.19 | Above Fair Value | ⚠️ See Analysis |
| BSX | $52.40 | $76.27 | Above Fair Value | ⛔ Overvalued |
| BSY | $33.40 | $33.17 | 0.69% | 👍 Buy |
| BTBT | $3.37 | $1.80 | 87.22% | ✅ Strong Buy |
| BTDR | $13.20 | $12.59 | Insufficient EBITDA | ❌ Avoid |
| BTE | $4.33 | $3.53 | 22.66% | ✅ Strong Buy |
| BTG | $8.55 | $5.06 | 68.97% | ✅ Strong Buy |
| BTI | $94.97 | $62.80 | 51.23% | ✅ Strong Buy |
| BTM | $4.55 | $0.83 | 448.19% | ✅ Strong Buy |
| BTMD | $13.67 | $2.23 | 513.00% | ✅ Strong Buy |
| BTSG | $19.10 | $39.68 | Avoid | ❌ Avoid |
| BTU | $22.70 | $36.92 | Above Fair Value | ⛔ Overvalued |
| BUD | $64.65 | $75.81 | Above Fair Value | ⛔ Overvalued |
| BULL | $31.04 | $6.58 | Insufficient EBITDA | ✅ Strong Buy |
| BUR | $19.70 | $8.92 | 120.85% | ✅ Strong Buy |
| BURL | $229.85 | $311.63 | Above Fair Value | ⛔ Overvalued |
| BUSE | $28.31 | $27.27 | 3.81% | 👍 Buy |
| BV | $11.42 | $13.55 | Above Fair Value | ⛔ Overvalued |
| BVN | $37.05 | $36.95 | 0.27% | 👍 Buy |
| BVS | $10.58 | $8.51 | 24.32% | ✅ Strong Buy |
| BWA | $64.19 | $52.23 | 22.90% | ✅ Strong Buy |
| BWB | $31.37 | $19.97 | 57.09% | ✅ Strong Buy |
| BWFG | $69.62 | $50.40 | 38.13% | ✅ Strong Buy |
| BWIN | $37.54 | $19.57 | 91.82% | ✅ Strong Buy |
| BWMN | $25.91 | $35.33 | Above Fair Value | ⛔ Overvalued |
| BWMX | $821.44 | $17.97 | 4,471.17% | ✅ Strong Buy |
| BWXT | $71.47 | $197.19 | Above Fair Value | ⛔ Overvalued |
| BX | $102.21 | $129.69 | Above Fair Value | ⛔ Overvalued |
| BXC | $19.38 | $79.05 | Above Fair Value | ⛔ Overvalued |
| BXMT | $10.34 | $19.61 | Above Fair Value | ⛔ Overvalued |
| BXP | $20.28 | $64.72 | Above Fair Value | ⛔ Overvalued |
| BXSL | $44.88 | $24.89 | 80.31% | ✅ Strong Buy |
| BY | $47.92 | $33.51 | 43.00% | ✅ Strong Buy |
| BYRN | $12.11 | $14.69 | Above Fair Value | ⛔ Overvalued |
| BZH | $23.45 | $25.05 | Avoid | ❌ Avoid |
| C | $138.41 | $122.69 | 12.81% | 👍 Buy |
| CABO | $647.93 | $100.75 | Avoid | ❌ Avoid |
| CAC | $76.42 | $50.13 | 52.44% | ✅ Strong Buy |
| CACC | $540.67 | $508.90 | 6.24% | 👍 Buy |
| CACI | $488.73 | $618.50 | Above Fair Value | ⛔ Overvalued |
| CADE | $56.16 | $42.11 | 33.36% | ✅ Strong Buy |
| CAG | $22.96 | $19.35 | Avoid | ❌ Avoid |
| CAH | $115.22 | $226.32 | Above Fair Value | ⛔ Overvalued |
| CAKE | $58.50 | $63.25 | Above Fair Value | ⚠️ See Analysis |
| CAL | $11.94 | $12.98 | Avoid | ❌ Avoid |
| CALM | $86.74 | $82.53 | 5.10% | 👍 Buy |
| CALX | $30.71 | $53.18 | Insufficient EBITDA | ⛔ Overvalued |
| CAMT | $45.89 | $149.02 | Above Fair Value | ⛔ Overvalued |
| CAPL | $11.84 | $21.96 | Avoid | ❌ Avoid |
| CAPR | $3.48 | $24.72 | Insufficient EBITDA | ❌ Avoid |
| CAR | $164.16 | $120.42 | Avoid | ❌ Avoid |
| CARE | $26.11 | $22.11 | 18.09% | ✅ Strong Buy |
| CARG | $36.36 | $28.61 | 27.09% | ✅ Strong Buy |
| CARR | $45.16 | $63.92 | Above Fair Value | ⛔ Overvalued |
| CARS | $39.91 | $11.14 | 258.26% | ✅ Strong Buy |
| CART | $43.25 | $34.64 | 24.86% | ✅ Strong Buy |
| CASH | $144.23 | $93.72 | 53.89% | ✅ Strong Buy |
| CASS | $54.44 | $46.76 | 16.42% | 👍 Buy |
| CASY | $275.34 | $660.90 | Above Fair Value | ⛔ Overvalued |
| CAT | $307.08 | $726.20 | Above Fair Value | ⛔ Overvalued |
| CATY | $58.17 | $54.10 | 7.52% | 👍 Buy |
| CAVA | $8.61 | $69.96 | Above Fair Value | ⛔ Overvalued |
| CB | $390.81 | $330.97 | 18.08% | ✅ Strong Buy |
| CBAN | $26.47 | $21.07 | 25.63% | ✅ Strong Buy |
| CBFV | $44.44 | $37.26 | 19.27% | ✅ Strong Buy |
| CBL | $16.16 | $36.43 | Above Fair Value | ⛔ Overvalued |
| CBNK | $49.75 | $32.81 | 51.63% | ✅ Strong Buy |
| CBOE | $239.81 | $273.36 | Above Fair Value | ⚠️ See Analysis |
| CBRE | $94.72 | $169.67 | Above Fair Value | ⛔ Overvalued |
| CBRL | $8.68 | $33.81 | Avoid | ❌ Avoid |
| CBSH | $52.48 | $55.17 | Above Fair Value | ⚠️ See Analysis |
| CBT | $86.20 | $74.58 | 15.58% | 👍 Buy |
| CBU | $69.93 | $66.39 | 5.33% | 👍 Buy |
| CBZ | $55.62 | $38.27 | Avoid | ❌ Avoid |
| CC | $18.83 | $18.32 | Avoid | ❌ Avoid |
| CCAP | $23.13 | $14.40 | 60.63% | ✅ Strong Buy |
| CCB | $86.98 | $87.94 | Above Fair Value | ⚠️ See Analysis |
| CCBG | $53.12 | $43.51 | 22.09% | ✅ Strong Buy |
| CCEC | $26.67 | $20.46 | Avoid | ❌ Avoid |
| CCEP | $67.90 | $97.56 | Above Fair Value | ⛔ Overvalued |
| CCI | $50.39 | $80.88 | Insufficient EBITDA | ⛔ Overvalued |
| CCJ | $21.55 | $113.63 | Above Fair Value | ⛔ Overvalued |
| CCK | $108.28 | $112.88 | Above Fair Value | ⚠️ See Analysis |
| CCL | $44.16 | $33.99 | Avoid | ❌ Avoid |
| CCNE | $52.20 | $29.16 | 79.01% | ✅ Strong Buy |
| CCO | $0.63 | $2.17 | Avoid | ❌ Avoid |
| CCRN | $1.34 | $8.69 | Above Fair Value | ⛔ Overvalued |
| CCS | $78.30 | $69.79 | Avoid | ❌ Avoid |
| CCSI | $123.80 | $23.67 | 423.02% | ✅ Strong Buy |
| CCU | $11.71 | $14.48 | Above Fair Value | ⛔ Overvalued |
| CDE | $22.20 | $21.44 | 3.54% | 👍 Buy |
| CDNA | $15.87 | $19.47 | Insufficient EBITDA | ❌ Avoid |
| CDNS | $141.57 | $283.52 | Above Fair Value | ⛔ Overvalued |
| CDP | $21.03 | $32.45 | Above Fair Value | ⛔ Overvalued |
| CDRE | $30.03 | $41.63 | Above Fair Value | ⛔ Overvalued |
| CDW | $166.15 | $142.62 | 16.50% | 👍 Buy |
| CE | $49.47 | $54.88 | Avoid | ❌ Avoid |
| CECO | $16.11 | $72.37 | Above Fair Value | ⛔ Overvalued |
| CEG | $170.09 | $261.42 | Above Fair Value | ⛔ Overvalued |
| CELH | $32.63 | $50.57 | Above Fair Value | ⛔ Overvalued |
| CENT | $36.69 | $37.99 | Above Fair Value | ⚠️ See Analysis |
| CENTA | $36.81 | $34.08 | 8.01% | 👍 Buy |
| CENX | $68.31 | $52.40 | 30.36% | ✅ Strong Buy |
| CERT | $10.66 | $7.23 | 47.44% | ✅ Strong Buy |
| CEVA | $9.71 | $22.54 | Insufficient EBITDA | ❌ Avoid |
| CF | $134.46 | $92.64 | 45.14% | ✅ Strong Buy |
| CFBK | $49.40 | $33.31 | 48.30% | ✅ Strong Buy |
| CFFI | $120.39 | $79.71 | 51.04% | ✅ Strong Buy |
| CFFN | $10.05 | $7.60 | 32.24% | ✅ Strong Buy |
| CFG | $63.46 | $68.12 | Above Fair Value | ⚠️ See Analysis |
| CFLT | $8.84 | $30.57 | Insufficient EBITDA | ❌ Avoid |
| CFR | $156.30 | $146.69 | 6.55% | 👍 Buy |
| CG | $47.95 | $58.71 | Above Fair Value | ⛔ Overvalued |
| CGAU | $15.17 | $17.33 | Above Fair Value | ⚠️ See Analysis |
| CGBD | $19.23 | $11.98 | 60.52% | ✅ Strong Buy |
| CGNX | $22.23 | $42.37 | Above Fair Value | ⛔ Overvalued |
| CHCO | $150.87 | $127.84 | 18.01% | ✅ Strong Buy |
| CHCT | $13.47 | $18.13 | Above Fair Value | ⛔ Overvalued |
| CHD | $65.94 | $100.53 | Above Fair Value | ⛔ Overvalued |
| CHDN | $103.27 | $93.55 | Avoid | ❌ Avoid |
| CHE | $396.68 | $447.74 | Above Fair Value | ⚠️ See Analysis |
| CHEF | $33.27 | $66.67 | Above Fair Value | ⛔ Overvalued |
| CHGG | $0.19 | $0.79 | Insufficient EBITDA | ⛔ Overvalued |
| CHH | $142.48 | $109.28 | 30.38% | ✅ Strong Buy |
| CHKP | $192.49 | $180.91 | 6.40% | 👍 Buy |
| CHMG | $93.26 | $64.40 | 44.81% | ✅ Strong Buy |
| CHRD | $104.89 | $102.89 | 1.94% | 👍 Buy |
| CHRS | $7.88 | $2.14 | Avoid | ❌ Avoid |
| CHRW | $96.09 | $200.59 | Above Fair Value | ⛔ Overvalued |
| CHT | $26.51 | $41.57 | Avoid | ❌ Avoid |
| CHTR | $536.38 | $231.14 | Avoid | ❌ Avoid |
| CHWY | $25.74 | $28.02 | Above Fair Value | ⚠️ See Analysis |
| CI | $422.83 | $292.05 | 44.78% | ✅ Strong Buy |
| CIA | $3.87 | $5.98 | Above Fair Value | ⛔ Overvalued |
| CIEN | $99.66 | $271.32 | Above Fair Value | ⛔ Overvalued |
| CIFR | $6.20 | $14.73 | Above Fair Value | ⛔ Overvalued |
| CIG | $2.52 | $2.14 | 17.76% | ✅ Strong Buy |
| CIGI | $89.30 | $139.72 | Above Fair Value | ⛔ Overvalued |
| CIM | $21.79 | $12.38 | 76.01% | ✅ Strong Buy |
| CINF | $123.95 | $172.65 | Above Fair Value | ⛔ Overvalued |
| CION | $18.98 | $8.83 | 114.95% | ✅ Strong Buy |
| CIVB | $36.77 | $24.83 | 48.09% | ✅ Strong Buy |
| CIVI | $53.24 | $27.38 | 94.45% | ✅ Strong Buy |
| CIX | $21.70 | $23.81 | Above Fair Value | ⚠️ See Analysis |
| CKX | $3.88 | $11.00 | Above Fair Value | ⛔ Overvalued |
| CL | $70.31 | $94.41 | Above Fair Value | ⛔ Overvalued |
| CLAR | $2.05 | $3.62 | Insufficient EBITDA | ❌ Avoid |
| CLB | $16.76 | $18.56 | Above Fair Value | ⚠️ See Analysis |
| CLBK | $9.82 | $18.52 | Insufficient EBITDA | ⛔ Overvalued |
| CLBT | $11.05 | $14.17 | Above Fair Value | ⛔ Overvalued |
| CLDT | $0.15 | $7.57 | Above Fair Value | ⛔ Overvalued |
| CLF | $3.11 | $14.73 | Avoid | ❌ Avoid |
| CLFD | $17.55 | $30.91 | Avoid | ❌ Avoid |
| CLH | $122.75 | $265.98 | Above Fair Value | ⛔ Overvalued |
| CLMB | $80.69 | $122.65 | Above Fair Value | ⛔ Overvalued |
| CLMT | $0.40 | $25.19 | Avoid | ❌ Avoid |
| CLOV | $0.81 | $2.13 | Insufficient EBITDA | ❌ Avoid |
| CLS | $78.49 | $307.53 | Above Fair Value | ⛔ Overvalued |
| CLSK | $6.32 | $10.08 | Above Fair Value | ⛔ Overvalued |
| CLST | $9.02 | $15.82 | Insufficient EBITDA | ⛔ Overvalued |
| CLVT | $10.98 | $2.16 | Avoid | ❌ Avoid |
| CLX | $111.68 | $119.36 | Above Fair Value | ⚠️ See Analysis |
| CM | $157.14 | $96.68 | 62.54% | ✅ Strong Buy |
| CMA | $78.10 | $88.67 | Above Fair Value | ⚠️ See Analysis |
| CMBM | $0.73 | $1.41 | Insufficient EBITDA | ❌ Avoid |
| CMBT | $6.80 | $12.47 | Avoid | ❌ Avoid |
| CMC | $91.05 | $82.99 | 9.71% | 👍 Buy |
| CMCL | $50.09 | $28.46 | 76.00% | ✅ Strong Buy |
| CMCO | $31.17 | $22.76 | Avoid | ❌ Avoid |
| CMCSA | $55.51 | $31.37 | 76.95% | ✅ Strong Buy |
| CME | $215.09 | $302.27 | Above Fair Value | ⛔ Overvalued |
| CMG | $24.07 | $39.39 | Above Fair Value | ⛔ Overvalued |
| CMI | $358.67 | $577.73 | Above Fair Value | ⛔ Overvalued |
| CMP | $12.22 | $21.75 | Avoid | ❌ Avoid |
| CMPO | $19.34 | $24.46 | Insufficient EBITDA | ❌ Avoid |
| CMPR | $61.82 | $75.64 | Avoid | ❌ Avoid |
| CMRE | $37.94 | $15.92 | 138.32% | ✅ Strong Buy |
| CMS | $52.73 | $72.84 | Avoid | ❌ Avoid |
| CMT | $17.35 | $20.45 | Above Fair Value | ⛔ Overvalued |
| CNA | $73.14 | $49.83 | 46.78% | ✅ Strong Buy |
| CNC | $46.74 | $38.46 | Insufficient EBITDA | ❌ Avoid |
| CNH | $6.74 | $12.36 | Avoid | ❌ Avoid |
| CNI | $130.51 | $101.43 | 28.67% | ✅ Strong Buy |
| CNK | $22.32 | $25.77 | Above Fair Value | ⛔ Overvalued |
| CNM | $35.16 | $57.67 | Above Fair Value | ⛔ Overvalued |
| CNMD | $64.27 | $41.52 | Avoid | ❌ Avoid |
| CNO | $52.96 | $44.64 | 18.64% | ✅ Strong Buy |
| CNOB | $45.60 | $28.67 | 59.05% | ✅ Strong Buy |
| CNP | $26.43 | $40.05 | Avoid | ❌ Avoid |
| CNQ | $42.94 | $39.10 | 9.82% | 👍 Buy |
| CNR | $111.86 | $92.24 | 21.27% | ✅ Strong Buy |
| CNS | $55.04 | $62.71 | Above Fair Value | ⚠️ See Analysis |
| CNX | $50.48 | $40.27 | 25.35% | ✅ Strong Buy |
| CNXC | $155.89 | $39.93 | Insufficient EBITDA | ❌ Avoid |
| CNXN | $43.42 | $67.92 | Above Fair Value | ⛔ Overvalued |
| COCO | $25.34 | $58.96 | Above Fair Value | ⛔ Overvalued |
| COF | $212.66 | $222.79 | Above Fair Value | ⚠️ See Analysis |
| COFS | $54.19 | $30.33 | 78.67% | ✅ Strong Buy |
| COHN | $27.80 | $18.10 | 53.59% | ✅ Strong Buy |
| COHR | $89.05 | $227.68 | Above Fair Value | ⛔ Overvalued |
| COHU | $8.26 | $30.85 | Insufficient EBITDA | ❌ Avoid |
| COIN | $180.00 | $165.12 | 9.01% | 👍 Buy |
| COKE | $121.66 | $157.74 | Above Fair Value | ⛔ Overvalued |
| COLB | $45.80 | $32.07 | 42.81% | ✅ Strong Buy |
| COLD | $2.75 | $12.66 | Above Fair Value | ⛔ Overvalued |
| COLL | $133.48 | $47.61 | 180.36% | ✅ Strong Buy |
| COLM | $43.93 | $63.07 | Above Fair Value | ⛔ Overvalued |
| COMP | $4.87 | $12.27 | Insufficient EBITDA | ⛔ Overvalued |
| CON | $24.34 | $23.50 | Avoid | ❌ Avoid |
| COO | $62.83 | $82.10 | Above Fair Value | ⛔ Overvalued |
| COP | $73.94 | $107.62 | Above Fair Value | ⛔ Overvalued |
| COR | $240.95 | $359.25 | Above Fair Value | ⛔ Overvalued |
| CORT | $16.28 | $40.83 | Above Fair Value | ⛔ Overvalued |
| COST | $361.67 | $1,001.16 | Above Fair Value | ⛔ Overvalued |
| COTY | $6.97 | $2.66 | Avoid | ❌ Avoid |
| COUR | $9.33 | $5.91 | Insufficient EBITDA | ❌ Avoid |
| CP | $75.95 | $80.39 | Above Fair Value | ⚠️ See Analysis |
| CPAC | $1.86 | $10.74 | Above Fair Value | ⛔ Overvalued |
| CPAY | $563.38 | $354.19 | 59.06% | ✅ Strong Buy |
| CPB | $29.70 | $28.83 | Avoid | ❌ Avoid |
| CPF | $33.42 | $34.53 | Above Fair Value | ⚠️ See Analysis |
| CPK | $96.90 | $129.87 | Avoid | ❌ Avoid |
| CPNG | $5.40 | $17.72 | Above Fair Value | ⛔ Overvalued |
| CPRI | $20.03 | $20.18 | Avoid | ❌ Avoid |
| CPRT | $29.10 | $40.36 | Above Fair Value | ⛔ Overvalued |
| CPRX | $47.43 | $24.44 | 94.07% | ✅ Strong Buy |
| CPS | $24.22 | $34.62 | Avoid | ❌ Avoid |
| CPT | $18.13 | $106.63 | Above Fair Value | ⛔ Overvalued |
| CQP | $57.80 | $57.65 | Avoid | ❌ Avoid |
| CR | $119.22 | $196.22 | Above Fair Value | ⛔ Overvalued |
| CRAI | $119.53 | $184.96 | Above Fair Value | ⛔ Overvalued |
| CRBG | $77.11 | $31.16 | 147.46% | ✅ Strong Buy |
| CRC | $46.31 | $55.42 | Above Fair Value | ⛔ Overvalued |
| CRCT | $4.54 | $4.62 | Above Fair Value | ⚠️ See Analysis |
| CRDO | $92.98 | $111.40 | Above Fair Value | ⛔ Overvalued |
| CRESY | $25.68 | $12.83 | 100.16% | ✅ Strong Buy |
| CRGY | $18.19 | $10.12 | 79.74% | ✅ Strong Buy |
| CRH | $76.71 | $127.13 | Above Fair Value | ⛔ Overvalued |
| CRI | $43.07 | $36.79 | 17.07% | 👍 Buy |
| CRK | $9.16 | $21.57 | Avoid | ❌ Avoid |
| CRL | $153.74 | $189.21 | Avoid | ❌ Avoid |
| CRM | $265.11 | $191.35 | 38.55% | ✅ Strong Buy |
| CRMD | $10.95 | $7.69 | Insufficient EBITDA | ✅ Strong Buy |
| CRMT | $12.17 | $24.45 | Avoid | ❌ Avoid |
| CRNC | $17.00 | $7.77 | Avoid | ❌ Avoid |
| CROX | $200.55 | $85.81 | 133.71% | ✅ Strong Buy |
| CRS | $141.74 | $365.11 | Above Fair Value | ⛔ Overvalued |
| CRSR | $8.29 | $5.17 | 60.35% | ✅ Strong Buy |
| CRT | $6.39 | $8.47 | Above Fair Value | ⛔ Overvalued |
| CRUS | $147.42 | $142.78 | 3.25% | 👍 Buy |
| CRVL | $29.98 | $48.67 | Above Fair Value | ⛔ Overvalued |
| CRWD | $122.67 | $395.50 | Avoid | ❌ Avoid |
| CSAN | $37.18 | $4.42 | Avoid | ❌ Avoid |
| CSCO | $80.49 | $84.82 | Above Fair Value | ⚠️ See Analysis |
| CSGP | $18.71 | $50.28 | Above Fair Value | ⛔ Overvalued |
| CSGS | $86.57 | $80.06 | 8.13% | 👍 Buy |
| CSL | $319.85 | $403.86 | Above Fair Value | ⛔ Overvalued |
| CSR | $24.51 | $64.25 | Above Fair Value | ⛔ Overvalued |
| CSTM | $26.31 | $24.74 | 6.35% | 👍 Buy |
| CSV | $47.79 | $44.32 | Avoid | ❌ Avoid |
| CSW | $140.48 | $290.25 | Above Fair Value | ⛔ Overvalued |
| CSX | $32.47 | $40.61 | Above Fair Value | ⛔ Overvalued |
| CTAS | $82.34 | $195.87 | Above Fair Value | ⛔ Overvalued |
| CTBI | $93.09 | $65.49 | 42.14% | ✅ Strong Buy |
| CTKB | $0.24 | $4.47 | Insufficient EBITDA | ❌ Avoid |
| CTLP | $9.90 | $10.66 | Above Fair Value | ⚠️ See Analysis |
| CTMX | $4.96 | $5.67 | Above Fair Value | ⚠️ See Analysis |
| CTO | $2.12 | $18.59 | Above Fair Value | ⛔ Overvalued |
| CTOS | $1.14 | $6.87 | Avoid | ❌ Avoid |
| CTRA | $35.11 | $30.66 | 14.51% | 👍 Buy |
| CTRE | $27.19 | $38.84 | Above Fair Value | ⛔ Overvalued |
| CTRI | $7.43 | $28.93 | Avoid | ❌ Avoid |
| CTS | $31.02 | $55.78 | Above Fair Value | ⛔ Overvalued |
| CTSH | $103.81 | $77.08 | 34.68% | ✅ Strong Buy |
| CTVA | $45.72 | $72.60 | Above Fair Value | ⛔ Overvalued |
| CUBE | $25.80 | $38.39 | Above Fair Value | ⛔ Overvalued |
| CUBI | $108.47 | $76.28 | 42.20% | ✅ Strong Buy |
| CUK | $37.64 | $33.69 | Avoid | ❌ Avoid |
| CURB | $6.04 | $25.27 | Above Fair Value | ⛔ Overvalued |
| CURI | $0.61 | $3.30 | Above Fair Value | ⛔ Overvalued |
| CUZ | $4.36 | $25.64 | Above Fair Value | ⛔ Overvalued |
| CVAC | $3.67 | $4.66 | Above Fair Value | ⛔ Overvalued |
| CVBF | $19.85 | $21.43 | Above Fair Value | ⚠️ See Analysis |
| CVCO | $382.08 | $538.73 | Above Fair Value | ⛔ Overvalued |
| CVE | $14.68 | $20.57 | Above Fair Value | ⛔ Overvalued |
| CVGW | $21.28 | $25.43 | Above Fair Value | ⛔ Overvalued |
| CVI | $19.17 | $24.54 | Above Fair Value | ⛔ Overvalued |
| CVLG | $22.01 | $29.11 | Above Fair Value | ⛔ Overvalued |
| CVLT | $90.22 | $86.07 | 4.82% | 👍 Buy |
| CVNA | $89.29 | $403.67 | Above Fair Value | ⛔ Overvalued |
| CVS | $89.01 | $78.35 | Avoid | ❌ Avoid |
| CVX | $104.89 | $180.86 | Above Fair Value | ⛔ Overvalued |
| CW | $199.91 | $649.32 | Above Fair Value | ⛔ Overvalued |
| CWAN | $5.09 | $23.85 | Avoid | ❌ Avoid |
| CWBC | $44.44 | $25.41 | 74.89% | ✅ Strong Buy |
| CWCO | $18.91 | $37.03 | Above Fair Value | ⛔ Overvalued |
| CWEN | $22.12 | $38.64 | Avoid | ❌ Avoid |
| CWH | $10.88 | $13.62 | Avoid | ❌ Avoid |
| CWK | $15.96 | $16.16 | Avoid | ❌ Avoid |
| CWST | $22.61 | $104.65 | Above Fair Value | ⛔ Overvalued |
| CWT | $36.70 | $44.47 | Avoid | ❌ Avoid |
| CX | $8.70 | $12.20 | Above Fair Value | ⛔ Overvalued |
| CXM | $8.73 | $6.00 | 45.50% | ✅ Strong Buy |
| CXT | $57.40 | $56.05 | 2.41% | 👍 Buy |
| CXW | $17.75 | $18.72 | Above Fair Value | ⚠️ See Analysis |
| CYBR | $89.34 | $391.77 | Avoid | ❌ Avoid |
| CYH | $10.19 | $3.15 | Avoid | ❌ Avoid |
| CZFS | $117.13 | $65.72 | 78.24% | ✅ Strong Buy |
| CZNC | $32.47 | $23.49 | 38.23% | ✅ Strong Buy |
| CZR | $5.01 | $20.52 | Above Fair Value | ⛔ Overvalued |
| CZWI | $27.02 | $19.00 | 42.21% | ✅ Strong Buy |
| D | $48.60 | $62.33 | Avoid | ❌ Avoid |
| DAC | $359.95 | $102.08 | 252.62% | ✅ Strong Buy |
| DAKT | $15.55 | $25.41 | Above Fair Value | ⛔ Overvalued |
| DAL | $87.66 | $75.35 | 16.34% | 👍 Buy |
| DAN | $22.36 | $31.69 | Avoid | ❌ Avoid |
| DAR | $20.41 | $48.20 | Avoid | ❌ Avoid |
| DASH | $57.75 | $182.47 | Above Fair Value | ⛔ Overvalued |
| DAVA | $15.17 | $5.46 | 177.84% | ✅ Strong Buy |
| DAVE | $199.55 | $183.22 | 8.91% | 👍 Buy |
| DAY | $61.15 | $69.86 | Avoid | ❌ Avoid |
| DB | $49.54 | $37.22 | 33.10% | ✅ Strong Buy |
| DBI | $4.77 | $6.95 | Avoid | ❌ Avoid |
| DBRG | $5.64 | $15.43 | Above Fair Value | ⛔ Overvalued |
| DBX | $64.70 | $25.00 | 158.80% | ✅ Strong Buy |
| DCI | $70.86 | $109.03 | Above Fair Value | ⛔ Overvalued |
| DCO | $49.69 | $121.08 | Avoid | ❌ Avoid |
| DCOM | $60.82 | $36.23 | 67.87% | ✅ Strong Buy |
| DCTH | $4.21 | $9.37 | Insufficient EBITDA | ⛔ Overvalued |
| DD | $23.18 | $46.73 | Above Fair Value | ⛔ Overvalued |
| DDD | $0.80 | $2.20 | Insufficient EBITDA | ⛔ Overvalued |
| DDOG | $46.69 | $111.69 | Above Fair Value | ⛔ Overvalued |
| DDS | $412.73 | $666.51 | Above Fair Value | ⛔ Overvalued |
| DE | $315.05 | $583.11 | Avoid | ❌ Avoid |
| DEA | $6.72 | $24.16 | Above Fair Value | ⛔ Overvalued |
| DEC | $49.25 | $13.35 | 268.91% | ✅ Strong Buy |
| DECK | $114.57 | $115.45 | Above Fair Value | ⚠️ See Analysis |
| DEI | $1.22 | $10.59 | Above Fair Value | ⛔ Overvalued |
| DELL | $178.05 | $121.05 | 47.09% | ✅ Strong Buy |
| DENN | $6.14 | $6.25 | Avoid | ❌ Avoid |
| DEO | $134.44 | $96.88 | 38.77% | ✅ Strong Buy |
| DFH | $23.54 | $19.57 | Avoid | ❌ Avoid |
| DFIN | $67.77 | $48.29 | 40.34% | ✅ Strong Buy |
| DG | $109.30 | $146.65 | Above Fair Value | ⛔ Overvalued |
| DGICA | $27.92 | $18.98 | 47.10% | ✅ Strong Buy |
| DGICB | $33.68 | $19.69 | 71.05% | ✅ Strong Buy |
| DGII | $36.06 | $44.16 | Above Fair Value | ⛔ Overvalued |
| DGX | $154.01 | $190.71 | Above Fair Value | ⛔ Overvalued |
| DH | $4.66 | $1.99 | Insufficient EBITDA | ❌ Avoid |
| DHI | $140.36 | $156.27 | Above Fair Value | ⚠️ See Analysis |
| DHIL | $151.28 | $171.00 | Above Fair Value | ⚠️ See Analysis |
| DHR | $129.75 | $216.61 | Above Fair Value | ⛔ Overvalued |
| DHT | $17.22 | $14.87 | 15.80% | 👍 Buy |
| DHX | $2.37 | $1.99 | Avoid | ❌ Avoid |
| DIN | $70.52 | $36.00 | Avoid | ❌ Avoid |
| DINO | $69.84 | $58.59 | 19.20% | ✅ Strong Buy |
| DIOD | $26.66 | $60.84 | Above Fair Value | ⛔ Overvalued |
| DIS | $102.42 | $108.70 | Above Fair Value | ⚠️ See Analysis |
| DIT | $12.23 | $113.15 | Avoid | ❌ Avoid |
| DJCO | $1,390.07 | $575.92 | 141.37% | ✅ Strong Buy |
| DK | $22.55 | $35.53 | Insufficient EBITDA | ❌ Avoid |
| DKL | $44.84 | $52.59 | Avoid | ❌ Avoid |
| DKNG | $27.13 | $26.62 | Insufficient EBITDA | ❌ Avoid |
| DKS | $205.09 | $208.29 | Above Fair Value | ⚠️ See Analysis |
| DLB | $78.73 | $64.85 | 21.40% | ✅ Strong Buy |
| DLNG | $17.88 | $3.76 | 375.53% | ✅ Strong Buy |
| DLR | $57.41 | $171.62 | Above Fair Value | ⛔ Overvalued |
| DLTR | $93.12 | $123.83 | Above Fair Value | ⛔ Overvalued |
| DLX | $26.92 | $27.80 | Avoid | ❌ Avoid |
| DMLP | $26.92 | $24.53 | 9.74% | 👍 Buy |
| DNOW | $14.54 | $16.76 | Above Fair Value | ⛔ Overvalued |
| DOC | $4.99 | $16.85 | Above Fair Value | ⛔ Overvalued |
| DOCN | $34.57 | $62.92 | Avoid | ❌ Avoid |
| DOCS | $45.26 | $27.73 | 63.22% | ✅ Strong Buy |
| DOCU | $81.70 | $47.13 | 73.35% | ✅ Strong Buy |
| DOLE | $16.91 | $16.23 | 4.19% | 👍 Buy |
| DOMH | $60.29 | $3.73 | Insufficient EBITDA | ✅ Strong Buy |
| DOMO | $0.08 | $5.23 | Insufficient EBITDA | ❌ Avoid |
| DORM | $133.69 | $130.10 | 2.76% | 👍 Buy |
| DOV | $154.64 | $223.66 | Above Fair Value | ⛔ Overvalued |
| DOW | $10.58 | $31.78 | Above Fair Value | ⛔ Overvalued |
| DOX | $141.23 | $73.34 | 92.57% | ✅ Strong Buy |
| DPZ | $325.53 | $394.88 | Avoid | ❌ Avoid |
| DRH | $5.34 | $9.56 | Above Fair Value | ⛔ Overvalued |
| DRI | $191.94 | $216.27 | Above Fair Value | ⚠️ See Analysis |
| DRS | $16.25 | $38.93 | Above Fair Value | ⛔ Overvalued |
| DRVN | $21.16 | $17.06 | Avoid | ❌ Avoid |
| DSGR | $22.40 | $30.86 | Avoid | ❌ Avoid |
| DSGX | $51.63 | $66.78 | Above Fair Value | ⛔ Overvalued |
| DSP | $9.50 | $10.35 | Above Fair Value | ⚠️ See Analysis |
| DSX | $2.67 | $2.29 | Avoid | ❌ Avoid |
| DT | $32.98 | $33.71 | Above Fair Value | ⚠️ See Analysis |
| DTE | $99.58 | $134.82 | Avoid | ❌ Avoid |
| DTM | $77.57 | $128.58 | Above Fair Value | ⛔ Overvalued |
| DUK | $85.69 | $121.86 | Avoid | ❌ Avoid |
| DUOL | $214.03 | $119.40 | 79.25% | ✅ Strong Buy |
| DV | $20.21 | $9.34 | 116.38% | ✅ Strong Buy |
| DVA | $221.06 | $140.83 | Avoid | ❌ Avoid |
| DVN | $58.13 | $43.81 | 32.69% | ✅ Strong Buy |
| DX | $16.34 | $14.07 | 16.13% | 👍 Buy |
| DXC | $49.50 | $15.20 | 225.66% | ✅ Strong Buy |
| DXCM | $42.40 | $69.97 | Above Fair Value | ⛔ Overvalued |
| DXPE | $78.65 | $149.61 | Above Fair Value | ⛔ Overvalued |
| DXYZ | $21.68 | $30.88 | Above Fair Value | ⛔ Overvalued |
| DY | $175.94 | $400.47 | Above Fair Value | ⛔ Overvalued |
| E | $40.88 | $42.32 | Above Fair Value | ⚠️ See Analysis |
| EA | $92.58 | $200.00 | Above Fair Value | ⛔ Overvalued |
| EAT | $159.51 | $168.93 | Above Fair Value | ⚠️ See Analysis |
| EBAY | $60.64 | $86.55 | Above Fair Value | ⛔ Overvalued |
| EBC | $29.08 | $21.89 | 32.85% | ✅ Strong Buy |
| EBF | $19.56 | $20.41 | Above Fair Value | ⚠️ See Analysis |
| EBMT | $27.19 | $23.45 | 15.95% | 👍 Buy |
| EC | $18.61 | $12.23 | 52.17% | ✅ Strong Buy |
| ECG | $72.91 | $97.29 | Above Fair Value | ⛔ Overvalued |
| ECL | $129.88 | $290.33 | Above Fair Value | ⛔ Overvalued |
| ECO | $39.89 | $40.32 | Above Fair Value | ⚠️ See Analysis |
| ECPG | $122.30 | $57.75 | 111.77% | ✅ Strong Buy |
| ECVT | $7.23 | $11.05 | Avoid | ❌ Avoid |
| ED | $79.07 | $107.34 | Avoid | ❌ Avoid |
| EE | $21.11 | $37.11 | Above Fair Value | ⛔ Overvalued |
| EEFT | $155.51 | $75.02 | 107.29% | ✅ Strong Buy |
| EEX | $1.70 | $4.92 | Avoid | ❌ Avoid |
| EFC | $23.46 | $13.00 | 80.46% | ✅ Strong Buy |
| EFSC | $76.44 | $59.89 | 27.63% | ✅ Strong Buy |
| EFX | $137.31 | $195.62 | Above Fair Value | ⛔ Overvalued |
| EFXT | $15.90 | $17.83 | Above Fair Value | ⚠️ See Analysis |
| EG | $714.21 | $328.39 | 117.49% | ✅ Strong Buy |
| EGAN | $6.46 | $10.00 | Above Fair Value | ⛔ Overvalued |
| EGBN | $22.75 | $27.58 | Insufficient EBITDA | ⛔ Overvalued |
| EGHT | $6.78 | $2.62 | Avoid | ❌ Avoid |
| EGO | $50.22 | $39.02 | 28.70% | ✅ Strong Buy |
| EGP | $92.29 | $189.91 | Above Fair Value | ⛔ Overvalued |
| EGY | $11.15 | $4.84 | 130.37% | ✅ Strong Buy |
| EHAB | $8.96 | $11.13 | Insufficient EBITDA | ❌ Avoid |
| EHC | $98.69 | $105.39 | Above Fair Value | ⚠️ See Analysis |
| EHTH | $2.41 | $2.22 | 8.56% | 👍 Buy |
| EIG | $22.56 | $45.46 | Above Fair Value | ⛔ Overvalued |
| EIX | $80.19 | $64.01 | Avoid | ❌ Avoid |
| EL | $47.45 | $99.47 | Avoid | ❌ Avoid |
| ELAN | $13.75 | $25.20 | Avoid | ❌ Avoid |
| ELF | $52.65 | $82.09 | Avoid | ❌ Avoid |
| ELMD | $17.43 | $29.11 | Above Fair Value | ⛔ Overvalued |
| ELP | $11.17 | $9.27 | 20.50% | ✅ Strong Buy |
| ELS | $39.95 | $65.48 | Above Fair Value | ⛔ Overvalued |
| ELV | $394.17 | $338.98 | 16.28% | 👍 Buy |
| EMBC | $23.93 | $10.87 | Avoid | ❌ Avoid |
| EME | $381.88 | $764.35 | Above Fair Value | ⛔ Overvalued |
| EMN | $80.92 | $77.43 | 4.51% | 👍 Buy |
| EMR | $111.95 | $157.38 | Above Fair Value | ⛔ Overvalued |
| ENB | $33.16 | $50.32 | Avoid | ❌ Avoid |
| ENIC | $4,647.53 | $4.24 | Avoid | ❌ Avoid |
| ENOV | $38.42 | $22.59 | Insufficient EBITDA | ❌ Avoid |
| ENPH | $49.86 | $49.80 | 0.12% | 👍 Buy |
| ENR | $38.76 | $23.40 | Avoid | ❌ Avoid |
| ENS | $149.49 | $172.22 | Above Fair Value | ⛔ Overvalued |
| ENSG | $101.91 | $197.80 | Above Fair Value | ⛔ Overvalued |
| ENTG | $47.13 | $122.37 | Avoid | ❌ Avoid |
| ENVA | $136.69 | $161.10 | Above Fair Value | ⛔ Overvalued |
| EOG | $133.13 | $113.70 | 17.09% | 👍 Buy |
| EPAC | $28.18 | $42.67 | Above Fair Value | ⛔ Overvalued |
| EPAM | $243.34 | $186.68 | 30.35% | ✅ Strong Buy |
| EPC | $36.73 | $20.75 | Avoid | ❌ Avoid |
| EPD | $34.41 | $34.91 | Above Fair Value | ⚠️ See Analysis |
| EPM | $0.74 | $4.10 | Above Fair Value | ⛔ Overvalued |
| EPR | $39.06 | $56.25 | Above Fair Value | ⛔ Overvalued |
| EPRT | $21.26 | $31.75 | Above Fair Value | ⛔ Overvalued |
| EPSN | $4.96 | $4.85 | 2.27% | 👍 Buy |
| EQBK | $76.82 | $47.49 | 61.76% | ✅ Strong Buy |
| EQH | $54.27 | $45.52 | 19.22% | ✅ Strong Buy |
| EQIX | $270.89 | $848.12 | Above Fair Value | ⛔ Overvalued |
| EQNR | $34.67 | $27.52 | 25.98% | ✅ Strong Buy |
| EQR | $24.84 | $63.89 | Above Fair Value | ⛔ Overvalued |
| EQT | $50.90 | $56.79 | Above Fair Value | ⚠️ See Analysis |
| EQX | $13.57 | $14.56 | Above Fair Value | ⚠️ See Analysis |
| ERIC | $8.01 | $11.16 | Above Fair Value | ⛔ Overvalued |
| ERIE | $218.51 | $287.71 | Above Fair Value | ⛔ Overvalued |
| ERII | $12.57 | $15.47 | Above Fair Value | ⛔ Overvalued |
| ERO | $47.69 | $30.61 | 55.80% | ✅ Strong Buy |
| ES | $65.24 | $67.36 | Avoid | ❌ Avoid |
| ESAB | $82.11 | $134.05 | Above Fair Value | ⛔ Overvalued |
| ESCA | $12.25 | $14.31 | Above Fair Value | ⛔ Overvalued |
| ESE | $132.43 | $253.10 | Above Fair Value | ⛔ Overvalued |
| ESEA | $225.63 | $53.50 | 321.74% | ✅ Strong Buy |
| ESI | $22.60 | $29.94 | Above Fair Value | ⛔ Overvalued |
| ESLT | $171.33 | $665.00 | Above Fair Value | ⛔ Overvalued |
| ESNT | $76.83 | $65.28 | 17.69% | ✅ Strong Buy |
| ESOA | $4.84 | $9.42 | Avoid | ❌ Avoid |
| ESP | $43.60 | $56.87 | Above Fair Value | ⛔ Overvalued |
| ESPR | $1.37 | $3.40 | Avoid | ❌ Avoid |
| ESQ | $102.18 | $115.37 | Above Fair Value | ⚠️ See Analysis |
| ESRT | $1.80 | $6.75 | Above Fair Value | ⛔ Overvalued |
| ESS | $119.90 | $258.06 | Above Fair Value | ⛔ Overvalued |
| ESTC | $49.06 | $59.12 | Above Fair Value | ⛔ Overvalued |
| ET | $14.67 | $17.94 | Avoid | ❌ Avoid |
| ETD | $21.68 | $24.54 | Above Fair Value | ⚠️ See Analysis |
| ETN | $188.50 | $373.82 | Above Fair Value | ⛔ Overvalued |
| ETR | $55.90 | $97.96 | Avoid | ❌ Avoid |
| ETSY | $37.08 | $57.82 | Above Fair Value | ⛔ Overvalued |
| EVCM | $12.36 | $10.76 | Avoid | ❌ Avoid |
| EVER | $49.46 | $18.09 | 173.41% | ✅ Strong Buy |
| EVH | $3.39 | $2.85 | Avoid | ❌ Avoid |
| EVI | $11.31 | $23.50 | Above Fair Value | ⛔ Overvalued |
| EVR | $298.62 | $357.73 | Above Fair Value | ⛔ Overvalued |
| EVRG | $58.60 | $76.75 | Avoid | ❌ Avoid |
| EVTC | $84.76 | $27.02 | 213.69% | ✅ Strong Buy |
| EW | $53.60 | $78.71 | Above Fair Value | ⛔ Overvalued |
| EWBC | $115.21 | $122.50 | Above Fair Value | ⚠️ See Analysis |
| EWCZ | $8.16 | $4.03 | Avoid | ❌ Avoid |
| EXAS | $11.43 | $103.18 | Insufficient EBITDA | ❌ Avoid |
| EXC | $36.77 | $44.33 | Avoid | ❌ Avoid |
| EXE | $114.24 | $110.37 | 3.51% | 👍 Buy |
| EXEL | $51.15 | $43.90 | 16.51% | 👍 Buy |
| EXFY | $3.21 | $1.38 | Avoid | ❌ Avoid |
| EXK | $7.30 | $11.36 | Avoid | ❌ Avoid |
| EXLS | $35.77 | $31.70 | 12.84% | 👍 Buy |
| EXP | $233.66 | $225.85 | 3.46% | 👍 Buy |
| EXPD | $100.11 | $165.04 | Above Fair Value | ⛔ Overvalued |
| EXPE | $242.33 | $236.85 | 2.31% | 👍 Buy |
| EXPI | $2.43 | $8.66 | Avoid | ❌ Avoid |
| EXPO | $41.37 | $79.79 | Above Fair Value | ⛔ Overvalued |
| EXR | $102.00 | $140.01 | Above Fair Value | ⛔ Overvalued |
| EXTR | $18.31 | $15.24 | 20.14% | ✅ Strong Buy |
| EYE | $11.72 | $28.92 | Above Fair Value | ⛔ Overvalued |
| EZPW | $19.66 | $25.63 | Above Fair Value | ⛔ Overvalued |
| F | $16.48 | $13.80 | Avoid | ❌ Avoid |
| FA | $15.45 | $11.94 | Avoid | ❌ Avoid |
| FAF | $67.71 | $67.34 | 0.55% | 👍 Buy |
| FANG | $157.15 | $166.93 | Above Fair Value | ⚠️ See Analysis |
| FAST | $18.83 | $47.73 | Above Fair Value | ⛔ Overvalued |
| FBIN | $57.38 | $61.85 | Above Fair Value | ⚠️ See Analysis |
| FBIZ | $86.18 | $59.85 | 43.99% | ✅ Strong Buy |
| FBK | $71.30 | $61.61 | 15.73% | 👍 Buy |
| FBNC | $72.70 | $62.23 | 16.82% | 👍 Buy |
| FBP | $26.78 | $23.22 | 15.33% | 👍 Buy |
| FBRT | $17.66 | $10.18 | 73.48% | ✅ Strong Buy |
| FC | $17.94 | $19.49 | Above Fair Value | ⚠️ See Analysis |
| FCAP | $69.47 | $54.20 | 28.17% | ✅ Strong Buy |
| FCBC | $25.74 | $41.31 | Above Fair Value | ⛔ Overvalued |
| FCCO | $38.80 | $30.84 | 25.81% | ✅ Strong Buy |
| FCF | $24.40 | $18.83 | 29.58% | ✅ Strong Buy |
| FCFS | $144.46 | $181.92 | Above Fair Value | ⛔ Overvalued |
| FCN | $130.12 | $178.93 | Above Fair Value | ⛔ Overvalued |
| FCNCA | $3,008.67 | $2,160.99 | 39.23% | ✅ Strong Buy |
| FCPT | $17.86 | $25.34 | Above Fair Value | ⛔ Overvalued |
| FCX | $41.69 | $60.67 | Above Fair Value | ⛔ Overvalued |
| FDBC | $70.12 | $47.32 | 48.18% | ✅ Strong Buy |
| FDP | $32.99 | $38.47 | Above Fair Value | ⛔ Overvalued |
| FDS | $393.35 | $207.32 | 89.73% | ✅ Strong Buy |
| FDUS | $26.68 | $18.86 | 41.46% | ✅ Strong Buy |
| FDX | $260.87 | $369.23 | Above Fair Value | ⛔ Overvalued |
| FE | $31.51 | $46.63 | Avoid | ❌ Avoid |
| FELE | $66.41 | $107.55 | Above Fair Value | ⛔ Overvalued |
| FENC | $8.57 | $7.84 | Avoid | ❌ Avoid |
| FERG | $164.91 | $262.76 | Above Fair Value | ⛔ Overvalued |
| FFBC | $48.06 | $30.90 | 55.53% | ✅ Strong Buy |
| FFIC | $23.26 | $16.84 | 38.12% | ✅ Strong Buy |
| FFIN | $38.34 | $34.78 | 10.24% | 👍 Buy |
| FFIV | $350.59 | $276.57 | 26.76% | ✅ Strong Buy |
| FFWM | $4.92 | $6.43 | Insufficient EBITDA | ⛔ Overvalued |
| FG | $69.67 | $28.38 | 145.49% | ✅ Strong Buy |
| FGBI | $5.07 | $8.93 | Insufficient EBITDA | ⛔ Overvalued |
| FHB | $35.22 | $27.23 | 29.34% | ✅ Strong Buy |
| FHI | $49.87 | $52.12 | Above Fair Value | ⚠️ See Analysis |
| FHN | $24.80 | $26.23 | Above Fair Value | ⚠️ See Analysis |
| FIBK | $39.54 | $38.82 | 1.85% | 👍 Buy |
| FICO | $1,100.77 | $1,391.00 | Above Fair Value | ⛔ Overvalued |
| FIG | $4.38 | $21.99 | Insufficient EBITDA | ❌ Avoid |
| FIGS | $1.97 | $10.74 | Above Fair Value | ⛔ Overvalued |
| FIHL | $53.76 | $19.40 | 177.11% | ✅ Strong Buy |
| FIS | $101.97 | $51.93 | Avoid | ❌ Avoid |
| FISI | $30.89 | $35.14 | Above Fair Value | ⚠️ See Analysis |
| FISV | $163.60 | $60.00 | 172.67% | ✅ Strong Buy |
| FITB | $64.54 | $55.08 | 17.18% | 👍 Buy |
| FIVE | $118.35 | $202.61 | Above Fair Value | ⛔ Overvalued |
| FIVN | $61.66 | $17.08 | Avoid | ❌ Avoid |
| FIX | $437.76 | $1,230.26 | Above Fair Value | ⛔ Overvalued |
| FIZZ | $34.51 | $35.30 | Above Fair Value | ⚠️ See Analysis |
| FKWL | $0.51 | $4.10 | Above Fair Value | ⛔ Overvalued |
| FLEX | $39.50 | $63.98 | Above Fair Value | ⛔ Overvalued |
| FLG | $15.85 | $14.27 | Insufficient EBITDA | 👍 Buy |
| FLGT | $3.87 | $23.44 | Insufficient EBITDA | ❌ Avoid |
| FLNC | $3.70 | $19.44 | Insufficient EBITDA | ❌ Avoid |
| FLNG | $30.78 | $26.38 | 16.68% | 👍 Buy |
| FLO | $14.47 | $11.96 | Avoid | ❌ Avoid |
| FLOC | $28.90 | $22.84 | 26.53% | ✅ Strong Buy |
| FLR | $27.94 | $46.92 | Avoid | ❌ Avoid |
| FLS | $52.33 | $85.46 | Above Fair Value | ⛔ Overvalued |
| FLUT | $161.01 | $152.53 | Avoid | ❌ Avoid |
| FLXS | $42.65 | $57.55 | Above Fair Value | ⛔ Overvalued |
| FLYW | $16.47 | $11.25 | 46.40% | ✅ Strong Buy |
| FMAO | $36.86 | $28.29 | 30.29% | ✅ Strong Buy |
| FMBH | $69.61 | $44.59 | 56.11% | ✅ Strong Buy |
| FMC | $37.91 | $14.76 | Avoid | ❌ Avoid |
| FMNB | $25.62 | $13.53 | 89.36% | ✅ Strong Buy |
| FMX | $58.35 | $110.37 | Above Fair Value | ⛔ Overvalued |
| FN | $203.79 | $503.99 | Above Fair Value | ⛔ Overvalued |
| FNB | $14.66 | $18.90 | Above Fair Value | ⛔ Overvalued |
| FND | $33.74 | $69.38 | Above Fair Value | ⛔ Overvalued |
| FNF | $81.18 | $57.61 | 40.91% | ✅ Strong Buy |
| FNKO | $1.07 | $3.97 | Avoid | ❌ Avoid |
| FNLC | $47.42 | $30.01 | 58.01% | ✅ Strong Buy |
| FNV | $100.69 | $232.08 | Above Fair Value | ⛔ Overvalued |
| FNWD | $31.59 | $38.79 | Above Fair Value | ⛔ Overvalued |
| FOLD | $7.88 | $14.30 | Avoid | ❌ Avoid |
| FONR | $15.49 | $18.56 | Above Fair Value | ⛔ Overvalued |
| FOR | $41.76 | $29.27 | 42.67% | ✅ Strong Buy |
| FORM | $22.86 | $90.29 | Above Fair Value | ⛔ Overvalued |
| FORR | $18.70 | $7.27 | Avoid | ❌ Avoid |
| FORTY | $84.71 | $132.38 | Above Fair Value | ⛔ Overvalued |
| FOUR | $100.88 | $59.28 | Avoid | ❌ Avoid |
| FOX | $33.46 | $58.35 | Above Fair Value | ⛔ Overvalued |
| FOXA | $70.27 | $64.78 | 8.47% | 👍 Buy |
| FOXF | $20.18 | $19.20 | Avoid | ❌ Avoid |
| FPI | $4.02 | $11.61 | Above Fair Value | ⛔ Overvalued |
| FR | $26.75 | $59.79 | Above Fair Value | ⛔ Overvalued |
| FRAF | $50.13 | $48.06 | 4.31% | 👍 Buy |
| FRBA | $24.24 | $17.11 | 41.67% | ✅ Strong Buy |
| FRD | $20.31 | $20.14 | Avoid | ❌ Avoid |
| FRHC | $1.64 | $122.76 | Above Fair Value | ⛔ Overvalued |
| FRME | $57.31 | $42.34 | 35.36% | ✅ Strong Buy |
| FRO | $31.52 | $29.37 | Avoid | ❌ Avoid |
| FROG | $19.63 | $47.99 | Insufficient EBITDA | ❌ Avoid |
| FRPH | $3.63 | $23.96 | Above Fair Value | ⛔ Overvalued |
| FRPT | $37.59 | $69.90 | Above Fair Value | ⛔ Overvalued |
| FRSH | $14.14 | $8.92 | Insufficient EBITDA | ❌ Avoid |
| FRST | $16.66 | $14.26 | Insufficient EBITDA | 👍 Buy |
| FRT | $53.62 | $105.76 | Above Fair Value | ⛔ Overvalued |
| FSBC | $40.41 | $41.38 | Above Fair Value | ⚠️ See Analysis |
| FSBW | $38.63 | $42.28 | Above Fair Value | ⚠️ See Analysis |
| FSFG | $52.21 | $33.98 | 53.65% | ✅ Strong Buy |
| FSK | $31.96 | $12.86 | 148.52% | ✅ Strong Buy |
| FSLR | $314.87 | $218.73 | 43.95% | ✅ Strong Buy |
| FSLY | $1.83 | $8.57 | Insufficient EBITDA | ❌ Avoid |
| FSM | $14.85 | $10.38 | 43.06% | ✅ Strong Buy |
| FSS | $58.65 | $116.71 | Above Fair Value | ⛔ Overvalued |
| FSTR | $16.00 | $31.74 | Above Fair Value | ⛔ Overvalued |
| FSV | $86.98 | $160.80 | Above Fair Value | ⛔ Overvalued |
| FTAI | $85.79 | $272.61 | Above Fair Value | ⛔ Overvalued |
| FTDR | $79.68 | $57.33 | 38.98% | ✅ Strong Buy |
| FTI | $32.00 | $59.06 | Above Fair Value | ⛔ Overvalued |
| FTK | $15.71 | $17.33 | Above Fair Value | ⚠️ See Analysis |
| FTLF | $14.74 | $15.36 | Avoid | ❌ Avoid |
| FTNT | $76.50 | $82.76 | Above Fair Value | ⚠️ See Analysis |
| FTRE | $10.50 | $14.65 | Insufficient EBITDA | ❌ Avoid |
| FTS | $33.48 | $54.01 | Avoid | ❌ Avoid |
| FTV | $53.38 | $60.12 | Above Fair Value | ⚠️ See Analysis |
| FUBO | $6.04 | $1.58 | Insufficient EBITDA | ✅ Strong Buy |
| FUL | $62.43 | $66.06 | Avoid | ❌ Avoid |
| FULT | $30.53 | $22.75 | 34.20% | ✅ Strong Buy |
| FUN | $0.65 | $18.73 | Avoid | ❌ Avoid |
| FUNC | $61.56 | $39.60 | 55.45% | ✅ Strong Buy |
| FUSB | $13.94 | $15.59 | Above Fair Value | ⚠️ See Analysis |
| FVCB | $20.81 | $15.99 | 30.14% | ✅ Strong Buy |
| FVRR | $43.80 | $15.46 | 183.31% | ✅ Strong Buy |
| FWONA | $51.60 | $77.96 | Avoid | ❌ Avoid |
| FWONK | $33.12 | $85.25 | Avoid | ❌ Avoid |
| FWRG | $5.25 | $17.54 | Avoid | ❌ Avoid |
| FXNC | $30.10 | $28.60 | 5.24% | 👍 Buy |
| GABC | $61.01 | $44.37 | 37.50% | ✅ Strong Buy |
| GAIN | $9.54 | $13.89 | Above Fair Value | ⛔ Overvalued |
| GAMB | $17.99 | $4.42 | 307.01% | ✅ Strong Buy |
| GAP | $31.81 | $29.13 | 9.20% | 👍 Buy |
| GATX | $131.50 | $188.43 | Avoid | ❌ Avoid |
| GBCI | $50.68 | $53.19 | Above Fair Value | ⚠️ See Analysis |
| GBDC | $9.82 | $12.55 | Above Fair Value | ⛔ Overvalued |
| GBLI | $30.92 | $28.60 | 8.11% | 👍 Buy |
| GBTG | $8.13 | $5.61 | 44.92% | ✅ Strong Buy |
| GBX | $59.17 | $54.60 | Avoid | ❌ Avoid |
| GCBC | $19.72 | $24.51 | Above Fair Value | ⛔ Overvalued |
| GCMG | $15.01 | $9.89 | 51.77% | ✅ Strong Buy |
| GCO | $21.95 | $29.07 | Avoid | ❌ Avoid |
| GCT | $39.73 | $40.25 | Above Fair Value | ⚠️ See Analysis |
| GD | $249.60 | $360.07 | Above Fair Value | ⛔ Overvalued |
| GDDY | $167.48 | $97.22 | 72.27% | ✅ Strong Buy |
| GDEN | $8.46 | $27.69 | Above Fair Value | ⛔ Overvalued |
| GDOT | $21.64 | $12.02 | 80.03% | ✅ Strong Buy |
| GDRX | $7.20 | $2.44 | 195.08% | ✅ Strong Buy |
| GDYN | $8.23 | $7.13 | 15.43% | 👍 Buy |
| GE | $100.80 | $321.00 | Above Fair Value | ⛔ Overvalued |
| GEF | $60.64 | $75.29 | Avoid | ❌ Avoid |
| GEHC | $90.32 | $80.65 | 11.99% | 👍 Buy |
| GEL | $22.91 | $17.19 | Avoid | ❌ Avoid |
| GEN | $27.72 | $24.25 | Avoid | ❌ Avoid |
| GENI | $7.22 | $6.09 | Avoid | ❌ Avoid |
| GEO | $14.60 | $15.90 | Above Fair Value | ⚠️ See Analysis |
| GES | $22.76 | $16.81 | Avoid | ❌ Avoid |
| GETY | $2.39 | $1.18 | Avoid | ❌ Avoid |
| GEV | $272.11 | $779.35 | Above Fair Value | ⛔ Overvalued |
| GFF | $85.36 | $94.84 | Avoid | ❌ Avoid |
| GFI | $43.01 | $53.51 | Above Fair Value | ⛔ Overvalued |
| GFL | $12.79 | $42.52 | Avoid | ❌ Avoid |
| GFS | $31.10 | $42.91 | Above Fair Value | ⛔ Overvalued |
| GGG | $61.09 | $92.76 | Above Fair Value | ⛔ Overvalued |
| GHC | $782.20 | $1,158.23 | Above Fair Value | ⛔ Overvalued |
| GHI | $24.23 | $7.64 | 217.15% | ✅ Strong Buy |
| GHM | $22.89 | $83.24 | Above Fair Value | ⛔ Overvalued |
| GIB | $141.58 | $82.73 | 71.14% | ✅ Strong Buy |
| GIC | $27.00 | $32.68 | Above Fair Value | ⛔ Overvalued |
| GIII | $39.20 | $30.51 | 28.48% | ✅ Strong Buy |
| GIL | $60.10 | $71.23 | Above Fair Value | ⛔ Overvalued |
| GILD | $100.56 | $152.50 | Above Fair Value | ⛔ Overvalued |
| GILT | $7.45 | $18.46 | Above Fair Value | ⛔ Overvalued |
| GIS | $61.64 | $47.87 | Avoid | ❌ Avoid |
| GL | $243.53 | $146.51 | 66.22% | ✅ Strong Buy |
| GLAD | $39.69 | $19.02 | 108.68% | ✅ Strong Buy |
| GLBE | $29.71 | $32.61 | Above Fair Value | ⚠️ See Analysis |
| GLDD | $16.01 | $15.58 | 2.76% | 👍 Buy |
| GLNG | $14.51 | $42.27 | Above Fair Value | ⛔ Overvalued |
| GLOB | $120.08 | $60.03 | 100.03% | ✅ Strong Buy |
| GLP | $30.30 | $46.94 | Avoid | ❌ Avoid |
| GLPG | $3.13 | $33.36 | Avoid | ❌ Avoid |
| GLPI | $43.04 | $45.32 | Above Fair Value | ⚠️ See Analysis |
| GLRE | $28.18 | $14.04 | 100.71% | ✅ Strong Buy |
| GLUE | $4.78 | $19.55 | Insufficient EBITDA | ⛔ Overvalued |
| GLW | $43.86 | $122.16 | Above Fair Value | ⛔ Overvalued |
| GLXY | $8.37 | $19.76 | Insufficient EBITDA | ⛔ Overvalued |
| GM | $86.97 | $84.24 | Avoid | ❌ Avoid |
| GMAB | $32.76 | $30.90 | 6.02% | 👍 Buy |
| GME | $10.79 | $24.98 | Above Fair Value | ⛔ Overvalued |
| GMED | $70.28 | $87.81 | Above Fair Value | ⛔ Overvalued |
| GMRE | $1.94 | $36.63 | Above Fair Value | ⛔ Overvalued |
| GNE | $10.37 | $14.15 | Above Fair Value | ⛔ Overvalued |
| GNK | $19.62 | $20.77 | Above Fair Value | ⚠️ See Analysis |
| GNRC | $121.19 | $183.53 | Above Fair Value | ⛔ Overvalued |
| GNTX | $30.23 | $24.12 | 25.33% | ✅ Strong Buy |
| GNW | $5.56 | $9.03 | Above Fair Value | ⛔ Overvalued |
| GO | $11.25 | $10.07 | 11.72% | 👍 Buy |
| GOGO | $9.26 | $4.18 | Avoid | ❌ Avoid |
| GOLF | $55.66 | $101.54 | Above Fair Value | ⛔ Overvalued |
| GOOD | $2.05 | $11.52 | Above Fair Value | ⛔ Overvalued |
| GOOG | $233.16 | $323.10 | Above Fair Value | ⛔ Overvalued |
| GOOGL | $233.01 | $322.86 | Above Fair Value | ⛔ Overvalued |
| GOOS | $12.56 | $11.24 | 11.74% | 👍 Buy |
| GORO | $0.59 | $1.59 | Insufficient EBITDA | ❌ Avoid |
| GPC | $116.71 | $148.51 | Above Fair Value | ⛔ Overvalued |
| GPI | $550.31 | $346.28 | Avoid | ❌ Avoid |
| GPK | $22.86 | $13.26 | Avoid | ❌ Avoid |
| GPN | $219.51 | $72.86 | 201.28% | ✅ Strong Buy |
| GPOR | $316.09 | $212.22 | 48.94% | ✅ Strong Buy |
| GPRE | $2.12 | $13.85 | Avoid | ❌ Avoid |
| GPRK | $10.74 | $8.32 | 29.09% | ✅ Strong Buy |
| GPRO | $0.80 | $1.00 | Insufficient EBITDA | ❌ Avoid |
| GRAB | $1.06 | $4.27 | Above Fair Value | ⛔ Overvalued |
| GRBK | $97.82 | $75.46 | 29.63% | ✅ Strong Buy |
| GRC | $30.03 | $65.70 | Above Fair Value | ⛔ Overvalued |
| GRFS | $16.00 | $9.28 | 72.41% | ✅ Strong Buy |
| GRMN | $167.57 | $202.33 | Above Fair Value | ⛔ Overvalued |
| GRND | $10.76 | $10.23 | 5.18% | 👍 Buy |
| GRNT | $9.55 | $5.10 | 87.25% | ✅ Strong Buy |
| GROW | $0.89 | $3.00 | Insufficient EBITDA | ⛔ Overvalued |
| GRRR | $24.07 | $11.75 | Insufficient EBITDA | ❌ Avoid |
| GS | $737.47 | $928.75 | Above Fair Value | ⛔ Overvalued |
| GSAT | $6.61 | $57.65 | Above Fair Value | ⛔ Overvalued |
| GSBC | $83.49 | $64.07 | 30.31% | ✅ Strong Buy |
| GSBD | $18.53 | $9.20 | 101.41% | ✅ Strong Buy |
| GSHD | $32.39 | $66.17 | Above Fair Value | ⛔ Overvalued |
| GSK | $43.11 | $60.23 | Above Fair Value | ⛔ Overvalued |
| GSL | $122.51 | $36.66 | 234.18% | ✅ Strong Buy |
| GSM | $1.42 | $5.16 | Avoid | ❌ Avoid |
| GT | $12.46 | $10.54 | Avoid | ❌ Avoid |
| GTES | $19.18 | $26.81 | Above Fair Value | ⛔ Overvalued |
| GTLB | $23.99 | $32.13 | Insufficient EBITDA | ❌ Avoid |
| GTLS | $164.24 | $207.45 | Avoid | ❌ Avoid |
| GTM | $20.22 | $7.31 | Avoid | ❌ Avoid |
| GTN | $26.03 | $4.35 | Avoid | ❌ Avoid |
| GTX | $21.63 | $19.21 | 12.60% | 👍 Buy |
| GTY | $19.98 | $30.81 | Above Fair Value | ⛔ Overvalued |
| GVA | $76.64 | $130.18 | Above Fair Value | ⛔ Overvalued |
| GWRE | $64.65 | $128.19 | Above Fair Value | ⛔ Overvalued |
| GWRS | $4.39 | $8.83 | Avoid | ❌ Avoid |
| GWW | $727.12 | $1,197.65 | Above Fair Value | ⛔ Overvalued |
| GXO | $35.95 | $58.91 | Avoid | ❌ Avoid |
| H | $39.61 | $162.87 | Avoid | ❌ Avoid |
| HAE | $78.18 | $59.34 | 31.75% | ✅ Strong Buy |
| HAFC | $27.14 | $28.09 | Above Fair Value | ⚠️ See Analysis |
| HAFN | $9.80 | $6.24 | 57.05% | ✅ Strong Buy |
| HAIN | $1.63 | $1.23 | Insufficient EBITDA | ❌ Avoid |
| HAL | $32.28 | $34.98 | Above Fair Value | ⚠️ See Analysis |
| HALO | $137.08 | $81.23 | 68.76% | ✅ Strong Buy |
| HAS | $73.25 | $93.84 | Avoid | ❌ Avoid |
| HASI | $33.75 | $36.13 | Above Fair Value | ⚠️ See Analysis |
| HAYW | $12.07 | $16.71 | Above Fair Value | ⛔ Overvalued |
| HBAN | $22.27 | $19.27 | 15.57% | 👍 Buy |
| HBB | $33.13 | $19.48 | 70.07% | ✅ Strong Buy |
| HBCP | $93.23 | $63.04 | 47.89% | ✅ Strong Buy |
| HBI | $8.49 | $6.47 | Avoid | ❌ Avoid |
| HBIO | $0.95 | $0.50 | Insufficient EBITDA | ❌ Avoid |
| HBM | $14.89 | $24.73 | Above Fair Value | ⛔ Overvalued |
| HBNC | $31.85 | $18.58 | Insufficient EBITDA | ✅ Strong Buy |
| HBT | $25.16 | $29.51 | Above Fair Value | ⛔ Overvalued |
| HCA | $378.33 | $501.69 | Above Fair Value | ⛔ Overvalued |
| HCAT | $4.89 | $2.15 | Insufficient EBITDA | ❌ Avoid |
| HCC | $33.93 | $89.05 | Above Fair Value | ⛔ Overvalued |
| HCI | $306.38 | $163.29 | 87.63% | ✅ Strong Buy |
| HCKT | $28.94 | $16.17 | 78.97% | ✅ Strong Buy |
| HCM | $15.40 | $15.18 | Avoid | ❌ Avoid |
| HCSG | $13.32 | $19.40 | Above Fair Value | ⛔ Overvalued |
| HD | $273.23 | $385.15 | Above Fair Value | ⛔ Overvalued |
| HDB | $26.35 | $34.46 | Above Fair Value | ⛔ Overvalued |
| HDSN | $6.16 | $7.41 | Above Fair Value | ⛔ Overvalued |
| HE | $10.13 | $17.08 | Insufficient EBITDA | ⛔ Overvalued |
| HEI | $112.99 | $326.67 | Above Fair Value | ⛔ Overvalued |
| HELE | $47.77 | $18.76 | Avoid | ❌ Avoid |
| HESM | $31.29 | $35.73 | Above Fair Value | ⚠️ See Analysis |
| HFBL | $19.56 | $18.44 | 6.07% | 👍 Buy |
| HFWA | $41.25 | $28.19 | 46.33% | ✅ Strong Buy |
| HG | $58.57 | $29.70 | 97.21% | ✅ Strong Buy |
| HGV | $59.14 | $47.64 | Avoid | ❌ Avoid |
| HHH | $45.11 | $82.04 | Avoid | ❌ Avoid |
| HI | $36.12 | $31.98 | Avoid | ❌ Avoid |
| HIFS | $338.37 | $333.37 | 1.50% | 👍 Buy |
| HIG | $164.67 | $142.56 | 15.51% | 👍 Buy |
| HII | $247.99 | $397.77 | Above Fair Value | ⛔ Overvalued |
| HIMS | $12.52 | $23.02 | Avoid | ❌ Avoid |
| HIPO | $8.15 | $29.50 | Insufficient EBITDA | ⛔ Overvalued |
| HIVE | $3.48 | $2.33 | 49.36% | ✅ Strong Buy |
| HIW | $8.41 | $26.01 | Above Fair Value | ⛔ Overvalued |
| HL | $11.46 | $22.77 | Above Fair Value | ⛔ Overvalued |
| HLF | $28.88 | $16.99 | 69.98% | ✅ Strong Buy |
| HLI | $148.93 | $172.96 | Above Fair Value | ⛔ Overvalued |
| HLIO | $40.21 | $72.52 | Above Fair Value | ⛔ Overvalued |
| HLIT | $7.28 | $10.10 | Above Fair Value | ⛔ Overvalued |
| HLMN | $8.50 | $10.48 | Above Fair Value | ⛔ Overvalued |
| HLN | $8.11 | $10.98 | Above Fair Value | ⛔ Overvalued |
| HLNE | $146.64 | $131.72 | 11.33% | 👍 Buy |
| HLT | $150.72 | $314.38 | Avoid | ❌ Avoid |
| HLX | $3.98 | $8.56 | Above Fair Value | ⛔ Overvalued |
| HMC | $38.92 | $32.82 | 18.59% | ✅ Strong Buy |
| HMN | $66.09 | $43.18 | 53.06% | ✅ Strong Buy |
| HMY | $25.46 | $20.37 | 24.99% | ✅ Strong Buy |
| HNI | $53.46 | $52.55 | 1.73% | 👍 Buy |
| HNNA | $11.68 | $9.88 | 18.22% | ✅ Strong Buy |
| HNRG | $8.65 | $20.06 | Insufficient EBITDA | ❌ Avoid |
| HNST | $2.17 | $2.29 | Above Fair Value | ⚠️ See Analysis |
| HNVR | $34.73 | $23.36 | 48.67% | ✅ Strong Buy |
| HOFT | $10.25 | $15.54 | Insufficient EBITDA | ❌ Avoid |
| HOG | $50.25 | $20.49 | Avoid | ❌ Avoid |
| HOLX | $64.76 | $74.81 | Above Fair Value | ⛔ Overvalued |
| HOMB | $35.03 | $30.59 | 14.51% | 👍 Buy |
| HON | $172.24 | $238.38 | Above Fair Value | ⛔ Overvalued |
| HOOD | $48.80 | $82.82 | Above Fair Value | ⛔ Overvalued |
| HOPE | $18.00 | $12.51 | 43.88% | ✅ Strong Buy |
| HOUS | $1.75 | $17.64 | Avoid | ❌ Avoid |
| HOV | $27.05 | $125.88 | Avoid | ❌ Avoid |
| HP | $7.47 | $35.97 | Above Fair Value | ⛔ Overvalued |
| HPE | $33.98 | $23.61 | Avoid | ❌ Avoid |
| HPK | $3.49 | $4.79 | Above Fair Value | ⛔ Overvalued |
| HPQ | $44.19 | $19.65 | 124.89% | ✅ Strong Buy |
| HQI | $8.90 | $10.95 | Above Fair Value | ⛔ Overvalued |
| HQY | $78.59 | $79.45 | Above Fair Value | ⚠️ See Analysis |
| HRB | $50.58 | $32.88 | 53.83% | ✅ Strong Buy |
| HRI | $101.71 | $180.31 | Avoid | ❌ Avoid |
| HRL | $21.90 | $24.93 | Above Fair Value | ⚠️ See Analysis |
| HRMY | $67.20 | $37.27 | 80.31% | ✅ Strong Buy |
| HROW | $19.65 | $47.32 | Avoid | ❌ Avoid |
| HRTG | $69.93 | $26.54 | 163.49% | ✅ Strong Buy |
| HSBC | $142.70 | $89.29 | 59.82% | ✅ Strong Buy |
| HSHP | $1.04 | $10.48 | Avoid | ❌ Avoid |
| HSIC | $70.01 | $79.72 | Above Fair Value | ⚠️ See Analysis |
| HSII | $44.58 | $59.01 | Above Fair Value | ⛔ Overvalued |
| HST | $13.09 | $19.35 | Above Fair Value | ⛔ Overvalued |
| HSTM | $13.50 | $20.09 | Above Fair Value | ⛔ Overvalued |
| HSY | $122.24 | $231.53 | Above Fair Value | ⛔ Overvalued |
| HTB | $43.64 | $44.55 | Above Fair Value | ⚠️ See Analysis |
| HTBK | $11.95 | $13.70 | Above Fair Value | ⚠️ See Analysis |
| HTCR | $1.90 | $0.26 | Insufficient EBITDA | ❌ Avoid |
| HTGC | $26.40 | $16.45 | 60.49% | ✅ Strong Buy |
| HTH | $24.45 | $39.83 | Above Fair Value | ⛔ Overvalued |
| HTLD | $5.32 | $11.47 | Above Fair Value | ⛔ Overvalued |
| HTO | $44.85 | $52.37 | Above Fair Value | ⛔ Overvalued |
| HUBB | $338.35 | $503.80 | Above Fair Value | ⛔ Overvalued |
| HUBG | $24.65 | $41.96 | Above Fair Value | ⛔ Overvalued |
| HUBS | $210.04 | $232.58 | Above Fair Value | ⚠️ See Analysis |
| HUM | $209.74 | $193.94 | 8.15% | 👍 Buy |
| HURN | $122.37 | $169.67 | Above Fair Value | ⛔ Overvalued |
| HUT | $0.59 | $53.06 | Above Fair Value | ⛔ Overvalued |
| HVT | $21.66 | $27.31 | Above Fair Value | ⛔ Overvalued |
| HWC | $100.92 | $74.41 | 35.63% | ✅ Strong Buy |
| HWKN | $56.91 | $134.38 | Above Fair Value | ⛔ Overvalued |
| HWM | $55.00 | $223.16 | Above Fair Value | ⛔ Overvalued |
| HXL | $31.06 | $86.00 | Above Fair Value | ⛔ Overvalued |
| HY | $1.78 | $36.48 | Avoid | ❌ Avoid |
| HZO | $14.07 | $29.98 | Avoid | ❌ Avoid |
| IAC | $6.78 | $35.65 | Insufficient EBITDA | ⛔ Overvalued |
| IAG | $23.88 | $19.12 | 24.90% | ✅ Strong Buy |
| IART | $31.96 | $11.26 | Avoid | ❌ Avoid |
| IAS | $14.24 | $10.34 | 37.72% | ✅ Strong Buy |
| IBCP | $46.17 | $36.60 | 26.15% | ✅ Strong Buy |
| IBKR | $54.76 | $74.59 | Above Fair Value | ⛔ Overvalued |
| IBM | $129.87 | $298.93 | Above Fair Value | ⛔ Overvalued |
| IBN | $30.72 | $31.18 | Above Fair Value | ⚠️ See Analysis |
| IBOC | $105.84 | $74.58 | 41.91% | ✅ Strong Buy |
| IBP | $160.87 | $328.92 | Above Fair Value | ⛔ Overvalued |
| IBTA | $29.20 | $20.54 | 42.16% | ✅ Strong Buy |
| ICE | $138.12 | $169.00 | Above Fair Value | ⛔ Overvalued |
| ICFI | $94.15 | $87.07 | 8.13% | 👍 Buy |
| ICHR | $6.54 | $32.15 | Avoid | ❌ Avoid |
| ICL | $6.14 | $5.49 | 11.84% | 👍 Buy |
| ICLR | $217.79 | $150.59 | 44.62% | ✅ Strong Buy |
| ICMB | $2.77 | $2.83 | Above Fair Value | ⚠️ See Analysis |
| ICUI | $111.23 | $154.16 | Above Fair Value | ⛔ Overvalued |
| IDA | $84.98 | $135.33 | Avoid | ❌ Avoid |
| IDT | $54.78 | $48.26 | 13.51% | 👍 Buy |
| IDXX | $320.72 | $644.61 | Above Fair Value | ⛔ Overvalued |
| IEP | $10.14 | $8.02 | Avoid | ❌ Avoid |
| IESC | $262.84 | $455.88 | Above Fair Value | ⛔ Overvalued |
| IEX | $133.91 | $211.37 | Above Fair Value | ⛔ Overvalued |
| IFF | $65.04 | $74.82 | Avoid | ❌ Avoid |
| IGIC | $30.00 | $25.60 | 17.19% | 👍 Buy |
| IHG | $83.34 | $144.83 | Above Fair Value | ⛔ Overvalued |
| IHRT | $5.67 | $3.24 | Avoid | ❌ Avoid |
| IHS | $10.22 | $8.22 | Insufficient EBITDA | ❌ Avoid |
| III | $4.78 | $5.24 | Above Fair Value | ⚠️ See Analysis |
| IIIN | $40.09 | $36.61 | 9.51% | 👍 Buy |
| IIIV | $21.24 | $20.97 | 1.29% | 👍 Buy |
| IIPR | $72.21 | $48.65 | 48.43% | ✅ Strong Buy |
| ILMN | $95.22 | $119.72 | Insufficient EBITDA | ⛔ Overvalued |
| IMAX | $22.79 | $37.28 | Above Fair Value | ⛔ Overvalued |
| IMKTA | $58.20 | $84.90 | Above Fair Value | ⛔ Overvalued |
| IMMR | $18.28 | $6.68 | 173.65% | ✅ Strong Buy |
| IMO | $102.02 | $112.68 | Above Fair Value | ⚠️ See Analysis |
| IMPP | $28.78 | $3.33 | 764.26% | ✅ Strong Buy |
| IMXI | $25.57 | $15.55 | 64.44% | ✅ Strong Buy |
| INBK | $42.66 | $22.00 | Insufficient EBITDA | ✅ Strong Buy |
| INCY | $106.44 | $108.39 | Above Fair Value | ⚠️ See Analysis |
| INDB | $122.57 | $86.01 | 42.51% | ✅ Strong Buy |
| INDV | $38.57 | $34.36 | 12.25% | 👍 Buy |
| INFU | $5.11 | $7.72 | Above Fair Value | ⛔ Overvalued |
| INFY | $16.62 | $16.84 | Above Fair Value | ⚠️ See Analysis |
| ING | $31.55 | $30.06 | 4.96% | 👍 Buy |
| INGM | $40.35 | $21.81 | 85.01% | ✅ Strong Buy |
| INGR | $155.93 | $120.11 | 29.82% | ✅ Strong Buy |
| INOD | $19.15 | $47.59 | Above Fair Value | ⛔ Overvalued |
| INSE | $7.61 | $8.70 | Above Fair Value | ⚠️ See Analysis |
| INSP | $39.44 | $65.70 | Above Fair Value | ⛔ Overvalued |
| INSW | $66.86 | $61.06 | 9.50% | 👍 Buy |
| INTA | $29.61 | $23.92 | Insufficient EBITDA | ❌ Avoid |
| INTC | $12.76 | $50.59 | Above Fair Value | ⛔ Overvalued |
| INTR | $16.76 | $8.87 | 88.95% | ✅ Strong Buy |
| INTU | $620.10 | $443.77 | 39.73% | ✅ Strong Buy |
| INVA | $31.45 | $21.80 | 44.27% | ✅ Strong Buy |
| INVH | $17.28 | $26.34 | Above Fair Value | ⛔ Overvalued |
| INVX | $19.74 | $25.35 | Above Fair Value | ⛔ Overvalued |
| IOSP | $68.22 | $86.31 | Above Fair Value | ⛔ Overvalued |
| IOT | $16.70 | $25.42 | Insufficient EBITDA | ⛔ Overvalued |
| IP | $14.32 | $46.58 | Avoid | ❌ Avoid |
| IPAR | $79.37 | $102.37 | Above Fair Value | ⛔ Overvalued |
| IPGP | $26.57 | $109.61 | Above Fair Value | ⛔ Overvalued |
| IPI | $11.75 | $32.88 | Above Fair Value | ⛔ Overvalued |
| IQV | $191.95 | $187.49 | Avoid | ❌ Avoid |
| IR | $47.43 | $98.50 | Above Fair Value | ⛔ Overvalued |
| IRDM | $15.02 | $20.00 | Avoid | ❌ Avoid |
| IREN | $27.18 | $41.83 | Above Fair Value | ⛔ Overvalued |
| IRM | $33.69 | $95.78 | Avoid | ❌ Avoid |
| IRMD | $37.63 | $95.97 | Above Fair Value | ⛔ Overvalued |
| IRS | $1.04 | $16.14 | Insufficient EBITDA | ⛔ Overvalued |
| IRT | $3.93 | $16.60 | Above Fair Value | ⛔ Overvalued |
| IRWD | $8.37 | $4.56 | 83.55% | ✅ Strong Buy |
| ISRG | $212.11 | $488.15 | Above Fair Value | ⛔ Overvalued |
| ISSC | $11.65 | $19.59 | Above Fair Value | ⛔ Overvalued |
| ISTR | $45.03 | $30.11 | 49.55% | ✅ Strong Buy |
| IT | $336.68 | $156.33 | 115.36% | ✅ Strong Buy |
| ITGR | $82.59 | $86.45 | Above Fair Value | ⚠️ See Analysis |
| ITIC | $248.21 | $279.27 | Above Fair Value | ⚠️ See Analysis |
| ITRI | $108.63 | $104.05 | 4.40% | 👍 Buy |
| ITRN | $57.89 | $45.96 | 25.96% | ✅ Strong Buy |
| ITT | $100.30 | $206.87 | Above Fair Value | ⛔ Overvalued |
| ITW | $190.16 | $293.57 | Above Fair Value | ⛔ Overvalued |
| IVR | $13.97 | $8.82 | 58.39% | ✅ Strong Buy |
| IVT | $14.47 | $30.42 | Above Fair Value | ⛔ Overvalued |
| IVZ | $31.48 | $26.82 | 17.38% | 👍 Buy |
| IX | $33.69 | $32.30 | Avoid | ❌ Avoid |
| J | $95.91 | $148.81 | Above Fair Value | ⛔ Overvalued |
| JACK | $60.38 | $22.77 | Avoid | ❌ Avoid |
| JAKK | $25.10 | $18.10 | 38.67% | ✅ Strong Buy |
| JAMF | $20.65 | $13.05 | Insufficient EBITDA | ❌ Avoid |
| JAZZ | $219.70 | $165.50 | Avoid | ❌ Avoid |
| JBHT | $134.83 | $227.91 | Above Fair Value | ⛔ Overvalued |
| JBI | $9.42 | $7.27 | 29.57% | ✅ Strong Buy |
| JBL | $184.16 | $258.25 | Above Fair Value | ⛔ Overvalued |
| JBSS | $89.09 | $78.61 | 13.33% | 👍 Buy |
| JBTM | $117.81 | $168.55 | Above Fair Value | ⛔ Overvalued |
| JCI | $66.57 | $137.65 | Above Fair Value | ⛔ Overvalued |
| JEF | $58.06 | $58.94 | Above Fair Value | ⚠️ See Analysis |
| JHG | $63.14 | $48.22 | 30.94% | ✅ Strong Buy |
| JHX | $22.27 | $23.64 | Avoid | ❌ Avoid |
| JILL | $33.51 | $16.80 | 99.46% | ✅ Strong Buy |
| JJSF | $71.10 | $82.54 | Above Fair Value | ⛔ Overvalued |
| JKHY | $124.42 | $173.36 | Above Fair Value | ⛔ Overvalued |
| JLL | $249.61 | $342.76 | Above Fair Value | ⛔ Overvalued |
| JMSB | $26.38 | $20.88 | 26.34% | ✅ Strong Buy |
| JNJ | $205.86 | $239.99 | Above Fair Value | ⛔ Overvalued |
| JOE | $29.07 | $68.56 | Above Fair Value | ⛔ Overvalued |
| JOUT | $20.92 | $46.88 | Above Fair Value | ⛔ Overvalued |
| JPM | $301.82 | $322.40 | Above Fair Value | ⚠️ See Analysis |
| JRSH | $3.66 | $3.07 | 19.22% | ✅ Strong Buy |
| JRVR | $15.91 | $7.04 | Insufficient EBITDA | ✅ Strong Buy |
| JVA | $3.12 | $3.10 | 0.65% | 👍 Buy |
| K | $44.95 | $83.44 | Above Fair Value | ⛔ Overvalued |
| KAI | $139.06 | $343.11 | Above Fair Value | ⛔ Overvalued |
| KALU | $77.15 | $138.51 | Avoid | ❌ Avoid |
| KBDC | $16.44 | $14.06 | 16.93% | 👍 Buy |
| KBH | $61.33 | $60.94 | 0.64% | 👍 Buy |
| KBR | $48.93 | $43.49 | 12.51% | 👍 Buy |
| KD | $66.54 | $23.49 | 183.27% | ✅ Strong Buy |
| KDP | $35.03 | $28.41 | Avoid | ❌ Avoid |
| KE | $17.57 | $26.29 | Above Fair Value | ⛔ Overvalued |
| KELYA | $18.07 | $11.11 | Avoid | ❌ Avoid |
| KEP | $79.69 | $21.56 | 269.62% | ✅ Strong Buy |
| KEX | $87.01 | $122.38 | Above Fair Value | ⛔ Overvalued |
| KEY | $29.02 | $23.21 | Insufficient EBITDA | ✅ Strong Buy |
| KEYS | $187.66 | $230.95 | Above Fair Value | ⛔ Overvalued |
| KFRC | $35.56 | $36.08 | Above Fair Value | ⚠️ See Analysis |
| KFY | $75.33 | $68.11 | 10.60% | 👍 Buy |
| KGC | $30.92 | $32.09 | Above Fair Value | ⚠️ See Analysis |
| KGS | $36.20 | $49.91 | Avoid | ❌ Avoid |
| KHC | $41.11 | $24.64 | Avoid | ❌ Avoid |
| KIM | $11.93 | $21.83 | Above Fair Value | ⛔ Overvalued |
| KINS | $28.69 | $16.05 | 78.75% | ✅ Strong Buy |
| KKR | $94.27 | $103.20 | Above Fair Value | ⚠️ See Analysis |
| KLAC | $1,017.14 | $1,442.95 | Above Fair Value | ⛔ Overvalued |
| KLC | $7.70 | $4.83 | Avoid | ❌ Avoid |
| KLIC | $32.79 | $70.92 | Above Fair Value | ⛔ Overvalued |
| KMB | $99.34 | $104.33 | Above Fair Value | ⚠️ See Analysis |
| KMI | $17.28 | $30.50 | Avoid | ❌ Avoid |
| KMPR | $50.66 | $34.24 | 47.96% | ✅ Strong Buy |
| KMT | $22.55 | $40.32 | Above Fair Value | ⛔ Overvalued |
| KMX | $41.46 | $47.17 | Avoid | ❌ Avoid |
| KN | $17.44 | $26.98 | Above Fair Value | ⛔ Overvalued |
| KNF | $45.51 | $80.00 | Above Fair Value | ⛔ Overvalued |
| KNOP | $10.17 | $10.39 | Avoid | ❌ Avoid |
| KNSA | $17.80 | $43.09 | Insufficient EBITDA | ⛔ Overvalued |
| KNSL | $475.94 | $414.10 | 14.93% | 👍 Buy |
| KNTK | $26.56 | $41.58 | Avoid | ❌ Avoid |
| KNX | $21.63 | $60.17 | Above Fair Value | ⛔ Overvalued |
| KO | $60.16 | $79.03 | Above Fair Value | ⛔ Overvalued |
| KOF | $103.06 | $110.90 | Above Fair Value | ⚠️ See Analysis |
| KOP | $51.36 | $32.30 | Avoid | ❌ Avoid |
| KR | $76.73 | $67.50 | 13.67% | 👍 Buy |
| KRC | $15.99 | $35.00 | Above Fair Value | ⛔ Overvalued |
| KREF | $5.74 | $7.32 | Above Fair Value | ⛔ Overvalued |
| KRG | $6.10 | $24.87 | Above Fair Value | ⛔ Overvalued |
| KRMN | $6.58 | $95.36 | Avoid | ❌ Avoid |
| KRNY | $11.69 | $8.15 | 43.44% | ✅ Strong Buy |
| KRO | $0.80 | $6.08 | Avoid | ❌ Avoid |
| KROS | $29.95 | $17.57 | Insufficient EBITDA | ✅ Strong Buy |
| KRP | $11.79 | $13.79 | Above Fair Value | ⛔ Overvalued |
| KRT | $23.66 | $25.85 | Above Fair Value | ⚠️ See Analysis |
| KRUS | $3.76 | $79.29 | Above Fair Value | ⛔ Overvalued |
| KRYS | $162.25 | $272.74 | Above Fair Value | ⛔ Overvalued |
| KSS | $18.12 | $18.50 | Above Fair Value | ⚠️ See Analysis |
| KTB | $71.60 | $67.03 | 6.82% | 👍 Buy |
| KTOS | $11.67 | $94.41 | Above Fair Value | ⛔ Overvalued |
| KVHI | $2.95 | $5.95 | Avoid | ❌ Avoid |
| KVUE | $16.75 | $18.13 | Above Fair Value | ⚠️ See Analysis |
| KVYO | $14.43 | $19.14 | Insufficient EBITDA | ❌ Avoid |
| KWR | $106.11 | $170.07 | Avoid | ❌ Avoid |
| L | $90.69 | $111.27 | Above Fair Value | ⛔ Overvalued |
| LAD | $440.79 | $344.24 | Avoid | ❌ Avoid |
| LADR | $10.04 | $10.27 | Above Fair Value | ⚠️ See Analysis |
| LAKE | $5.89 | $9.65 | Insufficient EBITDA | ❌ Avoid |
| LAMR | $110.48 | $133.23 | Above Fair Value | ⛔ Overvalued |
| LAR | $3.72 | $6.73 | Insufficient EBITDA | ❌ Avoid |
| LARK | $44.74 | $28.15 | 58.93% | ✅ Strong Buy |
| LASR | $5.34 | $51.12 | Insufficient EBITDA | ❌ Avoid |
| LAUR | $28.70 | $35.01 | Above Fair Value | ⛔ Overvalued |
| LAZ | $36.87 | $56.80 | Above Fair Value | ⛔ Overvalued |
| LB | $29.68 | $56.72 | Insufficient EBITDA | ⛔ Overvalued |
| LBRDA | $187.57 | $53.64 | 249.68% | ✅ Strong Buy |
| LBRDK | $91.45 | $53.76 | 70.11% | ✅ Strong Buy |
| LBRT | $12.88 | $25.23 | Above Fair Value | ⛔ Overvalued |
| LCII | $111.89 | $154.65 | Above Fair Value | ⛔ Overvalued |
| LCNB | $25.85 | $17.48 | 47.88% | ✅ Strong Buy |
| LCUT | $4.53 | $3.34 | Avoid | ❌ Avoid |
| LDI | $2.55 | $2.15 | Insufficient EBITDA | ✅ Strong Buy |
| LDOS | $201.20 | $192.99 | 4.25% | 👍 Buy |
| LE | $10.62 | $17.99 | Above Fair Value | ⛔ Overvalued |
| LEA | $167.53 | $140.95 | 18.86% | ✅ Strong Buy |
| LECO | $174.64 | $298.88 | Above Fair Value | ⛔ Overvalued |
| LEG | $13.69 | $12.89 | Insufficient EBITDA | 👍 Buy |
| LEN | $99.52 | $114.02 | Above Fair Value | ⚠️ See Analysis |
| LEN-B | $95.70 | $106.67 | Above Fair Value | ⚠️ See Analysis |
| LEU | $92.99 | $263.47 | Above Fair Value | ⛔ Overvalued |
| LEVI | $21.25 | $20.55 | 3.41% | 👍 Buy |
| LFST | $3.77 | $6.83 | Above Fair Value | ⛔ Overvalued |
| LFT | $3.24 | $1.35 | 140.00% | ✅ Strong Buy |
| LFUS | $191.56 | $349.68 | Above Fair Value | ⛔ Overvalued |
| LFVN | $20.05 | $5.03 | 298.61% | ✅ Strong Buy |
| LGIH | $58.45 | $59.12 | Avoid | ❌ Avoid |
| LGND | $169.26 | $190.44 | Above Fair Value | ⚠️ See Analysis |
| LHX | $160.16 | $349.66 | Above Fair Value | ⛔ Overvalued |
| LIEN | $17.52 | $10.11 | 73.29% | ✅ Strong Buy |
| LIF | $24.86 | $54.41 | Above Fair Value | ⛔ Overvalued |
| LII | $463.93 | $529.98 | Above Fair Value | ⚠️ See Analysis |
| LILA | $3.43 | $8.00 | Avoid | ❌ Avoid |
| LILAK | $3.41 | $8.08 | Avoid | ❌ Avoid |
| LIN | $303.08 | $448.24 | Above Fair Value | ⛔ Overvalued |
| LINC | $9.30 | $26.13 | Above Fair Value | ⛔ Overvalued |
| LIND | $4.00 | $20.07 | Avoid | ❌ Avoid |
| LION | $4.62 | $9.04 | Above Fair Value | ⛔ Overvalued |
| LITE | $164.22 | $551.99 | Avoid | ❌ Avoid |
| LIVN | $58.26 | $66.56 | Avoid | ❌ Avoid |
| LKFN | $73.03 | $62.62 | 16.62% | 👍 Buy |
| LKQ | $44.82 | $34.58 | 29.61% | ✅ Strong Buy |
| LLY | $672.30 | $1,058.18 | Above Fair Value | ⛔ Overvalued |
| LLYVA | $29.73 | $80.01 | Insufficient EBITDA | ❌ Avoid |
| LLYVK | $27.49 | $81.46 | Insufficient EBITDA | ❌ Avoid |
| LMAT | $42.26 | $87.42 | Above Fair Value | ⛔ Overvalued |
| LMB | $51.63 | $86.13 | Above Fair Value | ⛔ Overvalued |
| LMNR | $9.74 | $14.45 | Insufficient EBITDA | ❌ Avoid |
| LMT | $373.34 | $623.58 | Above Fair Value | ⛔ Overvalued |
| LNC | $84.56 | $40.31 | 109.77% | ✅ Strong Buy |
| LNG | $243.15 | $213.11 | 14.10% | 👍 Buy |
| LNKB | $11.55 | $9.29 | 24.33% | ✅ Strong Buy |
| LNN | $100.37 | $134.03 | Above Fair Value | ⛔ Overvalued |
| LNT | $46.54 | $66.69 | Avoid | ❌ Avoid |
| LNTH | $84.53 | $64.89 | 30.27% | ✅ Strong Buy |
| LOAN | $3.97 | $4.51 | Above Fair Value | ⚠️ See Analysis |
| LOAR | $11.42 | $65.55 | Above Fair Value | ⛔ Overvalued |
| LOB | $63.64 | $40.83 | 55.87% | ✅ Strong Buy |
| LOCO | $13.03 | $10.94 | 19.10% | ✅ Strong Buy |
| LOGI | $99.27 | $91.45 | 8.55% | 👍 Buy |
| LOPE | $164.38 | $169.72 | Above Fair Value | ⚠️ See Analysis |
| LOVE | $24.21 | $13.22 | 83.13% | ✅ Strong Buy |
| LOW | $226.66 | $278.38 | Above Fair Value | ⛔ Overvalued |
| LPG | $37.46 | $32.35 | 15.80% | 👍 Buy |
| LPL | $4.52 | $3.96 | 14.14% | 👍 Buy |
| LPLA | $335.58 | $385.14 | Above Fair Value | ⚠️ See Analysis |
| LPRO | $1.70 | $1.69 | Insufficient EBITDA | 👍 Buy |
| LPX | $42.69 | $96.97 | Above Fair Value | ⛔ Overvalued |
| LQDT | $24.20 | $32.51 | Above Fair Value | ⛔ Overvalued |
| LRCX | $136.80 | $231.01 | Above Fair Value | ⛔ Overvalued |
| LRN | $130.65 | $87.83 | 48.75% | ✅ Strong Buy |
| LSBK | $13.89 | $15.37 | Above Fair Value | ⚠️ See Analysis |
| LSCC | $24.88 | $86.41 | Above Fair Value | ⛔ Overvalued |
| LSTR | $86.12 | $162.08 | Above Fair Value | ⛔ Overvalued |
| LTC | $19.98 | $37.39 | Above Fair Value | ⛔ Overvalued |
| LTH | $29.25 | $29.82 | Above Fair Value | ⚠️ See Analysis |
| LTM | $78.70 | $64.84 | 21.38% | ✅ Strong Buy |
| LUCK | $6.57 | $6.63 | Avoid | ❌ Avoid |
| LULU | $247.89 | $172.85 | 43.41% | ✅ Strong Buy |
| LUNR | $1.09 | $17.52 | Insufficient EBITDA | ❌ Avoid |
| LUV | $25.92 | $54.26 | Above Fair Value | ⛔ Overvalued |
| LVS | $55.56 | $57.80 | Above Fair Value | ⚠️ See Analysis |
| LW | $59.79 | $50.12 | 19.29% | ✅ Strong Buy |
| LXFR | $15.58 | $15.50 | 0.52% | 👍 Buy |
| LXP | $22.63 | $51.55 | Above Fair Value | ⛔ Overvalued |
| LXU | $6.09 | $9.66 | Avoid | ❌ Avoid |
| LYB | $26.90 | $55.10 | Avoid | ❌ Avoid |
| LYFT | $10.10 | $16.46 | Above Fair Value | ⛔ Overvalued |
| LYG | $6.11 | $5.91 | 3.38% | 👍 Buy |
| LYTS | $16.32 | $22.89 | Above Fair Value | ⛔ Overvalued |
| LYV | $29.34 | $140.84 | Above Fair Value | ⛔ Overvalued |
| LZ | $10.98 | $8.05 | 36.40% | ✅ Strong Buy |
| LZB | $37.75 | $38.80 | Above Fair Value | ⚠️ See Analysis |
| M | $23.12 | $22.70 | 1.85% | 👍 Buy |
| MA | $474.83 | $548.74 | Above Fair Value | ⛔ Overvalued |
| MAA | $72.83 | $132.13 | Above Fair Value | ⛔ Overvalued |
| MAN | $44.15 | $36.64 | Avoid | ❌ Avoid |
| MANH | $131.65 | $145.07 | Above Fair Value | ⚠️ See Analysis |
| MANU | $3.89 | $17.34 | Above Fair Value | ⛔ Overvalued |
| MAPS | $2.28 | $0.72 | 216.67% | ✅ Strong Buy |
| MAR | $215.21 | $333.24 | Above Fair Value | ⛔ Overvalued |
| MARA | $9.73 | $8.24 | 18.08% | ✅ Strong Buy |
| MAS | $82.43 | $72.87 | 13.12% | 👍 Buy |
| MASI | $116.82 | $139.15 | Insufficient EBITDA | ❌ Avoid |
| MAT | $22.93 | $21.49 | 6.70% | 👍 Buy |
| MATV | $10.45 | $14.55 | Avoid | ❌ Avoid |
| MATW | $16.59 | $27.16 | Avoid | ❌ Avoid |
| MATX | $161.12 | $162.94 | Above Fair Value | ⚠️ See Analysis |
| MAX | $24.47 | $8.95 | 173.41% | ✅ Strong Buy |
| MBC | $13.03 | $13.59 | Above Fair Value | ⚠️ See Analysis |
| MBCN | $37.45 | $34.86 | 7.43% | 👍 Buy |
| MBI | $7.83 | $6.58 | Insufficient EBITDA | ✅ Strong Buy |
| MBIN | $70.12 | $42.48 | 65.07% | ✅ Strong Buy |
| MBLY | $7.16 | $8.71 | Above Fair Value | ⛔ Overvalued |
| MBUU | $27.47 | $31.24 | Above Fair Value | ⚠️ See Analysis |
| MBWM | $82.53 | $54.71 | 50.85% | ✅ Strong Buy |
| MC | $46.14 | $73.25 | Above Fair Value | ⛔ Overvalued |
| MCB | $167.63 | $96.39 | 73.91% | ✅ Strong Buy |
| MCBS | $29.13 | $29.97 | Above Fair Value | ⚠️ See Analysis |
| MCD | $260.03 | $327.16 | Above Fair Value | ⛔ Overvalued |
| MCFT | $22.31 | $25.17 | Above Fair Value | ⚠️ See Analysis |
| MCHP | $45.87 | $76.01 | Avoid | ❌ Avoid |
| MCK | $569.87 | $948.68 | Above Fair Value | ⛔ Overvalued |
| MCO | $352.75 | $452.49 | Above Fair Value | ⛔ Overvalued |
| MCRB | $11.25 | $13.96 | Insufficient EBITDA | ⛔ Overvalued |
| MCRI | $87.03 | $98.87 | Above Fair Value | ⚠️ See Analysis |
| MCS | $5.92 | $15.62 | Above Fair Value | ⛔ Overvalued |
| MCW | $10.05 | $6.14 | 63.68% | ✅ Strong Buy |
| MCY | $101.53 | $95.19 | 6.66% | 👍 Buy |
| MD | $31.18 | $20.89 | Insufficient EBITDA | ✅ Strong Buy |
| MDB | $112.25 | $344.35 | Insufficient EBITDA | ❌ Avoid |
| MDBH | $22.79 | $3.21 | 609.97% | ✅ Strong Buy |
| MDGL | $39.17 | $477.60 | Insufficient EBITDA | ❌ Avoid |
| MDLN | $17.86 | $47.30 | Above Fair Value | ⛔ Overvalued |
| MDLZ | $43.01 | $60.02 | Avoid | ❌ Avoid |
| MDT | $93.69 | $102.90 | Above Fair Value | ⚠️ See Analysis |
| MDU | $12.18 | $20.34 | Avoid | ❌ Avoid |
| MDV | $1.62 | $15.30 | Above Fair Value | ⛔ Overvalued |
| MDXG | $4.45 | $5.15 | Above Fair Value | ⛔ Overvalued |
| MED | $0.36 | $11.36 | Above Fair Value | ⛔ Overvalued |
| MEDP | $316.84 | $542.04 | Above Fair Value | ⛔ Overvalued |
| MEG | $21.57 | $24.69 | Avoid | ❌ Avoid |
| MEI | $5.93 | $9.09 | Avoid | ❌ Avoid |
| MEOH | $45.97 | $47.23 | Above Fair Value | ⚠️ See Analysis |
| MESO | $1.20 | $15.95 | Insufficient EBITDA | ❌ Avoid |
| MET | $115.82 | $76.38 | 51.64% | ✅ Strong Buy |
| META | $538.65 | $661.46 | Above Fair Value | ⛔ Overvalued |
| MFA | $20.73 | $9.74 | 112.83% | ✅ Strong Buy |
| MFC | $34.62 | $38.04 | Above Fair Value | ⚠️ See Analysis |
| MFIC | $16.86 | $11.31 | 49.07% | ✅ Strong Buy |
| MFIN | $23.06 | $10.34 | 123.02% | ✅ Strong Buy |
| MG | $12.47 | $14.67 | Above Fair Value | ⛔ Overvalued |
| MGA | $68.58 | $54.02 | 26.95% | ✅ Strong Buy |
| MGEE | $48.40 | $79.58 | Above Fair Value | ⛔ Overvalued |
| MGIC | $17.79 | $21.85 | Above Fair Value | ⛔ Overvalued |
| MGM | $31.24 | $37.49 | Above Fair Value | ⛔ Overvalued |
| MGNI | $16.97 | $11.29 | 50.31% | ✅ Strong Buy |
| MGPI | $33.68 | $26.27 | Avoid | ❌ Avoid |
| MGRC | $83.72 | $119.43 | Above Fair Value | ⛔ Overvalued |
| MGY | $24.88 | $26.99 | Above Fair Value | ⚠️ See Analysis |
| MGYR | $24.56 | $18.40 | 33.48% | ✅ Strong Buy |
| MHK | $163.18 | $131.89 | 23.72% | ✅ Strong Buy |
| MHO | $170.76 | $141.86 | 20.37% | ✅ Strong Buy |
| MIDD | $151.64 | $161.11 | Avoid | ❌ Avoid |
| MIR | $8.74 | $24.07 | Above Fair Value | ⛔ Overvalued |
| MIRM | $0.27 | $100.47 | Insufficient EBITDA | ❌ Avoid |
| MITK | $22.39 | $11.83 | 89.26% | ✅ Strong Buy |
| MITT | $12.87 | $8.48 | 51.77% | ✅ Strong Buy |
| MKC | $52.69 | $67.42 | Above Fair Value | ⛔ Overvalued |
| MKC-V | $50.40 | $67.21 | Above Fair Value | ⛔ Overvalued |
| MKL | $1,629.53 | $2,102.15 | Above Fair Value | ⛔ Overvalued |
| MKSI | $134.98 | $242.96 | Avoid | ❌ Avoid |
| MKTX | $152.15 | $162.33 | Above Fair Value | ⚠️ See Analysis |
| MLAB | $107.02 | $93.27 | Avoid | ❌ Avoid |
| MLCO | $10.63 | $6.35 | Avoid | ❌ Avoid |
| MLI | $98.25 | $117.86 | Above Fair Value | ⛔ Overvalued |
| MLKN | $28.52 | $22.54 | Avoid | ❌ Avoid |
| MLM | $321.82 | $690.00 | Above Fair Value | ⛔ Overvalued |
| MLR | $36.97 | $44.60 | Above Fair Value | ⛔ Overvalued |
| MMI | $9.90 | $26.60 | Above Fair Value | ⛔ Overvalued |
| MMM | $104.24 | $172.65 | Above Fair Value | ⛔ Overvalued |
| MMS | $133.70 | $75.08 | 78.08% | ✅ Strong Buy |
| MMSI | $55.51 | $82.50 | Above Fair Value | ⛔ Overvalued |
| MMYT | $28.98 | $57.10 | Avoid | ❌ Avoid |
| MNDY | $122.15 | $98.00 | 24.64% | ✅ Strong Buy |
| MNKD | $2.84 | $5.78 | Above Fair Value | ⛔ Overvalued |
| MNR | $12.24 | $12.33 | Above Fair Value | ⚠️ See Analysis |
| MNRO | $9.47 | $21.00 | Above Fair Value | ⛔ Overvalued |
| MNSB | $29.61 | $22.86 | 29.53% | ✅ Strong Buy |
| MNST | $40.68 | $82.54 | Above Fair Value | ⛔ Overvalued |
| MNTK | $1.50 | $1.81 | Above Fair Value | ⛔ Overvalued |
| MO | $46.47 | $65.40 | Above Fair Value | ⛔ Overvalued |
| MOD | $62.75 | $215.72 | Above Fair Value | ⛔ Overvalued |
| MOFG | $46.76 | $48.18 | Insufficient EBITDA | ⚠️ See Analysis |
| MOH | $190.16 | $131.72 | 44.37% | ✅ Strong Buy |
| MORN | $194.53 | $165.47 | 17.56% | 👍 Buy |
| MOS | $35.60 | $28.60 | 24.48% | ✅ Strong Buy |
| MOV | $15.62 | $24.50 | Above Fair Value | ⛔ Overvalued |
| MP | $8.12 | $61.26 | Avoid | ❌ Avoid |
| MPAA | $17.34 | $13.14 | 31.96% | ✅ Strong Buy |
| MPB | $52.53 | $34.61 | 51.78% | ✅ Strong Buy |
| MPC | $156.30 | $203.00 | Above Fair Value | ⛔ Overvalued |
| MPLX | $61.96 | $56.00 | 10.64% | 👍 Buy |
| MPTI | $47.16 | $64.38 | Above Fair Value | ⛔ Overvalued |
| MPW | $1.60 | $5.02 | Above Fair Value | ⛔ Overvalued |
| MPWR | $397.98 | $1,229.82 | Above Fair Value | ⛔ Overvalued |
| MPX | $5.37 | $8.22 | Above Fair Value | ⛔ Overvalued |
| MRAM | $5.31 | $10.92 | Above Fair Value | ⛔ Overvalued |
| MRBK | $26.17 | $20.71 | 26.36% | ✅ Strong Buy |
| MRCC | $6.99 | $6.33 | 10.43% | 👍 Buy |
| MRCY | $20.07 | $82.20 | Avoid | ❌ Avoid |
| MRK | $119.10 | $121.93 | Above Fair Value | ⚠️ See Analysis |
| MRP | $40.24 | $31.69 | Insufficient EBITDA | ❌ Avoid |
| MRTN | $3.50 | $13.56 | Above Fair Value | ⛔ Overvalued |
| MRVL | $54.96 | $80.28 | Above Fair Value | ⛔ Overvalued |
| MRX | $64.12 | $40.48 | 58.40% | ✅ Strong Buy |
| MS | $147.70 | $179.96 | Above Fair Value | ⛔ Overvalued |
| MSA | $126.11 | $193.13 | Above Fair Value | ⛔ Overvalued |
| MSB | $16.66 | $35.20 | Above Fair Value | ⛔ Overvalued |
| MSBI | $22.55 | $23.98 | Insufficient EBITDA | ⚠️ See Analysis |
| MSCI | $469.57 | $557.78 | Above Fair Value | ⛔ Overvalued |
| MSDL | $22.29 | $15.18 | 46.84% | ✅ Strong Buy |
| MSEX | $37.31 | $51.24 | Avoid | ❌ Avoid |
| MSFT | $402.94 | $401.14 | 0.45% | 👍 Buy |
| MSGE | $25.10 | $60.85 | Avoid | ❌ Avoid |
| MSI | $308.93 | $422.18 | Above Fair Value | ⛔ Overvalued |
| MSM | $68.28 | $95.56 | Above Fair Value | ⛔ Overvalued |
| MSTR | $513.33 | $134.93 | Insufficient EBITDA | ✅ Strong Buy |
| MT | $50.08 | $61.30 | Above Fair Value | ⛔ Overvalued |
| MTB | $311.39 | $238.01 | 30.83% | ✅ Strong Buy |
| MTCH | $64.70 | $31.63 | 104.55% | ✅ Strong Buy |
| MTD | $997.11 | $1,373.57 | Above Fair Value | ⛔ Overvalued |
| MTDR | $77.53 | $47.35 | 63.74% | ✅ Strong Buy |
| MTG | $41.35 | $27.31 | 51.41% | ✅ Strong Buy |
| MTH | $78.40 | $75.91 | 3.28% | 👍 Buy |
| MTN | $131.27 | $138.64 | Avoid | ❌ Avoid |
| MTRN | $71.63 | $151.37 | Above Fair Value | ⛔ Overvalued |
| MTSI | $91.87 | $235.87 | Avoid | ❌ Avoid |
| MTUS | $10.71 | $21.30 | Above Fair Value | ⛔ Overvalued |
| MTW | $7.96 | $15.03 | Avoid | ❌ Avoid |
| MTX | $77.12 | $72.77 | Avoid | ❌ Avoid |
| MTZ | $99.98 | $259.16 | Above Fair Value | ⛔ Overvalued |
| MU | $555.56 | $394.69 | 40.76% | ✅ Strong Buy |
| MUFG | $13.13 | $19.14 | Above Fair Value | ⛔ Overvalued |
| MUSA | $383.30 | $377.89 | 1.43% | 👍 Buy |
| MVBF | $18.60 | $28.90 | Above Fair Value | ⛔ Overvalued |
| MVO | $20.33 | $1.41 | 1,341.84% | ✅ Strong Buy |
| MVST | $3.09 | $2.53 | Insufficient EBITDA | ❌ Avoid |
| MWA | $21.15 | $29.18 | Above Fair Value | ⛔ Overvalued |
| MXL | $19.93 | $18.72 | Insufficient EBITDA | ❌ Avoid |
| MYE | $15.83 | $22.17 | Above Fair Value | ⛔ Overvalued |
| MYGN | $0.46 | $5.12 | Insufficient EBITDA | ❌ Avoid |
| MYRG | $110.24 | $268.76 | Above Fair Value | ⛔ Overvalued |
| MZTI | $117.34 | $154.74 | Above Fair Value | ⛔ Overvalued |
| NABL | $8.33 | $5.61 | 48.48% | ✅ Strong Buy |
| NAGE | $4.42 | $5.20 | Above Fair Value | ⛔ Overvalued |
| NAT | $2.13 | $4.26 | Avoid | ❌ Avoid |
| NATH | $94.45 | $101.20 | Above Fair Value | ⚠️ See Analysis |
| NATL | $78.86 | $40.17 | 96.32% | ✅ Strong Buy |
| NATR | $12.70 | $26.33 | Above Fair Value | ⛔ Overvalued |
| NAVI | $11.04 | $10.05 | 9.85% | 👍 Buy |
| NBBK | $40.25 | $22.37 | 79.93% | ✅ Strong Buy |
| NBHC | $45.04 | $41.75 | 7.88% | 👍 Buy |
| NBIS | $15.18 | $86.10 | Insufficient EBITDA | ❌ Avoid |
| NBIX | $133.05 | $141.20 | Above Fair Value | ⚠️ See Analysis |
| NBN | $169.01 | $125.34 | 34.84% | ✅ Strong Buy |
| NBR | $116.00 | $69.78 | 66.24% | ✅ Strong Buy |
| NBTB | $67.75 | $46.65 | 45.23% | ✅ Strong Buy |
| NBTX | $15.95 | $20.85 | Insufficient EBITDA | ❌ Avoid |
| NC | $41.64 | $54.20 | Above Fair Value | ⛔ Overvalued |
| NCDL | $13.61 | $13.49 | 0.89% | 👍 Buy |
| NCI | $3.40 | $1.15 | 195.65% | ✅ Strong Buy |
| NCLH | $38.85 | $23.32 | Avoid | ❌ Avoid |
| NCMI | $1.25 | $3.58 | Above Fair Value | ⛔ Overvalued |
| NCNO | $18.92 | $18.15 | Avoid | ❌ Avoid |
| NCSM | $56.55 | $38.67 | 46.24% | ✅ Strong Buy |
| NDAQ | $58.68 | $84.83 | Above Fair Value | ⛔ Overvalued |
| NDSN | $201.34 | $290.18 | Above Fair Value | ⛔ Overvalued |
| NE | $12.65 | $39.20 | Above Fair Value | ⛔ Overvalued |
| NECB | $48.26 | $24.75 | 94.99% | ✅ Strong Buy |
| NEE | $56.39 | $89.47 | Avoid | ❌ Avoid |
| NEM | $89.58 | $115.32 | Above Fair Value | ⛔ Overvalued |
| NEN | $70.35 | $63.75 | Avoid | ❌ Avoid |
| NEO | $2.10 | $11.42 | Insufficient EBITDA | ❌ Avoid |
| NEOG | $5.13 | $10.80 | Insufficient EBITDA | ❌ Avoid |
| NET | $20.63 | $173.21 | Avoid | ❌ Avoid |
| NEU | $650.25 | $723.90 | Above Fair Value | ⚠️ See Analysis |
| NEWT | $28.52 | $13.94 | 104.59% | ✅ Strong Buy |
| NFBK | $17.50 | $13.87 | 26.17% | ✅ Strong Buy |
| NFG | $95.85 | $85.77 | 11.75% | 👍 Buy |
| NFLX | $60.02 | $82.20 | Above Fair Value | ⛔ Overvalued |
| NGD | $15.11 | $10.57 | 42.95% | ✅ Strong Buy |
| NGG | $93.24 | $88.06 | 5.88% | 👍 Buy |
| NGS | $25.23 | $36.48 | Above Fair Value | ⛔ Overvalued |
| NGVC | $30.17 | $26.43 | 14.15% | 👍 Buy |
| NGVT | $62.86 | $72.69 | Insufficient EBITDA | ❌ Avoid |
| NHC | $81.41 | $161.57 | Above Fair Value | ⛔ Overvalued |
| NHI | $41.97 | $84.07 | Above Fair Value | ⛔ Overvalued |
| NI | $26.31 | $44.10 | Avoid | ❌ Avoid |
| NIC | $196.93 | $152.25 | 29.35% | ✅ Strong Buy |
| NJR | $47.01 | $52.42 | Avoid | ❌ Avoid |
| NKE | $35.21 | $63.92 | Above Fair Value | ⛔ Overvalued |
| NKSH | $29.36 | $38.94 | Above Fair Value | ⛔ Overvalued |
| NL | $6.94 | $6.19 | 12.12% | 👍 Buy |
| NLY | $36.96 | $22.85 | 61.75% | ✅ Strong Buy |
| NMFC | $18.03 | $7.96 | 126.51% | ✅ Strong Buy |
| NMIH | $63.67 | $41.05 | 55.10% | ✅ Strong Buy |
| NMM | $133.41 | $60.22 | 121.54% | ✅ Strong Buy |
| NMR | $9.90 | $9.12 | Avoid | ❌ Avoid |
| NMRK | $22.65 | $16.85 | Avoid | ❌ Avoid |
| NNBR | $1.95 | $1.63 | Avoid | ❌ Avoid |
| NNI | $121.13 | $132.12 | Avoid | ❌ Avoid |
| NNN | $30.28 | $42.91 | Above Fair Value | ⛔ Overvalued |
| NOC | $427.31 | $709.11 | Above Fair Value | ⛔ Overvalued |
| NODK | $1.51 | $13.57 | Above Fair Value | ⛔ Overvalued |
| NOG | $52.81 | $25.64 | 105.97% | ✅ Strong Buy |
| NOK | $4.25 | $7.07 | Above Fair Value | ⛔ Overvalued |
| NOMD | $24.99 | $12.90 | Avoid | ❌ Avoid |
| NOV | $14.10 | $18.91 | Above Fair Value | ⛔ Overvalued |
| NOVT | $60.31 | $141.47 | Above Fair Value | ⛔ Overvalued |
| NOW | $87.33 | $100.74 | Above Fair Value | ⛔ Overvalued |
| NPB | $32.64 | $17.23 | Insufficient EBITDA | ✅ Strong Buy |
| NPKI | $6.19 | $14.11 | Above Fair Value | ⛔ Overvalued |
| NPO | $108.53 | $267.57 | Above Fair Value | ⛔ Overvalued |
| NRC | $15.81 | $15.94 | Above Fair Value | ⚠️ See Analysis |
| NRDS | $31.59 | $10.54 | 199.72% | ✅ Strong Buy |
| NREF | $12.90 | $14.85 | Above Fair Value | ⛔ Overvalued |
| NRG | $119.05 | $153.32 | Above Fair Value | ⛔ Overvalued |
| NRIM | $40.06 | $25.85 | 54.97% | ✅ Strong Buy |
| NRP | $82.30 | $120.39 | Above Fair Value | ⛔ Overvalued |
| NRT | $5.20 | $9.26 | Above Fair Value | ⛔ Overvalued |
| NRXP | $1.94 | $1.91 | Insufficient EBITDA | ❌ Avoid |
| NSA | $8.81 | $32.68 | Above Fair Value | ⛔ Overvalued |
| NSC | $185.06 | $306.48 | Above Fair Value | ⛔ Overvalued |
| NSIT | $122.43 | $89.14 | 37.35% | ✅ Strong Buy |
| NSP | $31.46 | $38.92 | Above Fair Value | ⛔ Overvalued |
| NSSC | $23.22 | $43.65 | Above Fair Value | ⛔ Overvalued |
| NTAP | $133.11 | $103.34 | 28.81% | ✅ Strong Buy |
| NTB | $85.11 | $53.08 | 60.34% | ✅ Strong Buy |
| NTCT | $42.02 | $27.67 | Insufficient EBITDA | ✅ Strong Buy |
| NTGR | $4.48 | $20.50 | Insufficient EBITDA | ❌ Avoid |
| NTIC | $5.21 | $9.09 | Above Fair Value | ⛔ Overvalued |
| NTNX | $43.56 | $40.26 | 8.20% | 👍 Buy |
| NTR | $71.51 | $68.61 | 4.23% | 👍 Buy |
| NTRS | $153.97 | $152.15 | 1.20% | 👍 Buy |
| NTST | $4.78 | $19.33 | Above Fair Value | ⛔ Overvalued |
| NU | $15.87 | $17.40 | Above Fair Value | ⚠️ See Analysis |
| NUE | $143.08 | $192.84 | Above Fair Value | ⛔ Overvalued |
| NUS | $20.76 | $10.81 | Insufficient EBITDA | ✅ Strong Buy |
| NUVB | $8.22 | $5.70 | Insufficient EBITDA | ❌ Avoid |
| NVAX | $29.64 | $8.25 | Insufficient EBITDA | ✅ Strong Buy |
| NVDA | $183.27 | $185.41 | Above Fair Value | ⚠️ See Analysis |
| NVEC | $47.17 | $64.70 | Above Fair Value | ⛔ Overvalued |
| NVGS | $19.94 | $18.23 | 9.38% | 👍 Buy |
| NVMI | $145.96 | $459.95 | Above Fair Value | ⛔ Overvalued |
| NVR | $7,193.45 | $8,009.84 | Above Fair Value | ⚠️ See Analysis |
| NVS | $145.65 | $156.42 | Above Fair Value | ⚠️ See Analysis |
| NVST | $19.68 | $29.10 | Above Fair Value | ⛔ Overvalued |
| NVT | $62.83 | $112.64 | Above Fair Value | ⛔ Overvalued |
| NWBI | $19.39 | $13.34 | 45.35% | ✅ Strong Buy |
| NWE | $50.28 | $68.18 | Avoid | ❌ Avoid |
| NWFL | $53.80 | $31.89 | 68.70% | ✅ Strong Buy |
| NWL | $7.14 | $4.63 | Avoid | ❌ Avoid |
| NWN | $40.59 | $48.07 | Avoid | ❌ Avoid |
| NWPX | $39.95 | $74.32 | Above Fair Value | ⛔ Overvalued |
| NWS | $18.67 | $25.65 | Above Fair Value | ⛔ Overvalued |
| NWSA | $18.60 | $22.50 | Above Fair Value | ⛔ Overvalued |
| NX | $27.73 | $21.29 | Insufficient EBITDA | ❌ Avoid |
| NXPI | $242.63 | $224.32 | 8.16% | 👍 Buy |
| NXST | $299.44 | $221.27 | 35.33% | ✅ Strong Buy |
| NXT | $78.77 | $121.37 | Above Fair Value | ⛔ Overvalued |
| NYT | $42.26 | $68.11 | Above Fair Value | ⛔ Overvalued |
| O | $23.46 | $63.23 | Above Fair Value | ⛔ Overvalued |
| OBDC | $19.16 | $11.46 | 67.19% | ✅ Strong Buy |
| OBK | $48.74 | $45.63 | 6.82% | 👍 Buy |
| OBT | $44.13 | $35.21 | 25.33% | ✅ Strong Buy |
| OC | $148.58 | $135.74 | Avoid | ❌ Avoid |
| OCFC | $30.75 | $19.78 | 55.46% | ✅ Strong Buy |
| OCSL | $19.81 | $12.14 | 63.18% | ✅ Strong Buy |
| ODC | $45.66 | $64.31 | Above Fair Value | ⛔ Overvalued |
| ODD | $53.52 | $30.07 | 77.98% | ✅ Strong Buy |
| ODFL | $71.87 | $202.47 | Above Fair Value | ⛔ Overvalued |
| ODP | $36.18 | $28.00 | 29.21% | ✅ Strong Buy |
| OEC | $9.35 | $7.05 | Avoid | ❌ Avoid |
| OFG | $60.39 | $40.94 | 47.51% | ✅ Strong Buy |
| OFIX | $10.59 | $12.80 | Insufficient EBITDA | ❌ Avoid |
| OFLX | $30.97 | $37.32 | Above Fair Value | ⛔ Overvalued |
| OFS | $12.25 | $4.46 | 174.66% | ✅ Strong Buy |
| OGE | $32.69 | $43.96 | Avoid | ❌ Avoid |
| OGN | $94.69 | $8.21 | Avoid | ❌ Avoid |
| OGS | $65.17 | $82.49 | Avoid | ❌ Avoid |
| OHI | $27.42 | $45.28 | Above Fair Value | ⛔ Overvalued |
| OI | $19.90 | $16.63 | Avoid | ❌ Avoid |
| OII | $22.88 | $32.19 | Above Fair Value | ⛔ Overvalued |
| OIS | $4.31 | $9.10 | Above Fair Value | ⛔ Overvalued |
| OKE | $86.60 | $81.84 | Avoid | ❌ Avoid |
| OKTA | $84.99 | $86.74 | Above Fair Value | ⚠️ See Analysis |
| OLED | $122.62 | $121.11 | 1.25% | 👍 Buy |
| OLLI | $71.23 | $112.50 | Above Fair Value | ⛔ Overvalued |
| OLN | $6.26 | $24.83 | Avoid | ❌ Avoid |
| OLP | $11.66 | $22.44 | Above Fair Value | ⛔ Overvalued |
| OLPX | $1.47 | $1.50 | Above Fair Value | ⚠️ See Analysis |
| OMAB | $134.08 | $124.48 | 7.71% | 👍 Buy |
| OMC | $97.08 | $69.87 | 38.94% | ✅ Strong Buy |
| OMCL | $27.44 | $37.07 | Above Fair Value | ⛔ Overvalued |
| OMER | $6.78 | $11.23 | Insufficient EBITDA | ❌ Avoid |
| OMF | $71.65 | $61.64 | 16.24% | 👍 Buy |
| ON | $44.35 | $65.20 | Above Fair Value | ⛔ Overvalued |
| ONB | $39.74 | $25.88 | 53.55% | ✅ Strong Buy |
| ONC | $114.39 | $353.92 | Insufficient EBITDA | ⛔ Overvalued |
| ONEW | $10.06 | $13.86 | Insufficient EBITDA | ❌ Avoid |
| ONIT | $160.27 | $42.27 | 279.16% | ✅ Strong Buy |
| ONON | $20.93 | $43.47 | Above Fair Value | ⛔ Overvalued |
| ONTF | $2.36 | $7.89 | Insufficient EBITDA | ❌ Avoid |
| ONTO | $96.83 | $208.50 | Above Fair Value | ⛔ Overvalued |
| OOMA | $22.07 | $11.86 | 86.09% | ✅ Strong Buy |
| OPAL | $24.45 | $2.41 | Avoid | ❌ Avoid |
| OPBK | $27.42 | $14.20 | 93.10% | ✅ Strong Buy |
| OPCH | $25.90 | $34.00 | Above Fair Value | ⛔ Overvalued |
| OPRA | $23.06 | $12.71 | 81.43% | ✅ Strong Buy |
| OPRX | $15.63 | $10.89 | Insufficient EBITDA | ✅ Strong Buy |
| OPY | $136.04 | $92.48 | 47.10% | ✅ Strong Buy |
| OR | $20.79 | $40.03 | Above Fair Value | ⛔ Overvalued |
| ORA | $36.63 | $123.15 | Avoid | ❌ Avoid |
| ORC | $12.99 | $7.61 | 70.70% | ✅ Strong Buy |
| ORCL | $197.79 | $142.82 | 38.49% | ✅ Strong Buy |
| ORGO | $3.02 | $3.77 | Above Fair Value | ⛔ Overvalued |
| ORI | $42.66 | $41.77 | 2.13% | 👍 Buy |
| ORLA | $14.09 | $15.60 | Above Fair Value | ⚠️ See Analysis |
| ORLY | $67.02 | $94.22 | Above Fair Value | ⛔ Overvalued |
| ORMP | $18.82 | $3.41 | Insufficient EBITDA | ✅ Strong Buy |
| ORN | $3.74 | $14.13 | Above Fair Value | ⛔ Overvalued |
| ORRF | $60.12 | $39.48 | 52.28% | ✅ Strong Buy |
| OS | $3.85 | $23.51 | Insufficient EBITDA | ❌ Avoid |
| OSBC | $32.45 | $21.04 | 54.23% | ✅ Strong Buy |
| OSCR | $0.07 | $12.24 | Avoid | ❌ Avoid |
| OSIS | $149.54 | $271.26 | Above Fair Value | ⛔ Overvalued |
| OSK | $148.72 | $171.71 | Above Fair Value | ⛔ Overvalued |
| OSPN | $27.57 | $11.25 | 145.07% | ✅ Strong Buy |
| OSW | $17.64 | $21.27 | Above Fair Value | ⛔ Overvalued |
| OTEX | $72.23 | $25.07 | 188.11% | ✅ Strong Buy |
| OTIS | $97.35 | $89.85 | 8.35% | 👍 Buy |
| OTTR | $83.89 | $87.15 | Above Fair Value | ⚠️ See Analysis |
| OUT | $12.56 | $26.89 | Above Fair Value | ⛔ Overvalued |
| OVBC | $42.58 | $42.76 | Above Fair Value | ⚠️ See Analysis |
| OVLY | $43.14 | $33.62 | 28.32% | ✅ Strong Buy |
| OVV | $54.74 | $46.53 | 17.64% | 👍 Buy |
| OWL | $22.94 | $12.52 | Avoid | ❌ Avoid |
| OXBR | $0.12 | $1.11 | Insufficient EBITDA | ⛔ Overvalued |
| OXM | $34.44 | $40.02 | Above Fair Value | ⛔ Overvalued |
| OXY | $22.90 | $46.31 | Above Fair Value | ⛔ Overvalued |
| OZK | $63.89 | $51.40 | 24.30% | ✅ Strong Buy |
| PAA | $19.25 | $19.40 | Above Fair Value | ⚠️ See Analysis |
| PAAS | $42.59 | $55.21 | Above Fair Value | ⛔ Overvalued |
| PAC | $187.05 | $287.51 | Above Fair Value | ⛔ Overvalued |
| PACS | $33.60 | $38.68 | Above Fair Value | ⛔ Overvalued |
| PAG | $165.11 | $166.68 | Above Fair Value | ⚠️ See Analysis |
| PAGP | $22.08 | $20.71 | 6.62% | 👍 Buy |
| PAHC | $42.44 | $53.07 | Avoid | ❌ Avoid |
| PANL | $6.04 | $8.71 | Above Fair Value | ⛔ Overvalued |
| PANW | $80.35 | $159.32 | Above Fair Value | ⛔ Overvalued |
| PAR | $7.60 | $22.24 | Insufficient EBITDA | ❌ Avoid |
| PARR | $67.58 | $43.30 | 56.07% | ✅ Strong Buy |
| PATH | $13.02 | $12.89 | Insufficient EBITDA | 👍 Buy |
| PATK | $54.84 | $140.85 | Avoid | ❌ Avoid |
| PAX | $17.78 | $14.16 | 25.56% | ✅ Strong Buy |
| PAY | $9.94 | $24.81 | Above Fair Value | ⛔ Overvalued |
| PAYC | $245.05 | $130.97 | 87.10% | ✅ Strong Buy |
| PAYO | $4.82 | $6.33 | Above Fair Value | ⛔ Overvalued |
| PAYS | $5.76 | $3.72 | 54.84% | ✅ Strong Buy |
| PAYX | $118.83 | $98.53 | 20.60% | ✅ Strong Buy |
| PB | $69.01 | $74.51 | Above Fair Value | ⚠️ See Analysis |
| PBA | $36.21 | $42.69 | Above Fair Value | ⛔ Overvalued |
| PBF | $22.54 | $35.51 | Insufficient EBITDA | ❌ Avoid |
| PBH | $71.40 | $66.33 | 7.64% | 👍 Buy |
| PBHC | $17.40 | $12.97 | 34.16% | ✅ Strong Buy |
| PBI | $13.63 | $10.78 | Avoid | ❌ Avoid |
| PBT | $3.89 | $18.42 | Above Fair Value | ⛔ Overvalued |
| PBYI | $8.75 | $6.94 | 26.08% | ✅ Strong Buy |
| PCAR | $66.14 | $127.35 | Above Fair Value | ⛔ Overvalued |
| PCB | $23.16 | $23.57 | Above Fair Value | ⚠️ See Analysis |
| PCG | $22.42 | $16.40 | Avoid | ❌ Avoid |
| PCH | $10.80 | $41.73 | Above Fair Value | ⛔ Overvalued |
| PCOR | $23.57 | $51.29 | Insufficient EBITDA | ❌ Avoid |
| PCRX | $48.50 | $21.00 | 130.95% | ✅ Strong Buy |
| PCTY | $167.79 | $117.85 | 42.38% | ✅ Strong Buy |
| PCYO | $10.14 | $11.15 | Above Fair Value | ⚠️ See Analysis |
| PD | $22.27 | $8.04 | Insufficient EBITDA | ❌ Avoid |
| PDCC | $55.52 | $13.49 | 311.56% | ✅ Strong Buy |
| PDFS | $18.77 | $29.07 | Above Fair Value | ⛔ Overvalued |
| PDLB | $13.53 | $16.95 | Above Fair Value | ⛔ Overvalued |
| PEBK | $44.56 | $38.61 | 15.41% | 👍 Buy |
| PEBO | $52.87 | $34.18 | 54.68% | ✅ Strong Buy |
| PECO | $13.06 | $37.53 | Above Fair Value | ⛔ Overvalued |
| PEG | $60.37 | $80.65 | Avoid | ❌ Avoid |
| PEGA | $42.25 | $40.12 | 5.31% | 👍 Buy |
| PEN | $48.24 | $341.02 | Above Fair Value | ⛔ Overvalued |
| PENG | $35.98 | $18.78 | 91.59% | ✅ Strong Buy |
| PENN | $12.27 | $13.41 | Avoid | ❌ Avoid |
| PEP | $138.27 | $170.49 | Above Fair Value | ⛔ Overvalued |
| PETS | $0.15 | $2.88 | Above Fair Value | ⛔ Overvalued |
| PFBC | $104.90 | $91.19 | 15.03% | 👍 Buy |
| PFE | $48.84 | $27.22 | 79.43% | ✅ Strong Buy |
| PFG | $136.57 | $97.34 | 40.30% | ✅ Strong Buy |
| PFGC | $77.44 | $94.40 | Avoid | ❌ Avoid |
| PFIS | $93.47 | $56.12 | 66.55% | ✅ Strong Buy |
| PFLT | $16.82 | $9.51 | 76.87% | ✅ Strong Buy |
| PFS | $33.93 | $23.79 | 42.62% | ✅ Strong Buy |
| PFSI | $207.28 | $95.60 | 116.82% | ✅ Strong Buy |
| PG | $127.70 | $159.17 | Above Fair Value | ⛔ Overvalued |
| PGC | $41.96 | $35.23 | 19.10% | ✅ Strong Buy |
| PGNY | $31.48 | $21.95 | 43.42% | ✅ Strong Buy |
| PGR | $266.21 | $202.29 | 31.60% | ✅ Strong Buy |
| PH | $496.98 | $976.49 | Above Fair Value | ⛔ Overvalued |
| PHG | $19.55 | $29.46 | Above Fair Value | ⛔ Overvalued |
| PHIN | $69.33 | $73.69 | Above Fair Value | ⚠️ See Analysis |
| PHM | $132.69 | $135.09 | Above Fair Value | ⚠️ See Analysis |
| PHR | $22.62 | $12.20 | Insufficient EBITDA | ✅ Strong Buy |
| PI | $35.73 | $116.04 | Avoid | ❌ Avoid |
| PII | $21.05 | $69.33 | Avoid | ❌ Avoid |
| PINE | $3.76 | $19.64 | Above Fair Value | ⛔ Overvalued |
| PINS | $39.05 | $19.60 | 99.23% | ✅ Strong Buy |
| PIPR | $242.81 | $364.38 | Above Fair Value | ⛔ Overvalued |
| PJT | $166.62 | $162.50 | 2.54% | 👍 Buy |
| PK | $8.37 | $11.53 | Above Fair Value | ⛔ Overvalued |
| PKBK | $42.23 | $28.71 | 47.09% | ✅ Strong Buy |
| PKE | $6.06 | $24.32 | Above Fair Value | ⛔ Overvalued |
| PKG | $166.73 | $238.86 | Above Fair Value | ⛔ Overvalued |
| PKOH | $32.76 | $24.94 | Avoid | ❌ Avoid |
| PKX | $52.46 | $63.27 | Above Fair Value | ⛔ Overvalued |
| PLAB | $31.33 | $37.24 | Above Fair Value | ⛔ Overvalued |
| PLAY | $10.02 | $19.27 | Avoid | ❌ Avoid |
| PLBC | $89.67 | $53.41 | 67.89% | ✅ Strong Buy |
| PLD | $41.69 | $136.95 | Above Fair Value | ⛔ Overvalued |
| PLMR | $161.06 | $127.62 | 26.20% | ✅ Strong Buy |
| PLNT | $65.79 | $91.61 | Above Fair Value | ⛔ Overvalued |
| PLOW | $31.25 | $40.37 | Above Fair Value | ⛔ Overvalued |
| PLPC | $115.21 | $280.41 | Above Fair Value | ⛔ Overvalued |
| PLTK | $14.37 | $3.57 | 302.52% | ✅ Strong Buy |
| PLTR | $16.46 | $135.90 | Above Fair Value | ⛔ Overvalued |
| PLUS | $78.09 | $86.82 | Above Fair Value | ⚠️ See Analysis |
| PLX | $1.56 | $2.89 | Above Fair Value | ⛔ Overvalued |
| PLXS | $104.19 | $206.22 | Above Fair Value | ⛔ Overvalued |
| PLYM | $34.25 | $21.98 | 55.82% | ✅ Strong Buy |
| PM | $95.01 | $182.81 | Above Fair Value | ⛔ Overvalued |
| PMT | $28.29 | $12.22 | 131.51% | ✅ Strong Buy |
| PNC | $230.76 | $242.48 | Above Fair Value | ⚠️ See Analysis |
| PNFP | $179.02 | $102.26 | 75.06% | ✅ Strong Buy |
| PNNT | $7.50 | $5.68 | 32.04% | ✅ Strong Buy |
| PNR | $72.13 | $97.35 | Above Fair Value | ⛔ Overvalued |
| PNTG | $17.48 | $30.35 | Above Fair Value | ⛔ Overvalued |
| PNW | $64.57 | $93.52 | Avoid | ❌ Avoid |
| PODD | $88.39 | $241.93 | Above Fair Value | ⛔ Overvalued |
| POOL | $230.08 | $266.16 | Above Fair Value | ⛔ Overvalued |
| POR | $43.05 | $50.65 | Avoid | ❌ Avoid |
| POST | $106.81 | $114.61 | Avoid | ❌ Avoid |
| POWI | $32.47 | $47.34 | Above Fair Value | ⛔ Overvalued |
| POWL | $212.22 | $584.22 | Above Fair Value | ⛔ Overvalued |
| PPC | $62.60 | $43.37 | 44.34% | ✅ Strong Buy |
| PPG | $125.15 | $126.51 | Above Fair Value | ⚠️ See Analysis |
| PPL | $26.82 | $35.92 | Avoid | ❌ Avoid |
| PR | $18.70 | $16.93 | 10.45% | 👍 Buy |
| PRA | $14.20 | $24.35 | Above Fair Value | ⛔ Overvalued |
| PRAA | $33.20 | $11.45 | 189.96% | ✅ Strong Buy |
| PRCH | $3.80 | $7.25 | Above Fair Value | ⛔ Overvalued |
| PRDO | $33.61 | $31.71 | 5.99% | 👍 Buy |
| PRG | $46.80 | $34.60 | 35.26% | ✅ Strong Buy |
| PRGO | $33.71 | $14.64 | Avoid | ❌ Avoid |
| PRI | $367.67 | $275.87 | 33.28% | ✅ Strong Buy |
| PRIM | $76.71 | $160.54 | Above Fair Value | ⛔ Overvalued |
| PRK | $173.41 | $176.52 | Above Fair Value | ⚠️ See Analysis |
| PRKS | $55.49 | $37.03 | Avoid | ❌ Avoid |
| PRLB | $26.66 | $67.17 | Above Fair Value | ⛔ Overvalued |
| PRM | $18.48 | $26.94 | Above Fair Value | ⛔ Overvalued |
| PRMB | $30.05 | $19.63 | Avoid | ❌ Avoid |
| PRO | $17.32 | $23.25 | Insufficient EBITDA | ❌ Avoid |
| PROV | $17.62 | $16.26 | 8.36% | 👍 Buy |
| PRSU | $16.46 | $37.49 | Avoid | ❌ Avoid |
| PRT | $3.36 | $3.54 | Above Fair Value | ⚠️ See Analysis |
| PRTA | $14.20 | $8.91 | Insufficient EBITDA | ❌ Avoid |
| PRTH | $12.59 | $5.55 | Avoid | ❌ Avoid |
| PRU | $194.08 | $102.80 | 88.79% | ✅ Strong Buy |
| PRVA | $18.58 | $21.99 | Above Fair Value | ⛔ Overvalued |
| PSA | $227.82 | $287.00 | Above Fair Value | ⛔ Overvalued |
| PSBD | $20.20 | $11.45 | 76.42% | ✅ Strong Buy |
| PSEC | $3.39 | $2.64 | Insufficient EBITDA | ✅ Strong Buy |
| PSFE | $35.93 | $7.11 | Avoid | ❌ Avoid |
| PSIX | $76.41 | $80.97 | Above Fair Value | ⚠️ See Analysis |
| PSMT | $90.62 | $156.83 | Above Fair Value | ⛔ Overvalued |
| PSN | $47.96 | $69.44 | Above Fair Value | ⛔ Overvalued |
| PSO | $12.44 | $12.26 | 1.47% | 👍 Buy |
| PSTG | $41.40 | $70.99 | Above Fair Value | ⛔ Overvalued |
| PSTL | $10.69 | $19.21 | Above Fair Value | ⛔ Overvalued |
| PSX | $113.69 | $157.80 | Above Fair Value | ⛔ Overvalued |
| PTC | $166.77 | $155.72 | 7.10% | 👍 Buy |
| PTCT | $130.28 | $74.68 | Insufficient EBITDA | ✅ Strong Buy |
| PTGX | $7.91 | $84.49 | Above Fair Value | ⛔ Overvalued |
| PTLO | $3.03 | $5.96 | Avoid | ❌ Avoid |
| PTON | $2.78 | $4.63 | Avoid | ❌ Avoid |
| PUBM | $3.73 | $6.49 | Above Fair Value | ⛔ Overvalued |
| PUK | $29.24 | $32.63 | Above Fair Value | ⚠️ See Analysis |
| PVH | $148.31 | $66.12 | Avoid | ❌ Avoid |
| PVL | $0.94 | $1.79 | Above Fair Value | ⛔ Overvalued |
| PWP | $15.66 | $23.26 | Insufficient EBITDA | ⛔ Overvalued |
| PWR | $159.69 | $508.11 | Above Fair Value | ⛔ Overvalued |
| PX | $21.01 | $10.20 | 105.98% | ✅ Strong Buy |
| PYPL | $102.06 | $40.42 | 152.50% | ✅ Strong Buy |
| PZZA | $34.57 | $34.68 | Avoid | ❌ Avoid |
| QCOM | $221.87 | $137.34 | 61.55% | ✅ Strong Buy |
| QCRH | $95.11 | $95.40 | Above Fair Value | ⚠️ See Analysis |
| QDEL | $35.46 | $29.10 | Insufficient EBITDA | ❌ Avoid |
| QGEN | $40.20 | $50.95 | Above Fair Value | ⛔ Overvalued |
| QLYS | $181.42 | $110.80 | 63.74% | ✅ Strong Buy |
| QNST | $21.52 | $12.24 | 75.82% | ✅ Strong Buy |
| QRVO | $113.14 | $83.72 | 35.14% | ✅ Strong Buy |
| QSR | $73.13 | $70.90 | Avoid | ❌ Avoid |
| QTWO | $46.51 | $57.02 | Above Fair Value | ⛔ Overvalued |
| QUAD | $13.38 | $6.32 | 111.71% | ✅ Strong Buy |
| QXO | $6.56 | $23.01 | Avoid | ❌ Avoid |
| R | $195.52 | $217.50 | Above Fair Value | ⚠️ See Analysis |
| RACE | $204.56 | $333.79 | Above Fair Value | ⛔ Overvalued |
| RAIL | $8.95 | $12.44 | Above Fair Value | ⛔ Overvalued |
| RAMP | $47.22 | $23.21 | 103.45% | ✅ Strong Buy |
| RAY | $5.99 | $4.36 | 37.39% | ✅ Strong Buy |
| RBB | $18.36 | $22.06 | Above Fair Value | ⛔ Overvalued |
| RBBN | $3.88 | $1.96 | Avoid | ❌ Avoid |
| RBC | $200.33 | $544.02 | Above Fair Value | ⛔ Overvalued |
| RBCAA | $100.76 | $74.15 | 35.89% | ✅ Strong Buy |
| RBRK | $1.61 | $51.07 | Insufficient EBITDA | ❌ Avoid |
| RCI | $80.14 | $36.07 | 122.18% | ✅ Strong Buy |
| RCKY | $33.40 | $33.34 | 0.18% | 👍 Buy |
| RCL | $270.09 | $348.00 | Above Fair Value | ⛔ Overvalued |
| RDDT | $83.10 | $139.83 | Insufficient EBITDA | ⛔ Overvalued |
| RDN | $49.82 | $33.56 | 48.45% | ✅ Strong Buy |
| RDNT | $9.56 | $69.24 | Above Fair Value | ⛔ Overvalued |
| RDVT | $25.43 | $40.78 | Above Fair Value | ⛔ Overvalued |
| REAL | $0.43 | $13.09 | Insufficient EBITDA | ❌ Avoid |
| RECT | $1.96 | $1.54 | 27.27% | ✅ Strong Buy |
| REFI | $12.04 | $12.10 | Above Fair Value | ⚠️ See Analysis |
| REG | $40.32 | $75.22 | Above Fair Value | ⛔ Overvalued |
| REGN | $692.98 | $785.51 | Above Fair Value | ⚠️ See Analysis |
| REI | $2.94 | $1.24 | 137.10% | ✅ Strong Buy |
| RELL | $6.36 | $11.36 | Above Fair Value | ⛔ Overvalued |
| RELY | $21.01 | $13.01 | Insufficient EBITDA | ✅ Strong Buy |
| REPX | $52.41 | $28.51 | 83.83% | ✅ Strong Buy |
| RES | $3.66 | $5.77 | Above Fair Value | ⛔ Overvalued |
| REVG | $53.31 | $63.90 | Above Fair Value | ⛔ Overvalued |
| REX | $26.29 | $35.54 | Above Fair Value | ⛔ Overvalued |
| REXR | $18.03 | $38.97 | Above Fair Value | ⛔ Overvalued |
| REYN | $25.99 | $22.77 | 14.14% | 👍 Buy |
| REZI | $31.27 | $36.38 | Avoid | ❌ Avoid |
| RF | $24.57 | $30.93 | Above Fair Value | ⛔ Overvalued |
| RGA | $215.63 | $225.36 | Above Fair Value | ⚠️ See Analysis |
| RGCO | $18.41 | $21.85 | Avoid | ❌ Avoid |
| RGEN | $30.12 | $142.18 | Above Fair Value | ⛔ Overvalued |
| RGLD | $155.43 | $265.77 | Above Fair Value | ⛔ Overvalued |
| RGP | $2.61 | $4.37 | Avoid | ❌ Avoid |
| RGR | $16.90 | $38.33 | Above Fair Value | ⛔ Overvalued |
| RH | $169.63 | $211.16 | Avoid | ❌ Avoid |
| RHI | $26.21 | $31.40 | Above Fair Value | ⛔ Overvalued |
| RHP | $63.33 | $97.96 | Above Fair Value | ⛔ Overvalued |
| RICK | $27.30 | $24.30 | Avoid | ❌ Avoid |
| RIG | $1.47 | $5.39 | Avoid | ❌ Avoid |
| RIGL | $75.14 | $34.15 | 120.03% | ✅ Strong Buy |
| RIO | $104.01 | $93.41 | 11.35% | 👍 Buy |
| RIOT | $1.23 | $14.45 | Above Fair Value | ⛔ Overvalued |
| RITM | $27.43 | $10.73 | 155.64% | ✅ Strong Buy |
| RJF | $182.29 | $172.14 | 5.90% | 👍 Buy |
| RKT | $8.43 | $18.88 | Above Fair Value | ⛔ Overvalued |
| RL | $240.40 | $342.89 | Above Fair Value | ⛔ Overvalued |
| RLGT | $4.32 | $7.15 | Above Fair Value | ⛔ Overvalued |
| RLI | $47.78 | $61.72 | Above Fair Value | ⛔ Overvalued |
| RLJ | $0.65 | $7.97 | Above Fair Value | ⛔ Overvalued |
| RM | $46.24 | $35.55 | 30.07% | ✅ Strong Buy |
| RMAX | $18.32 | $7.40 | Avoid | ❌ Avoid |
| RMBI | $16.05 | $14.31 | 12.16% | 👍 Buy |
| RMBS | $50.12 | $107.10 | Above Fair Value | ⛔ Overvalued |
| RMD | $212.45 | $271.63 | Above Fair Value | ⛔ Overvalued |
| RMNI | $5.31 | $3.29 | Insufficient EBITDA | ✅ Strong Buy |
| RMR | $12.86 | $17.60 | Above Fair Value | ⛔ Overvalued |
| RNG | $74.30 | $27.03 | 174.88% | ✅ Strong Buy |
| RNR | $562.71 | $300.56 | 87.22% | ✅ Strong Buy |
| RNST | $56.63 | $41.80 | 35.48% | ✅ Strong Buy |
| RNW | $363.68 | $5.20 | Avoid | ❌ Avoid |
| ROAD | $49.05 | $127.05 | Avoid | ❌ Avoid |
| ROCK | $62.69 | $53.91 | 16.29% | 👍 Buy |
| ROG | $37.29 | $105.93 | Above Fair Value | ⛔ Overvalued |
| ROK | $254.85 | $415.02 | Above Fair Value | ⛔ Overvalued |
| ROKU | $9.61 | $85.85 | Above Fair Value | ⛔ Overvalued |
| ROL | $24.82 | $64.84 | Above Fair Value | ⛔ Overvalued |
| ROOT | $51.04 | $62.08 | Above Fair Value | ⛔ Overvalued |
| ROP | $368.86 | $362.42 | 1.78% | 👍 Buy |
| ROST | $124.36 | $190.74 | Above Fair Value | ⛔ Overvalued |
| RPAY | $17.42 | $3.38 | 415.38% | ✅ Strong Buy |
| RPD | $39.42 | $10.81 | Avoid | ❌ Avoid |
| RPM | $83.66 | $116.94 | Above Fair Value | ⛔ Overvalued |
| RPRX | $76.27 | $44.65 | Avoid | ❌ Avoid |
| RPT | $8.44 | $15.63 | Insufficient EBITDA | ⛔ Overvalued |
| RRBI | $101.86 | $91.04 | 11.88% | 👍 Buy |
| RRC | $53.66 | $36.57 | 46.73% | ✅ Strong Buy |
| RRR | $39.44 | $65.45 | Avoid | ❌ Avoid |
| RRX | $124.27 | $211.80 | Avoid | ❌ Avoid |
| RS | $217.96 | $353.27 | Above Fair Value | ⛔ Overvalued |
| RSG | $117.07 | $219.94 | Above Fair Value | ⛔ Overvalued |
| RSI | $11.62 | $17.67 | Above Fair Value | ⛔ Overvalued |
| RTO | $30.17 | $32.16 | Above Fair Value | ⚠️ See Analysis |
| RTX | $91.79 | $198.66 | Above Fair Value | ⛔ Overvalued |
| RUN | $14.05 | $19.93 | Insufficient EBITDA | ❌ Avoid |
| RUSHA | $40.87 | $72.64 | Above Fair Value | ⛔ Overvalued |
| RUSHB | $38.87 | $66.53 | Above Fair Value | ⛔ Overvalued |
| RVLV | $17.98 | $26.92 | Above Fair Value | ⛔ Overvalued |
| RVSB | $3.87 | $5.41 | Above Fair Value | ⛔ Overvalued |
| RVTY | $74.73 | $101.59 | Above Fair Value | ⛔ Overvalued |
| RWAY | $20.81 | $8.85 | 135.14% | ✅ Strong Buy |
| RWT | $11.81 | $5.66 | 108.66% | ✅ Strong Buy |
| RXO | $1.45 | $16.90 | Avoid | ❌ Avoid |
| RY | $122.01 | $170.40 | Above Fair Value | ⛔ Overvalued |
| RYAAY | $71.52 | $68.61 | 4.24% | 👍 Buy |
| RYAM | $3.84 | $8.06 | Avoid | ❌ Avoid |
| RYAN | $44.19 | $47.52 | Above Fair Value | ⚠️ See Analysis |
| RYI | $16.90 | $29.94 | Avoid | ❌ Avoid |
| RYN | $7.41 | $22.46 | Above Fair Value | ⛔ Overvalued |
| SA | $0.67 | $30.00 | Insufficient EBITDA | ❌ Avoid |
| SABR | $3.36 | $1.19 | Avoid | ❌ Avoid |
| SAFE | $24.45 | $15.07 | 62.24% | ✅ Strong Buy |
| SAFT | $59.81 | $80.22 | Above Fair Value | ⛔ Overvalued |
| SAH | $92.55 | $62.46 | Avoid | ❌ Avoid |
| SAIA | $134.35 | $415.46 | Above Fair Value | ⛔ Overvalued |
| SAIC | $181.18 | $98.36 | Avoid | ❌ Avoid |
| SAIL | $5.05 | $14.71 | Above Fair Value | ⛔ Overvalued |
| SAM | $171.58 | $246.76 | Above Fair Value | ⛔ Overvalued |
| SAMG | $15.96 | $14.90 | 7.11% | 👍 Buy |
| SANM | $136.32 | $149.79 | Above Fair Value | ⚠️ See Analysis |
| SAP | $150.60 | $203.34 | Above Fair Value | ⛔ Overvalued |
| SAR | $30.77 | $23.47 | 31.10% | ✅ Strong Buy |
| SARO | $20.70 | $30.57 | Above Fair Value | ⛔ Overvalued |
| SB | $6.62 | $5.58 | 18.64% | ✅ Strong Buy |
| SBAC | $212.41 | $180.74 | Avoid | ❌ Avoid |
| SBCF | $46.44 | $35.09 | 32.35% | ✅ Strong Buy |
| SBET | $58.46 | $7.03 | Insufficient EBITDA | ❌ Avoid |
| SBFG | $32.19 | $22.12 | 45.52% | ✅ Strong Buy |
| SBGI | $15.51 | $13.69 | Avoid | ❌ Avoid |
| SBH | $32.67 | $16.16 | 102.17% | ✅ Strong Buy |
| SBLK | $27.72 | $22.72 | 22.01% | ✅ Strong Buy |
| SBR | $49.79 | $69.55 | Above Fair Value | ⛔ Overvalued |
| SBRA | $9.15 | $19.03 | Above Fair Value | ⛔ Overvalued |
| SBS | $24.62 | $27.59 | Above Fair Value | ⚠️ See Analysis |
| SBSI | $32.34 | $33.55 | Above Fair Value | ⚠️ See Analysis |
| SBUX | $60.39 | $99.45 | Above Fair Value | ⛔ Overvalued |
| SCCO | $104.15 | $200.04 | Above Fair Value | ⛔ Overvalued |
| SCHL | $24.25 | $34.11 | Above Fair Value | ⛔ Overvalued |
| SCHW | $121.15 | $105.08 | 15.29% | 👍 Buy |
| SCI | $64.02 | $85.11 | Avoid | ❌ Avoid |
| SCL | $37.62 | $62.73 | Above Fair Value | ⛔ Overvalued |
| SCM | $16.50 | $11.82 | 39.59% | ✅ Strong Buy |
| SCS | $14.62 | $16.14 | Above Fair Value | ⚠️ See Analysis |
| SCSC | $51.93 | $38.39 | 35.27% | ✅ Strong Buy |
| SCVL | $22.22 | $20.55 | 8.13% | 👍 Buy |
| SD | $20.82 | $16.81 | 23.85% | ✅ Strong Buy |
| SDA | $3.83 | $1.89 | Insufficient EBITDA | ❌ Avoid |
| SDRL | $11.45 | $39.90 | Above Fair Value | ⛔ Overvalued |
| SE | $85.99 | $108.54 | Above Fair Value | ⛔ Overvalued |
| SEB | $5,436.27 | $5,434.73 | 0.03% | 👍 Buy |
| SEDG | $4.92 | $35.92 | Insufficient EBITDA | ❌ Avoid |
| SEE | $46.51 | $41.82 | Avoid | ❌ Avoid |
| SEI | $17.34 | $51.58 | Above Fair Value | ⛔ Overvalued |
| SEIC | $110.39 | $84.45 | 30.72% | ✅ Strong Buy |
| SELF | $3.94 | $5.07 | Above Fair Value | ⛔ Overvalued |
| SEM | $16.85 | $15.69 | Avoid | ❌ Avoid |
| SEMR | $6.69 | $11.81 | Above Fair Value | ⛔ Overvalued |
| SENEA | $109.26 | $119.48 | Above Fair Value | ⚠️ See Analysis |
| SEVN | $8.58 | $8.93 | Above Fair Value | ⚠️ See Analysis |
| SEZL | $94.13 | $67.71 | 39.02% | ✅ Strong Buy |
| SF | $145.11 | $130.61 | 11.10% | 👍 Buy |
| SFBC | $41.08 | $44.15 | Above Fair Value | ⚠️ See Analysis |
| SFBS | $106.84 | $85.68 | 24.70% | ✅ Strong Buy |
| SFD | $29.64 | $24.47 | 21.13% | ✅ Strong Buy |
| SFL | $1.29 | $9.15 | Avoid | ❌ Avoid |
| SFM | $88.51 | $67.32 | 31.48% | ✅ Strong Buy |
| SFNC | $28.47 | $21.81 | Insufficient EBITDA | ✅ Strong Buy |
| SFST | $76.40 | $59.40 | 28.62% | ✅ Strong Buy |
| SGA | $3.38 | $11.32 | Above Fair Value | ⛔ Overvalued |
| SGC | $7.70 | $10.33 | Avoid | ❌ Avoid |
| SGHC | $13.57 | $9.11 | 48.96% | ✅ Strong Buy |
| SGI | $58.10 | $96.32 | Avoid | ❌ Avoid |
| SGML | $7.35 | $5.88 | Avoid | ❌ Avoid |
| SGRY | $11.02 | $13.56 | Avoid | ❌ Avoid |
| SGU | $20.87 | $13.17 | 58.47% | ✅ Strong Buy |
| SHAK | $19.39 | $98.30 | Above Fair Value | ⛔ Overvalued |
| SHBI | $26.49 | $20.33 | 30.30% | ✅ Strong Buy |
| SHC | $12.81 | $17.75 | Avoid | ❌ Avoid |
| SHEL | $77.39 | $75.29 | 2.79% | 👍 Buy |
| SHIP | $24.26 | $10.67 | Avoid | ❌ Avoid |
| SHLS | $8.39 | $10.29 | Above Fair Value | ⛔ Overvalued |
| SHO | $1.11 | $9.15 | Above Fair Value | ⛔ Overvalued |
| SHOO | $30.20 | $35.71 | Above Fair Value | ⛔ Overvalued |
| SHOP | $30.64 | $112.05 | Above Fair Value | ⛔ Overvalued |
| SHW | $246.25 | $361.98 | Above Fair Value | ⛔ Overvalued |
| SIG | $138.49 | $97.00 | 42.77% | ✅ Strong Buy |
| SIGA | $15.21 | $6.70 | 127.01% | ✅ Strong Buy |
| SIGI | $111.95 | $90.10 | 24.25% | ✅ Strong Buy |
| SII | $60.74 | $118.87 | Above Fair Value | ⛔ Overvalued |
| SIMO | $107.18 | $128.06 | Above Fair Value | ⛔ Overvalued |
| SIRI | $43.47 | $21.68 | Insufficient EBITDA | ❌ Avoid |
| SITC | $7.88 | $6.45 | 22.17% | ✅ Strong Buy |
| SITE | $72.28 | $150.01 | Above Fair Value | ⛔ Overvalued |
| SITM | $105.19 | $418.69 | Insufficient EBITDA | ❌ Avoid |
| SJM | $115.36 | $109.51 | Insufficient EBITDA | ❌ Avoid |
| SKIN | $2.83 | $1.28 | Avoid | ❌ Avoid |
| SKM | $15.14 | $28.42 | Above Fair Value | ⛔ Overvalued |
| SKT | $19.35 | $33.55 | Above Fair Value | ⛔ Overvalued |
| SKWD | $80.66 | $43.98 | 83.40% | ✅ Strong Buy |
| SKY | $55.42 | $83.59 | Above Fair Value | ⛔ Overvalued |
| SKYT | $0.62 | $30.35 | Above Fair Value | ⛔ Overvalued |
| SKYW | $129.94 | $105.96 | 22.63% | ✅ Strong Buy |
| SLB | $42.86 | $50.70 | Above Fair Value | ⛔ Overvalued |
| SLF | $91.84 | $65.21 | 40.84% | ✅ Strong Buy |
| SLG | $0.34 | $43.72 | Above Fair Value | ⛔ Overvalued |
| SLGN | $58.23 | $48.89 | Avoid | ❌ Avoid |
| SLI | $8.50 | $4.38 | Insufficient EBITDA | ✅ Strong Buy |
| SLM | $46.22 | $27.30 | 69.30% | ✅ Strong Buy |
| SLNO | $33.63 | $41.53 | Insufficient EBITDA | ❌ Avoid |
| SLP | $19.78 | $14.57 | Insufficient EBITDA | ✅ Strong Buy |
| SLQT | $4.45 | $1.10 | 304.55% | ✅ Strong Buy |
| SLRC | $11.71 | $15.19 | Above Fair Value | ⛔ Overvalued |
| SLVM | $45.60 | $50.74 | Above Fair Value | ⚠️ See Analysis |
| SM | $61.21 | $21.08 | 190.37% | ✅ Strong Buy |
| SMA | $3.86 | $32.06 | Above Fair Value | ⛔ Overvalued |
| SMBC | $99.47 | $65.50 | 51.86% | ✅ Strong Buy |
| SMBK | $50.70 | $42.99 | 17.93% | ✅ Strong Buy |
| SMCI | $44.83 | $34.38 | 30.40% | ✅ Strong Buy |
| SMFG | $21.00 | $23.04 | Above Fair Value | ⚠️ See Analysis |
| SMG | $60.31 | $66.34 | Above Fair Value | ⚠️ See Analysis |
| SMP | $51.89 | $44.13 | 17.58% | 👍 Buy |
| SMPL | $31.78 | $17.33 | 83.38% | ✅ Strong Buy |
| SMTC | $32.40 | $86.50 | Above Fair Value | ⛔ Overvalued |
| SN | $90.22 | $116.72 | Above Fair Value | ⛔ Overvalued |
| SNA | $318.22 | $369.34 | Above Fair Value | ⛔ Overvalued |
| SNCY | $18.73 | $21.84 | Above Fair Value | ⛔ Overvalued |
| SND | $1.31 | $4.91 | Above Fair Value | ⛔ Overvalued |
| SNDK | $977.04 | $597.95 | Insufficient EBITDA | ❌ Avoid |
| SNDR | $11.42 | $29.48 | Above Fair Value | ⛔ Overvalued |
| SNEX | $102.73 | $120.54 | Above Fair Value | ⛔ Overvalued |
| SNN | $25.62 | $34.69 | Above Fair Value | ⛔ Overvalued |
| SNOW | $37.65 | $168.43 | Insufficient EBITDA | ❌ Avoid |
| SNPS | $316.02 | $426.88 | Avoid | ❌ Avoid |
| SNV | $85.90 | $50.05 | 71.63% | ✅ Strong Buy |
| SNX | $188.44 | $171.38 | 9.95% | 👍 Buy |
| SNY | $69.41 | $47.83 | 45.12% | ✅ Strong Buy |
| SO | $63.90 | $90.08 | Avoid | ❌ Avoid |
| SOFI | $8.77 | $20.86 | Above Fair Value | ⛔ Overvalued |
| SOL | $6.47 | $1.94 | Insufficient EBITDA | ❌ Avoid |
| SOLV | $100.42 | $78.12 | 28.55% | ✅ Strong Buy |
| SON | $78.33 | $51.32 | Avoid | ❌ Avoid |
| SONY | $16.95 | $22.26 | Above Fair Value | ⛔ Overvalued |
| SPB | $63.58 | $75.72 | Above Fair Value | ⛔ Overvalued |
| SPFI | $55.15 | $43.21 | 27.63% | ✅ Strong Buy |
| SPG | $148.45 | $199.60 | Above Fair Value | ⛔ Overvalued |
| SPGI | $403.05 | $439.28 | Above Fair Value | ⚠️ See Analysis |
| SPH | $29.45 | $19.75 | Avoid | ❌ Avoid |
| SPNS | $28.27 | $43.45 | Above Fair Value | ⛔ Overvalued |
| SPNT | $29.53 | $20.79 | 42.04% | ✅ Strong Buy |
| SPOK | $12.25 | $13.23 | Above Fair Value | ⚠️ See Analysis |
| SPOT | $173.65 | $422.61 | Above Fair Value | ⛔ Overvalued |
| SPRO | $15.88 | $2.42 | Insufficient EBITDA | ❌ Avoid |
| SPSC | $90.62 | $79.53 | 13.94% | 👍 Buy |
| SPT | $20.76 | $8.00 | Insufficient EBITDA | ❌ Avoid |
| SPXC | $105.69 | $222.32 | Above Fair Value | ⛔ Overvalued |
| SQM | $48.48 | $71.48 | Above Fair Value | ⛔ Overvalued |
| SR | $73.19 | $86.08 | Avoid | ❌ Avoid |
| SRAD | $7.77 | $16.99 | Above Fair Value | ⛔ Overvalued |
| SRBK | $6.82 | $17.50 | Above Fair Value | ⛔ Overvalued |
| SRCE | $106.17 | $70.45 | 50.70% | ✅ Strong Buy |
| SRE | $64.48 | $87.36 | Avoid | ❌ Avoid |
| SRI | $3.14 | $8.47 | Insufficient EBITDA | ❌ Avoid |
| SRPT | $64.33 | $18.50 | Avoid | ❌ Avoid |
| SSB | $127.14 | $107.82 | 17.92% | ✅ Strong Buy |
| SSD | $134.75 | $194.28 | Above Fair Value | ⛔ Overvalued |
| SSNC | $120.82 | $77.39 | 56.12% | ✅ Strong Buy |
| SSP | $5.91 | $3.39 | Avoid | ❌ Avoid |
| SSRM | $34.00 | $24.16 | Insufficient EBITDA | ✅ Strong Buy |
| SSSS | $38.15 | $8.98 | Insufficient EBITDA | ✅ Strong Buy |
| SSTK | $81.16 | $18.68 | 334.48% | ✅ Strong Buy |
| SSYS | $3.90 | $11.25 | Insufficient EBITDA | ❌ Avoid |
| ST | $57.70 | $35.99 | Avoid | ❌ Avoid |
| STAA | $3.28 | $17.58 | Insufficient EBITDA | ❌ Avoid |
| STAG | $23.79 | $39.31 | Above Fair Value | ⛔ Overvalued |
| STBA | $41.58 | $44.13 | Above Fair Value | ⚠️ See Analysis |
| STC | $62.91 | $71.44 | Above Fair Value | ⚠️ See Analysis |
| STE | $158.94 | $252.16 | Above Fair Value | ⛔ Overvalued |
| STEL | $31.12 | $39.17 | Above Fair Value | ⛔ Overvalued |
| STEP | $38.52 | $62.43 | Insufficient EBITDA | ⛔ Overvalued |
| STGW | $12.77 | $5.18 | Avoid | ❌ Avoid |
| STKL | $3.74 | $6.40 | Avoid | ❌ Avoid |
| STLD | $155.68 | $202.39 | Above Fair Value | ⛔ Overvalued |
| STM | $17.51 | $29.85 | Above Fair Value | ⛔ Overvalued |
| STN | $77.17 | $101.53 | Above Fair Value | ⛔ Overvalued |
| STNG | $70.59 | $68.43 | 3.16% | 👍 Buy |
| STOK | $1.16 | $32.40 | Insufficient EBITDA | ⛔ Overvalued |
| STRA | $108.55 | $81.36 | 33.42% | ✅ Strong Buy |
| STRL | $152.85 | $401.29 | Above Fair Value | ⛔ Overvalued |
| STRW | $14.69 | $13.05 | 12.57% | 👍 Buy |
| STRZ | $1.02 | $9.20 | Above Fair Value | ⛔ Overvalued |
| STT | $152.11 | $132.35 | 14.93% | 👍 Buy |
| STVN | $13.44 | $15.50 | Above Fair Value | ⛔ Overvalued |
| STWD | $20.53 | $18.12 | 13.30% | 👍 Buy |
| STX | $141.35 | $429.32 | Above Fair Value | ⛔ Overvalued |
| STZ | $187.77 | $164.33 | Avoid | ❌ Avoid |
| SU | $51.31 | $53.80 | Above Fair Value | ⚠️ See Analysis |
| SUI | $44.06 | $125.69 | Above Fair Value | ⛔ Overvalued |
| SUN | $71.11 | $57.60 | Avoid | ❌ Avoid |
| SUNS | $19.38 | $9.30 | 108.39% | ✅ Strong Buy |
| SUPN | $60.54 | $51.65 | 17.21% | 👍 Buy |
| SUPV | $4.54 | $11.01 | Above Fair Value | ⛔ Overvalued |
| SVM | $10.47 | $10.41 | 0.58% | 👍 Buy |
| SVV | $8.92 | $11.53 | Avoid | ❌ Avoid |
| SWBI | $3.58 | $11.68 | Above Fair Value | ⛔ Overvalued |
| SWK | $70.51 | $89.39 | Avoid | ❌ Avoid |
| SWKH | $33.81 | $17.25 | 96.00% | ✅ Strong Buy |
| SWKS | $91.95 | $62.10 | 48.07% | ✅ Strong Buy |
| SWX | $50.79 | $83.26 | Above Fair Value | ⛔ Overvalued |
| SXC | $6.94 | $8.27 | Above Fair Value | ⛔ Overvalued |
| SXI | $127.24 | $254.24 | Above Fair Value | ⛔ Overvalued |
| SXT | $50.29 | $97.48 | Above Fair Value | ⛔ Overvalued |
| SYBT | $86.24 | $71.20 | 21.12% | ✅ Strong Buy |
| SYF | $86.80 | $75.16 | 15.49% | 👍 Buy |
| SYK | $240.23 | $358.29 | Above Fair Value | ⛔ Overvalued |
| SYM | $13.83 | $59.74 | Insufficient EBITDA | ❌ Avoid |
| SYNA | $82.03 | $89.23 | Avoid | ❌ Avoid |
| SYY | $85.64 | $86.53 | Above Fair Value | ⚠️ See Analysis |
| T | $28.46 | $27.13 | 4.90% | 👍 Buy |
| TAC | $4.10 | $13.24 | Avoid | ❌ Avoid |
| TAK | $1,170.26 | $17.89 | Avoid | ❌ Avoid |
| TALK | $2.06 | $3.88 | Above Fair Value | ⛔ Overvalued |
| TAP | $74.50 | $51.76 | Avoid | ❌ Avoid |
| TARS | $20.52 | $64.62 | Insufficient EBITDA | ❌ Avoid |
| TATT | $25.11 | $47.88 | Above Fair Value | ⛔ Overvalued |
| TBBK | $72.36 | $62.02 | 16.67% | 👍 Buy |
| TBCH | $14.58 | $12.07 | 20.80% | ✅ Strong Buy |
| TBI | $3.41 | $5.42 | Insufficient EBITDA | ❌ Avoid |
| TBPH | $13.52 | $20.48 | Insufficient EBITDA | ❌ Avoid |
| TCBI | $114.81 | $104.47 | 9.90% | 👍 Buy |
| TCBK | $62.89 | $52.23 | 20.41% | ✅ Strong Buy |
| TCBS | $11.06 | $17.16 | Insufficient EBITDA | ⛔ Overvalued |
| TCBX | $52.40 | $43.46 | 20.57% | ✅ Strong Buy |
| TCMD | $11.17 | $27.91 | Above Fair Value | ⛔ Overvalued |
| TCPC | $13.59 | $4.86 | Insufficient EBITDA | ✅ Strong Buy |
| TD | $67.12 | $96.68 | Above Fair Value | ⛔ Overvalued |
| TDC | $48.19 | $27.47 | 75.43% | ✅ Strong Buy |
| TDG | $755.74 | $1,285.53 | Avoid | ❌ Avoid |
| TDS | $3.96 | $45.80 | Above Fair Value | ⛔ Overvalued |
| TDW | $51.30 | $66.35 | Above Fair Value | ⛔ Overvalued |
| TDY | $441.61 | $647.56 | Above Fair Value | ⛔ Overvalued |
| TEAM | $123.26 | $94.72 | 30.13% | ✅ Strong Buy |
| TECH | $39.12 | $66.78 | Above Fair Value | ⛔ Overvalued |
| TECK | $33.02 | $55.01 | Above Fair Value | ⛔ Overvalued |
| TEF | $4.26 | $3.81 | 11.81% | 👍 Buy |
| TEL | $172.06 | $215.91 | Above Fair Value | ⛔ Overvalued |
| TEN | $50.33 | $26.99 | 86.48% | ✅ Strong Buy |
| TENB | $34.62 | $21.23 | 63.07% | ✅ Strong Buy |
| TER | $81.70 | $300.11 | Above Fair Value | ⛔ Overvalued |
| TEVA | $39.19 | $34.69 | 12.97% | 👍 Buy |
| TEX | $68.00 | $62.74 | 8.38% | 👍 Buy |
| TFC | $60.03 | $55.81 | 7.56% | 👍 Buy |
| TFII | $66.76 | $121.88 | Above Fair Value | ⛔ Overvalued |
| TFIN | $16.94 | $68.34 | Above Fair Value | ⛔ Overvalued |
| TFPM | $18.73 | $34.25 | Above Fair Value | ⛔ Overvalued |
| TFSL | $6.59 | $14.92 | Above Fair Value | ⛔ Overvalued |
| TFX | $222.88 | $108.42 | Avoid | ❌ Avoid |
| TG | $0.72 | $9.26 | Above Fair Value | ⛔ Overvalued |
| TGB | $3.62 | $7.85 | Avoid | ❌ Avoid |
| TGLS | $57.16 | $52.08 | 9.75% | 👍 Buy |
| TGNA | $33.59 | $19.07 | 76.14% | ✅ Strong Buy |
| TGS | $31.04 | $29.42 | 5.51% | 👍 Buy |
| TGT | $114.28 | $115.55 | Above Fair Value | ⚠️ See Analysis |
| TGTX | $27.04 | $28.86 | Above Fair Value | ⚠️ See Analysis |
| THC | $259.86 | $201.37 | 29.05% | ✅ Strong Buy |
| THFF | $103.13 | $67.83 | 52.04% | ✅ Strong Buy |
| THG | $230.68 | $175.97 | 31.09% | ✅ Strong Buy |
| THO | $71.16 | $119.98 | Above Fair Value | ⛔ Overvalued |
| THR | $33.10 | $50.42 | Above Fair Value | ⛔ Overvalued |
| THRM | $37.19 | $32.20 | 15.50% | 👍 Buy |
| THRY | $16.02 | $3.90 | 310.77% | ✅ Strong Buy |
| THS | $23.26 | $24.63 | Avoid | ❌ Avoid |
| TIC | $4.39 | $9.55 | Avoid | ❌ Avoid |
| TIGO | $52.62 | $66.95 | Above Fair Value | ⛔ Overvalued |
| TIGR | $24.22 | $8.14 | 197.54% | ✅ Strong Buy |
| TILE | $23.44 | $34.63 | Above Fair Value | ⛔ Overvalued |
| TIMB | $25.57 | $24.46 | 4.54% | 👍 Buy |
| TIPT | $15.07 | $17.74 | Above Fair Value | ⛔ Overvalued |
| TJX | $95.97 | $155.86 | Above Fair Value | ⛔ Overvalued |
| TK | $12.53 | $10.49 | 19.45% | ✅ Strong Buy |
| TKO | $92.62 | $211.90 | Above Fair Value | ⛔ Overvalued |
| TKR | $77.91 | $106.04 | Above Fair Value | ⛔ Overvalued |
| TLF | $16.20 | $3.18 | 409.43% | ✅ Strong Buy |
| TLK | $26.79 | $20.49 | 30.75% | ✅ Strong Buy |
| TLN | $171.20 | $345.00 | Above Fair Value | ⛔ Overvalued |
| TLX | $4.81 | $7.10 | Above Fair Value | ⛔ Overvalued |
| TM | $214.80 | $244.22 | Avoid | ❌ Avoid |
| TMDX | $67.18 | $135.06 | Above Fair Value | ⛔ Overvalued |
| TMHC | $91.24 | $65.18 | 39.98% | ✅ Strong Buy |
| TMO | $376.79 | $542.83 | Above Fair Value | ⛔ Overvalued |
| TMP | $105.94 | $84.34 | 25.61% | ✅ Strong Buy |
| TMUS | $181.35 | $197.39 | Above Fair Value | ⚠️ See Analysis |
| TNC | $86.40 | $81.97 | 5.40% | 👍 Buy |
| TNET | $87.41 | $55.96 | 56.20% | ✅ Strong Buy |
| TNL | $107.57 | $73.45 | Avoid | ❌ Avoid |
| TOL | $171.90 | $153.28 | 12.15% | 👍 Buy |
| TOWN | $53.83 | $37.65 | 42.97% | ✅ Strong Buy |
| TPB | $73.56 | $129.97 | Above Fair Value | ⛔ Overvalued |
| TPC | $43.70 | $83.48 | Insufficient EBITDA | ⛔ Overvalued |
| TPG | $48.16 | $55.02 | Above Fair Value | ⚠️ See Analysis |
| TPH | $31.38 | $35.46 | Above Fair Value | ⚠️ See Analysis |
| TPL | $586.47 | $366.03 | 60.22% | ✅ Strong Buy |
| TPR | $105.92 | $152.10 | Avoid | ❌ Avoid |
| TPVG | $10.89 | $5.73 | 90.05% | ✅ Strong Buy |
| TR | $20.68 | $39.29 | Above Fair Value | ⛔ Overvalued |
| TRC | $1.88 | $16.61 | Insufficient EBITDA | ❌ Avoid |
| TREE | $69.83 | $47.46 | 47.13% | ✅ Strong Buy |
| TREX | $27.92 | $44.00 | Above Fair Value | ⛔ Overvalued |
| TRGP | $136.02 | $211.44 | Avoid | ❌ Avoid |
| TRI | $67.11 | $88.07 | Above Fair Value | ⛔ Overvalued |
| TRIN | $26.88 | $16.19 | 66.03% | ✅ Strong Buy |
| TRIP | $27.00 | $12.77 | 111.43% | ✅ Strong Buy |
| TRMB | $61.37 | $66.15 | Above Fair Value | ⚠️ See Analysis |
| TRMD | $33.23 | $24.90 | 33.45% | ✅ Strong Buy |
| TRMK | $56.51 | $44.69 | 26.45% | ✅ Strong Buy |
| TRN | $28.13 | $30.39 | Avoid | ❌ Avoid |
| TRNO | $41.67 | $66.10 | Above Fair Value | ⛔ Overvalued |
| TRNS | $32.16 | $76.33 | Above Fair Value | ⛔ Overvalued |
| TROW | $176.96 | $94.58 | 87.10% | ✅ Strong Buy |
| TRP | $43.29 | $59.82 | Avoid | ❌ Avoid |
| TRS | $21.55 | $36.11 | Above Fair Value | ⛔ Overvalued |
| TRST | $30.67 | $46.07 | Above Fair Value | ⛔ Overvalued |
| TRTX | $8.40 | $8.95 | Above Fair Value | ⚠️ See Analysis |
| TRU | $72.81 | $73.48 | Above Fair Value | ⚠️ See Analysis |
| TRUP | $69.69 | $33.17 | 110.10% | ✅ Strong Buy |
| TRV | $396.63 | $301.49 | 31.56% | ✅ Strong Buy |
| TS | $51.37 | $46.91 | 9.51% | 👍 Buy |
| TSBK | $54.87 | $39.63 | 38.46% | ✅ Strong Buy |
| TSCO | $24.09 | $55.61 | Above Fair Value | ⛔ Overvalued |
| TSEM | $41.72 | $139.04 | Above Fair Value | ⛔ Overvalued |
| TSLA | $38.64 | $411.11 | Above Fair Value | ⛔ Overvalued |
| TSLX | $28.30 | $20.17 | 40.31% | ✅ Strong Buy |
| TSM | $307.98 | $348.85 | Above Fair Value | ⚠️ See Analysis |
| TSN | $52.72 | $65.26 | Above Fair Value | ⛔ Overvalued |
| TSQ | $6.71 | $6.63 | Avoid | ❌ Avoid |
| TT | $210.46 | $454.76 | Above Fair Value | ⛔ Overvalued |
| TTAM | $18.51 | $18.66 | Above Fair Value | ⚠️ See Analysis |
| TTAN | $19.74 | $63.74 | Insufficient EBITDA | ❌ Avoid |
| TTC | $88.23 | $98.20 | Above Fair Value | ⚠️ See Analysis |
| TTD | $45.29 | $27.04 | 67.49% | ✅ Strong Buy |
| TTE | $84.13 | $73.83 | 13.95% | 👍 Buy |
| TTEC | $18.29 | $3.03 | Insufficient EBITDA | ❌ Avoid |
| TTEK | $21.85 | $41.29 | Above Fair Value | ⛔ Overvalued |
| TTGT | $11.27 | $5.18 | Insufficient EBITDA | ❌ Avoid |
| TTI | $3.99 | $11.67 | Above Fair Value | ⛔ Overvalued |
| TTMI | $32.59 | $98.58 | Above Fair Value | ⛔ Overvalued |
| TTWO | $67.63 | $195.59 | Insufficient EBITDA | ❌ Avoid |
| TU | $10.64 | $14.13 | Avoid | ❌ Avoid |
| TVTX | $20.04 | $29.71 | Insufficient EBITDA | ❌ Avoid |
| TW | $67.81 | $112.13 | Above Fair Value | ⛔ Overvalued |
| TWI | $3.51 | $11.06 | Avoid | ❌ Avoid |
| TWIN | $15.09 | $16.60 | Above Fair Value | ⚠️ See Analysis |
| TWLO | $98.39 | $115.02 | Above Fair Value | ⛔ Overvalued |
| TWO | $15.69 | $11.04 | Avoid | ❌ Avoid |
| TX | $54.76 | $43.46 | 26.00% | ✅ Strong Buy |
| TXN | $132.65 | $221.44 | Above Fair Value | ⛔ Overvalued |
| TXNM | $38.45 | $58.99 | Avoid | ❌ Avoid |
| TXO | $5.35 | $12.04 | Above Fair Value | ⛔ Overvalued |
| TXRH | $106.37 | $190.97 | Above Fair Value | ⛔ Overvalued |
| TXT | $93.23 | $95.44 | Above Fair Value | ⚠️ See Analysis |
| TYL | $269.47 | $348.35 | Above Fair Value | ⛔ Overvalued |
| TZOO | $12.29 | $5.62 | 118.68% | ✅ Strong Buy |
| UAA | $1.44 | $7.56 | Avoid | ❌ Avoid |
| UAL | $157.16 | $115.91 | 35.59% | ✅ Strong Buy |
| UAMY | $1.72 | $8.61 | Insufficient EBITDA | ❌ Avoid |
| UAN | $190.93 | $102.39 | 86.47% | ✅ Strong Buy |
| UBCP | $19.40 | $14.00 | 38.57% | ✅ Strong Buy |
| UBER | $88.55 | $74.77 | 18.43% | ✅ Strong Buy |
| UBFO | $9.80 | $11.41 | Above Fair Value | ⛔ Overvalued |
| UBS | $32.93 | $43.91 | Above Fair Value | ⛔ Overvalued |
| UBSI | $38.34 | $45.52 | Above Fair Value | ⛔ Overvalued |
| UCB | $38.01 | $36.51 | 4.11% | 👍 Buy |
| UCTT | $16.53 | $48.29 | Avoid | ❌ Avoid |
| UDMY | $7.87 | $4.69 | Insufficient EBITDA | ✅ Strong Buy |
| UDR | $9.21 | $37.55 | Above Fair Value | ⛔ Overvalued |
| UE | $5.41 | $21.03 | Above Fair Value | ⛔ Overvalued |
| UEIC | $0.74 | $3.99 | Above Fair Value | ⛔ Overvalued |
| UFCS | $50.64 | $37.05 | 36.68% | ✅ Strong Buy |
| UFPI | $78.39 | $114.19 | Above Fair Value | ⛔ Overvalued |
| UFPT | $144.59 | $267.34 | Above Fair Value | ⛔ Overvalued |
| UG | $9.13 | $7.15 | 27.69% | ✅ Strong Buy |
| UGI | $41.62 | $37.09 | Avoid | ❌ Avoid |
| UGP | $5.46 | $5.09 | 7.27% | 👍 Buy |
| UHAL | $8.36 | $49.92 | Above Fair Value | ⛔ Overvalued |
| UHS | $308.17 | $218.56 | 41.00% | ✅ Strong Buy |
| UHT | $24.02 | $42.10 | Above Fair Value | ⛔ Overvalued |
| UI | $322.05 | $622.33 | Above Fair Value | ⛔ Overvalued |
| UIS | $13.09 | $2.33 | Avoid | ❌ Avoid |
| UL | $45.14 | $72.12 | Above Fair Value | ⛔ Overvalued |
| ULH | $13.16 | $18.04 | Avoid | ❌ Avoid |
| ULS | $35.93 | $71.49 | Above Fair Value | ⛔ Overvalued |
| ULTA | $498.71 | $690.37 | Above Fair Value | ⛔ Overvalued |
| UMBF | $171.60 | $134.32 | 27.75% | ✅ Strong Buy |
| UMC | $8.50 | $10.06 | Above Fair Value | ⛔ Overvalued |
| UMH | $2.14 | $15.91 | Above Fair Value | ⛔ Overvalued |
| UNB | $37.72 | $24.84 | 51.85% | ✅ Strong Buy |
| UNF | $105.47 | $201.35 | Above Fair Value | ⛔ Overvalued |
| UNFI | $31.03 | $40.69 | Avoid | ❌ Avoid |
| UNH | $261.04 | $276.65 | Above Fair Value | ⚠️ See Analysis |
| UNIT | $119.89 | $8.05 | 1,389.32% | ✅ Strong Buy |
| UNM | $110.42 | $74.56 | 48.10% | ✅ Strong Buy |
| UNP | $209.05 | $252.62 | Above Fair Value | ⛔ Overvalued |
| UNTY | $95.64 | $56.20 | 70.18% | ✅ Strong Buy |
| UPBD | $63.61 | $20.54 | 209.69% | ✅ Strong Buy |
| UPS | $93.15 | $117.34 | Above Fair Value | ⛔ Overvalued |
| UPWK | $25.21 | $18.93 | 33.17% | ✅ Strong Buy |
| URBN | $82.89 | $72.47 | 14.38% | 👍 Buy |
| URI | $621.45 | $899.55 | Above Fair Value | ⛔ Overvalued |
| UROY | $0.61 | $3.95 | Insufficient EBITDA | ⛔ Overvalued |
| USAC | $20.22 | $26.35 | Avoid | ❌ Avoid |
| USAS | $6.01 | $7.13 | Insufficient EBITDA | ❌ Avoid |
| USB | $68.32 | $60.69 | 12.57% | 👍 Buy |
| USCB | $30.96 | $20.13 | 53.80% | ✅ Strong Buy |
| USFD | $55.26 | $90.33 | Above Fair Value | ⛔ Overvalued |
| USLM | $74.24 | $108.55 | Above Fair Value | ⛔ Overvalued |
| USNA | $29.26 | $21.34 | 37.11% | ✅ Strong Buy |
| USPH | $43.87 | $85.58 | Above Fair Value | ⛔ Overvalued |
| UTHR | $496.16 | $485.36 | 2.23% | 👍 Buy |
| UTI | $10.59 | $25.52 | Above Fair Value | ⛔ Overvalued |
| UTL | $43.77 | $50.57 | Avoid | ❌ Avoid |
| UTMD | $67.84 | $61.64 | 10.06% | 👍 Buy |
| UTZ | $12.42 | $10.98 | Avoid | ❌ Avoid |
| UUUU | $2.05 | $21.22 | Insufficient EBITDA | ❌ Avoid |
| UVE | $68.80 | $31.71 | 116.97% | ✅ Strong Buy |
| UVSP | $45.36 | $35.83 | 26.60% | ✅ Strong Buy |
| UVV | $53.26 | $57.82 | Avoid | ❌ Avoid |
| UWMC | $4.62 | $4.75 | Avoid | ❌ Avoid |
| V | $336.52 | $331.58 | 1.49% | 👍 Buy |
| VABK | $46.91 | $42.04 | 11.58% | 👍 Buy |
| VAC | $90.54 | $55.58 | Avoid | ❌ Avoid |
| VAL | $47.83 | $62.41 | Above Fair Value | ⛔ Overvalued |
| VALU | $41.41 | $37.10 | 11.62% | 👍 Buy |
| VBNK | $21.06 | $16.40 | 28.41% | ✅ Strong Buy |
| VC | $139.35 | $100.90 | 38.11% | ✅ Strong Buy |
| VCEL | $6.28 | $36.19 | Above Fair Value | ⛔ Overvalued |
| VCIG | $16,317.00 | $0.38 | 4,293,847.37% | ✅ Strong Buy |
| VCTR | $52.83 | $71.25 | Above Fair Value | ⛔ Overvalued |
| VCYT | $31.24 | $36.19 | Above Fair Value | ⛔ Overvalued |
| VECO | $23.84 | $30.69 | Above Fair Value | ⛔ Overvalued |
| VEEV | $198.08 | $183.65 | 7.86% | 👍 Buy |
| VEL | $31.46 | $20.49 | 53.54% | ✅ Strong Buy |
| VERX | $15.69 | $15.73 | Above Fair Value | ⚠️ See Analysis |
| VET | $6.37 | $10.21 | Above Fair Value | ⛔ Overvalued |
| VFC | $11.65 | $20.34 | Avoid | ❌ Avoid |
| VG | $14.06 | $9.90 | Avoid | ❌ Avoid |
| VHI | $25.22 | $15.51 | 62.60% | ✅ Strong Buy |
| VIA | $1.18 | $20.56 | Insufficient EBITDA | ❌ Avoid |
| VIAV | $10.86 | $26.38 | Above Fair Value | ⛔ Overvalued |
| VICI | $35.47 | $28.76 | 23.33% | ✅ Strong Buy |
| VICR | $31.83 | $159.87 | Above Fair Value | ⛔ Overvalued |
| VIK | $65.31 | $76.99 | Above Fair Value | ⛔ Overvalued |
| VINP | $118.01 | $12.18 | 868.88% | ✅ Strong Buy |
| VIRC | $8.84 | $6.50 | 36.00% | ✅ Strong Buy |
| VIRT | $90.45 | $38.53 | 134.75% | ✅ Strong Buy |
| VITL | $27.80 | $26.85 | 3.54% | 👍 Buy |
| VLGEA | $45.90 | $38.33 | 19.75% | ✅ Strong Buy |
| VLO | $145.78 | $202.68 | Above Fair Value | ⛔ Overvalued |
| VLTO | $88.94 | $90.57 | Above Fair Value | ⚠️ See Analysis |
| VLY | $12.72 | $13.71 | Above Fair Value | ⚠️ See Analysis |
| VMC | $141.03 | $323.72 | Above Fair Value | ⛔ Overvalued |
| VMD | $9.12 | $8.64 | 5.56% | 👍 Buy |
| VMI | $294.73 | $473.68 | Above Fair Value | ⛔ Overvalued |
| VNO | $58.63 | $31.27 | 87.50% | ✅ Strong Buy |
| VNOM | $31.30 | $42.89 | Avoid | ❌ Avoid |
| VNT | $40.30 | $42.10 | Above Fair Value | ⚠️ See Analysis |
| VOC | $3.09 | $2.85 | 8.42% | 👍 Buy |
| VOD | $11.99 | $15.11 | Above Fair Value | ⛔ Overvalued |
| VOXR | $1.03 | $5.18 | Above Fair Value | ⛔ Overvalued |
| VOYA | $141.10 | $75.90 | 85.90% | ✅ Strong Buy |
| VPG | $12.58 | $55.98 | Above Fair Value | ⛔ Overvalued |
| VRE | $10.07 | $16.64 | Above Fair Value | ⛔ Overvalued |
| VREX | $11.93 | $14.00 | Avoid | ❌ Avoid |
| VRRM | $25.58 | $18.87 | 35.56% | ✅ Strong Buy |
| VRSK | $183.58 | $179.10 | 2.50% | 👍 Buy |
| VRSN | $236.93 | $224.17 | 5.69% | 👍 Buy |
| VRT | $73.67 | $195.58 | Above Fair Value | ⛔ Overvalued |
| VRTS | $343.82 | $140.29 | 145.08% | ✅ Strong Buy |
| VRTX | $360.16 | $477.92 | Above Fair Value | ⛔ Overvalued |
| VSAT | $5.30 | $41.70 | Avoid | ❌ Avoid |
| VSCO | $42.19 | $62.44 | Above Fair Value | ⛔ Overvalued |
| VSEC | $52.45 | $199.99 | Above Fair Value | ⛔ Overvalued |
| VSH | $10.42 | $19.95 | Above Fair Value | ⛔ Overvalued |
| VST | $42.09 | $149.65 | Above Fair Value | ⛔ Overvalued |
| VSTS | $4.00 | $7.18 | Avoid | ❌ Avoid |
| VTLE | $106.10 | $17.92 | Avoid | ❌ Avoid |
| VTOL | $92.54 | $45.00 | 105.64% | ✅ Strong Buy |
| VTR | $6.83 | $82.55 | Above Fair Value | ⛔ Overvalued |
| VTRS | $27.98 | $14.58 | Avoid | ❌ Avoid |
| VTS | $8.34 | $21.56 | Above Fair Value | ⛔ Overvalued |
| VVV | $36.31 | $37.53 | Above Fair Value | ⚠️ See Analysis |
| VVX | $81.24 | $67.29 | 20.73% | ✅ Strong Buy |
| VYX | $11.79 | $9.85 | 19.70% | ✅ Strong Buy |
| VZ | $78.84 | $46.31 | 70.24% | ✅ Strong Buy |
| W | $37.17 | $92.60 | Insufficient EBITDA | ❌ Avoid |
| WAB | $141.36 | $246.32 | Above Fair Value | ⛔ Overvalued |
| WABC | $55.42 | $52.48 | 5.60% | 👍 Buy |
| WAFD | $47.97 | $33.71 | 42.30% | ✅ Strong Buy |
| WAL | $128.15 | $94.39 | 35.77% | ✅ Strong Buy |
| WASH | $50.52 | $36.75 | 37.47% | ✅ Strong Buy |
| WAT | $314.96 | $381.29 | Above Fair Value | ⛔ Overvalued |
| WAY | $29.28 | $24.30 | 20.49% | ✅ Strong Buy |
| WBD | $5.15 | $27.36 | Above Fair Value | ⛔ Overvalued |
| WBS | $80.91 | $73.13 | 10.64% | 👍 Buy |
| WBTN | $4.93 | $11.17 | Insufficient EBITDA | ❌ Avoid |
| WCC | $196.01 | $315.27 | Avoid | ❌ Avoid |
| WCN | $79.30 | $169.20 | Above Fair Value | ⛔ Overvalued |
| WD | $72.85 | $63.23 | Avoid | ❌ Avoid |
| WDAY | $227.19 | $162.92 | 39.45% | ✅ Strong Buy |
| WDC | $126.15 | $282.58 | Above Fair Value | ⛔ Overvalued |
| WDFC | $117.04 | $238.53 | Above Fair Value | ⛔ Overvalued |
| WDS | $22.48 | $18.15 | 23.86% | ✅ Strong Buy |
| WEAV | $1.73 | $6.25 | Insufficient EBITDA | ❌ Avoid |
| WEC | $67.69 | $111.42 | Avoid | ❌ Avoid |
| WELL | $30.51 | $195.92 | Above Fair Value | ⛔ Overvalued |
| WEN | $14.96 | $8.02 | Avoid | ❌ Avoid |
| WERN | $6.08 | $34.76 | Above Fair Value | ⛔ Overvalued |
| WES | $57.58 | $41.12 | 40.03% | ✅ Strong Buy |
| WEX | $282.07 | $158.95 | Avoid | ❌ Avoid |
| WEYS | $31.86 | $32.83 | Above Fair Value | ⚠️ See Analysis |
| WFC | $91.14 | $93.97 | Above Fair Value | ⚠️ See Analysis |
| WFG | $0.97 | $73.37 | Above Fair Value | ⛔ Overvalued |
| WFRD | $81.07 | $105.51 | Above Fair Value | ⛔ Overvalued |
| WGO | $38.92 | $48.79 | Above Fair Value | ⛔ Overvalued |
| WGS | $15.81 | $84.29 | Insufficient EBITDA | ⛔ Overvalued |
| WH | $82.11 | $77.29 | Avoid | ❌ Avoid |
| WHD | $47.52 | $58.00 | Above Fair Value | ⛔ Overvalued |
| WHF | $13.75 | $6.46 | 112.85% | ✅ Strong Buy |
| WHG | $14.26 | $17.84 | Above Fair Value | ⛔ Overvalued |
| WHR | $82.13 | $86.52 | Avoid | ❌ Avoid |
| WINA | $259.25 | $452.68 | Above Fair Value | ⛔ Overvalued |
| WING | $91.18 | $264.01 | Above Fair Value | ⛔ Overvalued |
| WIT | $2.53 | $2.51 | 0.80% | 👍 Buy |
| WIX | $129.67 | $75.42 | 71.93% | ✅ Strong Buy |
| WK | $31.46 | $69.85 | Insufficient EBITDA | ❌ Avoid |
| WKC | $24.93 | $27.99 | Avoid | ❌ Avoid |
| WLDN | $54.08 | $115.20 | Above Fair Value | ⛔ Overvalued |
| WLFC | $182.83 | $200.18 | Avoid | ❌ Avoid |
| WLK | $10.00 | $95.93 | Avoid | ❌ Avoid |
| WLKP | $22.76 | $20.68 | 10.06% | 👍 Buy |
| WLY | $65.70 | $29.24 | 124.69% | ✅ Strong Buy |
| WLYB | $29.40 | $29.79 | Above Fair Value | ⚠️ See Analysis |
| WM | $140.61 | $226.79 | Above Fair Value | ⛔ Overvalued |
| WMB | $30.10 | $66.92 | Avoid | ❌ Avoid |
| WMG | $35.10 | $29.05 | 20.83% | ✅ Strong Buy |
| WMK | $48.58 | $73.68 | Above Fair Value | ⛔ Overvalued |
| WMS | $97.62 | $175.38 | Above Fair Value | ⛔ Overvalued |
| WMT | $42.30 | $131.18 | Above Fair Value | ⛔ Overvalued |
| WNC | $85,313.00 | $11.03 | Insufficient EBITDA | ✅ Strong Buy |
| WNEB | $11.59 | $14.32 | Above Fair Value | ⛔ Overvalued |
| WOOF | $2.33 | $2.62 | Avoid | ❌ Avoid |
| WOR | $49.07 | $59.10 | Above Fair Value | ⛔ Overvalued |
| WPC | $37.90 | $71.21 | Above Fair Value | ⛔ Overvalued |
| WPM | $54.46 | $135.98 | Above Fair Value | ⛔ Overvalued |
| WPP | $49.30 | $18.48 | 166.77% | ✅ Strong Buy |
| WRB | $66.94 | $70.41 | Above Fair Value | ⚠️ See Analysis |
| WRBY | $5.99 | $25.52 | Above Fair Value | ⛔ Overvalued |
| WRLD | $151.72 | $123.09 | 23.26% | ✅ Strong Buy |
| WS | $37.18 | $47.70 | Above Fair Value | ⛔ Overvalued |
| WSBC | $53.07 | $37.89 | 40.06% | ✅ Strong Buy |
| WSBF | $17.42 | $18.05 | Above Fair Value | ⚠️ See Analysis |
| WSC | $16.90 | $22.26 | Avoid | ❌ Avoid |
| WSFS | $76.62 | $70.65 | 8.45% | 👍 Buy |
| WSM | $139.54 | $220.67 | Above Fair Value | ⛔ Overvalued |
| WSO | $216.87 | $419.92 | Above Fair Value | ⛔ Overvalued |
| WSR | $8.00 | $14.99 | Above Fair Value | ⛔ Overvalued |
| WST | $125.09 | $248.95 | Above Fair Value | ⛔ Overvalued |
| WT | $15.89 | $15.74 | 0.95% | 👍 Buy |
| WTBA | $42.36 | $26.31 | 61.00% | ✅ Strong Buy |
| WTFC | $189.71 | $161.35 | 17.58% | 👍 Buy |
| WTM | $1,767.89 | $2,185.00 | Above Fair Value | ⛔ Overvalued |
| WTRG | $33.00 | $37.42 | Avoid | ❌ Avoid |
| WTS | $151.93 | $319.22 | Above Fair Value | ⛔ Overvalued |
| WTTR | $4.07 | $12.89 | Above Fair Value | ⛔ Overvalued |
| WTW | $278.00 | $330.04 | Above Fair Value | ⛔ Overvalued |
| WU | $13.10 | $10.28 | 27.43% | ✅ Strong Buy |
| WWD | $135.62 | $388.50 | Above Fair Value | ⛔ Overvalued |
| WWR | $0.39 | $0.91 | Insufficient EBITDA | ❌ Avoid |
| WWW | $16.49 | $18.59 | Avoid | ❌ Avoid |
| WY | $2.65 | $26.64 | Avoid | ❌ Avoid |
| WYNN | $99.00 | $117.96 | Avoid | ❌ Avoid |
| XEL | $55.44 | $75.90 | Avoid | ❌ Avoid |
| XERS | $4.34 | $7.01 | Insufficient EBITDA | ❌ Avoid |
| XHR | $5.99 | $15.56 | Above Fair Value | ⛔ Overvalued |
| XMTR | $8.89 | $66.03 | Insufficient EBITDA | ❌ Avoid |
| XOM | $98.21 | $149.05 | Above Fair Value | ⛔ Overvalued |
| XOMA | $14.39 | $24.86 | Insufficient EBITDA | ⛔ Overvalued |
| XPEL | $31.51 | $51.93 | Above Fair Value | ⛔ Overvalued |
| XPER | $17.86 | $5.38 | 231.97% | ✅ Strong Buy |
| XPO | $44.79 | $203.61 | Above Fair Value | ⛔ Overvalued |
| XPOF | $9.44 | $8.55 | Insufficient EBITDA | ❌ Avoid |
| XPON | $622.07 | $0.78 | Insufficient EBITDA | ❌ Avoid |
| XPRO | $14.13 | $16.66 | Above Fair Value | ⛔ Overvalued |
| XRAY | $21.33 | $13.76 | Insufficient EBITDA | ❌ Avoid |
| XRX | $15.07 | $2.34 | Insufficient EBITDA | ❌ Avoid |
| XYL | $82.34 | $142.12 | Above Fair Value | ⛔ Overvalued |
| XYZ | $57.98 | $55.97 | 3.59% | 👍 Buy |
| YELP | $46.63 | $24.42 | 90.95% | ✅ Strong Buy |
| YETI | $57.34 | $47.15 | 21.61% | ✅ Strong Buy |
| YEXT | $12.05 | $4.90 | 145.92% | ✅ Strong Buy |
| YORW | $23.14 | $31.81 | Avoid | ❌ Avoid |
| YOU | $34.72 | $33.76 | 2.84% | 👍 Buy |
| YUM | $117.60 | $162.93 | Avoid | ❌ Avoid |
| YUMC | $44.88 | $57.95 | Above Fair Value | ⛔ Overvalued |
| YYAI | $119.03 | $1.15 | 10,250.43% | ✅ Strong Buy |
| Z | $32.34 | $54.97 | Above Fair Value | ⛔ Overvalued |
| ZBH | $128.37 | $89.91 | 42.78% | ✅ Strong Buy |
| ZBRA | $246.67 | $251.40 | Above Fair Value | ⚠️ See Analysis |
| ZD | $122.32 | $33.51 | 265.03% | ✅ Strong Buy |
| ZDGE | $4.63 | $3.09 | Insufficient EBITDA | ✅ Strong Buy |
| ZETA | $15.08 | $16.89 | Insufficient EBITDA | ⚠️ See Analysis |
| ZEUS | $21.95 | $51.14 | Avoid | ❌ Avoid |
| ZG | $31.79 | $54.50 | Above Fair Value | ⛔ Overvalued |
| ZGN | $4.55 | $10.39 | Above Fair Value | ⛔ Overvalued |
| ZIM | $35.72 | $20.68 | 72.73% | ✅ Strong Buy |
| ZION | $94.67 | $65.29 | 45.00% | ✅ Strong Buy |
| ZIP | $6.13 | $2.11 | Avoid | ❌ Avoid |
| ZM | $100.35 | $92.20 | 8.84% | 👍 Buy |
| ZS | $88.48 | $167.33 | Above Fair Value | ⛔ Overvalued |
| ZTS | $140.18 | $127.42 | 10.01% | 👍 Buy |
| ZUMZ | $12.67 | $24.91 | Above Fair Value | ⛔ Overvalued |
| ZVRA | $13.31 | $8.60 | Insufficient EBITDA | ✅ Strong Buy |
| ZWS | $25.01 | $52.78 | Above Fair Value | ⛔ Overvalued |
| ZYME | $4.64 | $22.72 | Insufficient EBITDA | ❌ Avoid |
